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 Abstract
In mammals, epigenetic modifications and trans-acting effectors coordinate gene 
expression during development and impose transcriptional memories that define 
specific cell lineages and cell-types. Methylation at CpG dinucleotides is an 
epigenetic mechanism through which transcriptional silencing is established and 
heritably maintained through development. Functionally, DNA methylation regulates 
key biological processes such as X-chromosome inactivation, transposon repression 
and genomic imprinting. However, the extent to which DNA methylation is the 
primary regulator of single-copy gene expression and the precise mechanism of 
methylation-dependent silencing remain undetermined. Here, I identify a novel set of 
germline-specific candidate genes putatively regulated by DNA methylation. 
Analysis of one candidate gene, Tex19, demonstrates that promoter CpG methylation 
is the primary and exclusive mechanism for regulating developmental silencing in 
somatic lineages. Genetic or pharmacological removal of CpG methylation triggers 
robust de-repression of Tex19 and loss of transcriptional memory. Moreover, Tex19 
critically relies on de novo methylation, mediated by Dnmt3b, to impose silencing in
differentiating ES cells and somatic cells in vivo from embryonic day (E)7.5. 
Reporter gene and ChIP analysis demonstrate that Tex19 is strongly activated by 
general transcription factors and is not marked by repressive histone modifications in 
somatic lineages, consistent with differential DNA methylation per se being the 
primary mechanism of regulating expression. Full transcriptional silencing of Tex19 
is critically dependent on the methyl-binding protein (MBP) Kaiso, which is only 
recruited to methylated Tex19 promoter. The reliance on DNA methylation and 
Kaiso for silencing in somatic cells establishes an epigenetic memory responsible for 
maintaining expression in germline and pluripotent cell types through successive 
developmental cycles. This thesis represents the first causal report of lineage-
specific promoter DNA methylation directing silencing of an in vivo gene through 
recruitment of an MBP. 
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Conrad H Waddington originally coined the term ‘Epigenetics’ in 1942 as a 
portmanteau of epigenesis (the development of an organism) and genetics (the study 
of hereditary and variation) (Waddington, 1942). To Waddington, epigenetics 
described a conceptual model of how genotypes might interact with the environment 
during development to generate a phenotype. Since then epigenetics has been a term 
of evolving definition. In 1987 Robin Holliday described epigenetics as “the study of 
changes in gene expression, which occur in organisms with differentiated cells, and 
the mitotic inheritance of given pattern of gene expression” (Holiday, 1987; Holiday, 
1994). Holiday’s definition extended Waddington’s ideas by acknowledging 
epigenetic processes are not just restricted to development and also defined the 
molecular basis as heritable regulation of gene expression. More recently however, 
Riggs and colleagues narrowed the definition of epigenetics to “the study of 
mitotically and/or meiotically heritable changes in gene function that cannot be 
explained by changes in DNA sequence” (Riggs et al., 1996). This definition makes 
it clear what epigenetics is not - inheritance of mutational DNA change, but leaves 
open the question of what mechanisms are at work. Because the extent to which 
many epigenetic processes, such as histone modifications, are truly heritable is 
uncertain (although it is apparent they are at least re-imposed) Riggs and colleague’s 
definition has been refined to its current incarnation. Thus, in the modern sense, 
epigenetics is the study of stable changes in gene expression potential that are not 
attributable to alterations in DNA (Bird, 2007). In the broadest sense, any additional 
information stably superimposed onto the DNA sequence can be considered 
‘epigenetic’.  
 
          1
Epigenetic phenomena explain several deviations away from normal Mendelian 
genetics including paramutation, position effect variegation (PEV) and transgene 
inactivation (Coe Jr, 1968; Karpen & Allshire, 1997; Chandler, 2007). These 
examples challenge the contemporary view that phenotype is dictated linearly by 
DNA and suggest that DNA sequence alone is insufficient to determine the observed 
phenotype. Perhaps the most striking role of epigenetics though, is in directing and 
maintaining the differentiation of a totipotent zygote to the myriad cell-types of a 
multicellular organism (Gurdon, 1992; reviewed by Hemberger et al., 2009). Here, 
the progressive restriction of potential that characterises development is guided by 
coordinated changes in gene expression. The correct spatial and temporal expression 
of these genes is achieved by epigenetic processes and trans-acting factors that 
impose stable transcriptional memories that define the lineage and developmental 
potential of each cell. Thus, cellular differentiation can be considered an epigenetic 
process, governed by changes in what Waddington described as the ‘epigenetic 
landscape’ (Fig 1.1) (Waddington, 1957). Epigenetics is in short, a collection of 
mechanisms that considerably extends the information potential of the genetic code 
through manipulation, but not alteration, of the genotype. To accomplish this, 
epigenetic processes influence chromatin structure and accessibility (Wolffe & 
Matzke, 1999). 





PGC Fibroblast Neuron T-cell
Fig 1.1. Epigenetic restriction of developmental potential - Waddington’s canal.  An 
adaptation of C. H. Waddington's epigenetic landscape, showing cell populations with different 
developmental potentials. Cellular development is illustrated as marbles rolling down a 
landscape (epigenetic restriction) into one of several potential valleys (cell fates). Colored 
marbles correspond to various differentiation states. Black, totipotent; Navy, pluripotent; Red, 
multipotent; Green, unipotent. PGCs (shown in black) represent a unique specialised cell type, 
that upon fertilisation, can acquire totipotent epigenetic and developmental potential. 
Differentiated cells can also be experimentally reprogrammed to pluripotent iPS cells by 
defined factors (Takahashi & Yamanaka, 2006). Figure modified from Waddington (1957).
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1.2 Chromatin Structure  
 
Eukaryotic DNA is packaged with histone and non-histone proteins into chromatin. 
This has two important consequences. Firstly, it allows the packaging and 
compaction of ~1.8m of DNA into a nucleus typically 5-20m in diameter. 
Secondly, it promotes the regulation of essential cellular events including 
transcription, lineage specification, DNA replication and cell division.  The 
fundamental unit of chromatin is the nucleosome, which is composed of an octamer 
of the four core histones (H2A, H2B, H3 and H4) around which 147bp of DNA is 
super-helically coiled 1.65 times (Corner & Thomas, 1974; Allan et al., 1980; Luger 
et al., 1997). Additionally linker histones, which do not form part of the core 
nucleosome, bind to the structure through their interaction with both DNA and core 
histone H2A (Boulikas et al., 1980). Each nucleosome is coupled via 10-70bp of 
linker DNA producing an ~11nm chromatin fibre, the so-called ‘beads on a string’ 
arrangement (Olins & Olins, 1974). This structure can further compact to a 30nm 
chromatin fibre, which is the functional unit of chromatin. Despite its importance, 
the structure of the 30nm fibre remains undetermined, with evidence to support both 
the bent linker DNA ‘solenoid’ and straight linker DNA ‘zigzag’ models (Finch & 
Klug, 1976; Woodcock et al., 1984; Robinson & Rhodes, 2006). Ultimately 
chromatin is able to resolve to highly condensed mitotic chromosomes but the 
mechanistic basis of this ‘higher order’ compaction is unclear (Khorasanizadeh, 
2004).  
 
Grossly, there are two types of chromatin environment – transcriptionally silent 
heterochromatin and active or at least permissive, euchromatin, each of which is 
associated with characteristic epigenetic modifications. Heterochromatin can be 
further sub-divided to constitutive and facultative forms (Brown, 1966). Constitutive 
heterochromatin (c-Het) is invariant between cells and during development and 
mostly contains repetitive centromeric, telomeric and satellite sequences. When 
stained with 4,6-diamino-phenylindole (DAPI) c-Het is seen as dark foci 
(particularly in mice) due to the condensed structure of the chromatin and because 
DAPI preferentially binds the AT-rich sequences that compose the c-Het satellite 
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repeats. Epigenetically, c-Het is marked by hypermethylated CpG dinucleotides, 
hypoacetylated histones, and tri-methylated histone 3 lysine 9 (H3K9me3) which 
recruits heterochromatin protein 1 (HP1) (Lachner et al., 2001; Kouzarides, 2007). 
The favoured model predicts these modifications interact to form a positive feedback 
loop that stably maintains chromatin condensation. Here, HP1 bound to H3K9me3 
via its chromodomain, acts as docking platform to recruit other repressive factors to 
heterochromatin (Li et al., 2002a; Smallwood et al., 2007; Bergman & Cedar, 2009). 
Unlike c-Het, facultative heterochromatin (f-Het) represents sub-regions of the 
genome where the chromatin compaction state changes throughout development and 
can therefore be considered dynamically silenced. In contrast, euchromatin is an 
‘open’ structure that is either permissive or actively transcribed and marked by 
hyperacetylation and di- and tri- methylation of histone 3 lysine 4 (H3K4me2/3).  
Mechanistically, the decondensed nucelosome arrays in euchromatin allow 
regulatory proteins access to bind DNA and function.  
 
Within the broad domains of euchromatin and heterochromatin are complex 
landscapes of epigenetically modified histones and DNA including punctate sites at 
regulatory elements, insulators and transcriptional start sites (Barski et al., 2007). 
These localised epigenetic modifications guide the gene-specific expression patterns 
required for a cell to differentiate and remain stably lineage-committed. The sum 
total of all epigenetic information in each cell is termed the ‘epigenome’ (Goldberg 
et al., 2007). Because the epigenome is highly variable between cell types and over 
time there must be at least as many epigenomes, and hence chromatin structures, as 
there are cell types at any given time-point. The importance of the epigenome to 
complex mammalian development is epitomised by the so-called C-value enigma 
(Gregory, 2001; Gregory, 2002). This points out that while the roundworm C.elegans 
is a considerably simpler organism than humans and correspondingly its genome is 
approximately 30 times smaller, both organisms contain ~20,000 genes.  Therefore, 
enhanced organismal complexity and genome size are not accompanied by an 
increase in gene number. This presents the problem that there are a vastly amplified 
number of cryptic binding sequences for transcription factors not associated with 
genes, which could lead to deregulated and ectopic gene expression. To address this, 
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it is suggested that epigenetic systems have co-evolved with increasing genome size 
to organise chromatin into permissive gene-containing and inaccessible closed 
portions (Wray et al., 2003). For example, the invertebrate to vertebrate transition 
was paralleled by the emergence of global DNA methylation to stably silence the 
transcriptional noise that was an inescapable by-product of enhanced genome 
complexity (Bird & Tweedie, 1995). This process has led to the intricate epigenetic 
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1.3 Epigenetic Mechanisms in Mammals
 
Many epigenetic mechanisms contribute to establishing and maintaining the 
transcriptional profile of a mammalian cell. Of these, methylation of CpG 
dinucleotides and modification of histones are the best characterised (Jaenisch & 
Bird, 2003). However, nucleosome variants, sub-nuclear localisation, replication 
timing and regulatory non-coding RNAs also contribute to the epigenetic landscape 
of a cell (Mahy et al., 2002; Donaldson, 2005; Fraser & Bickmore, 2007). Broadly, 
these epigenetic mechanisms regulate transcription by directly influencing chromatin 
structure or being interpreted by proteins that recognize a precise epigenetic signal 
and affect the appropriate biological response (Klose & Bird, 2006). These systems 
may operate independently or, more commonly, functionally interact to form 
feedback loops that perpetuate gene expression states. Within epigenetic feedback 
loops different mechanisms may have subtly different roles. For example, one 
epigenetic modification may initiate a gene expression state while another recruited 
by the initiating mark, stably maintains that state. Because of this combinatorial 
regulation by epigenetic processes, each mechanism discussed here cannot always be 
considered in isolation. 
1.3.1 Histone Modifications
 
In 1964, Allfrey and colleagues demonstrated that the core histone proteins are 
subject to multiple post-translational modifications and speculated this might have a 
role in gene activity (Allfrey et al., 1964). Since then over 100 modifications of 
defined residues have been characterised, largely at the N-terminal tails that protrude 
from nucleosomes, but also in the core globular domains (Fig 1.2) (Bernstein et al., 
2007; Mersefelder & Parthun, 2006). The major effect of histone modifications is to 
regulate transcription by creating a docking site for non-histone effecter proteins to 
modify chromatin structure. However in some cases, strongly charged modifications 
can alter chromatin structure directly, through disrupting the DNA-histone 
interaction (Lachner et al., 2001; McGhee & Felsenfeld, 1980; Turner, 2000). A 
diverse range of histone modifications have been reported including; acetylation, 






































































Fig 1.2. Epigenetic modifications of core histones. Defined residues in each histone 
protein can be modified by A: acetylation (red), M: methylation (green) and P: phosphorylation 
(white). Different epigenetic and transcriptional consequences have been observed 
depending on the specific residue modified and the modification itself. The amino acid 
residues of each of the four core histones are shown using standard single letter nomeclature. 
K: lysine, R: arginine , S: serine.  The location of each residue within the primary sequence of 
the histone is shown by the italicised number. Only a subset of the reported modifications is 
shown.
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methylation, phosphorylation, ubiquitination, sumoylation, formylation, deimination, 
ADP ribosylation, and proline isomerization (Kouzarides, 2007). Each of these 
modifications is generally associated with a particular transcriptional outcome 
depending on the chemical modification itself, the histone residue modified and, the 
site within the transcriptional unit. The effect on local transcription of some of the 




1.3.1.1 The histone code
 
The great potential for different combinations of modifications at any particular 
locus can introduce a large degree of variation into the chromatin template. This 
Histone 
Modification/Variant Typical Location Transcriptional Effect Reference
Ac H3/H4 TSS ++ Roh et al., 2006 
H3K4me1 Bimodal over TSS + Barski et al., 2007 
H3K4me2 Bimodal over TSS ++ Kim et al., 2005 
H3K4me3 TSS ++ Kim et al., 2005 
H3K9me1 TSS + Barski et al., 2007 
H3K9me2 Promoter - Bannister et al., 2001 
H3K9me3 Promoter - Mikkelsen et al., 2007 
H3K27me1 Promoter + Barski et al., 2007 
H3K27me2 Promoter - Boyer et al., 2006 
H3K27me3 Promoter - Boyer et al., 2006 
H3K36me1 Gene body + Barski et al., 2007 
H3K36me3 Gene body ++ Joshi & Struhl, 2005 
H3K79me1 TSS -/+ Barski et al., 2007 
H3K79me2 TSS -/+ Barski et al., 2007 
H3K79me3 TSS + Vakoc et al., 2006 
H4K20me1 Gene body ++ Talasz et al., 2005 
H4K20me3 TSS - Schotta et al., 2004 
H3R2me1 Promoter -/+ Barski et al., 2007 
H3R2me2 (as) Promoter -/+ Barski et al., 2007 
H4R3me1 TSS -/+ Huang et al., 2005 
H2BUb1 Gene body + Zhu et al., 2005 
H2AUB1 TSS - Wang et al., 2006 
H2A.Z Bimodal over TSS ++ Bruce et al., 2005 
Macro-H2A TSS -  
H3.3 TSS ++ Chow et al., 2005 
Table 1.1. Effect of histone modifications on transcription. Key, ++ is strongly positively 
correlated with transcription, + is positively correlated with transcription, -/+ shows no 
observable correlation and – is negatively correlated with transcription. TSS: transcriptional 
start site. 
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forms the basis of the ‘histone code’, which postulates that multiple modifications 
provide a cumulative or sequential code that dictates the local chromatin landscape 
(Strahl & Allis, 2000). Ultimately, this predicts that we will be able to “read” the 
functional status of any region through the combination of histone modifications 
present. In an alternative model, Bernstein and Schreiber argue that multiple 
modifications can act as a signalling network to confer ‘bistability, robustness and 
adaptability” (Schreiber & Bernstein, 2002).  Recently, several genome-wide studies 
have examined the distribution of histone modifications across the genome in an 
effort to ‘crack’ the histone code. These have used the availability of high-
throughput sequencing technology to give nucleotide level resolution of histone 
modifications in the context of transcriptional status and developmental stage 
(Birney at al., 2007; Barski et al., 2007; Mikkelsen et al., 2007). 
1.3.1.2 Histone Methylation
 
The most prevalent modification of core histones is methylation, which can occur in 
the mono-, di- or tri- methylated forms at lysine residues or symmetrical and 
asymmetrical forms at arginines (Bannister et al., 2002; Zhang & Reinberg, 2002). 
These modifications are dynamically deposited and removed by groups of enzymes 
collectively referred to as histone methyltransferases (HMTs) and histone 
demethylases (HDMs), respectively. Unlike acetylation and phosphorylation, it is 
thought that histone methylation does not directly alter chromatin structure but 
recruits downstream protein complexes, which recognise methylated residues 
through chromo-domains (Kouzarides, 2007).   
 
Early evidence suggested methylation of histone 3 lysine 4 (H3K4) was associated 
with the transcriptionally active macronucleus of Tetrahymena (Strahl et al., 1999). 
Subsequent mammalian genome wide and localised studies have confirmed that 
H3K4 mono-, di- and tri- methylations all associate with active promoters albeit each 
with different distributions around the transcriptional start sites (TSS) (Table 1.1) 
(Bernstein et al., 2002; Barski et al., 2007; Heintzman et al., 2007). Interestingly, 
work in the erythroid lineage showed that H3K4me2 is always present at promoters 
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marked by H3K4me3 but that the reciprocal is not true, suggesting H3K4me2 is 
required for H3K4me3 deposition (Orford et al., 2008).  The derivatives of H3K4 
can be used to discriminate different types of regulatory element, with mono- and di- 
methylated H3K4 marking dynamic enhancers and di- and tri- H3K4 present at 
active promoters (Heintzmann et al., 2007). Recently, it was shown that H3K4me3 at 
active promoters is recognised by the TAF3 component of TFIID, directly linking 
this histone modification to the transcriptional machinery, in addition to its role in 
recruiting co-activators (Vermeulen et al., 2007).  
 
Methylation of H3 Lysine 9 (H3K9) is generally regarded as a repressive 
modification. H3K9me3 is highly enriched at heterochromatic regions, where it 
creates a binding site for heterochromatin protein 	
	
appears to be the default state for inactive portions of the genome (Rea et al., 2000; 
Lachner et al., 2001; Bernstein et al., 2007). In contrast, H3K9me2 appears to 
dynamically mark repressed regions in a tissue specific manner. Feldman (2006) and 
colleagues have reported that G9a catalysed H3K9me2 is the initiating mark that 
creates a local heterochromatin structure at the proximal promoter of the 
pluripotency factor Oct3/4 during ES cell differentiation. Moreover, highly 
conserved ‘blocks’ (up to 5Mb) of H3K9me2 modified chromatin accumulate in 
differentiated cells and are correlated with repression of local genes (Wen et al., 
2009).  Surprisingly, H3K9me1 has been found to be more closely associated with 
active transcriptional start sites (Barski et al., 2007). 
 
Histone H3 lysine 27 (H3K27) methylation was first described as a repressive 
modification catalysed by the PRC2 complex (Cao et al., 2002). Subsequent genome-
wide studies have confirmed H3K27me3 associates with repressed genes, 
particularly key developmental loci, including the Hox clusters (Boyer et al., 2006; 
Lee et al., 2006). Intriguingly, Bernstein and colleagues (2006) noted that in ES cells 
many repressed regions marked by H3K27me3 were also modified with H3K4me3, a 
mark normally associated with gene activity. Sequential ChIP analysis confirmed 
that the same allele carried both the repressive and activating modification, leading 
to the term ‘bivalent domain’. Following differentiation, the authors found that 
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bivalency generally resolved to either the H3K4me3 or H3K27me3 states, leading to 
either activation or repression of the locus (Bernstein et al., 2006). However, more 
recent studies have also identified bivalent domains in progenitor and differentiated 
cells (Mohn et al., 2008; Barski et al., 2007; Mikkelsen et al., 2007). Because many 
bivalently marked loci are key developmental genes, it is postulated that the bivalent 
state keeps genes repressed but ‘poised’ or ‘primed’ to rapidly respond to 
downstream developmental cues, without the requirement for epigenetic 
reprogramming at the loci. 
1.3.1.3 Histone Acetylation
 
Acetylation of histones was one of the first modifications to be discovered and is 
now known to be required for nucleosome assembly and to promote transcriptional 
activity (Allfrey, 1964; Mello & Almouzni, 2001; Roh et al., 2005). The relationship 
between histone acetylation at promoters and gene activity was initially described 
through chromatin immunoprecipitation (ChIP) studies (Hebbes et al., 1988). This 
association has been supported by genome-wide ChIP analysis using microarrays 
(ChIP on chip) and mass sequencing (ChIP-seq) (Roh et al., 2005; Mikkelsen et al., 
2007; Heintzman et al., 2007). Mechanistically, acetylated histones neutralize the 
charge interaction between positive histone tails and the negative DNA backbone, 
which decondenses chromatin leading to a permissive state for active transcription 
(McGhee & Felsenfeld, 1980). In addition, proteins containing a bromo-domain can 
recognise and bind to acetylated histones and mediate downstream effects (Dhalluin 
et al., 1999). In vivo, the acetylation state of histones is rapidly maintained in a 
dynamic equilibrium by enzymes that catalyse acetylation, histone acetyltranferases 
(HATs), and remove the modification, histone deactylases (HDACs). The dynamic 
interaction of these two processes is essential, as inhibition of HDACs results in 
severely disrupted development of amphibian and mammalian embryos and mis-
expression of many genes in mammalian cells (Almouzni et al., 1994; Lagger et al., 
2002; Lande-Diner et al., 2007).  
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There are many other reported modifications of histones in vivo, including 
methylation of lysines 36 and 79 of histone H3, lysine 20 of H4 in addition to 
methylation of arginine residues (Hublitz et al., 2009). Other modifications such as 
ubiquitination of H2A and H2B, sumoylation of all four core histones and proline 
isomerization have also been observed (Wang et al., 2005; Nathan et al., 2006; 
Nelson et al., 2006). However while genome-wide studies are developing an 
understanding of the function of these marks, not a great deal is known about their 
ability to modulate transcription and chromatin structure or indeed other processes 
such as recombination, repair and replication (Kouzarides, 2007).   
1.3.1.4 Crosstalk
The presence or absence of a particular histone mark does not always lead to a 
specific transcriptional outcome. This is at least partly because many histone 
modifications ‘crosstalk’ to establish expression states. For example, H3K9me3 
recruits HP1 to promote a repressive chromatin structure. However, modification of 
the adjacent serine residue (H3S10) by phosphorylation prevents HP1 interacting 
with H3K9me3, leading to a reduction in heterochromatin bound HP1 despite the 
presence of its binding platform, H3K9me3. Functionally, transient phosphorylation 
of H3S10 may occur during mitosis to allow replication factors access to 
heterochromatin while maintaining a memory for which regions of the genome 
should be silenced. Consistent with this and as a further example of histone crosstalk, 
in S. cerevisiae phosphorylation of histone H3S10 promotes acetylation of H3 lysine 
14 establishing an ‘open’ chromatin template (Walter et al., 2008). Thus in keeping 
with the histone code model, each histone modification and/or variant should not 
always be thought of as an independent regulatory mark, but as part of a complex 
interconnected mechanism. 
 
1.3.2 Core Histone Variants
With the exception of Histone H4, non-allelic variants of all the core histones have 
been identified, which have roles in gene regulation, DNA repair and chromosome 
segregation (Malik & Henikoff, 2003; Pursala & Bhargava, 2005). The important 
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cellular role of histone variants is highlighted by the fact that some variants show a 
greater debris of cross-species conservation than the canonical histones.  
1.3.2.1 Variants of H2A
Of the variants of H2A, Macro-H2A is incorporated into heterochromatin and key 
developmental genes in ES cells where it may promote transcriptional repression 
while H2ABdb has a mutually exclusive pattern indicating it may have a role in 
active regions (Bushbeck et al., 2009; Costanzi & Pehrson, 1998; Chadwick & 
Willard, 2001). H2A.X has a specialised role in localising to sites of double stranded 
DNA breaks and targeting them for repair (Malik & Henikoff, 2003). The widely 
studied H2A.Z seems to have the biggest role in gene regulation and is essential for 
both Drosophila and mammals (Clarkson et al., 1999; Faast et al., 2001). In yeast 
HA.Z is associated with active gene promoters and chromatin domain boundaries, 
with similar patterns observed in metazoans (Meneghini et al., 2003; Farris et al., 
2005). Consistent with a role in transcriptional activation and separation of 
functional chromatin domains, H2A.Z was found to be mutually exclusive of DNA 
methylation in Arabidopsis (Zilberman et al., 2008). The incorporation of H2A.Z at 
promoters is thought to modify the nucleosome surface structure, which aids in the 
recruitment of transcription factors and co-activators (Raisner & Madhani, 2006).  
1.3.2.2 Variants of H3
The H3 variant H3.3 is a replication-independent histone that, like H2A.Z, 
accumulates at actively transcribed promoters and has been observed to incorporate 
into a transgene array in vivo as it undergoes activation (Chow et al., 2005; Janicki et 
al., 2004). Incorporation of H3.3 is thought to destabilise the nucleosome, allowing 
access for transcription factors. Interestingly, the combination of H3.3 and H2A.Z 
creates the least stable nucleosome, suggesting these variants could functionally 
interact (Jin and Felsenfeld, 2007). In Xenopus, Histone H3.3 has been suggested to 
promote epigenetic memory by maintaining an active chromatin structure following 
replication (Ng & Gurdon, 2008). The replication-dependent histone H3 variants, 
H3.1 and H3.2 differ by one amino acid and are commonly considered to be 
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functionally equivalent, although a recent report has suggested H3.2 may be 
associated with transcriptionally repressed chromatin (Hake et al., 2006). CENP-A is 
the final H3 variant and has a highly specialised and essential role in chromosomal 
kinetochore formation (Palmer et al., 1991). 
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1.4 DNA Methylation 
 
As early as 1975 DNA methylation was proposed to be an epigenetic system 
responsible for maintenance of a gene expression state through mitotic divisions 
(Holliday & Pugh, 1975; Riggs, 1975). CpG methylation has since been recognised 
as an important contributor to the stability of gene expression patterns through 
promoting the formation of transcriptionally inactive chromatin in diverse organisms 
(Wolffe & Matzke, 1999). Importantly, DNA methylation satisfies Riggs (1996) 
stringent definition of an epigenetic system in that it is truly mitotically and 
meiotically heritable. In prokaryotes, both adenine and cytosine residues are found to 
be methylated as part of the host restriction system that selectively cleaves 
unmethylated foreign DNA. However, in multicellular eukaryotes, methylation of 
DNA only occurs at cytosine residues that reside predominately, but not exclusively, 
within the genomic context of a CpG dinucleotide (Hotchkiss, 1948; Wyatt, 1950, 
Ramsahoye et al., 2000; Bestor, 2000). Interestingly, a novel modification of DNA, 
5’hydroxymethylation has recently been reported in mouse neurons and ES cells, but 
the functional significance and distribution of this modification is yet to be 
determined (Kriaucionis & Heintz, 2009; Tahiliani et al., 2009). Likewise, the 
precise role of non-CpG methylation, which can represent up to 25% of total 
cytosine methylation in ES cells, is yet to be established (Ramsahoye et al., 2000, 
Lister et al., 2009). 
 
CpG methylation plays an essential role in vertebrate development and consequently 
high levels of DNA methylation are found in vertebrate genomes (Li et al., 1992; 
Suzuki & Bird, 2008). In contrast, many invertebrates including D.melanogaster and 
C.elegans have low or (almost) undetectable genomic DNA methylation levels and 
the yeasts S.cerevisiae and S.Pombe also lack DNA methylation (Tweedie et al., 
1997; Proffitt et al., 1984; Antequera et al., 1984). This appears to suggest that DNA 
methylation per se is not an evolutionarily requisite for development. However, 
increasingly, genomic methylation is being found to play important roles in 
organisms where it had previously been overlooked. For example, cytosine 
methylation has recently been shown to regulate retrotransposon silencing and 
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telomere integrity in Drosophila (Phalke et al., 2009). Moreover many invertebrates 
do exhibit significant global levels of DNA methylation (Field et al., 2004). In the 
honeybee A.Melifera, genomic methylation plays a crucial role in social structure 
organisation. Here, under normal conditions larvae nurtured with royal jelly develop 
into queens whereas unnurtured larvae of the same clonal origin mature into worker 
bees. Inhibition of de novo methylation induces larvae to develop into queens 
irrespective of exposure to royal jelly, suggesting DNA methylation epigenetically 
stabilises key developmental specifications (worker or queen) in honeybees 
(Kucharski et al., 2008; Barchuk et al., 2007). DNA methylation is also essential for 
normal development in non-mammalian vertebrates such as Xenopus laevis and 
zebrafish Danio rerio (Stancheva & Meehan, 2000; Anderson et al., 2009). However, 
as the focus of this thesis is primarily on mammalian systems, the discussion herein 
concentrates on DNA methylation in the context of mammals. 
 
In mammals, it is proposed that the fundamental role of DNA methylation is to 
repress transcription and heritably maintain a silenced chromatin state (Bird, 1984). 
This function has been directly demonstrated in several distinct biological processes 
including X-chromosome inactivation, imprinting, cell differentiation, repression of 
transposable elements and stable reinforcement of epigenetically silenced genes 
(Heard et al., 1997; Li et al., 1993; Jackson et al., 2004; Walsh et al., 1998; Feng et 
al., 2006; Bird & Wolffe, 1999). Because CpG methylation is involved in many 
essential cellular functions, aberrant patterns of methylation are implicated in diverse 
pathologies such as carcinogenesis, disease susceptibility and in aging (Bird, 2002; 
Egger et al., 2004). Furthermore, genetic studies with mice lacking DNA 
methyltransferases (Dnmts) have demonstrated DNA methylation is essential for 
embryonic development and for survival of differentiated cells (Li et al., 1992; 
Okano et al., 1999, Jackson-Grusby et al., 2001; Damelin & Bestor, 2007). Despite 
the biological importance of DNA methylation, many questions regarding its 
function remain, including; how is it targeted or excluded from specific regions of 
the genome, what is the mechanism through which transcriptional repression is 
achieved, and what influences do the complex interactions with other epigenetic 
systems have. 
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1.4.2 Distribution of DNA methylation across the mammalian genome
 
1.4.2.1 CpG islands
In differentiated cells, approximately 4% of cytosines are methylated which 
corresponds to ~80% of all potential CpGs (Gruenbaum, 1981). However, the 
distribution of DNA methylation across the mammalian genome is not uniform, but 
bimodal. Almost all CpGs are methylated except those that reside within discrete 
fractions of the genome termed CpG islands (CGIs), which remain largely 
unmethylated. CGIs thus represent short regions of DNA enriched in CpGs but 
devoid of methylation, at least in the germline, which ensures they do not undergo 
the mutational loss of CpGs (through deamination) that afflicts the rest of the 
genome (Bird, 1986, Suzuki & Bird, 2008). In mammals, CGIs have an average 
length of ~1,000bp, are GC-rich compared with bulk genomic DNA and are typically 
associated with gene promoters or regulatory elements. Indeed, approximately ~60% 
of mouse genes including most housekeeping genes have CGI promoters and, 
consistent with this association, CGIs are generally characterised by a 
transcriptionally permissive chromatin state (Tazi & Bird, 1990; Zhu et al., 2008; 
Weber et al., 2007; Guenther et al., 2007). 
 
Identification of CGIs is generally achieved computationally using a criteria of 
observed to expected ratio (Obs/Exp) of 0.6 and >55% GC content over a 500bp 
window (Takai & Jones, 2002). The Obs/Exp ratio indicates the fraction of CpGs 
present compared to what would be expected if this dinucleotide were randomly 
distributed throughout the genome. However, because CpG dinucleotides have been 
evolutionarily depleted from mammalian genomes, at most loci this ratio is generally 
very low (0.1-0.2). In some studies the length parameter has been reduced to 200bp 
to enrich the number of CGIs, but this can result in up to a 10-fold excess of false 
positives, largely Alu elements. Recently, a method of CGI detection based on 
sequencing human blood fragments has been developed that takes into account 
clustering but uniquely, also requires the absence of methylated CpGs (Illingworth et 
al., 2008).  Mechanistically, it is hypothesised that CGIs remain unmethylated due to 
their interactions with active transcription factors or through characteristic histone 
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modifications such as H3K4me2, which may preclude the methylation machinery 
from binding to CGIs directly or indirectly (Weber et al., 2007; Meissner et al., 
2008). In support, the methyltransferase cofactor Dnmt3L only recognizes CpGs 
associated with unmodified H3K4 and recruits and/or stimulates Dnmt3a mediated 
de novo methylation at these sites (Ooi et al., 2007; Jia et al., 2007). As all 
hypomethylated CpG-rich promoters are constitutively H3K4 methylated, regardless 
of activity, this modification may account for the hypomethylated state of CGIs 
(Barrera et al., 2008; Mohn et al., 2008; Guenther et al., 2007). Alternatively, 
Antequera & Bird (1999) proposed that CGIs may be replication origins and their 
unmethylated status represents a ‘footprint’ as a consequence of this function.  
However, the precise mechanism that excludes most CGIs from genomic 
methylation remains an open question (Illingworth & Bird, 2009). 
 
1.4.2.2 Promoter methylation
Several recent studies have used massive parallel bisulphate sequencing or 
methylated DNA ImmunoPrecipitation (MeDIP) to examine the DNA methylation 
landscape at promoters in the context of gene activity. A study in humans sub-
divided promoters to distinguish strong CpG islands (HCP), weak CpG islands (ICP) 
and sequences with no local enrichment of CpGs (LCP) (Fig 1.3a). According to 
these classifications, most autosomal HCPs (97%) were hypomethylated, regardless 
of transcriptional status whereas the majority of LCPs were methylated, but the low 
density of CpGs was not sufficient for gene repression (Fig 1.3) (Weber et al., 2007). 
On the rare occasions when HCPs were methylated, they were silenced, indicating 
that repression by DNA methylation requires a high local density of 5mC. 
Interestingly, ICPs were distinct in that although they were generally unmethylated, 
they were preferential targets for de novo methylation in somatic cells compared to 
the germline and this was sufficient to silence transcription. This indicates that weak 
CpG islands are more prone to methylation as development proceeds, and potentially 
suggests a role for de novo methylation in repressing lineage-specific genes 
associated with ICPs. (Weber et al., 2007). In support, a second study in mice also 
observed that weak CpG islands (ICPs) were associated with de novo methylation 
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Fig 1. 3. Distribution of CpG dinucleotides in mammalian genomes. a.) Examples of the 
promoter classifications: low CpG-density (LCP) (Olfr275), intermediate CpG-density (ICP) 
(PiwiL2) and high CpG-density (HCP) (HoxA1). The horizontal line represents the region 
-2000bp to +600bp of the transcriptional start siite (TSS) which is represented by an arrow. 
Each vertical line represents a single CpG dinucleotide. b.) A histogram of gene promoter 
CpG ratio (observed/expected) in the mouse genome according to tissue of expression. Gene 
expression data for 48 mouse tissues was retrieved from the BioGPS database and CpG 
content was determined for all promoters in the dataset (n = 13, 729). Total genes exhibit a 
bimodal distribution. However, ubiquitously expressed housekeeping genes (expression 
level>150 in >30 tissues) are mostly CpG-rich indicating these genes are not regulated by 
promoter CpG methylation. Tissue-specific genes (expression level>150 in <10tissues ) show 
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during differentiation and following extended proliferation in vitro (Meissner et al., 
2008). These observations suggest that DNA methylation is not a general mechanism 
for dynamically regulating the expression of genes associated with HCPs and LCPs 
either tissue-specifically or developmentally. In contrast, genes associated with ICPs, 
particularly germline specific genes, frequently show differential methylation 
patterns that strongly correlate with gene activity, indicating weak CpG island 
promoters are preferential targets for regulation by DNA methylation.  Whether the 
susceptibility of ICPs to dynamic DNA methylation reflects shared sequence 
features, the characteristics of the larger chromatin domain, or an intrinsic property is 
a question of great interest. Recently, an intriguing study has suggested that DNA 
methylation may be the only epigenetic mark at 30% of silenced genes in mouse ES 
cells. Interestingly, the pool of genes where DNA methylation was the only mark are 
greatly enriched in ICPs (Fouse et al., 2008). This indicates that DNA methylation 
could function exclusively of other epigenetic systems at some promoters, 
particularly weak CpG islands, while complementing other epigenetic regulatory 
mechanisms at others.  
 
1.4.2.3 Global Methylation patterns
 
Several large-scale studies have recently investigated the genomic DNA methylation 
pattern outside of gene promoters. A mass-sequencing study of 1.9 million CpG sites 
on human chromosomes 6, 20 and 22 in twelve tissues confirmed the bimodal nature 
of the genomic landscape, with the majority of genomic regions being heavily 
methylated and CpG-rich regulatory sequences being hypomethylated (Eckhardt et 
al., 2006). Interestingly, this report and others also noted that consistent with other 
non-CGI regions of the genome, gene-bodies were hypermethylated, even when 
transcriptionally active (Rabinowicz et al., 2003; Rakyan et al., 2004). It is 
hypothesised that this gene-body methylation may have a role in preventing aberrant 
initiation and transcriptional interference outside of the canonical TSS. Indeed global 
DNA methylation per se may function to inhibit cryptic transcriptional initiation 
(Suzuki & Bird, 2008; Weber & Schubeler, 2007). Eckhardt and colleagues also 
noted many tissue-specific differentially methylated regions (T-DMR) that were 
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correlated with conserved non-coding sequences but very few genomic regions that 
were differentially methylated according to age or gender. In contrast to this later 
result a recent study reported that dizygotic twins had significantly discordant DNA 
methylation patterns compared with monozygotic twins (Kaminsky et al., 2009). 
Other global analyses have suggested the mammalian genome contains many T-
DMRs. A study using restriction landmark genomic sequencing (RLGS) with NotI, 
identified 247 T-DMRs that varied between embryonic stem (ES), embryonic germ 
(EG) and trophoblast stem (TS) cells (Shiota et al., 2002). However, the functional 
significance of most T-DMRs has yet to be tested and, notably they rarely occur in 
promoter CGIs where the CpG density is high enough to influence transcription.  
 
1.4.3 Enzymes that deposit DNA Methylation in mammals
 
The enzymes responsible for targeting and maintaining global DNA methylation are 
known as DNA methyltransferases (Dnmt). In mammals, they are constructed from a 
complex set of functional modules, broadly divided into the N-terminal ‘regulatory’ 
domain and the C-terminal ‘catalytic’ domain. Dnmt2, which lacks a regulatory 
domain, is the exception to this rule. The regulatory domain functions largely as an 
interaction module, allowing multiple protein-protein interactions, DNA binding and 
nuclear localisation (Chen & Li, 2006). Conversely, the C-terminal domain 
comprises ten motifs responsible for the enzyme’s catalytic activity. Six of these 
motifs are conserved in nearly all cytosine methyltransferases across the evolutionary 
spectrum from bacteria to mammals (Fig 1.4) (Posfai et al., 1989). Indeed, DNA 
methyltransferases in general are highly conserved among eukaryotes with 
methylated genomes.
1.4.3.1 de novo vs maintenance methyltransferases  
 
At least three methyltransferase enzymes, Dnmt1, Dnmt3a and Dnmt3b coordinate 
the establishment and maintenance of DNA methylation patterns in mammals (Li, 
2002a; Goll & Bestor, 2005). These enzymes have conventionally been organised 
into two general classes according to their preferred substrate. The ‘de novo' 
methyltransferases, Dnmt3a and Dnmt3b, target cytosine methylation to previously 
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unmethylated CpG dinucleotides, whereas the ‘maintenance’ enzyme, Dnmt1, 
preserves existing methylated sites. (Okano et al., 1999; Bestor et al., 1988; Siedlecki 
& Zielenkiewicz, 2006). Despite these classifications, the distinction between de 
novo and maintenance methyltransferases is not clear-cut. For example, the effect of 
disruption of Dnmt3a and Dnmt3b in ES cells suggests that these enzymes have an 
essential role in maintaining global DNA methylation. Here, an extended absence 
(70 passages) of Dnmt3a and Dnmt3b renders the genome severely hypomethylated, 
with only 0.6% of CpGs retaining methylation as opposed to ~70% in wild-type ES 
cells (Jackson et al., 2004; Chen et al., 2003). Moreover in vitro, the ‘maintenance’ 
methyltransferase Dnmt1 has greater de novo methylation activity on unmethylated 
substrates than Dnmt3a and Dnmt3b, and has recently been implicated in de novo 
methylation of CpG islands in vivo (Jair et al., 2006; Bestor et al., 1988; Esteve et al., 
2005a). Indeed, Dnmt1 can interact with Dnmt3a and Dnmt3b in a co-operative 
complex in vivo, blurring the distinction between de novo and maintenance 
methylation activity (Kim et al., 2002). Despite this, the consensus remains that the 
primary role for Dnmt1 is in maintaining methylation patterns, whereas that of 
Dnmt3a and Dnmt3b is in de novo synthesis of CpG methylation. 
1.4.3.2  Dnmt1 
 
The first eukaryotic cytosine methyltransferase to be purified and cloned was Dnmt1 
(Bestor et al., 1988). A 5-30 fold preference for hemi-methylated CpGs over 
unmethylated substrates led to its characterisation as the maintenance 
methyltransferase, whereby it duplicates pre-existing patterns of methylation during 
replication. This classification was additionally based on Dnmt1’s interaction with 
replication foci during S-phase, which promotes efficient methylation of newly 
synthesised strands but is not strictly required (Chuang et al., 1997; Jeltsch, 2006; 
Schermelleh et al., 2007). By preserving patterns of methylation at each replication 
cycle, Dnmt1 provides heritability to genomic methylation allowing long-term 
potentiation of epigenetic states (Yoder et al., 1997).  
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Dnmt1 is essential for normal vertebrate development - Dnmt1 deficient mice die 
around embryonic day (E)8.5, at the onset of gastrulation (Table 1.2) (Li et al., 
1992). As such, the biological role of Dnmt1 has been investigated largely through 
genetic studies in murine embryonic stem (ES) cells and embryonic fibroblasts 
(MEFs).  Disruption of Dnmt1 by homologous recombination generates several 
novel phenotypes (Table 1.2). The most striking consequence of Dnmt1 deletion is a 
95% reduction in genomic methylation levels (Lei et al., 1996). Other reported 
effects include a 10-fold increase in the mutation rates of exogenous marker genes in 
ES cells and bi-allelic expression of several, but not all, imprinted genes (Chen et al., 
1998; Li et al., 1993). For example, H19 and Kcnq1ot1 are expressed from both 
alleles whereas Igf2 and Kcnq1 are expressed from neither (Goll & Bestor, 2005). 
Partial inactivation of both X-chromosomes has been observed in mutant embryos 
due to the aberrant cis-activation of Xist (Panning and Jaenisch., 1996). Counter-
intuitively, there is also upregulation of many X-linked genes in ES cells, as a result 
of the demethylation of their associated CpG island promoters (Fouse et al., 2008). 
Finally, loss of Dnmt1 results in extensive demethylation of LTR regions and 
consequentially, expression of IAP transposable elements (Walsh et al., 1998). The 
phenotypic severity of transposon deregulation has led many to postulate Dnmt1 
primarily evolved to repress transposons by maintaining methylation at these 
sequences (Goll and Bestor, 2005). However, neither Dnmt1 deficient cells nor 
hypomethylated cancer cells have shown enhanced rates of transposition (Zilberman 
et al., 2007; Suzuki & Bird, 2008).  
 
An important and as yet not fully understood finding is that ES cells deficient in 
Dnmt1 develop normally in an undifferentiated state but die of p53-mediated 
apoptosis when induced to differentiate (Li et al., 1992). Interestingly, Dnmt1-
deficient ES cells can initiate differentiation, as shown by alkaline-phosphotase 
negative colonies, but lack the capacity to differentiate down specific lineages 
(Jackson et al., 2004). The same p53-mediated apoptotic fate is exhibited by mouse 
embryonic fibroblasts (MEFs) when Dnmt1 is conditionally deleted ex vivo (Jackson-
Grusby et al., 2003). Apoptosis is also the underlying cause of death in Xenopus 
embryos depleted of Dnmt1 (Stancheva et al., 2001). 
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Protein Functions Mutant Phenotype Reference
Methyltransferases    
  Dnmt1 
Maintenance methylation; 
putative roles in DNA 
repair and replication and 
direct repression   
Embryonic lethal by E8.5; 
hypomethylation; loss of imprinting and 
X-linked gene expression; transposon 
activation. ES cells  
Viable 
Li et al, 1992 
Lei et al, 1996 
 
Dnmt1o Oocyte-specific isoform 
 
Loss of maternal imprints 
 





No phenotype Okano et al, 1998 
Dnmt3a De novo establishment of methylation 
Postnatal lethal (~4weeks); 
Spermatogenesis defects, defective de
novo methylation 
Okano et al, 1999 
Dnmt3b De novo establishment of methylation 
Embryonic lethal by E14-18, defective 
de novo methylation of minor satellite; 
ICF syndrome 
Okano et al, 1999 
Dnmt3L Co-factor required for maternal methylation 
Abnormal maternal imprinting; male 
sterility 
Bourc’his et al, 
2001 




   
MeCP2 Methyl-binding protein; recruit co-repressors Mild neurological abnormalities in adults Guy et al, 2001 
Mbd1 Methyl-binding protein; recruit co-repressors 
Behaviour abnormalities; Defects in 
adult neurogenesis Zhao et al, 2003 
Mbd2 Methyl-binding protein; recruit co-repressors Defects in maternal behaviour  Hendrich et al, 2001 
Mbd3 NuRD complex Embryonic lethal by E6.5 Hendrich et al, 2001 
Mbd4 
Repair enzyme, methyl-
binding protein; recruit 
HDACs 




Sequence specific & 
methyl-binding protein; 
recruit co-repressors   
Resistance to intestinal cancer Prokhortchouk et al, 2006 
Zbtb4 Methyl-binding protein ND  





   
Eed Histone H3 lys27 methylation Embryonic lethal 
Niswander et al, 
1988 
Hdac1 Histone deactylation Embryonic lethal by E10.5, excessive histone acetylation Lagger et al, 2002 
G9a Histone H3 lys9 di-methylation 
Embryonic lethal by E8.5; loss of K3K9 
methylation in euchromatin 




Histone H3 lys9 tri-
methylation 
Embryonic lethal by E14.5, 
chromosomal instability, increased 
tumour risk 
Peters et al, 2001 
 
Ezh2 
Histone H3 lys27 tri-
methylation; PRC2/3 
complex 
Peri-implanation lethal; defect in 
primitive ectoderm O’Carroll et al, 2001 
     Table 1.2. Mouse mutant phenotypes of selected epigenetic mediators. 
          26
Somatic Dnmt1 is a ~190kDa protein expressed strongly in proliferating cells and 
ubiquitously in somatic tissues throughout mammalian development (Chen & Li., 
2006) but is present at significantly lower levels in noncycling cells. Throughout G1-
phase, Dnmt1 is diffusely distributed around the nucleoplasm but co-localises with 
replication foci during S-phase when its cell cycle regulated expression is highest.  
Dnmt1 is transcribed from 3 promoters and utilizes 5’ sex-specific  exons.  An 
oocyte  specific  form, Dnmt1o  (175kDa),  is  transcribed from the most 5’ promoter 
and lacks the N-terminal 118 amino acids of somatic Dnmt1.   The   truncation   
stabilizes Dnmt1o and allows the variant  to accumulate to high levels in the 
cytoplasm of noncycling mouse oocytes via an interaction with annexin V (Ding & 
Chaillet, 2002; Doherty et al., 2002). The functional significance of this is currently 
unclear, although some evidence suggests that Dnmt1o provides maintenance 
methylation specifically at imprinted loci during the fourth embryonic S-phase 
(Howell et al., 2001). The second and primary promoter, 6kb 3’ of the oocyte 
specific site, produces the full-length Dnmt1 transcript expressed in somatic and ES 
cells. The third Dnmt1 promoter, which is the most 3’, is used during sperm 
development and produces a non-translated transcript (Dnmt1s) that may be utilized 
to down-regulate Dnmt1 protein levels in pachytene spermatocytes (Mertineit et al., 
1998). 
 
Structurally, the large N-terminal regulatory domain of Dnmt1 is separated from the 
catalytic domain by 13 alternating glycyl and lycyl residues. The N-terminal portion 
harbours several functional domains including a nuclear localisation sequence 
(NLS), DMAP interaction module, a PCNA-binding domain (PBD) and a bromo 
adjacent homology domain (BAH). Moreover, the N-terminal module is responsible 
for targeting Dnmt1 to hemi-methylated DNA during replication. The PBD domain 
interacts with proliferating cell nuclear antigen (PCNA) during S-phase, which 
concentrates Dnmt1 activity at replication forks (Chuang., 1997; Hermann et al., 
2004). This interaction increases the efficiency of maintenance methylation but is not 
required for the inherent processivity of Dnmt1 (Vilkaistis et al., 2005; Schermelleh 
et al., 2007). The intrinsic sequence specificity for CpG, but not hemi-methyl CpG, is 
a property of the catalytic domain as demonstrated by domain swap experiments. 
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Here, the catalytic domains of prokaryotic methyltransferases with diverse target 
sequences were fused to the N-terminal region of Dnmt1. This did not alter the target 
specificities of the prokaryotic catalytic domains but did impart a novel preference 
for hemi-methylated DNA (Pradhan & Roberts, 2000). An additional cysteine rich 
zinc finger DNA binding domain (CXXC) is located centrally within the N-terminus 
and appears to facilitate unmethylated CpG DNA binding (Fatemi et al., 2001). 
 
Dnmt1 has been reported to interact with an increasingly large number of proteins 
including; DMAP1 (Dnmt1 associated protein), Rb, E2F1 transcription factor, 
hSNF2H (ATP-dependent remodelling factor), PCNA, Suvar39 (histone 
methyltransferase), HDAC1 and 2 (histone deacetylase 1 and 2) and NP95  (Chuang 
et al., 1997; Rountree et al., 2000; Robertson et al., 2000; Fuks et al., 2003 Goll & 
Bestor, 2005; Sharif et al., 2007). The wealth of interactions between Dnmt1 and 
chromatin modifying proteins provides a link between DNA methylation, histone 
modifications and chromatin structure, which serves to stably reinforce epigenetic 
states. Additionally, the reported interactions with several key co-repressors support 
a role for Dnmt1 as part of a direct transcriptional repression complex. Dnmt1 has 
been reported to form complexes with HDAC1, Rb and E2F that repress 
transcription independent of changes in DNA methylation (Fuks et al.,2000; 
Robertson et al., 2000). Furthermore, knock down of Dnmt1 induces activation of 
unmethylated Sp1-responsive genes in mice (Milutinovic et al., 2004). A recent 
report in human cancer cells has also noted general mitotic catastrophe when Dnmt1 
is completely depleted. Importantly the effect was observed before replication 
associated DNA demethylation could occur, indicating Dnmt1 has an essential 
function aside from maintenance methylation (Chen et al., 2007). In Xenopus, a 
partial knock down of xDnmt1 results in ectopic gene activation independently of 
changes in promoter methylation. Here, gene silencing could be re-imposed by both 
wt and crucially, catalytically mutant forms of DNMT1, strongly supporting an in 
vivo non-catalytic repressive function for Dnmt1 (Dunican et al., 2008). Further 
studies have shown that xDnmt1 per se may also function as part of a DNA damage 
recognition complex and downstream apoptotic inducer (Ruzov et al., 2009c). 
However, in the context of ES cells, the catalytic function of Dnmt1 is essential to 
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rescue the differentiation phenotype of Dnmt1-null cells (Damelin & Bestor, 2007).  
Thus, the general significance of direct repression by Dnmt1 in mammalian systems 
is yet to be determined (Supplementary thesis chapter available, see pp 273). 
 
1.4.3.3  Dnmt3a & Dnmt3b
 
Two functional cytosine methyltransferases reside in this family, Dnmt3a and 
Dnmt3b. Expression of these enzymes is greatest during early developmental stages, 
where their primary role is genome-wide de novo methylation, although they show 
the same propensity for hemi-methylated DNA (Okano et al., 1999). Following 
gastrulation, Dnmt3a and Dnmt3b activity decreases leading to a profound reduction 
of de novo methylation during differentiation. The expression of Dnmt3b remains 
very low except in the testes, thyroid and bone marrow whereas Dnmt3a is expressed 
at reduced levels ubiquitously (Xie et al., 1999).  Dnmt3a null mice survive to term 
but are runted and die within 4 weeks with progressive loss of germ cells in males 
(Table 1.2). However, global DNA methylation patterns seem to remain intact 
(Okano et al., 1999). Dnmt3b deficient mice die in late gestation (~E14.5) but 
Dnmt3b hypomorphs can survive to adulthood and display some of the 
characteristics of Immunodeficiency, Centromere instability and Facial anomalies 
(ICF) syndrome, which is associated with point mutations in DNMT3B in humans 
(Table 1.2 )(Okano et al., 1999). The more severe phenotype exhibited by Dnmt3b-/- 
mice as compared to Dnmt3a-/-, suggests that Dnmt3b has a more important role in 
embryonic development. Consistent with this, Dnmt3b is expressed earlier during 
embryonic development, with Dnmt3b de novo activity first appearing in the inner 
cell mass at the implantation stage (Watanabe et al., 2002).  Combined deletion of 
Dnmt3a and Dnmt3b is embryonic lethal at ~E8.5, equivalent to the Dnmt1-/- 
phenotype but with a lesser extent of demethylation (Okano et al., 1999). The 
embryonic lethality of both the Dnmt1-/- and Dnmt [3a-/-, 3b-/-] mice demonstrates 
that maintenance and de novo methylation are both required for development. 
Double de novo mutant ES cells retain methylation in early passages including most 
imprints, but are progressively demethylated during extended culture (Jackson et al., 
2004). This suggests that Dnmt1 is inherently inefficient at maintaining methylation 
and that in wild-type cells, reiterative de novo methylation is required to preserve 
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methylation patterns. In support of this a recent study found Dnmt1 to be <99% 
efficient (Schermelleh et al., 2007). Unlike Dnmt1 deficient ES cells, Dnmt [3a-/-,
3b-/-] ES cells can differentiate into embryoid bodies, which consist of all three germ 
layers, but only at early passages (<25), before they are severely hypomethylated 
(Jackson et al., 2004).  
 
Dnmt3a and Dnmt3b are highly homologous at their C-terminal catalytic domain but 
differ at their N-termini (Fig 1.4). The respective N-terminal domains are responsible 
for targeting chromatin, via the PWWP domain, and imparting subtle differences in 
specificity. In this respect, it appears Dnmt3b is specialised for methylation of 
specific regions of the genome such as pericentromeric repeats and CpG islands on 
the inactive X, whereas Dnmt3a is required for maternal imprints of differentially 
methylated regions (DMRs), in addition to their general de novo roles (Siedlecki & 
Zielenkiewicz, 2006). Protein interaction domains in the regulatory N-termini also 
mediate binding to transcriptional co-repressors (Qiu et al., 2002). Dnmt3b is 
associated with Sin3a, SUMO1/Ubc9, condensin and the chromatin remodelling 
enzyme hSNF2H while Dnmt3a has been shown to bind the co-repressor RP58 and 
the oncogenic factor PML-RAR (Goll & Bestor, 2005). Both also interact with 
Dnmt1 and histone deacetylases (HDAC). These observations indicate Dnmt3a and 
Dnmt3b are part of regulatory mechanisms that modulate transcription through 
recruitment of co-repressors able to influence chromatin structure in addition to de 
novo methylation.  
1.4.3.4  Dnmt2
Of the known cytosine methyltransferase homologues, Dnmt2 is the most highly 
conserved. It is also the most widely distributed homologue across species (Hermann 
et al., 2004). This strong sequence conservation, particularly within the 10 catalytic 
motifs, indicates a role in cytosine methylation (Okano et al., 1998; Yoder & Bestor, 
1998). Despite this, as of yet Dnmt2 has undetectably weak or no methyltransferase 
activity in mammals but intriguingly, is the primary enzyme responsible for non-
CpG and CpG methylation in early Drosophila embryos where it functions to repress 
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retrotransposons and maintain telomere integrity (Hermann et al., 2003; Phalke et al., 
2009). Recent work has demonstrated an additional, potentially novel function in 
mammals. In vitro, purified Dnmt2 can specifically methylate cytosine residues in 
tRNAAsp but not in DNA (Goll et al., 2006). The purpose of this modification and 
why it requires such strong conservation of Dnmt2 remain questions of great interest.  
1.4.3.5 Facilitators of DNA methylation
 
An increasing number of non-methyltransferase proteins have been shown to be 
required to maintain global levels and/or discrete regions of DNA methylation.  
These ‘facilitator’ proteins play an essential role in targeting or stimulating 
methyltransferase activity or in sensitising the chromatin structure to de novo DNA 
methylation.  One key facilitator protein, which belongs to the Dnmt3 family, is 
Dnmt3L. This protein is similar to Dnmt3a and Dnmt3b at its terminal regions but 
crucially lacks the central PWWP and ATRX domains and is restricted to only 
mammals. Currently, no methyltransferase activity has been attributed to Dnmt3L 
and it is not necessary for zygotic development. However, Dnmt3L is specifically 
expressed in the germ cells where it functions as a regulatory co-factor that 
stimulates the methyltransferase activity of Dnmt3a and Dmnt3b up to 15-fold 
(Gowher et al., 2005). This activity is necessary for the establishment of maternal 
imprinted methylation patterns (Hata et al., 2002; Kaneda et al., 2004). In males, 
Dnmt3L deficiency results in impaired spermatogenesis probably as a result of the 
demethylation and aberrant expression of interspersed repeated sequences in germ 
cells (Table 1.2) (Bourc’his & Bestor, 2005; Webster et al., 2005). Deficiency of a 
second facilitator, Lsh, leads to global demethylation at satellite sequences, 
imprinted genes and single-copy genes and, perinatal death (Dennis et al., 2001; Xi 
et al., 2007; Geiman et al., 2001). Lsh has homology to chromatin remodelling 
proteins and may promote a permissive chromatin structure for methylation. 
Alternatively, it may stimulate or target de novo activity through its interaction with 
Dnmt3a and Dnmt3b (Zhu et al., 2006). A third protein Uhrf1 (also known as NP95), 
has recently been shown to be essential for maintaining genome-wide DNA 
methylation through its interaction with Dnmt1. Uhrf1 preferentially binds hemi 
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methylated CpGs through its SRA (SET and RING associated) domain and thus 
targets Dnmt1 to these sites. Disruption of Uhrf1 leads to a mislocalisation of Dnmt1 
in S-phase and a reduction in global CpG methylation levels (Bostick et al.,2007; 
Sharif et al., 2007).   
1.4.4 Reaction Mechanism
The mechanism of DNA methylation was originally proposed by Wu and Santi in 
1987 and subsequently modified by Verdine and colleagues (Wu & Santi, 1987; 
Bestor & Verdine, 1994). A reactive cysteine in the conserved prolycysteinyl motif 
(PC box) of domain IV initiates nucleophilic attack at carbon-6 (C6) of the 
pyrimidine ring. This causes activation of carbon-5 (C5) and the transfer of a methyl 
group from the reaction methyl donor, S-adenonsylmethionine (SAM). 
Subsequently, the methyltransferase enzyme is released from the 5’-6’ dihydro 
intermediate by 
-elimination. Interestingly, a study that used 5-fluocytosine to trap 
methyltransferases onto their CpG substrate revealed that to gain access to target 
sequences, the enzyme ‘flips’ the cytosine out of the double helix during catalysis 
(Klimasauskas et al., 1994). The method of trapping DNA methyltransferases onto 
chromatin has also been used to examine the biochemically-induced effects of 
hypomethylation. Here, the nucleotide analogue, 5-aza deoxycytidine (5-aza dC) can 
be incorporated into DNA, including at CpG sites. Crucially, 5-aza dC has a nitrogen 
at position 5 of the pyrimidine ring instead of a carbon. Because DNA 
methyltransferases are unable to methylate the nitrogen, they cannot release through 

-elimination and become covalently trapped onto the DNA resulting in a significant 
depletion in the amount of enzyme available for methylating normal CpG sequences 
(Taylor & Jones, 1982). The reduction in the pool of the ‘maintenance’ 
methyltransferase, Dnmt1, leads to passive demethylation in cultured cells after two 
divisions, as synthesis proceeds without methylation of the new strand. Additionally, 
5-aza dC may operate through a second mechanism whereby Dnmt1 protein is 
depleted directly, through targeting for proteosomal degradation (Ghoshal et al., 
2005).    
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1.4.5 Regulation of transcription by DNA methylation
In general, DNA methylation is an epigenetic modification that is responsible for the 
heritable propagation of gene silencing patterns. Promoter CpG methylation can 
promote stable silencing even when sequence specific transcription factors are 
present enabling the formation of transcriptional memory and maintenance of lineage 
commitment. However, the global distribution of CpG methylation at promoters 
suggests that expression of only a small proportion of genes can be controlled by 
DNA methylation (Weber et al., 2007; Meissner et al., 2008). These analyses show 
CpG dense promoters are constitutively unmethylated regardless of gene activity 
whereas methylated promoters tend to have CpG densities to low to efficiently 
silence transcription. Thus, DNA methylation does not seem to be a wide-ranging 
mechanism for dynamically regulating gene expression. Instead it is largely 
restricted to the stable silencing of transcription within specific, but crucial, 




In each somatic cell of female mammalian embryos one randomly chosen X-
chromosome is transcriptionally silenced (Xi), except prior to the epiblast stage when 
the paternal X is preferentially silenced (Heard et al. 1997; Mak et al., 2004; 
Okamoto et al., 2005). This repression is mediated by the expression of the non-
coding, but functional RNA Xist. The Xist RNA silences genes on the chromosome 
from which it was expressed, by coating the X-chromosome in cis and promoting the 
acquisition of repressive histone marks (Kohlmaier et al., 2004). This appears to be 
sufficient to silence all the target genes on the inactive X-chromosome. However, 
many gene promoters, including CGIs, subsequently undergo de novo methylation 
following implantation (Lock et al., 1987; Norris et al., 1991). Promoter methylation 
seems to contribute to stably maintaining gene silencing, as experimental 
hypomethylation through 5-aza dC treatment or conditional deletion of Dnmt1 leads 
to derepression of genes on the Xi (Czankovski et al., 2001; Sado et al., 2000). 
Additionally, in extra-embryonic tissues and marsupials, where X-inactivation takes 
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place without DNA methylation, genes on the Xi become reactivated over time 
(Samollow et al., 1995; Migeon et al., 1989; Cedar & Bergman, 2009) 
1.4.5.2 Imprinting
 
Imprinted genes are a class of mammalian autosomal genes that are mono-allelically 
expressed in the embryo and/or adult. The mono-allelic expression of imprinted 
genes critically relies on parent of origin DNA methylation signals. Generally, one 
parentally derived allele is extensively methylated while the other exhibits little of no 
methylation at CpG-rich regulatory sequences (DMRs) (Plass & Soloway, 2002). 
Imprinted DNA methylation is introduced during gametogenesis, according to sex, 
by Dnmt3a and Dnmt3L. Following fertilization, imprinted DMRs are preserved by 
Dnmt1o during cleavage divisions and then by the somatic form of Dnmt1 in 
embryonic and adult tissues (Howell et al., 2001; Li et al., 1993).  
 
Imprinted methylation affects expression of genes in several, often complex ways, 
which vary at different imprinted loci. In the simplest cases, DMRs, which overlap 
the CGI promoter of an imprinted gene, can directly silence expression when 
methylated. However, imprinting frequently involves the mono-allelic methylation of 
imprinting control regions (ICRs), which can be many kilobases from the gene or 
gene clusters they regulate in cis. These ICRs can regulate imprinted genes through 
two broad mechanisms (Reik, 2007). Firstly, they can act as epigenetically 
modulated chromatin insulators. When unmethylated, these sequences recruit 
chromatin-insulator proteins that prevent interactions between distant enhancers and 
promoters, leading to silencing. One such example is the maternally expressed H19 
locus and the nearby paternally expressed Igf-2 gene. Here, the chromatin-organising 
protein CTCF binds to the unmethylated maternal ICR, but not the methylated 
paternal loci, and blocks interactions between Igf2 and an enhancer 80kb 
downstream of H19. This causes silencing of Igf2 on the maternal allele and the 
reciprocal activation of H19 (Hark et al., 2000; Szabo et al., 2000). In Dnmt1-null 
mice embryos, the paternal H19 allele is aberrantly expressed whereas the paternal 
Igf-2 is aberrantly silenced due to loss of the DNA methylation imprint and CTCF 
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recruitment (Li et al., 1993; Kato & Sasaki, 2005). The second mechanism involves 
functional non-coding nuclear RNAs that are regulated by DMRs overlapping their 
promoter. Expression of imprinted non-coding RNAs from the unmethylated DMR 
leads to silencing of target genes in cis through accumulation of repressive histone 
modifications (Umlauf et al., 2004; Lewis et al., 2004). Here, silencing may be 
targeted by the RNA during transcription or alternatively through a localised coating 
mechanism as observed for Xist RNA (Kanduri et al., 2006; Lewis et al., 2006; Reik, 




Mutated interspersed DNA transposons and retro-transposons constitute over 45% of 
the genome, and represent a severe hazard to the genetic integrity of the organisms 
they reside in (Smit & Riggs, 1996). One manifestation of this threat is through 
insertional mutagenesis. Equally, chimeric transcripts and aberrant gene expression 
mediated by transposon promoters and antisense transcripts, can cause detrimental 
effects (Goll & Bestor, 2005). In response, mammals utilize DNA methylation as a 
primary mechanism to stably silence transcription of some transposons, particularly 
Intercisternal A Particle (IAP) elements. In addition to mediating promoter 
repression, DNA methylation irreversibly inactivates transposable elements over 
time through promoting accumulation of cytosine to thymidine transitions via 
deamination of m5C (Schorderet & Gartler, 1992). In the absence of DNA 
methylation, a significant increase in IAP transcription has been reported in early 
embryos and conditional mutant fibroblasts (Walsh et al., 1998; Jackson-Grusby et 
al., 2001). Furthermore, in spermatogonia prevented from de novo methylating their 
genome by Dnmt3L deletion, LINE and IAP retrotransposons were highly 
transcribed (Bourc’his et al., 2007; Webster et al., 2005). Aberrant activation of 
transposable elements has also been reported in globally demethylated Lsh mutant 
mice (Dennis et al., 2001; Xie et al., 2007). To maintain the heritable repression of 
transposable elements, many are partially resistant to the erasure of DNA 
methylation in the zygote and in PGCs. The preservation of methylation at these 
sequences in the zygote is probably mediated by Dnmt1o and serves to prevent 
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mutational changes during this epigenetic reprogramming event (Gaudet et al., 
2004). How Dnmt1o promotes the maintenance of IAP methylation and indeed 
imprints, in the context of a progressively demethylated zygotic genome is unclear. 
1.4.5.4 Single-copy genes
While there is irrevocable evidence that DNA methylation modulates the activity of 
imprinted genes, transposons and the maintenance of X-chromosome inactivation, 
the extent to which promoter methylation regulates developmental and tissue-
specific gene expression is unresolved. It is noteworthy that the role of DNA 
methylation in long-term stable gene silencing is undisputed. However in general, 
repression by DNA methylation is considered to occur downstream of other 
epigenetic or trans-acting factors that signal the initial inactivation event. For 
example, in the case of the pluripotency factor Oct3/4, initial repression during 
differentiation is mediated by sequence-specific repressors such as GCNF 
(Fuhrmann et al., 2001). The locus is then progressively silenced through acquisition 
of G9a mediated H3K9 dimethylation and recruitment of HP1. These events lead to 
localised heterochromatization at the loci and only then, de novo methylation by 
Dnmt3a and Dnmt3b, which functions to reinforce the epigenetic state and prevent 
aberrant re-expression (Feldman et al., 2006; Chen et al., 2003). Indeed, in 
differentiating Dnmt[3a, 3b] null ES cells, Oct3/4 can occasionally be reactivated. 
This indicates that promoter methylation is a secondary system to add an additional 
layer of repression at the Oct3/4 loci and in effect, mediates the maintenance rather 
than initiation of gene silencing (Feldman et al., 2006; Jackson-Grusby et al., 2001; 
Lande-Diner et al., 2006). Consistent with a maintenance role, a CpG-free transgene 
is silenced comparably to a CpG-containing transgene but only the CpG containing 
transgene is resistant to re-activation due to the presence of DNA methylation (Feng 
et al., 2006).  
 
While the dynamic silencing of Oct3/4 does not rely on DNA methylation, it may 
represent a specialised example of a highly regulated gene that employs the 
combinatorial effects of several epigenetic systems to ensure sustained repression. 
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This may reflect the vital requirement to maintain Oct3/4 silencing in order to 
preserve lineage commitment, prevent de-differentiation and protect against 
carcinogenesis (Hochedlinger et al., 2005). In contrast, many genes display relatively 
few levels of epigenetic regulation and these may be candidates for direct regulation 
by CpG methylation. Indeed, in ES cells ~30% of repressed genes are marked only 
by DNA methylation and between 5-10% of genes are de-repressed in the absence of 
global methylation in ES and somatic cells (Fouse et al., 2008; Jackson-Grusby et al., 
2001). To distinguish between the genes directly regulated by DNA methylation and 
those activated as a secondary effect of global mis-expression in these reports, 
several studies have correlated gene expression in vivo to promoter methylation. 
Here, work on the cell-type specific expression of the maspin gene potentially 
suggests a role for DNA methylation in tissue specific regulation. The promoter of 
human maspin is unmethylated in tissue types that actively express the gene but 
hypermethylated in tissues in which the gene remains silent (Futscher et al., 2002). 
Importantly, transcriptional repression is relieved by inhibition of Dnmt1 and loss of 
promoter methylation.  
 
Work correlating gene expression with DNA methylation has also noted a number of 
CGI promoter genes that are specifically hypomethylated and expressed in germ 
cells but repressed and methylated in somatic tissues. These germline genes are often 
found de-repressed in 5’ aza dC treated cells and in hypomethylated tumours, leading 
to the term cancer/testis (CT) antigens. Most prominent in this group are the MAGE 
genes, but Pgk2, Pdha-2 and Ant4 have also been reported to be demethylated and 
expressed specifically in germ cells (De Smet et al., 1999; Zhang et al., 1998; 
Iannello et al., 2000; Rodic et al., 2005). A recent report has also suggested that 
DNA methylation may mediate the temporal activation of Dazl, Mvh and GCNA in 
murine germ cells (Maatouk et al., 2006). Here, the promoters are heavily methylated 
in somatic cells and primordial germ cells (PGCs) preceding their arrival at the 
embryonic gonads at E10.5, but are demethylated coincident with initiation of 
expression in PGCs by E13.5. This work is consistent with global methylation 
analyses, which have indicated an enrichment of germ cell specific genes associated 
with hypermethylated HCP or ICP promoters in somatic cells (Weber et al., 2007; 
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Meissner et al., 2008). Because ICP and HCP promoters are rarely found to be 
methylated, this suggests that the promoter methylation observed at germline specific 
genes could represent a specialised function for DNA methylation in somatic 
silencing of this class of genes.  
 
While an increasing number of genes, particularly germline associated genes, have 
been reported to be regulated by DNA methylation, it is important to note that 
currently these associations are largely correlative.  The lack of cause and effect 
reports leaves open the possibility that promoter methylation states at the reported 
loci could be a consequence of transcriptional activity and not a cause of gene 
activity per se. Alternatively, DNA methylation might maintain repression at these 
loci, but like at Oct3/4, may be a secondary epigenetic mark directed by dynamic 
histone modifications and not the primary system. To address this, one study has 
used a phenotypic assay to demonstrate the importance of DNA methylation at the 
Elf5 gene. Here, the Elf5 promoter is hypomethylated and expressed in the 
trophoblast lineage but methylated and silenced in the epiblast. Methylation and 
repression of Elf5 in the epiblast results in fixation of lineage commitment, as shown 
by Dnmt1 deficient ES cells, which lose their stable embryonic lineage restriction 
and are able to adopt trophoblast cell fates in vitro and in chimeras (Ng et al., 
2008b). Thus, lineage specific DNA methylation at the Elf5 loci regulates gene 
expression, as manifested through stable lineage commitment.  
 
Increasingly, the role of DNA methylation in regulating single-copy genes seems to 
be in restricting expression of key developmental genes and germ cell genes to 
specific lineages (Hayashi et al., 2008; Ng et al., 2008; Maatouk et al., 2006). By this 
rationale DNA methylation is essential for the progressive reduction in 
developmental potency and consistent with this, hypomethylated ES cells proliferate 
normally until induced to differentiate. Moreover, 5-aza dC treated somatic cells can 
be reprogrammed to induced pluripotent cells (iPS) at greatly enhanced rates 
(Mikkelsen et al., 2008). However, the scarcity of cause and effect reports continues 
to sustain the argument that DNA methylation is a secondary ‘maintenance’ system 
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for single-copy gene regulation and primarily functions in other processes such as 
repression of transposons and imprinting.  
 
1.4.6 Mechanisms of Repression by DNA methylation
 
Two primary models have emerged to describe the mechanism through which DNA 
methylation at regulatory sequences can influence transcription in mammalian cells. 
Firstly, methylated CpGs may directly preclude some transcription factors and 
regulatory proteins from binding to DNA. Depending on the genomic context and 
nature of the protein excluded from DNA, this can have either positive or inhibitory 
effects on transcription (Fig 1.5) (Watt & Molloy, 1988; Bell & Felsenfeld, 2000). 
Secondly, DNA methylation can create docking sites for proteins that specifically 
recognise methylated CpGs. These proteins, known as methyl-CpG binding proteins 
(MBPs), recruit co-repressors that modulate chromatin structure and modify histones 
leading to local heterochromatization and transcriptional repression (Fig 1.5) (Boyes 
& Bird, 1991; Jones et al., 1998; Ng et al., 1999). Additionally, methyltransferases 
per se may directly contribute to repression at methylated and non-methylated 
sequences (Fig 1.5) (Rountree et al 2000; Fuks et al., 2000; Dunican et al., 2008) 
 
1.4.6.1 Methyl-CpG Binding proteins
 
The first protein to specifically bind methylated CpGs, MeCP2, was identified 20 
years ago (Meehan et al., 1989; Lewis et al., 1992; Meehan et al., 1992). The domain 
responsible for localising MeCP2 to methylated DNA was named the methyl-CpG 
binding domain (MBD) and was subsequently identified in several other proteins 
including MBD1, MBD2, MBD3 and MBD4, which are collectively known as the 
MBD protein family (Fig 1.6) (Nan et al., 1993; Cross et al., 1997; Hendrich & Bird, 
1998). Of these proteins, only mammalian MBD3 lacks the capacity to bind 
methylated CpGs due to a substitution of a key binding residue (Saito & Ishikawa, 
2002). The structure of the MBD domain complexed with methylated DNA 
suggested MBD proteins would recognise methyl-CpG regardless of genomic 
context (Ohki et al., 2001). However, it has since emerged that MeCP2 preferentially 
binds methyl-CpGs flanked by A/T rich sequences and that MBD1 may bind 











Fig 1.5. Putative mechanisms of DNA methylation-mediated repression. Unmethylated 
CpGs are shown as white circles and methylated CpGs as black circles. Green elipses 
represent core histones complexed with DNA. a.) Unmethylated promoters  are permissive to 
transcription in the presence of appropriate transcription factors (TF). However DNA 
methylation can lead to repression and chromain condensation through one of several 
putative mehanisms including b.) Methyl-CpG binding proteins (MBP) can recognise 
methylated DNA and target co-repressor complexes to silence transcription and modify the 
local chromatin. c.)  DNA methylation in the recognition site of some transcription factors can 
block them from binding DNA. This can directly inhibit transcriptional activation  d.) DNA 
methyltrasferases (Dnmt) can recruit co-repressors such as histone deacteylases (HDAC) and 
histone methyltransferases (HMT) to repress transcription during de novo or maintenance 
methylation activity. This mode of repression may also occur independently of 
methyltransferase activity.   
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unmethylated CpGs (Klose et al., 2005; Jorgensen et al., 2004). MBD proteins 
repress transcription, at least in part, through targeting histone deacetylases, lysine 
methyltransferases and chromatin remodelling factors to methylated DNA which 
promotes an inactive chromatin structure (Nan et al., 1998, Ng et al., 2000). Each 
MBD protein interacts with characteristic co-repressors, although it is unclear 
whether all co-factors are in the same complex. For example MeCP2 is found 
associated with ATRX, the Sin3a/HDAC complex and H3K9 methyl-transferase 
activity (Jones et al., 1998; Fuks et al., 2003; Nan et al., 2007) whereas MBD1 
typically associates with H3K9 methyl-transferases SETDB1 and SU39H1, and HP1 
(Fujita et al., 2003; Sarraf & Stancheva, 2004).  
 
A second group of proteins, the zinc-finger family, comprising Kaiso, Zbtb4 and 
Zbtb38, have also been identified as having methyl-CpG binding activity (Fig 1.6). 
These proteins recognise methylated DNA through a conserved zinc-finger domain 
and similarly to MBDs, target transcriptional repression to these regions 
(Prokhortchouk et al., 2001). The founding member, Kaiso, was initially identified in 
a screen for proteins that interact with the p120 catenin but was also independently 
recognized as binding to the S100A4 gene in a methyl-dependent manner (Daniel & 
Reynolds, 1999; Prokhortchouk et al., 2001). Unlike MBDs, Kaiso was found to 
preferentially bind two consecutive methyl-CpGs. Kaiso interacts with the co-
repressor complex NCoR via its BTB domain and may mediate transcriptional 
repression through recruiting this complex to methylated target genes, such as MTA2 
(Yoon et al., 2003; Collins et al., 2001). In addition to binding methylated CpGs, 
Kaiso binds an unmethylated TCCTGCNA sequence (KBS) as is present in the 
matrilysin promoter and promotes repression (Spring et al., 2005). However, this 
property is not evolutionarily conserved and in Xenopus, the phenotype of xKaiso 
depletion is rescued by zebrafish Kaiso, which binds methylated DNA but not the 
KBS (Ruzov et al., 2009a; Ruzov et al., 2009b).  The remaining members of this 
family, Zbtb4 and Zbtb38, also possess a BTB domain but have additional zinc-
fingers through which they bind single methyl-CpGs and repress transcription (Filion 
et al., 2006). As of yet, no target genes have been identified as repressed by any of 
the kaiso-like proteins in a normal in vivo developmental context (Sasai & Defossez, 
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2009). It is noteworthy that a third family of methyl-binding proteins, the SRA (SET 
and Ring associated) containing Uhrf1 and Uhrf2, have been reported to 
preferentially bind hemi-methylated DNA through their SRA domain. However, this 
family has been implicated in the deposition of DNA methylation rather than 
interpreting it and carrying out a biological response (Bostick et al., 2007; Sharif et 
al., 2007; Unoki et al., 2004).  
 
Despite the apparent role of MBPs in repressing transcription of methylated 
templates in vitro, each MBP tested thus far is dispensable for development with 
mutant mice only exhibiting mild phenotypes (Table 1.2) (Hendrich et al., 2001; 
Chen et al., 2001; Guy et al., 2001; Zhao et al., 2004; Prokhortchouk et al., 2006). 
Additionally, in their absence only a limited number of genes are de-repressed and 
only to a modest extent (Barr et al., 2007; Kriaucionis et al., 2006; Sasai & Defossez, 
2009). In contrast, targeted deletion of Dnmts and loss of DNA methylation leads to 
embryonic lethality and global gene re-activation (Li et al., 1992; Okano et al., 1999, 
Jackson-Grusby et al., 2001). If MBPs are mediating the effects of CpG methylation, 
then why do these phenotypes differ so markedly? One explanation is that there is 
functional redundancy between MBPs allowing them to compensate for deletion of 
one another. An argument against this premise is that the combined disruption of 
MBD2, MeCP2 and Kaiso does not significantly alter the phenotype (Martin-
Cabellero et al., 2009; Guy et al 2001). However, with ever increasing numbers of 
methyl-binding proteins being discovered, even this triple knock out may not reveal 
the redundant functions of MBPs. An alternative explanation for MBP-null viable 
mice is that DNA methylation per se could be sufficient to maintain gene silencing 
without MBP recruitment. In this scenario, MBPs may function as an additional 
feedback mechanism to reinforce the repressed state but are not crucially required. It 
is also conceivable that MBPs do not have a global role in regulating gene expression 
states at all. However, work in Xenopus has suggested Kaiso, at least, has an 
important role. Here, morpholino knockdown of Kaiso has a similar phenotype to 
Dnmt1 knockdown, including ectopic de-repression of zygotic genes prior to the 
mid-blastula transition and embryonic lethality (Ruzov et al., 2004; Kim et al., 
2004b; Ruzov et al., 2009a). Thus, while MBPs remain the favoured mechanism 
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through which repression by DNA methylation is mediated, the extent to which these 




A second mechanism through which DNA methylation influences transcription is 
direct exclusion. Here, methylated sequences inhibit regulatory proteins from 
binding to their cognate DNA target sequence. This mechanism is distinct from 
MBD recruitment in that in prevents trans-acting factors from exerting influence 
rather than recruiting proteins that modify chromatin structure.  Such a situation is 
apparent with CTCF, a chromatin boundary insulator (Bell et al., 1999). Methylation 
prevents CTCF from binding to DNA, resulting in altered interactions between 
regulatory elements and promoters or modified chromatin domains. At the chicken 
-
globin insulator, methylation of just a single, specific CpG dinucleotide within the 
CTCF insulator abrogates binding (Renda et al., 2007). In mammals, this binary 
switch regulates the Igf2 and H19 imprinted genes that are expressed from parental 
specific alleles (Section 1.4.5.2) (Hark et al., 2002). In principle, all CTCF binding 
sites with consensus variants containing CpG dinucleotides possess the potential to 
regulate chromatin structure via DNA methylation. However, few examples of this 
kind of regulation have been reported to directly influence gene expression. A 
limited subset of other transcription factors have also been characterised that are 
blocked by DNA methylation, however, the effects on gene expression of their 
exclusion are unclear (Watt & Molloy, 1988; Tate & Bird, 1993; Jaenisch & Bird, 
2003).  
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1.5 Developmental epigenetic dynamics 
The cellular transition from totipotency to terminal differentiation can be defined by 
changes in gene expression. Thus, as echoed by Wolf Reik (2007), mammalian 
development is by definition, “epigenetic”. That is, the orchestrated changes in gene 
expression that direct development largely occur without altering the DNA sequence. 
Molecularly, the changes in expression are coordinated by transcription factors and 
epigenetic systems. These processes enforce heritable transcriptional memories that 
stably maintain lineage commitment. The developmental acquisition of stable 
epigenetic marks thus results in a progressive restriction of cellular potential, 
‘locking’ in’ cell fate. In contrast, re-acquisition of developmental potential (in the 
zygote, iPS cells and PGCs) is accomplished by specialised epigenetic 
reprogramming events that reset the epigenome to a pluripotent state (Fig 1.1) 
(Hochedlinger & Plath, 2009). The epigenetic dynamics during development 
therefore define the phases of differentiation and reprogramming that typify the 
mammalian life cycle.  
1.5.1 Epigenetic dynamics during embryonic development
 
The fertilization of an oocyte by a single sperm generates a unique totipotent cell 
with unparalleled cellular plasticity. To acquire this totipotent state, the genome 
undergoes dramatic changes in genome-wide DNA methylation patterns and histone 
modifications soon after fertilization. In mice, DNA methylation is actively erased 
from the paternal genome coincident with the removal of protamines and loading of 
chromatin onto histones (Fig 1.7 upper panel) (Mayer et al., 2000; Oswald et al., 
2000). The demethylase responsible for active demethylation is unknown but may 
operate through a mismatch or base-excision repair mechanism due to the stable 
nature of the covalent bond between methyl groups and cytosine residues (Reik, 
2007). In contrast, the maternal genome undergoes a slower, passive demethylation 
process throughout the subsequent cleavage divisions (Santos et al., 2002). The 
passive reduction of DNA methylation from the maternal genome is largely due to 
the exclusion of Dnmt1 from the nucleus at this stage (Howell et al., 2001). 
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However, the mechanism that protects the maternal genome from active 
demethylation has not been identified although it could be a consequence of the 
different chromatin organisations of the two pronuclei (Martens et al., 2005; Govin et 
al., 2007). Despite the global erasure of methylation after fertilization some 
sequences, such as allele specific ICRs and IAP elements, retain high levels of CpG 
methylation (Brandeis et al., 1993; Lane et al., 2003). Interestingly, Stella (also 
known as Dppa3) may have a role in protecting these sequences, as the absence of 
Stella from the zygote leads to aberrant loss of methylation from several imprinted 
loci and IAP elements (Nakamura et al., 2007). Functionally, the precise importance 
of zygotic demethylation to development is unclear, as the process is conserved 
between cow, mouse and pig but absent in sheep and rabbit, at least at the resolution 
of the 5’ methyl cytosine antibody (Beaujean et al., 2004, Meehan et al., 2005). 
Following implantation, the inner cell mass (ICM) but not the trophectoderm (TE),
undergoes global de novo re-methylation (Fig 1.7). The differential methylation of 
the ICM and TE occur coincident with the first zygotic lineage restriction that 
distinguishes the embryonic and trophoblast lineages, respectively (Santos et al., 
2002). Global levels of DNA methylation remain lower in extra-embryonic lineages 
compared to embryonic tissues throughout development but gene promoters may be 
an exception to this general depletion of methylation (Farthing et al., 2008). By the 
late blastocyst stage, the ICM separates into the epiblast lineage that will form the 
embryo, and the primitive endoderm that will form the visceral and parietal 
endoderm layers which contribute to extra-embryonic lineages. Post-gastrulation, de 
novo methylation and demethylation only occur at specifically targeted 
developmental and tissue-specific regions in somatic cells, although it is seen more 
widely in the development of cell lines in vitro (Kawai et al., 1994) and cancer cells 
(Jones  & Laird, 1999; Keshet et al., 2006). An exception to this is germ cells, which 
undergo further phases of epigenetic reprogramming.  
1.5.2 Epigenetics of Primordial Germ Cells
Primordial germ cells (PGCs) are the founder population of germ cells, which have 
the dual responsibility of differentiating into a specialised cell type (mature gametes)  
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Fig 1.7. Epigenetic dynamics during mouse embryonic and germ cell development. 
Top panel, embryonic epigenetics.  Very soon after fertilization DNA methylation is 
actively erased from the paternal pronucleus (shown as red genome/sperm) while the female 
pronucleus (blue genome) undergoes slower passive demethylation. H3K9me3 undergoes 
similar active erasure in the paternal pronucleus thus establishing an epigenetic asymmetry 
between the zygotic maternal and paternal genomes. In the absence of DNA methylation 
and H3K9 methylation, developmental gene repression is maintained by enhanced 
polycomb activity, particularly H3K27 methylation. De novo DNA methylation begins before 
the blastocyst stage and is largely complete by E6.5 with the genome fully re-methylated by 
late gastrulation (E7.5). Methylation may lock in stable silencing of pluripotency and lineage 
specific genes. Bottom panel, male PGC epigenetics. Primordial germ cells (PGCs) are 
specified at ~E7.25 in the extraembryonic mesoderm and begin migrating through the 
hindgut  to the embryonic gonad. At ~E.8.25 they undergo an initial epigenetic 
reprogramming event (left arrowhead) that includes partial erasure of DNA methylation and 
loss of H3K9me2 concomitant with gain of H3K4- and H3K27 methylation. Shortly after 
PGCs reach the gonad at ~E10.5 they undergo a second wave of epigenetic reprogramming 
that results in complete erasure of DNA methylation and transient loss of many histone 
modifications including H3K9- and H3K27 methylations and histone acetylations (second 
arrowhead). These genomic reprogramming events are necessary for expression germline 
specific and pluripotency genes and the eventual acquisition of totipotency. 
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and retaining the capacity to form a totipotent zygote and ultimately a new organism. 
PGCs are specified at ~E7.25 as a cluster of cells that emerge inside the 
extraembryonic mesoderm at the posterior end of the primitive streak (Ginsburg et 
al., 1990; Saitou et al., 2002). Prior to this, precursor cells expressing Blimp1, which 
is essential for PGC specification, can be identified as early as E6.25 (Lawson & 
Hage, 1994; Ohinata et al., 2005; Vincent et al., 2005). In Blimp1-deficient embryos, 
PGC-like cells express many somatic associated Hox genes, suggesting Blimp1 is 
crucial for silencing of the somatic programme (Ohinata et al., 2005). Following 
their specification, PGCs undergo two distinct phases of epigenetic reprogramming, 
which promote expression of germline and pluripotency genes, and repression of a 
somatic cell fate.
1.5.2.1 Migratory PGCs
The first PGC reprogramming event occurs during migration through the embryonic 
hindgut towards the developing gonads. Here, by E8.75, nascent PGCs show a 
significant loss of global H3K9me2 levels and DNA methylation compared to 
somatic neighbours, as determined by immunostaining (Fig 1.7 lower panel) (Seki et 
al., 2005; Seki et al., 2007). Loss of these marks is accompanied by cell cycle arrest 
at G2 and acquisition of high H3K27me3 levels by E9.5, which may complement the 
erasure of DNA methylation and H3K9me2 to maintain a repressive chromatin 
structure (Hajkova et al., 2008; Seki et al., 2007). The relative plasticity of 
H3K27me3 may also be required for PGCs to eventually regain totipotency. 
Migratory PGCs at this stage are also enriched for the activating marks H3K4me2/3 
and H3K9 acetylation relative to somatic neighbours, which may be important for 
expression of pluripotency factors such as Oct4, Stella and Nanog. Moreover, the 
enrichment of H3K4 and H3K27 methyl marks in PGCs prior to arrival at the gonad 
(at ~E10.5), leads to a striking resemblance to the chromatin state in ES cells (Fig 
1.7) (Sasaki & Matsui, 2008). Currently, this reprogramming phase has not been 
directly associated with specific changes in gene expression and may be ‘priming’ 
the epigenetic landscape for later events. As such, the epigenetic changes that occur 
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in migratory PGCs may represent lineage specific (germ cell) differentiation rather 
than a reprogramming event per se. 
1.5.2.2 Post- Migratory PGCs
Subsequent to entering the gonad at around E10.5, PGCs undergo another, more 
extensive phase of epigenetic reprogramming. This is characterised by genome wide 
active DNA demethylation between E11.5 and E12.5, including erasure of imprints 
and reactivation of the Xi chromosome (although reactivation may initiate during the 
migratory stage) (Hajkova et al., 2002; Monk & McLaren, 1981; Tam et al., 1994; de 
Napoles et al., 2007). Global levels of many repressive modifications including 
H3K9me3, H3K27me3 and linker histone H1 also decline at E11.5 (Fig 1.7 lower 
panel) (Hajkova et al., 2008). Intriguingly, loss of these histone marks is transient as 
they are regained globally by E12.5. This dynamic change in histone modifications is 
not just limited to repressive marks as the activating modification H3K9ac is also 
transiently lost at this stage. The transient global changes are accompanied by a 
decondensation of chromatin as revealed by enlarged nuclei. These data indicate that 
there is an extensive stripping of epigenetic information to completely reprogram the 
PGC genome at E11.5 to a pre-totipotent state. The dynamics of histone H2A.Z 
replacement in PGCs at this stage suggests the reprogramming occurs through global 
histone replacement, possibly via the histone chaperone NAP1 (Hajkova et al., 
2008). Moreover, chromatin remodelling and loss of histone marks in PGCs is 
preceded by erasure of DNA methylation, consistent with a model whereby DNA-
repair-driven demethylation directly induces histone replacement and chromatin state 
changes. This suggests that erasure of DNA methylation may be the initiating event 
for reprogramming at this stage. A minority of sequences, such as IAPs avoid 
complete reprogramming, however most studied regions are subject to resetting 
(Hajkova et al., 2002; Lane et al., 2003). One study has reported that demethylation 
and expression of Dazl, Mvh and, Sycp3 is induced following entry into the gonad 
suggesting that global erasure of DNA methylation regulates the timing of activation 
of these germline specific genes (Maatouk et al., 2006).  
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In contrast to the transient loss of histone modifications, de novo re-methylation of 
PGCs does not commence until E14.5 in the male germline and not until postnatal 
oocyte growth in the female germline (Fig 1.7) (Ueda et al., 2000; Li et al., 2004; 
Lucifero et al., 2004). Remethylation of PGCs allows sex-specific imprints to be 
established at ICRs. Additionally, some genic germline methylation patterns are 
established, particularly at germ cell specific CGI genes, which remain 
hypomethylated compared to somatic cells. The imprinted methylation patterns at 
ICRs are catalysed by the Dnmt3a-Dnmt3L complex, with the exception of the 
paternal Rasgfr1 imprint, which additionally requires Dnmt3b (Kaneda et al., 2004; 
Hata et al., 2002; Kato et al., 2007). The criteria by which imprinted loci are 
recognised and targeted in PGCs at this stage is unknown. However, the Dnmt3a-
Dnmt3L complex preferentially binds CpGs spaced with 10-nucleotide intervals, 
which are found at many imprinted loci (Jia et al., 2007). Combined with 
unmethylated H3K4, which promotes Dnmt3L binding, this may provide enough 
specificity for targeting de novo activity to imprinted regions (Ooi et al., 2007). In 
support, a recent report noted that oocytes deficient in the H3K4me2 demethylase 
KDM1b failed to methylate several imprinted loci (Ciccone et al., 2009). The PGC-
specific epigenetic patterns established in the gonad, are likely necessary for the 
specialised downstream functions of germ cells. Indeed promoter methylation 
patterns in EG cells and sperm resemble those of ES cells suggesting that while 
differentiating PGCs are a highly specialised cell type their genome is at least partly 
reprogrammed to a pluripotent state (Farthing et al., 2008).    
1.5.2.3 Mature germ-cell epigenetics
 
Proliferation of PGCs ceases at ~E13.5 coincident with the onset of sexual 
differentiation. At this stage, female germ cells enter prophase I of meiosis (Tam & 
Snow, 1981) whereas male germ cells enter mitotic arrest by E14.5, probably as a 
result of signals originating from the testis cord (McLaren, 1983). In male mice, 
spermatogenesis resumes around 3 days post partum (3dpp) and follows a defined 
differentiation pathway with the first haploid spermatids present from 19dpp. 
Epigenetically, global chromatin remodelling occurs at this stage with the histone-
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protamine exchange being the principal event. The global incorporation of basic 
protamines into sperm chromatin promotes DNA compaction which is both 
necessary for spermatozoa head size and to protect the genome from environmental 
insults (Sasaki & Matsui, 2008). However, despite the global protamine exchange, 
recent studies have noted that histones remain enriched at certain loci. Specifically, 
in human spermatozoa sequences with strong developmental ontologys including 
Hox genes, imprinted genes and developmental transcription factors were associated 
with regions of enriched histone deposition (Hammoud et al., 2009). Interestingly, 
histones were modified with H3K27me3 when present at loci that would be 
repressed in the early embryo and reciprocally H3K4me2/3 was present at future 
active or bivalent loci. Many developmental promoters were also DNA 
hypomethylated which contrasts with bulk sperm DNA which is hypermethylated. A 
second study using soluble and insoluble sperm chromatin fractions noted that 
histones were preferentially retained at promoter regions associated with CTCF 
binding sites (Arpanahi et al., 2009). Taken together these studies demonstrate that 
sperm DNA contains at least two chromatin packaging domains and that epigenetic 
marking in sperm is extensive. These modifications may have a role in directing the 
global reprogramming following fertilization or in excluding certain loci from 
reprogramming to promote heritable gene expression states.  
1.5.3 Epigenetic Systems during development
 
During development different subsets of genes are expressed to define the cellular 
lineage and potential. To regulate the dynamic expression of gene subsets, epigenetic 
processes utilize both short-term flexible systems and stable long-term heritable 
mechanisms (Reik, 2007). For example, because development is a progressive 
restriction of potential, genes required for early pluripotency are conceptually 
obsolete after somatic differentiation and therefore can be permanently silenced. In 
contrast, developmental genes are not required during early development but are 
necessary at later stages and thus need to be transiently repressed but ‘poised’ for 
expression without the requirement for epigenetic reprogramming. To achieve these 
distinct outcomes, different epigenetic systems operate which mediate either flexible 
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repression and activation or heritable silencing during development. These systems 
regulate different gene subsets depending on the developmental requirement and 
thus, epigenetic marks accumulate differentially according to cell-type and lineage. 
Reprogramming events enable the erasure of these marks and thereby allow the cycle 
of restriction of cell plasticity by these permanent and flexible epigenetic systems to 
repeat. 
 
1.5.3.1 Flexible epigenetic regulation
 
In mammals, the flexible repression of developmental associated genes, such as the 
Hox, Pou and Gata families, in pluripotent and multipotent cell-types is achieved 
through the Polycomb group (PcG) proteins (Lee et al., 2006). These proteins form 
two complexes, PRC2 and PRC1, which deposit H3K27me and H2A119ub1 to 
cooperatively mediate gene repression at targeted developmental loci and therefore 
maintain pluripotency. The importance of PcG proteins was demonstrated through 
ES cells deficient in the Eed or Suz12 components of PRC2, and therefore which 
lacked H3K27me3. Here, many developmental genes were de-repressed and the 
mutant ES cells were liable to spontaneously differentiate (Boyer et al., 2006; Lee et 
al., 2006). This is consistent with a model whereby PcG complexes maintain ES cell 
pluripotency and plasticity during embryonic development through transiently 
repressing developmental genes. The intriguing observation that that many PcG 
target genes were marked by extended regions of H3K4me3 as well as H3K27me3 - 
so called bivalent domains - led to the concept that these genes were poised for 
activation (Bernstein et al., 2006). In this model, the repressive H3K27me3 is 
dominant over H3K4me3 and therefore bivalent genes are transiently silenced until 
lineage specific differentiation induces depletion or removal of H3K27me3. Upon 
lineage specific loss of the repressive mark, genes transition from a ‘poised’ to an 
‘active’ state due to the primed H3K4me3 modification (Bernstein et al., 2006; 
Mikkelsen et al., 2007; Pan et al., 2007). Whether H3K27me3 is removed by down 
regulation of PRC components or an active demethylase at individual loci is 
unknown, but crucially, the mechanism allows repressive marks to be flexibly and 
quickly removed in response to downstream cues (Mohn et al., 2008; Barski et al., 
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2007; Zhao et al., 2008). Unlike Drosophila, a general polycomb response element 
(PRE) has not been identified in mammals and therefore it is unclear precisely how 
PcG proteins target specific developmental genes. One mouse sequence (PRE-kr) has 
recently been shown to recruit PcG complexes to loci containing the motif in an 
orientation specific manner and therefore may be a mammalian specific PRE (Sing et 
al., 2009). However, as the sequence is not present at all target loci, alternative 
targeting mechanisms must also be in operation (Schwartz & Pirrota, 2008). 
 
1.5.3.2 Stable epigenetic regulation
 
In contrast to developmental genes that are transiently repressed until required, 
pluripotency genes are stably epigenetically inactivated as cellular differentiation 
proceeds because in principle, they are only required in the germline. These genes 
are characteristically marked by repressive histone modifications, DNA methylation 
and replicate during late S-phase (Lande-Diner & Cedar, 2005). The classical 
example is Pou5f1 (encoding Oct3/4) (see Section 1.4.4), which acquires histone 
modifications and DNA methylation in a defined epigenetic cascade that results in 
permanent silencing of the locus (Feldman et al., 2006). Several distinct mechanisms 
cooperate to reinforce long-term stable silencing at pluripotency loci to prevent 
reactivation. The collaborative effort to maintain permanent silencing is probably 
due to the hazardous effects of ectopic reactivation of pluripotency genes in 
differentiated cell types such as a potential predisposition to cancer (Hochedlinger et 
al., 2005). Permanent epigenetic silencing is also utilized during development to 
preserve the fixation of cell fate. For example, heritable methylation of the Elf5 gene 
leads to stable silencing which prevents embryonic lineages from entering a 
trophoblast lineage fate (Ng et al., 2008; Hemberger et al., 2009). Thus, in general, 
distinct epigenetic systems modulate the activity of genes based on the 
developmental requirement for flexibility or stability of gene expression and/or 
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1.6 Pluripotent stem cells
1.6.1 Pluripotent cell types
 
1.6.1.1 ES cells
In 1981, two groups simultaneously isolated and cultured embryonic stem (ES) cells 
derived from the inner cell mass (ICM) of mouse blastocysts (Martin, 1981; Evans & 
Kaufman, 1981). Mouse ES (mES) cells have both the capacity to self-renew and to 
differentiate into lineages that represent every tissue found in an adult mouse. In vivo 
this pluripotent state exists only transiently, in the developing blastocyst. However in 
vitro, mES-cell pluripotency can be sustained indefinitely through continual 
exposure to defined factors (Chambers & Smith, 2004). Indeed, even following 
extensive culture, mES cells reintroduced into developing blastocysts retain their 
capacity to contribute to all adult tissues in chimeric animals, although earlier 
passage cells have a higher propensity to be transmitted through the germline. They 
additionally contribute to allantois, yolk-sac mesoderm and amnion (Bradely et al., 
1984). However, in accordance with their epiblast origin and unlike human ES cells 
(hES), mES cells contribute relatively insignificantly to the primitive endoderm and 
never to the trophectoderm (Beddington & Robertson, 1989). This partial lineage 
restriction is why mES cells are regarded as pluripotent, whereas early zygotic cells, 
which can contribute to all extra-embryonic lineages, are totipotent. Despite this, the 
capacity of mES cells to colonise the germ cell lineage in chimeric animals, makes 
them highly effective tools for manipulating the mouse genome and ultimately for 
generating mutant mice and cell lines (Downing & Battey Jr, 2004). 
 
Original lines of mES cells were maintained on cultures of irradiated or mitotically 
blocked ‘feeder’ fibroblasts. The observation that the critical pluripotency factor 
secreted by fibroblasts was leukaemia inhibitory factor (LIF), has led to the 
generation of feeder-free cell lines cultured in the presence of LIF and serum 
(Williams et al., 1988; Smith et al., 1988). In turn, this paradigm was enhanced upon 
discovery that serum in the media can be supplanted by bone morphogenetic proteins 
(BMPs), which function in collaboration with LIF to maintain mES cell self-renewal 
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(Ying et al., 2003a). Most recently the generation of 3i media, which inhibits FGF 
receptor tyrosine kinases, the ERK cascade and glycogen synthase kinase-3 (GSK3), 
has enabled continuous culture of mES cells capable of self renewal (Ying et al., 
2008). Because 3i media inhibits differentiation inducing FGF signals rather than 
promoting pluripotency per se, the development of this media demonstrated self-
renewal is an intrinsic property of the mES-cell state rather than a consequence of 
pluripotency promoting signals.   
 
Due to the relatively recent development and cost of 3i media most studies still 
utilize LIF for work with mES cells. Mechanistically, LIF functions through the 
gp130 receptor to trigger STAT3 in a JAK kinase modulated system (Niwa et al., 
1998). Withdrawal of LIF from cultured mES cells promotes spontaneous 
differentiation along multiple lineage paths. However, this can be used in 
combination with refined protocols to induce differentiation into a variety of cell-
types representing all three germ layers, but rarely trophoblast cells (Yasunaga et al., 
2005; Nishikawa et al., 1998; Ng et al., 2008; Chambers & Smith, 2004). A key 
differentiation method entails allowing mES cells to aggregate in suspension leading 
to structures called embryoid bodies (EB). This process mimics the process of 
embryogenesis and therefore differentiation into EBs is thought to occur on a 
comparable schedule to in vivo development, but without the structure of the 
developing embryo. Interestingly, a recent report has demonstrated that embryoid 
bodies establish an anteroposterior polarity and form a primitive streak-like region 
supporting the premise that EB formation closely resembles in vivo development (ten 
Berge et al., 2008). Most alternative methods differentiate mES cells during 
monolayer culture or on matrices, which lessens the parallels with embryonic 
development but allows enhanced access and manipulation of cultures. Here, 
addition of varying concentrations of growth factors (Okabe et al., 1996) or retinoic 
acid (Rohwedel et al., 1999) influences differentiation toward specific lineages. 
While these general methods result in a heterogeneous assortment of differentiated 
cells, innovative techniques have also been employed to attain a homogeneously 
differentiated populations (Rolletschek et al., 2001; Ying et al., 2003b). 
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1.6.1.2 Other pluripotent cells
 
In addition to the generation of mES cells from blastocyst stage embryos, other 
phases of mouse development allow the derivation of alternative pluripotent cell 
lines in vitro. Pluripotent embryonic carcinoma (EC) cells can be established from 
epiblast teratomas but contribute poorly to chimeras and rapidly lose plasticity in 
culture due to a propensity to be aneuploid (Hogan et al., 1994; Evans, 1972; 
Roassant & McBurney, 1982). More regularly, pluripotent embryonic germ (EG) are 
generated from the primordial germ layer between E8.5 and E12.5, with the 
efficiency of derivation being significantly higher from earlier stages (Matsui et al., 
1992; Durcova-Hills et al., 2001). EG cells have comparable developmental potency 
to ES cells and express the SSEA1 antigen, tissue non-specific alkaline phosphotase 
and Oct3/4, all of which are markers of pluripotency (Matsui et al., 1992). However, 
EG cells derived from post-migratory stage PGCs lack the correct complement of 
imprints leading to skeletal abnormalities in chimeras (Tada et al., 1998; Shamblott 
et al., 1998; Spivakov & Fisher, 2007). Recently, spermatagonial stem cells (SSCs) 
from adult males have also been derived and cultured (Kubuta & Brinster, 2006). 
Most recently, epiblast stem cells (EpiSC) have been derived from E5.5 to E6.5 rat 
and mouse epiblast tissue (Brons et al., 2007). EpiSC are able to differentiate to all 
three germ layers and form teratomas in immunodeficient mice but contribute very 
poorly to chimeras, possibly due to a partially limited capacity to develop into early 
lineages. However, recent evidence has suggested that epiSCs can de-differentiate to 
ES-like cells (rESCs) through extended culture with LIF suggesting that they are not 
developmentally limited (Bao et al., 2009).  Interestingly, both the expression profile 
and maintenance culture requirements suggest mouse epiSC are more comparable to 
human ES cells than to mES cells (Tesar et al., 2007; Brons et al., 2007). 
1.6.2 Maintenance of Pluripotency
 
1.6.2.1 Pluripotent Transcription Factor Networks
Attempts to characterise the mediators of self-renewal have examined both the 
epigenetic landscape and the transcriptional profile of ES cells. Analysis of the 
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genetic basis of pluripotency has identified a subset of genes exclusively expressed 
in mES cells (Ivanova et al., 2002; Imamura et al., 2006). Further work revealed at 
least three factors – Oct3/4, Sox2 and Nanog – form a core network of ‘master 
regulators’ that are important for pluripotency in mES cells (Boyer et al., 2005; 
Nichols et al.,1998; Chambers et al., 2003; Avilion et al., 2003). Genome-wide ChIP 
on chip analysis of these ‘regulators’ demonstrated cooperative binding by Oct4, 
Nanog and Sox2 at a sizeable number of developmental loci (Loh et al., 2006; 
Sharov et al., 2008). Interestingly, Oct4 and Nanog are associated with gene 
promoters irrespective of expression state, suggesting these key regulators can bind 
active as well as repressed targets. However, genes shown to be repressed were 
principally developmental loci involved in lineage commitment, whereas active 
genes bound by Oct4/Nanog were associated with an uncommitted state and 
expressed in cell-types able to self-renew (Loh et al., 2006; Boyer et al., 2005). Thus, 
this pluripotency network activates genes that promote self-renewal while silencing 
differentiation associated loci. Recently other factors such as Sall4 and Klf4 have 
been identified that extend this network of core pluripotency regulators (Zhang et al., 
2006; Yang et al., 2008). Additional reports have indicated that multiple core factors 
(greater than 4) cooperatively activate key pluripotency loci whereas genes with few 
core factors bound are generally repressed (Kim et al., 2008; Chen et al., 2008). It 
will therefore be important to delineate the precise role of each pluripotency factor 
and their interactions with one another in the future, as it has recently been shown 
that Nanog is not strictly required for maintenance of pluripotency at all in cultured 
mES cells (Chambers et al., 2007) 
 
Interestingly, many factors that comprise the core pluripotency network regulate 
their own expression either directly or indirectly by modulating the expression of 
epigenetic modifiers (Wu et al., 2006; Chew et al., 2005; Rodda et al., 2005; Loh et 
al., 2007). This creates a self-reinforcing loop of pluripotency but also suggests that 
disturbances to this equilibrium could cause a binary shift leading to repression of 
pluripotency factors and differentiation. For example, JMJD2C maintains Nanog 
expression by reversing H3K9me2 at the Nanog promoter but expression of JMJD2C 
itself is dependent on Oct3/4 levels which in turn are modulated by the G9a-EHMT1 
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complex directing H3K9me2 to the Oct3/4 promoter (Loh et al., 2007; Feldman et 
al., 2006; Hattori et al., 2007). Therefore, the dynamic balance between epigenetic 
modifiers and the core pluripotency factors maintains the pluripotent state. This 
highly-tuned system could explain the susceptibility of ES cells to spontaneously 
differentiate in vitro and the transient nature of the pluripotent state during 
development where stochastic events constantly affect the transcriptional equilibrium 
(Hemberger et al., 2009). 
1.6.2.2 Epigenetic basis of pluripotency   
 
The epigenetic landscape of pluripotent cells functionally cooperates with the core 
pluripotency transcription factors to maintain self-renewal. Principally, the 
H3K27me3 mark catalysed by polycomb group proteins maintains the transient 
repression of differentiation associated genes in pluripotent cells therefore promoting 
plasticity in culture and during embryonic development (Boyer et al., 2006). The 
responsive nature of this system is, at least partly, due to the epigenetic flexibility of 
the bivalent marks found predominately in ES cells. Interestingly, ~30% of genes are 
not marked by either bivalent modification but are found to be DNA methylated 
(Fouse et al., 2008). DNA methylation at these loci may represent a parallel system 
to polycomb that heritably stabilises gene expression and self-renewal in ES cells. 
However, as Dnmt1-null ES cells can proliferate and self-renew, the precise role of 
DNA methylation at these loci with respect to maintaining pluripotency is unknown.   
1.6.2.3 Epigenetic Reprogramming of somatic cells
 
Mammalian development is a unidirectional process during which epigenetic 
systems and transcription factors retain the memory of lineage specification. 
However, seminal experiments in amphibians and mammals showed the genomes of 
differentiated cells were able to generate viable cloned animals (Gurdon, 1962; 
Wilmut et al., 1997; Eggan et al., 2004). These studies indicated that the restriction 
of lineage potential can be manipulated and reversed suggesting epigenetic 
mechanisms rather than permanent genetic changes mediate developmental 
restriction (Hochedlinger & Jaenisch, 2006). More recent work has demonstrated that 
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differentiated nuclei can be dominantly reprogrammed to express markers of earlier 
embryonic stages by fusion with ES cells (Tada et al., 2001). These observations led 
to the astounding observation that temporally restricted ectopic expression of the 
quartet Oct4, Sox2, Klf4 and c-Myc can reprogram somatic fibroblasts to induced 
pluripotent (iPS) ES-like cells (Takahashi & Yamanaka, 2006; Takahashi et al., 
2007). Completely reprogrammed iPS cells exhibit transcriptional profiles and 
histone modification patterns very similar to ES cells. Moreover, there is erasure of 
DNA methylation at key pluripotency genes and reactivation of the inactive X 
chromosome in female cells (Maherali et al., 2007; Mikkelsen et al., 2008; Okita et 
al., 2007). Importantly, iPS cells can generate viable chimeric embryos and 
contribute to the germline demonstrating their functional pluripotency (Okita et al., 
2007; Wernig et al., 2007). Recent studies have demonstrated iPS cells can be 
derived from many cell types (Aoi et al., 2008; Wernig et al., 2008; Eminli et al., 
2008) and with alternative combinations of factors, such as Esrrb instead of Klf4 or 
by excluding c-myc entirely (Feng et al., 2009; Nakagawa et al., 2008). The 
efficiency of iPS cell derivation can also be increased by manipulating the epigenetic 
landscape with inhibitors of DNA methylation and histone lysine methylation 
(Mikkelsen et al., 2008; Shi et al., 2008). By transiently reducing DNA methylation 
it is hypothesised that stable silencing of pluripotency genes is weakened allowing 
more efficient reversal of lineage commitment. These data illustrate the central role 
of epigenetic processes and transcription factors in defining cellular memory. Further 
understanding of the epigenetic landscapes that dictate expression states and cellular 
memory will vastly broaden our medical and conceptual capacity. Indeed, 
epigenetically reprogrammed iPS cells have already led to potential patient-specific 
therapies for sickle cell anaemia (Hanna et al., 2007) and Parkinson’s disease 
(Wernig et al., 2008). 
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1.7 Thesis Objectives
 
Multiple epigenetic systems cooperate with trans-acting effectors to precisely 
regulate cellular patterns of gene expression. Determining how these mechanisms 
operate and interact is important for our understanding of normal developmental 
processes, transcriptional memory and ultimately human disease. This thesis aims to 
investigate the role of one major epigenetic modification, DNA methylation. DNA 
methylation has been well characterised as the primary mediator of mono-allelic 
gene expression, transposon silencing and maintenance of X-chromosome 
inactivation. However, the function of DNA methylation with respect to epigenetic 
regulation of single-copy genes is contentious. Central to the debate is the lack of 
evidence that differential DNA methylation patterns are the cause, rather than the 
consequence, of transcriptional activity. This continues to sustain the argument that, 
at best, promoter methylation is recruited by other epigenetic systems to ‘lock in’ a 
long-term silenced state and therefore is not a mechanism for regulating expression 
per se but a secondary maintenance system. I set out here to determine whether DNA 
methylation is the primary system for regulating the expression of any single-copy 
genes and thus the maintenance of transcriptional memory at these loci. 
 
The aims of this thesis are thus: 
 
1. To identify candidate genes potentially regulated primarily by DNA 
methylation. 
 
2.   To evaluate the functional role of promoter methylation at candidate 
genes in a developmental context. 
 
3. To investigate the mechanism through which promoter methylation 
silences candidate genes. 
 
   








2.1.1 Transformation of bacterial cells
   ! Escherichia coli (E. coli) (Invitrogen) were 
incubated with 10-100ng of DNA (not greater than 5% bacterial volume) on ice for 
30 minutes. The transformation mixture was heat shocked at 42°C for 45 seconds 
and cooled rapidly on ice for a further 2 minutes. Room temperature S.O.C rescue 
media was added to a final volume of 500μl and the mixture was incubated at 37°C 
with shaking for 1 hour. Transformed cells were then aseptically spread onto L-agar 
plates with the appropriate antibiotic added (Ampicillin at 50mg/ml, Kanamycin at 
50mg/ml, Chloramphenicol at 13mg/ml), inverted and incubated at 37°C overnight. 
For blue/white selection 80μl X-gal (25mg/ml) was pre-streaked onto the agar plates.  
2.1.2 Bacterial culture and isolation of plasmid DNA
 
For the preparation of plasmid DNA, transformed !  were incubated at 
37°C overnight with shaking (225rpm) in 5ml liquid Luria-Bertani (LB) culture 
medium containing the appropriate antibiotic. For maxi-preparations, 1ml of this 
starter culture was inoculated into 150ml of antibiotic containing LB and incubated 
at 37°C for a further 16 hours. Plasmid DNA was extracted with either the 
Nucleospin Plasmid kit (Machery-Nagal) for mini-preparations or the GenElute HP 
Endotoxin-Free Maxiprep Kit (Sigma) for maxi-preparations according to the 
manufacturer’s instructions.
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2.2 Mammalian Cell Culture
2.2.1 Cell culture 
All cells were incubated in a humidified atmosphere at 37ºC with 5% CO2.  Cell lines 
were cultured in optimised media according to their requirements as shown in Table 
2.1. ES cells were grown for 2-3 days in the presence of LIF and ‘fed’ with fresh 
media every day and three hours before passaging. To split ES cells, the culture 
media was aspirated and cell colonies were washed once in pre-warmed PBS. A 
small volume of trypsin-EDTA (10% v/v) was added and cells were incubated for 3 
minutes at 37°C. ES cells were dislodged by gentle agitation and 10ml of pre-
warmed media was added to inactivate the trypsin and create a single cell 
suspension. The cell suspension was counted and seeded on either pre-gelatinised 
(0.1% in PBS) or mitomycin C (10 μg/ml) treated MEF monolayer culture flasks at a 
concentration of 1.5 x 105 cells/ml, with 15ml added to a T75cm2 flask. All other cell 
lines were passaged every 2-3 days at a ratio of 1 in 5 to 1 in 10 as ES cells but 
without gelatinised or feeder layer culture flasks and with media replaced only 
during passaging (Table 2.1). 
 





GMEM; 15% FCS; 1xNEAA; 2mM L-Glutamine; 1mM Na 
Pyruvate; 0.1mM ß-Mecaptoethanol: 1000U/ml LIF; 
1000U/ml Pen; 650µg/ml Strep 
 
1 x 105 /ml 
gelatin 
 
ES WT E14’ 
DMEM; 10% FCS; 1xNEAA; 2mM L-Glutamine; 0.1mM ß-
Mecaptoethanol: 1000U/ml LIF; 1000U/ml Pen; 650µg/ml 
Strep 
 
1 x 105 /ml 
gelatin 
 
ES WT E14 
GMEM; 15% FCS; 1xNEAA; 2mM L-Glutamine; 1mM Na 
Pyruvate; 0.1mM ß-Mecaptoethanol: 1000U/ml LIF; 
1000U/ml Pen; 650µg/ml Strep 
 






GMEM; 15% FCS; 1xNEAA; 2mM L-Glutamine; 1mM Na 
Pyruvate; 0.1mM ß-Mecaptoethanol: 1000U/ml LIF; 
1000U/ml Pen; 650µg/ml Strep 
 
1 x 105 /ml 
gelatin 
 
ES Dnmt3b-/- J1 
GMEM; 15% FCS; 1xNEAA; 2mM L-Glutamine; 1mM Na 
Pyruvate; 0.1mM ß-Mecaptoethanol: 1000U/ml LIF; 
1000U/ml Pen; 650µg/ml Strep 
 








GMEM; 15% FCS; 1xNEAA; 2mM L-Glutamine; 1mM Na 
Pyruvate; 0.1mM ß-Mecaptoethanol: 1000U/ml LIF; 
1000U/ml Pen; 650µg/ml Strep 
 
1 x 105 /ml 
gelatin 
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ES Eed-/-  
DMEM; 10% FCS; 1xNEAA; 2mM L-Glutamine; 1mM Na 
Pyruvate; 0.1mM ß-Mecaptoethanol: 1000U/ml LIF; 
1000U/ml Pen; 650µg/ml Strep 
1 x 105 /ml 
feeders 
ES Hdac1-/- E14’ 
DMEM; 10% FCS; 1xNEAA; 2mM L-Glutamine; 0.1mM ß-
Mecaptoethanol: 1000U/ml LIF; 1000U/ml Pen; 650µg/ml 
Strep 
 
1 x 105 /ml 
gelatin 
 
pMEF WT  DMEM; 15% FCS; 1xNEAA; 2mM L-Glutamine; 1mM Na Pyruvate; 1000U/ml Pen; 650µg/ml Strep 1 in 6 





-/-  DMEM; 15% FCS; 1xNEAA; 2mM L-Glutamine; 1mM Na Pyruvate; 1000U/ml Pen; 650µg/ml Strep 1 in 5 
MEF Lsh-/-  DMEM; 15% FCS; 1xNEAA; 2mM L-Glutamine; 1mM Na Pyruvate; 1000U/ml Pen; 650µg/ml Strep 1 in 5 
Fibroblast WT  DMEM; 10% FCS; 1xNEAA; 2mM L-Glutamine; 1mM Na Pyruvate; 1000U/ml Pen; 650µg/ml Strep 1 in 8 
Fibroblast MBD2-/-  DMEM; 10% FCS; 1xNEAA; 2mM L-Glutamine; 1mM Na Pyruvate; 1000U/ml Pen; 650µg/ml Strep 1 in 8 










 DMEM; 10% FCS; 1xNEAA; 2mM L-Glutamine; 1mM Na Pyruvate; 1000U/ml Pen; 650µg/ml Strep 1 in 8 
Neuro2a WT  DMEM; 10% FCS; 1xNEAA0; 1000U/ml Pen; 650µg/ml Strep 1 in 8 
293T WT  DMEM; 10% FCS; 1000U/ml Pen; 650µg/ml Strep 1 in 10 
    
2.2.2 Freezing & thawing
Cell suspensions were frozen in 1ml aliquots of cell culture media supplemented 
with 10% (v/v) dimethyl sulfoxide (DMSO) in liquid nitrogen (N2). To facilitate a 
slow freezing process, cell aliquots were initially frozen at –20ºC for 2hrs, then 
transferred to –70ºC for 24hrs before being deposited in liquid N2. Cells were 
retrieved from liquid N2 by thawing in a 37ºC water bath, followed by dropwise 
dilution of the cell suspension in 10ml pre-warmed (37ºC) culture medium.  The 
cells were collected by centrifugation, to remove the DMSO, and seeded into 25cm2 
culture flasks. Flasks for ES cell culture were pre-coated with sterile 0.1% gelatin in 
PBS or mitomycin C treated primary MEFs (Table 2.1).
Table 2.1. Cell culture conditions and genotypes.
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2.2.3 Cell counting
Cells were harvested into a single cell suspension in PBS for counting. An aliquot of 
10ul was pipetted into a Neubauer haemocytometer (0.1mm depth, 1/400mm2) and 
the cell number in each of four 1mm2  areas was counted, averaged and multiplied by 
104. This number was multiplied appropriately for the dilution in PBS to obtain the 




Cells were seeded at least 24hrs prior to transfection in culture media lacking 
antibiotics and grown to a confluence of 70-80%. Plasmids were transfected into 
cells with lipofectamine 2000 (Invitrogen) in accordance with manufacturer’s 
instructions. Briefly, plasmid DNA and lipofectamine were incubated separately in 
an appropriate volume of Opti-mem (Gibco) for 5 minutes and then pooled with 
gentle mixing. The combined solution was incubated for a further 25 minutes before 
being added directly to cells. Lipofectamine 2000 was used at a ratio of 2.5μl per 
1μg of plasmid DNA except where stated. 
2.2.5 Soft agar growth assay
A basement layer of 0.5% agar (autoclaved) made with DMEM was set into 60mm 
culture plates. 1 x 105 cells in the appropriate culture medium and 0.3% agar were 
plated in suspension on the basement layer and incubated in a humidified atmosphere 
at 37°C. After 12 days, colonies were stained with 0.1% (w/v) crystal violet (in 20% 
ethanol) and counted.  
2.2.6 Poly(HEMA) anchorage-independent growth assay
  
Poly(2-hydroxyethyl methacrylate) (poly(HEMA)) prevents anchorage-dependent 
growth and therefore only transformed cells are able to proliferate on poly(HEMA) 
coated surfaces. To prepare plates, 50ul poly(HEMA) (5mg/ml in ethanol) (Sigma) 
was pipetted into 96-well tissue culture plates and allowed to air-dry at 37°C for 
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24hrs. For control, half the wells contained ethanol only. Coated plates were 
sterilized with ultraviolet (UV) immediately prior to use. For the measurement of 
anchorage-independent cell proliferation, 2.5 x 103 cells (p53-/-, dnmt1-/- p53-/-, 
pMEF, or 293T) were seeded per well, in triplicate, for each time point in a final 
volume of 150ul. The appropriate culture media for each cell type was used but 
phenol red was omitted as it interferes with absorbance readings. At each time point 
for growth to be measured, 15ul 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetra- 
zolium bromide (MTT) (5mg/ml in PBS) was added and the cells were further 
incubated at 37°C for 4hrs. The resulting MTT formazon was solubalised by adding 
SDS to a final concentration of 8% (w/v) and incubated at 37°C for a further 16 hrs. 
Because yellow coloured MTT is reduced to purple formazon only in living (viable) 
cells, measurement of absorbance wavelengths between 520-600nm gives a 
quantitative value for cell proliferation rates. The absorbance was measured at 
570nm and a reference wavelength of 690nm using a microplate reader (FluoSTAR 
optima F). The reference wavelength value was subtracted from the 570nm 
absorbance and averaged across the triplicate wells to give a growth ratio at each 
time-point +/- poly(HEMA). 
2.2.7 5-aza dC treatment and cellular recovery  
 
When cells reached a confluence of 40-50%, the culture media was replaced with 
media containing 1uM or 10uM 5-aza dC (10mM stock in 50% acetic acid solution) 
(Sigma) or control vehicle. Because 5-aza dC is highly unstable in solution, fresh 
media was added every 24hrs during treatment periods. Following treatment, cells 
were either harvested for downstream experiments or further cultured and passaged 
through a recovery period for up to 14 days in the absence of 5-aza dC.  
2.2.8 Differentiation of ES cells into embryoid bodies 
 
Confluent ES cells were trypsinised and diluted in differentiation media (appropriate 
cell media but lacking LIF) to a concentration of  3 x 104 cells per ml. Using a multi-
channel pipette, 120 drops of 20ul (~600 cells/drop) were applied to the lid of a 
100mm2  square bacterial (non-adhesive) culture dish. The lid was inverted over a 
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pool of 10ml PBS and incubated at 37°C. Approximately 4 dishes were required per 
time point for RNA/DNA analysis. After 2 days growth in hanging drops cells had 
aggregated into embryoid bodies (EB).  EBs were collected by washing and soft 
centrifugation, and placed in suspension culture in bacterial dishes for a further five 
days. A half-media change was made every day and EB’s were transferred to a fresh 
bacterial culture dish every second day. At day 7 the EB’s were transferred to a 
mammalian cell culture dish and allowed to adhere. Correct differentiation of EB’s 
was scored morphologically by the presence of rhythmically beating colonies, which 
typically appeared after 9-10 days and represent cardiomyocyte lineage 
differentiation.  
2.2.9 Retinoic acid differentiation of ES cells
 
All ES cells were seeded at a concentration of 1 x 105 per ml in gelatinised T75cm2 
flasks (20,000cells/cm2). After 12 hours growth in the presence of LIF, cells were 
washed twice with PBS and fresh differentiation media supplemented with retinoic 
acid (RA) (10-6M) (Sigma) was added. RA culture media was prepared in low light 
conditions and changed every 24 hours during the treatment period. 
2.2.10 in vitro embryonic gonad culture
The gonads of male and female CD1 mice were dissected from day E13.5 embryo’s 
(n = 30 x male, 32 x female) (Dr Ian Adams). Gonads were incubated on 8cm3 tissue 
culture (T/C) 1% agar blocks made up with PBS in a 35mm culture dish at 37°C. The 
culture dish was filled with PGC media (DMEM, 10% FCS, 2mM L-Glutamine, 
1mM Na Pyruvate; 0.1mM ß-Mecaptoethanol, 1000U/ml Pen; 650μg/ml Strep, 1 x 
Fungizone) and adjusted to just above the level of the upper plane of the T/C blocks. 
Fresh media +/- 1uM 5-aza dC was added every day. Gonads were fixed for in situ 
hybridisation after 48hrs (E15.5) or 72hrs (E16.5) of in vitro growth. 
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2.2.11 Generation of stable cell lines
The plasmid to be integrated was linearised at a unique site in a non-essential region 
for downstream applications (NotI for pZX-hDNMT1C1226Y) and purified by 
phenol/chloroform extraction. Linearised plasmids were transfected into cells with 
either Lipofectamine 2000 or by microporation. Transfected cells were grown for 
48hrs and then split at a ratio of 1 in 20 with the appropriate selection agent (Zeocin 
at 300μg/ml, Puromycin at 2.5μg/ml) added to select for stable integration of the 
plasmid. The optimal concentration of selection agent for selection of low copy 
number integrations was determined by a prior kill curve. Transfected cells were 
maintained under selection for 12 days with fresh media added every 2-3 days. After 
12 days, colonies which had expanded from a single cell clone were scored for the 
presence of absence of GFP which is present in the pZX vector. GFP positive, 
selection resistant colonies were picked, trypsinised and seeded into 96-well plates to 
allow clonal expansion. Once cells had reached sufficient numbers (~1x105 cells) 
they were scored for stable integration by RT-PCR for the gene of interest (hDNMT1 
or hDNMT1C1226Y).   
 
2.2.12 Generation of primary Mouse Embryonic Fibroblasts (MEFs)
E13.5 mouse embryos were dissected into PBS and the embryonic internal organs 
were removed from the abdominal cavity. The embryos were dissociated by 
aspirating into a 10-ml syringe through a fine 16-G needle and expelling the 
contents. Trypsin/EDTA solution was added to 1 x concentration and the cells were 
incubated at 37°C for 5 minutes followed by vigorous pippeting. An equal volume of 
primary MEF (pMEF) culture media was added and the remaining large tissue pieces 
were allowed to settle in a 50ml conical tube. The supernatant was centrifuged and 
re-suspended in 15ml fresh media per embryo. The cell suspension was plated into 
T75cm2  flasks using approximately one embryo per flask and grown until confluent.    
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2.3 DNA preparation and manipulation 
2.3.1 Gel electrophoresis 
 
DNA samples were resolved by horizontal electrophoresis through Hi-pure low EEO 
agarose gels ranging between 0.8-2% supplemented with 0.4μg/ml ethidium 
bromide. For expected DNA fragments <800bp, gels were made in conjunction with 
0.5 x TBE, for DNA fragments >800bp gels were made with 1 x TAE. Samples were 
loaded with the appropriate volume of 6x loading buffer (0.4% orange G, 0.03% 
bromophenol blue, 0.03% xylene cyanol FF, 15% Ficoll® 400, 10mM Tris-HCl (pH 
7.5) and 50mM EDTA (pH 8.0) and the resulting DNA fragment sizes were 
estimated with either GeneRuler 1kb ladder (Fermentas), 0.07-1.2kb ladder (Roche) 
or 100bp DNA marker (Promega)   
2.3.2 DNA  fragment extraction from agarose gels 
 
DNA fragments were purified from gels using the Nucleospin II extract kit 
(Machery-Nagal) according to the manufactures instructions. Briefly, transverse gel 
slices containing the DNA fragment(s) of interest were cut from the gel with a 
scalpel blade and dissolved in 2 gel slice volumes of buffer QT at 50ºC for 10 
minutes. The sample was centrifuged at 11,000g through the silica-gel column 
membrane included in the kit. This column retains DNA with high affinity at the 
elevated salt concentrations used here. Bound DNA was washed twice to remove 
impurities and dried by centrifugation for 1 minute at 11,000g. DNA was eluted with 
15-50μl of 10mM Tris depending on the required final concentration. 
 
2.3.3 Phenol/Chloroform and ethanol precipitation
 
An equal volume of 25:24:1 phenol:chloroform:isoamyl alcohol (50% buffered 
phenol, 48% chloroform [v/v]. 0.5% 3-methyl-1-butanol [v/v] pH >7.8) was added to 
at least 100μl of nucleic acid sample, pulse vortexed and centrifuged at 16,000g for 5 
minutes in a benchtop microcentrifuge. Aqueous and organic components divided 
into phases and the top aqueous layer was taken to the next stage of the process. To 
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remove residual phenol, an equal volume of chloroform was added to the aqueous 
sample, pulse vortexed and centrifuged at 16,000g for 5 minutes. The top aqueous 
phase was recovered and DNA was precipitated by addition of 1/10th volume of 3M 
sodium acetate and 2 volumes of ice-cold ethanol. For limiting quantities of DNA 
(<1μg) 1μl of glycoblue (15mg/ml, Ambion) was added to the precipitation. To 
recover the DNA, the sample was centrifuged at 16,000g for 20 minutes at 4ºC. The 
pellet was washed with 70% ethanol to remove residual salt, re-pelleted by 
centrifugation and left to air-dry at room temperature. The washed pellet was re-
suspended in the desired volume of MilliQ ultrapure dH2O. 
2.3.4 Nucleic acid quantification 
 
The concentration of nucleic acids was measured spectrophotometrically with a 
nanodrop ND-1000. 1μl of sample was loaded and the absorbance of the sample 
measured at a wavelength of 260nm (A260). An A260 value of 50 equal’s 1ug/ml of 
double stranded DNA or 40ug/ml single stranded RNA. A260/A280 and A260/A230 
ratios were recorded to determine the purity of the sample. 
 
2.3.5 pGEM T Easy cloning
 
Because Taq polymerases have a 3’ terminal deoxynucleotidyl transferase activity, 
they frequently add deoxyadenosine to 3’ ends of PCR products. The linearised 
pGEM-T easy vector (Promega) exploits this through having 3’deoxythymidine 
overhangs, which promote efficient ligation of PCR products. Purified PCR product 
was mixed with 50ng pGEM-T easy at an approximately 3:1 molar ratio and 
incubated in 1x ligation buffer (Promega) and 3 Weiss Units of T4 DNA Ligase for 1 




DNA was sequenced with the Big DyeTM terminator v3.1 sequencing kit according to 
the manufacturer’s instructions, with exception that 2μl of Big Dye was used in a 
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10μl reaction instead of 4μl. Products were ethanol precipitated and run on an ABI 
Prism 3730 genetic analyser. Sequence data was analysed with Bioedit Sequence 
Alignment Editor v9.0.9. 
 
2.3.7 in vitro methylation
Plasmids were incubated at 37ºC for 2hrs with the appropriate bacterial methylase 
and buffer (NEB) supplemented with 160μM S-Adenosyl methionine (SAM) or 
32μM SAM for HhaI methylase. The breakdown product of SAM, S-adenosyl-L-
homocysteine (SAH), inhibits the methyltransferase reaction. To shift the 
equilibrium towards driving the reaction, fresh SAM was added after 2hrs and the 
sample incubated for a further 1hr at 37ºC. Products were purified by 
phenol/chloroform extraction (Section 2.2.1) and the in vitro methylation was 




Samples were run on a large 1% agarose gel at 4°C and post stained with ethidium 
bromide. The gel was washed twice for 15 minutes in denaturing SS1 solution (0.5M 
NaOH, 0.5M NaCl) and then twice in neutralising SS2 solution (0.02M NaOH 1M 
AmmAc). The gel was pre-soaked in 20 x SSC and the DNA was transferred to a 
positively charged nylon membrane (Pal) overnight by capillary action. The 
membrane and gel were placed between Whatman paper saturated in 20 x SSC with 
the lower surface dipped into a reservoir of 20 x SCC. To draw the buffer upwards 
and transfer the DNA to the membrane, a wad (~15cm thick) of dry towels and 
weight was placed on the upper Whatman. Following confirmation of successful 
transfer, the membrane was baked at 80°C for at least 3 hours to immobilize DNA. 
The  "  " # 32P] dCTP (50uCi, GE Healthcare) labelled 
pMR150, which hybridises to mouse minor satellite. Membranes were exposed on 
phosphor screens and visualised with a FLA-5100 phosphorimager (reytek) and 
Advanced Image Data Analyser (AIDA) version 3.44.035.  
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2.4 RNA preparation and analysis 
2.4.1 Isolation and purification of RNA 
 
When cell numbers were not limiting (>1 x 104), Trizol reagent (Invitrogen) was 
used to purify RNA. Trizol was either added directly to cells in culture (after 
removing media) (1ml per 25cm2) or used to re-suspend trypsinised embryonic 
tissue. Trizol is a monophasic solution of phenol and guanidine isothiocyanate which 
disrupts cells and cell components while maintaining the integrity of RNA. After 2 
minutes at room temperature to disrupt nucleoprotein complexes 1/10th volume of 
bromochloropropane (BCP) was added and the solution mixed vigorously for 15 
seconds. Separation of the aqueous and organic phases was achieved by 
centrifugation at 12,000g for 15 minutes at 4°C in a microfuge. The RNA containing 
upper, aqueous phase was transferred to a fresh RNase free eppendorf and 
precipitated with an equal volume of isopropanol (and 1ul glycoblue (Ambion) for 
limiting quantities of RNA) for 10 minutes at room temperature. RNA was pelleted 
by centrifugation at 12,000g for 12 minutes and washed with 75% ethanol before re-
suspension in RNase-free ultra-pure MilliQ dH2O and long-term storage at –80°C.
For RNA isolation from small cell numbers (<1 x 104), such as flow sorted E10.5 
germ cells, the RNeasy mini kit (Qiagen) was used according to the manufacturer’s 
protocol 
2.4.2 Preparation of cDNA 
 
For the generation of complimentary DNA (cDNA) all RNA samples were DNase 
treated with Turbo DNA-free DNase (Ambion) according to the manufacturer’s 
instructions. Where possible, 5ug RNA was used in each DNase reaction. First strand 
cDNA synthesis was carried out with superscript II or superscript III reverse 
transcriptase (RT) (Invitrogen) and was primed with random hexamers. For a 20ul 
reaction, ~1.5ug DNased RNA, 150ng random primers and 1ul dNTPs (10uM) were 
heated to 65°C for 5 minutes. This reaction was then supplemented with first strand 
buffer (to 1x), 1ul DTT (0.1M), 1ul RNase inhibitor (Promega) and 200U 
Superscript III RT and incubated at 25°C for 5 minutes, 50°C for 1 hour and 70°C 
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for 15 minutes to heat in activate the RT. In parallel a reaction of pooled RNA’s 
without RT was performed as a control for contaminating DNA or template aerosols. 
Reverse transcribed cDNA’s were diluted to 50ul with ultra-pure MilliQ dH2O and 




To determine RNA transcription levels from genes, RT-polymerase chain reaction 
(RT-PCR) was used. RT-PCR was performed with 1.75mM MgCl2, 0.25uM each 
primer, 200nM dNTPs, 1 x PCR buffer (20 mM Tris-HCl (pH 8.4), 50 mM KCl.) 
and 1U platinum Taq (Invitrogen) using the first strand cDNA as a template. 
Platinum Taq  is complexed with a proprietary antibody until heat-activated and 
therefore doesn’t promote primer-dimer formation, which can strongly influence 
PCR kinetics. RT-PCR parameters were specific for primer sets (Appendix 1) but the 
majority were designed to perform optimally under these cycling conditions:  
 
95°C for 2 minutes 
94°C for 15 seconds 
 56°C for 20 seconds          18-35 cycles 
72°C for 25 seconds 
  72°C for 10 minutes
2.4.4 microRNA detection and quantification
 
Testis specific microRNA’s (miRNA) were analysed using the High-Specificity 
miRNA qRT-PCR Detection Kit (Stratagene) according to the manufacturer’s 
instructions. Briefly, 500ng total RNA was polyadenylated at the 3’ end with poly A  
polymerase (PAP), to elongate short miRNAs. As a control, parallel reactions were 
carried out without PAP. Polyadenylated or control RNA was then used as a template 
for first strand cDNA synthesis with the reaction primed by an RT adapter primer 
that anneals to the 3´ poly-A tail. The RT adaptor primer contains additional bases 
that create a universal sequence tag at the 5´ end of each cDNA. For quantitative 
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detection of miRNA targets, real-time qPCR (EvaGreen) (Stratagene) was used with 
a universal reverse primer that binds to the universal tag at the 5’ end of cDNAs. The 
specificity of the qPCR reaction was provided by the miRNA-specific forward 
primer. This primer was designed to be identical in sequence and length to the 
miRNA of interest. However, to ensure mispriming to similar miRNA’s was 
avoided, a bioinformatic analysis of all known mouse miRNA’s was completed to 
identify testis-specific miRNA’s that differ from all other miRNA’s by at least 2 
nucleotides in the 3’ region and 3 nucleotides in total. A further analysis with 
Stratagene’s online miRNA primer design guide was also undertaken to ensure 
specificity. For miRNA microarray analysis, total RNA extracted from each cell line 
was quantitated and analysed for integrity. Labelling and hybridisation to the custom 
miRNA expression array was performed at Leicester University (Dr Emma Wade).
2.4.5 Whole mount In situ hybridisation
 
Whole mount in situ hybridization was carried out with Tex19 3’UTR cRNA probes 
labeled with digoxigenin For probe generation, full-length Tex19 3'-UTR was 
transcribed from the T7 or SP6 promoters of linearised plasmid (pGemTEasy-
Tex193’UTR) to generate sense and antisense transcripts respectively. The 
transcription reaction was carried out with 500ng linearised plasmid, T7 or SP6 
polymerase, appropriate transcription buffer and the DIG RNA labeling kit (Roche) 
according to manufacturer’s instructions for 2 hours at 37°C. RNAs were purified by 
phenol/chloroform extraction and ethanol precipitation and aliquoted with DEPC 
treated MilliQ ultrapure dH2O.  
 
For in situ hybridization freshly dissected E13.5 gonads or in vitro cultured E15.5 
and E16.5 gonads were fixed in 4% paraformaldehyde (PFA) (in PBS) at 4°C 
overnight. Fixed gonads were washed twice with PBS then dehydrated through 50% 
methanol (in PBS 0.1% tween (PBSt)) and 100% methanol washes and stored at        
-20°C for less than 1 month.  Gonads were rehydrated through sequential washes of 
75%, 50%, 25% methanol (in PBSt) and twice with PBSt. Rehydrated embryo’s 
were incubated with 10ug/ml Proteinase K (PBSt) for 14 minutes, washed, and post-
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fixed with 4% PFA / 01% glutaraldehyde. Gonads were incubated with 1:1 
PBSt/hybridization mix and then hybridization mix (50% Formamide, 1.3x SSC, 
5mM EDTA, 50ug/ml Yeast RNA, 0.2% Tween-20, 0.5% CHAPS, 100ug/ml 
Heparin in DEPC dH2O) for 5 minutes. The gonad samples were then incubated with 
fresh hybridization mix for 1 hour at 68C before pre-warmed hybridization mix with 
1ug/ml DIG-labeled cRNA probe was added and incubated with rocking at 68C 
overnight.  Probe bound gonads were washed 4 x 30mins with prewarmed (68°C) 
hybridization mix and 4 x 30 minutes with MABT (100mM maleic acid, 150mM 
NaCl, 0.15 Tween-20 in DEPC in dH2O, pH7.5).  
 
Samples were incubated with MABT / 2% Boehringer blocking reagent (BBR) for 1 
hour, then 1 hour with MABT / BBR / 20% heat treated sheep serum. Following this 
a 1/2000 dilution of AP anti-DIG antibody (Boehringer) was added to gonads with 
fresh MABT / BBR / 20% serum and incubated overnight at 4°C.  Gonads were then 
rinsed and washed 3 x 1 hour with MABT and 2 x 15 minutes with NTMT (100mM 
NaCl, 100mM Tris pH 9.5, 50mM MgCl2, 1% Tween-20 in DEPC dH2O). To 
develop colour gonads were incubated with 1.5ml NTMT with 4.5ul/ml NBT 
(75mg/ml in DMFO) and 3.5ul/ml BCIP (X-phosphate; 50mg/ml in 70% DMFO) for 
1 hour to 5 hours in the dark. Once colour developed gonads were rinsed with PBSt 
and re-fixed in 4% PFA at 4°C overnight.
2.5 Protein preparation and analysis 
2.5.1 Cell extracts
Whole cell protein extracts were prepared by washing cells in PBS and adding an 
appropriate volume of Lammelli buffer (2% SDS, 10% glycerol, 5% 2-
mercaptoethanol, 0.004% bromphenol blue and  60mM Tris HCl, pH 6.9). The 
solution was sonicated briefly to shear chromatin and boiled for 5 minutes at 95°C to 
denature proteins. Alternatively for cleaner protein extracts, washed cells were 
incubated for 15 minutes on ice in RSB-150t (0.1% tween) and spun at 4,500g for 8 
minutes to (remove histones and cell component debris). The supernatant was taken 
and glycerol added to a 10% final concentration, before storage at –20°C   
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2.5.2 SDS-PAGE 
 
Cell protein extracts were resolved by denaturing sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS-PAGE). Briefly, a separating gel with 10-
12% acylamide (v/v), 375mM Tris-HCl (pH8.8), 0.1% SDS (w/v), 0.075% 
Ammonium persulphate (APS) (w/v),  0.15% N, N, N’, N’-Tetramethylethylene-
diamine (TEMED) (v/v) was prepared and allowed to set with a isopropanol overlay. 
Acrylamide was from 30% (29:1 acrylamide/bis-acrylamide (w/v)) stock (Severn 
Biotech). The isopropanol was rinsed away and a 4% acrylamide stacking gel with 
125mM Tris-HCl (pH 6.8), 0.1% SDS (w/v), 0.15% APS (w/v), 0.3% TEMED (v/v) 
was set on top with loading wells. Samples and pre-stained protein ladder 
(Fermentas) were loaded and the gel run in SDS-PAGE running buffer (25mM Tris-




Following protein separation by SDS-PAGE the stacking gel was removed and 
proteins were transferred to a nitrocellulose membrane (Amersham Hybond ECL) 
with a genie blotter (Idea Scientific) in transfer buffer (25mM Tris, 200mM Glycine, 
20% methanol) according to the manufacturer’s instructions. For proteins >150kDa, 
transfer buffer was reduced to 10% methanol and 0.1% SDS was added. Following 
transfer for ~45 minutes at 30amps membranes were blocked in 4% non-fat dry milk 
proteins (in PBS) (Marvel) for 1 hour at room temperature. Primary antibodies (anti-
Tex19 1:100 (Dr Ian Adams), anti-Dnmt1 1:1500 (Abcam), anti-Tubulin 1:2000, 
anti-T7 1:10,000 (Novagen)) were added at the appropriate dilution in fresh 1% milk 
proteins (in PBS / 0.2% tween (PBSt)) and incubated overnight with agitation at 4°C. 
Membranes were washed 3 x 5 minutes in PBSt before addition of the appropriate 
secondary antibody conjugated to horse-radish peroxidase in 1% milk proteins/PBSt 
for 1 hour at room temperature with constant agitation. Non-bound antibody was 
washed 3 x 15 minutes with PBSt and membranes were developed using 
chemilumuminescent detection (SuperSignal Western Pico Reagent, Pierce) for 5 
minutes. Signals were exposed on ECL Hyperfilm (Amersham-Pharmacia).
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2.6 Experimental procedures 
2.6.1 Real-Time quantitative PCR (qPCR)
 
Quantitative PCR analysis of cDNA or DNA fragments generated from ChIP was 
performed with Brilliant qPCR mastermix II (Stratagene) in a CFX96 qPCR 
thermocycler (Biorad). Reactions of 25ul were composed of 12.5ul mastermix, 1-2ul 
sample, 0.25uM each primer in MilliQ ultrapure dH2O. For every primer set, 
standards were created through 10-fold serial dilutions of input (ChIP) or a high 
expressing sample (qRT-PCR). Standards and samples were performed in duplicate 
according to the following cycling parameters: 
 
95°C for 10 minutes 
94°C for 15 seconds 
 56C for 15 seconds           18-35 cycles 
72°C for 20 seconds 
  60°C-95°C melt curve analysis 
 
 
After each 72°C extension, the fluorescence was measured and used to calculate the 
cycle number at which each standard and sample crossed a fluorescence threshold 
(Ct). As the Ct of a reaction is determined linearly by the amount of template present 
at the beginning, relative quantification can be achieved by normalising to a 
reference gene (such as Gapdh) and a standard curve. The standard curve was 
constructed by plotting the log of the dilution factor (log10) of standards against the 
Ct value obtained during amplification of each dilution. This allowed two outcomes. 
Firstly, the equation of the linear regression line, along with Pearson’s correlation 
coefficient (r), could be used to evaluate whether the qPCR assay was optimised. For 
a primer set to be considered optimised they should have produced an r >$-0.99$	
and an amplification efficiency between 90-105%. Secondly, the efficiency of both 
the target and reference primer set, as determined by correlation and linear 
regression, allowed the use of the stringent Pfaffl equation for determination of 
          77
normalised relative gene expression (Fleige & Pfaffl, 2006) This equation can be 
expressed as such: 
 
         (Etarget)*	@– sample) 
     (Eref)*	– sample) 
 
The Pfaffl method, unlike other methods, takes into account that the target (gene of 
interest) does not have the same amplification efficiency as the reference 
(normalisation gene) and therefore gives more accurate and reproducible results. 
Relative gene expression was determined based on the Pfaffl equation using CFX96 
manager and Excel 97. To ensure specific priming, a melt curve analysis was 
performed at the end of each qPCR to determine whether one or several products had 
been generated. Only reactions in which one product, of the expected melting 
temperature, was generated were used for further analysis.  
 
2.6.2 Plasmid constructs
In general, plasmid constructs were cloned via directional sticky end digestion and 
ligation using the rapid ligation kit (Roche). hDnmt1 was cloned into pZX in frame 
using the XbaI and MluI sites of pZX-Luc. Because hDNMT1 contains an internal 
XbaI site, I used Spe1 to digest DNMT1, which creates a complimentary overhang to 
Xba1, but eradicates the overall restriction site when cloned. An additional T7 tag 
and kozak sequence was incorporated into the forward primer sequence. The 
Xenopus Kaiso zinc-finger domain and GCNF were cloned into pVP16 in frame 
using the EcoR1 and XbaI sites. Germline specific promoters were cloned into 
pGL3-basic using MluI and BglII sites. 
2.6.3 Isolation of mouse germ cells by fluorescent activated cell sorting (FACS)
Matings of heterozygous mice carrying an Oct3/4 promoter cassette driving a GFP 
transgene, which is a specific marker for germ cells in post-blastocyst embryos, were 
set up.  The hindgut of E9.5 embryos and the gonads of E10.5 and morphologically 
sexed E13.5 embryos were dissected in PBS. Samples were trypsinised for 3 minutes 
Ratio = 
          78
and dissociated into a single cell suspension by pippeting and filtering through a 
40um membrane. Cells were re-suspended in a 5% FCS/ PBS solution. Flow 
cytometric cell sorting was performed using a BD FACSAriaII SORP (Becton 
Dickinson). The 488nm laser was used for measuring forward scatter, side scatter 
and GFP fluorescence (525/50nm bandpass filter). BD FACSDiva software (Becton 
Dickinson, Version 6.1.2) was used for instrument control and data analysis. A clear 
bi-modal distribution was observed with GFP expressing germ cells fluorescing >103 
orders of magnitude higher than testis somatic cells. GFP positive germ cells and 
GFP negative somatic cells were sorted into aliquots of 400 cells and at E13.5, 
additional aliquots of 4,000 cells. Aliquoted cells were gently pelleted, snap frozen 
and stored at –80°C. At E9.5 there were ~500 germ cells per embryo, at E10.5 ~1000 
germ cells per embryo and at E13.5 ~10,000 germ cells per embryo.  
2.6.4 Luciferase-reporter assays 
Plasmids were transfected into cells in a 24 well plate as described. All wells 
received 30ng thymidine kinase driven renilla luciferase (Tk-Rn) and 250ng of 
firefly luciferase driven by a germline-specific promoter cassette. For other firefly 
luciferase plasmids see appendix.  If cells were co-transfected with effector plasmids 
there were either control wells with empty plasmid or, where a dose curve was used, 
each well was balanced to have the same total amount of plasmid DNA. After 24 
hours cells were harvested and assayed for luciferase expression with the Dual 
Luciferase Assay kit (Promega) according to the manufacturer’s instructions. 
Fluorescence readings were made with a Lumat LB 9507 tube luminometer 
(Berthold Technologies). To account for variations in cell viability and transfection 
efficiency firefly luciferase was normalised to Tk-Rn.   
2.6.5 Native chromatin immunoprecipitation (n-ChIP)
 
A total of 5 x 107 cells were harvested, washed in ice cold PBS and re-suspended in 
NBA/B buffer (85mM NaCl, 5.5% Sucrose, 10 mM TrisHCl  pH 7.5, 0.2 mM 
EDTA, 0.2 mM PMSF, 1 mM DTT, 0.05% NP40, 1X Protease Inhibitors) for 3 
minutes on ice to disrupt cell membranes. Nuclei were centrifuged at 2,500rpm for 4 
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minutes at 4°C and re-suspended in NBR (85 mM NaCl, 5.5% Sucrose, 10 mM 
TrisHCl  pH 7.5, 3 mM MgCl2, 1.5 mM CaCl2, 0.2 mM PMSF, 1 mM DTT) and re-
centrifuged at 2,500rpm for 4 minutes at 4°C. Chromatin concentration was 
determined after a 5 minute DNase I digestion and measurement of the A260 with a 
spectrophotometer and diluted to 1ug/ul in 500ul aliquots. Chromatin aliquots were 
treated with 1ul RNase A/T1 cocktail (Ambion) for 5 minutes and then digested with 
micrococcal nuclease (MNase) at an optimal predetermined concentration (14U for 
p53-/- (P) and Dnmt-/- Trp53 -/- (DP) cells ) for 10 minutes at room temperature. At 
this concentration penta-nucleosomes were just visible by EtBr staining. The reaction 
was stopped by adding an equal volume of RBB buffer (215 mM NaCl, 10 mM 
TrisHCl pH 8, 20 mM EDTA, 5.5 % Sucrose, 2 % TritonX 100, 0.2 mM PMSF, 1 
mM DTT, 2X Protease Inhibitors) and chromatin was released from nuclei overnight 
on ice. 
 
The following day the sample was centrifuged at 5,000rpm for 5 minutes and the 
supernatant, containing the released chromatin, was transferred to a new tube. 1/10th  
of the sample was kept at –20°C as the input. Prewashed and blocked protein G 
beads (Amersham) in a 1:1 slurry with blocking solution (0.5% BSA in PBS) were 
added to the chromatin and rotated for 2 hours at 4°C and the pelleted to pre-clear 
chromatin of non-specific interactions with beads. In parallel, 60ul of slurry was 
suspended in 200ul block solution with 2-10ug antibody and rotated for 2 hours at 
4°C. 1ml of precleared chromatin (50-150ug) was added to the antibody bound beads 
and the immunoprecipitation (IP) carried out for 3hrs at 4°C. Following this, pre-
optimised washes were carried out appropriate to the antibody used.  Washed, 
immunoprecipitated material was eluted from the beads twice with 75ul elution 
buffer (0.1 M NaHCO3, 1 % SDS) at 30°C with vortexing. The eluted sample and the 
input were treated with 40ug proteinase K for 1 hour at 55°C and all samples were 
purified with the QiaQuick kit (Qiagen) according to the manufacturer’s instructions. 
The relative enrichment of immunoprecipitated samples was calculated by real-time 
qPCR using the 1/10th input to construct a standard curve. Enrichment is expressed 
as a percentage of total input.   
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2.6.6 Crosslinking chromatin immunoprecipitation (x-ChIP)
Cells were washed twice in ice cold PBS and crosslinked with 1% PFA (in PBS) for 
12 minutes at room temperature with gentle agitation. The crosslinking reaction was 
stopped by addition of glycine to a final concentration of 125mM. Fixed cells were 
washed twice with PBS and NCP buffer (200 mM NaCl, 1 mM EDTA, 0.5 mM 
EGTA, 10 mM Hepes pH=6.5, 0.25% Triton X-100) and re-suspended in 500ul SDS 
lysis buffer (50 mM Tris-HCl pH=8.1, 10 mM EDTA, 0.5% NP40, 1% SDS). 
Lysates were sonicated with a Biorup tor NG (Diagenode) to shear DNA to ~200bp-
1500bp for 3.5 minutes with 30 second on/off pulses on high as pre-determined by 
optimization.  Sonicated samples were centrifuged at 10,000g for 10 minutes to 
remove cellular degree and 1/10th inputs were removed. 225ul of IP buffer (20 mM 
Tris-HCl pH=8.1, 150 mM NaCl, 2 mM EDTA, 0.1% Triton X-100 (v/v), Protease 
inhibitors) was added to 125ul of chromatin suspension and precleared with 50ul 1:1 
protein G bead (Amersham) slurry and 5ug single-stranded salmon sperm DNA 
(ssssDNA) (Sigma) for 2 hours with rotating at 4°C. Preclearded supernatant was 
supplemented with 100ul IP buffer and 1-5ug appropriate antibody and 
immunoprecipitated overnight at 4°C with rotation. The following day, 50ul protein 
G slurry and 2ug ssssDNA was added to each IP and incubated for a further 2-3 
hours. Following this, pre-optimised washes were carried out appropriate to the 
antibody used. Washed, immunoprecipitated material was eluted from the beads 
twice with 75ul elution buffer (0.1 M NaHCO3, 1 % SDS (w/v)) at 30°C with 
vortexing and crosslinks were reversed by incubation at 67°C overnight. Samples 
were purified and quantitated as N-ChIP (Section 2.6.5).
2.6.7 5’ Rapid amplification of cDNA ends (5’ RACE)
The transcription start site(s) (TSS) of Tex19 were determined with the 5’ Rapid 
Amplification of cDNA Ends (5’RACE) kit v2.0 (Invitrogen) according to the 
manufacturer’s instructions. Briefly, first strand cDNA was synthesised from total 
RNA with a Tex19 specific upstream reverse primer (5’-TGACTCTGACAAGT 
ATTCC-3’). A homoploymeric cytosine tail was then added to the 3’ end using 
terminal deoxynucleotidyl transferase (TdT). The 5’ region of the Tex19 transcript 
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could then be PCR amplified using a nested Tex19 primer (5’-CTCTTGCCAGTC 
TCCCATCTC –3’) and a deoxyinosine-containing anchor primer which anneals to 
the poly-cytosine tract and contains a 5’ anchor tag. Nested PCR with a second 
nested Tex19 primer (5’-TGGTACAGCCATGCCTCATAG-3’) and an abridged 
anchor primer gives a specific product (of expected size 350bp) that contains the 5’ 
TSS of Tex19 in each sample. This PCR product was cloned into pGEM-T easy and 
sequenced with Sp6 polymerase.  
  
2.6.8 Bisulphite sequencing analysis
 
The methylation status of genomic CpGs was assayed by bisulphite sequencing with 
the EZ DNA Methylation Gold kit (Zymo Research) following the included protocol. 
This method distinguishes methylated from unmethylated CpG’s as unmethylated 
cytosines are converted to uracil in the presence of bisulphite whereas methylated 
CpG’s are protected. DNA sequencing can then identify unmethylated (thymine) and 
methylated (cytosine) CpGs, respectively. Where possible, 400ng genomic DNA was 
bisulphite treated with CT conversion reagent under the following conditions; 98C 
for 10minutes, 65°C for 2.5 hours, 4°C 1-12 hours and desulphinated through a silica 
column. Purified DNA was PCR amplified with bisulphite primers specific to the 
region of interest (Appendix 1) for 30 cycles. Where necessary, nested PCR using 
1/50th of the first PCR reaction was carried out for a further 20-35 cycles. PCR 
products of the expected size were gel purified, cloned into pGEM-T-Easy and 
 !E.coli. Colonies with an insert (white) where mini-prepped 
and sequenced with Sp6 polymerase. Bisulphite sequences were analysed for 
methylation status using Bioedit Sequence Alignment Editor v9.0.9 using published 
reference DNA sequences (Ensembl).  
 
For bisulphite analysis of limiting numbers (<1 x 104) of FACS sorted germ or testis 
somatic cells, an alternative method was used. Pelleted cells were directly lysed by 
addition of 20ul BS Prep buffer (20ug/ul Proteinase K, 1% SDS) at 56ºC for 1 hour. 
This solution was then added directly to CT conversion reagent and the protocol as 
above was followed. 
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2.6.9 Promoter-specific in vitro methylation
 
Plasmids containing the promoter of interest were in vitro methylated as described 
(Section 2.3.7). Following purification, the methylated promoter fragment control 
unmethylated fragments were digested out of the plasmid (pGL3-basic) with two 
unique site restriction endonucleases (KpnI and HindIII). The promoter fragments 
were purified by gel extraction and ligated back into unmethylated backbone vector 
(pGL3-basic) cut with KpnI and HindII with the rapid ligation kit (Roche). To 
identify re-insertions, plasmids were linearised at a non-functional site (SalI) and 
resolved on an agarose gel. Plasmids containing a methylated or control 
unmethylated promoter fragment were identified by size and by co-running a 
linearised starting plasmid. Plasmids of the appropriate size were gel extracted and 
purified by phenol/chloroform and ethanol precipitation. Approximately 15-20ng of 
plasmid containing a specifically methylated promoter region or control was 
obtained through each run. Once equalised, 10ng was transfected into each 24 well 
plate for luciferase reporter assays. 
2.6.10 Immunofluoresence
 
Cells were placed on poly-lysine coated slides in a humidified atmosphere for 20 
minutes or grown on ethanol-sterilized cover slips. For immunofluoresence, cells 
were fixed with 4% PFA for 10 minutes and washed twice with PBS before being 
permeabilised with 0.1% Triton-X (in PBS) for 10 minutes. Samples were blocked 
with 5% Donkey serum (in PBSt-Azide-BSA) for 1 hour and washed with PBS prior 
to addition of primary antibody in blocking solution for 1 hour at room temperature 
Antibodies were: rabbit anti-Oct4 (2μg/ml) (abcam - ab18976), rabbit anti-Nanog 
(3ug/ml) (Dr Ian Chambers), rabbit anti-Tex19 (5ug/ml) (Dr Ian Adams). Cells were 
washed three times in PBS and incubated with the appropriate secondary antibody 
(1:2000) (Alexa Fluor 488 or 594, Invitrogen) for 30 minutes. Following three final 
washes with PBS cells were stained with DAPI and mounted in Vectashield. Cells 
were visualised using a Zeiss Axioplan II fluorescence microscope with Plan-
neofluar objectives. Image capture and analysis were performed using in-house 
scripts written for IPLab Spectrum (Scanalytics Corp, Fairfax, VA). 
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2.6.11 Expression microarray
 
Total RNA was extracted from each cell line at two time points six days apart for 
biological replicates. The integrity of RNA samples was confirmed quantitatively by 
on-chip electrophoresis using the Bioanalyzer 2100 (Agilent). Biotinylated cRNA for 
hybridisation to Mouse Ref-8 v2 or Mouse Ref-6 v2 Expression BeadChips 
(Illumina) was generated using the TotalPrep RNA Amplification kit (Illumina) 
according to the manufactures instructions. Briefly, 250ng total RNA was used to 
synthesise double stranded DNA (dsDNA). Purified dsDNA was used as a template 
for in vitro transcription of biotin labelled cRNA for 6 hours at 37°C. Biotinylated 
cRNA was purified through filter cartridges and re-analysed using the Bioanalyzer 
2100 to confirm integrity. cRNA was adjusted to 150ng/ul and 5ul of each sample 
was hybridized to BeadChip expression arrays (performed by the Wellcome Trust 
Clinical Research Facility, Edinburgh).  Each biological replicate was synthesised in 
duplicate as technical replicates so that for each sample there were two biological 
replicates each of which had two technical replicates (n = 4 per sample).  
2.7 Bioinformatics and statistics
2.7.1 Microarray analysis
The raw data generated from microarray analysis was analysed with Beadstudio 
Gene Expression Module v3.4 (Illumina) using an average normalization with 
background removal. For differential expression analysis a t-test error model with 
multiple testing corrections using Benjamini and Hochberg false discovery rate was 
applied. The relatively high number of replicates used enabled high confidence 
multiple corrected t-test significance values. However in effect, this produced 
significant t-test differential values for genes with low fold-changes (e.g. >1.2 fold 
for high expressing genes).    
 
As a primary filter to determine genes significantly differentially expressed between 
samples I imposed a >6-fold expression change threshold. To determine fold-
changes I initially normalized and ranked transcripts according to the detection p-
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value, which is calculated based on signals of negative controls. The detection p-
value is calculated as 1-R/N, where R is the rank of the gene signal relative to 
negative controls and N is the number of negative controls. The detection p-value 
(set here as p <0.05)  can be interpreted as the probability of seeing a certain signal 
level without specific probe-target hybridisation. To generate fold-changes it was 
necessary to transform normalised and ranked data to account for negative 
expression signals. Thus, the expression signal (E) at which transcripts were 
considered statistically detected (p <0.05) was determined and all expression signals 
in the control sample (wild-type) >6-fold below E were normalised to a value equal 
to E/6. Expression fold-changes between samples were ranked and filtered according 
to detection (p <0.05) of the transcript in at least one sample. 98.2% of transcripts 
that recorded a >6-fold differential expression change were significant (t-test p 
<0.05) and 92.3% were highly significant (t-test p <0.01).      
2.7.2 Gene ontology (GO) and bioinformatic analysis
 
Functional annotations were performed using the program Database for Annotation, 
Visualization, and Integrated Discovery (DAVID) 2007 (Dennis et al. 2003). All 
analyses presented in this thesis used the same DAVID parameters. These parameters 
were Gene Ontology (GO) Biological Process, level 1 and 3, normalised to Illumina 
BeadChip v2 Ref-6 or Ref-8 backgrounds. The EASE p-value threshold was set at 
0.05, with a minimum number of 5 genes in the ontology category. Benjamini and 
Hochberg multiple testing corrections were determined but not applied as each gene 
can contribute to multiple ontologies and therefore does not produce a binary  
outcome. For tissue specificity analysis, DAVID v6 was used with a p-value 
threshold set at 0.05. Venn diagrams were generated with GeneVenn 
(http://www.bioinformatics.org/gvenn/index.htm). 
  
2.7.3 RT-PCR primer design
 
RT-PCR primers were designed using complimentary DNA sequences obtained from 
the ensembl genome browser. Primers were designed using Primer3 software 
(http://frodo.wi.mit.edu/primer3/) using the rodent and simple mis-priming library to 
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avoid generation of primers in degenerate or repetitive regions. Where possible 
primers were designed to overlap at least one exon-exon junction (intron-spanning) 
with a 3’ terminal GC clamp. Generally primer PCR products were between 100 and 
350bp. For quantitative RT-PCR some primer sets were retrieved from primerbank 
(http://pga.mgh.harvard.edu/primerbank/) (Spandidos et al., 2009), which contains 
sets of experimentally validated primers for 27,681 mouse genes. Primer sets 
retrieved from here were additionally validated through Primer3 and confirmed to be 
intron- spanning. All primer sets used in this thesis are shown in the Appendix 1. 
2.7.4 Bisulphite primer design 
Promoter sequences, obtained from the Ensembl genome browser, were uploaded 
and in silico bisulphite converted. Primers for bisulphite analysis were then designed 
with the Bisearch Primer Design and Search Tool (http://bisearch.enzim.hu/) using 
default settings. Sequential nested primer sets were selected based on the threshold 
score, which takes into account multiple amplification efficiency variables, and on 
the product size and genomic location of primer sets. Bisulphite primer sets are 
shown in Appendix 1.  
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Chapter 3




The precise functional roles of DNA methylation in mammals are far from 
determined. The current dogma predicts methylation of CpG dinucleotides silences 
some repetitive elements (Walsh et al., 1998), has an important but secondary role in 
X-inactivation (Lock et al., 1987; Heard et al., 1997) and appears to be the primary 
mark directing mono-allelic expression of embryonic imprinted genes (Murrell et al., 
2004; Bartolomei, 2009). However, the extent to which promoter methylation is the 
primary mechanism of repression at single-copy loci is unknown. While many 
studies have demonstrated correlative relationships between gene expression and 
CpG methylation, currently there are no examples in the literature of genes directly 
and unequivocally regulated by DNA methylation in vivo. 
  
As part of a strategy to identify and characterise genes regulated by DNA 
methylation, an initial set of candidate loci must be derived. The fundamental aim of 
this chapter is thus to identify novel candidate genes putatively regulated by 
promoter CpG methylation. These genes will then be used as targets for 
comprehensive cause and effect analyses in subsequent chapters. The method used to 
derive candidate genes here is of crucial importance. A balance must be struck 
between inclusion and specificity to eliminate false-positives yet include what could 
potentially be a very small number of bona fide methylation-dependent genes. 
Previous studies have identified candidates by screening for genes that are 
differentially methylated during development (Maatouk et al., 2006; Ng et al., 2008) 
or tissue-specifically (Suzuki et al., 2007; Shen et al., 2007; Weber et al., 2007;). 
However, it is not clear in these reports whether the observed changes in DNA 
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methylation are directed by other upstream epigenetic mechanisms or indeed, 
whether differential methylation is a cause or a consequence of transcriptional 
activity. Moreover, due to the restricted number of tissues or time points that can be 
tested, only a limited number of candidates can be identified. Another approach to 
identify methylation-dependent candidate genes is to examine the expression profile 
of ES (Fouse et al., 2008) or somatic cells (Jackson-Grusby et al., 2001) lacking 
DNA methyltransferases. This method identifies a large number of mis-expressed 
target genes but the majority would be predicted to be false-positives or indirect hits 
as a result of global changes in transcription factor networks and/or other epigenetic 
modifications. This hypothesis is borne out through in silico analysis of the 
upregulated genes, which demonstrates ~75% are associated with CpG island 
promoters which are unmethylated prior to Dnmt1 inactivation. It is therefore unclear 
which, if any, of the genes upregulated in genetic studies would be candidates for 
direct regulation by promoter DNA methylation per se.  
 
In this chapter I have used a novel combination of genetic and biochemical analyses 
of gene expression patterns to identify candidate genes regulated by DNA 
methylation. By cross-referencing candidate genes from three independent 
experimental approaches, this method enriches for targets that consistently respond 
to different functional assays that test the role of DNA methylation in maintaining 
gene silencing. This combination of complementary approaches is predicted to 
reduce indirect hits and false-positives, and therefore select for bona fide candidate 
genes. In summary, through requiring candidate genes to satisfy several successive 
experimental predictions and employing highly stringent thresholds, I have generated 
a novel set of candidate genes potentially regulated by promoter CpG methylation for 
downstream analysis in future chapters.  
 
3.2 Mouse Embryonic Fibroblasts lacking Dnmt1 are globally 
hypomethylated 
 
As the first experimental approach to identify candidate loci I utilised Dnmt1, Trp53 
double-null mouse embryonic fibroblasts (MEFs) that have been reported to be 
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globally hypomethylated (Lande-Diner et al., 2006). Because the absence of Dnmt1 
in somatic cells induces p53-mediated apoptosis it is necessary to inactivate p53 
(encoded by Trp53) in these MEFs. To control for this, MEFs lacking only p53 were 
used (both cell lines were a kind gift of Prof. Howard Cedar). For brevity, the 
hypomethylated Dnmt1-/- Trp53-/- cells are hereafter referred to as the DP line and 
control Trp53-/-  (Dnmt1+/-) cells are referred to as the P line. I predicted that genes 
de-repressed in DP cells would form the initial broad set of candidate loci for 
subsequent analyses to refine to an enriched list. Prior to a global gene expression 
analysis, I characterised and confirmed the genotype and cellular properties of DP 
and control P cells 
 
The knockout strategy used to generate the DP line deleted a 900bp region at the 5’ 
end of the somatic Dnmt1 transcript (Li et al., 1992). This corresponds to deletion of 
20bp of the 5’UTR, the coding portion of the first exon and the splice acceptor site 
(Fig 3.1). Because this deletion truncates the N-terminal region of Dnmt1 protein it 
is known as the n-allele, to distinguish it from the subsequently generated c-allele, 
which disrupts a portion of the C-terminal domain (Lei et al., 1996). To confirm DP 
cells lacked Dnmt1 I performed quantitative RT-PCR (qRT-PCR) to determine 
whether Dnmt1 transcripts were present. Using primers that overlapped the 5’ 
deleted region, I was unable to detect Dnmt1 transcript in DP cells but could readily 
detect Dnmt1 in control P cells (Fig 3.1 left panel). This data suggests that as 
expected DP cells lack the 5’ region of Dnmt1 (n-allele). However, qRT-PCR 
directed to the 3’ region of the transcript showed Dnmt1 RNA was present in DP 
cells but at 7-fold reduced levels compared to P cells (Fig 3.1 right panel). This data 
is consistent with previous publications, which have noted that alternative splicing of 
the n-allele leads to a truncated but functional Dnmt1 protein albeit at significantly 
reduced levels (Lei et al., 1996). Importantly, at these reduced levels the abundance 
of Dnmt1 is not sufficient to maintain global DNA methylation levels and cells still 
become progressively hypomethylated over just a few generations.  
 
To confirm the DP cells used here were hypomethylated, I used the 5mC antibody, 
which recognises methylated cytosines. Staining with the 5mC antibody was 












































Fig 3.1. Analysis of Dnmt1 transcript levels in DP and P cells.  Top: schematic of mouse 
Dnmt1 protein (1616 amino acids) showing the N-terminal region deleted in DP cells (shown 
in blue) (n-allele) and the functional domains (red) . The N-terminal domain of Dnmt1 contains  
a nuclear localization signal (NLS), an CXXC DNA-binding motif, a bromo-adjacent homology 
domain (BAH), a proliferating cell nuclear antigen-binding domain (PBD) that contributes to 
targeting to the replication fork (see Fig 1.4) and replication foci targeting sequence (RFTS).  
The C-terminal catalytic domains includes six conserved motifs shown in black: Lower left 
panel: qRT-PCR demonstrating Dnmt1 transcript was not  detected in DP cells using primers 
that overlapped the deleted region, indicating these are bona fide n-allele Dnmt1-null cells. 
Lower right panel: qRT-PCR showing primers directed toward the C-terminal region could 
detect weak Dnmt1 transcript in DP cells suggesting an alternatively spliced transcript was 
being produced. Shown is relative expression normalised to Gapdh.    
P DP
Dnmt1 
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Fig 3.2. DP cells are globally hypomethylated.  a.) P cells and b.) DP cells were fixed and 
stained with the 5mC antibody (red) and DAPI (blue). a.) P cells exhibited strong staining at 
discrete foci whereas b.) DP cells showed significantly reduced and diffusely distributed 
staining indicating DP cells were globally hypomethylated. Scale = 20µm. c.) Structure of the 
MBDx4 protein which binds methylated CpGs with high avidity (Jorgensen et al., 2006). d & 
g.) P and DP cells were stained with DAPI and e & h.) transfected with the MBDx4 expression 
construct and stained with HA antibody. f & i.) Merge showing strong DNA methylation (red) 
co-localises with heterochromatin chromocentres (blue) (DAPI) in P cells but is weakly 
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markedly reduced in DP cells compared to P cells (Fig 3.2a & b). Furthermore, the 
residual methyl-cytosine staining detected in DP cells was diffusely dispersed around 
the nucleus (Fig 3.2b). In contrast the strong methyl-cytosine staining in P cells 
formed distinct nuclear foci, which probably represent heterochromatic 
chromocentres (Fig 3.2a). To ascertain whether residual DNA methylation in DP 
cells was mis-localised because a loss of heterochromatin or due to alternative 
reasons, such as reiterative de novo methylation, I used the poly-MBD method 
developed by Jorgensen et al (2006). Here, a tagged poly-MBD1 methyl-binding 
domain fusion protein (poly-MBDx4) is transiently expressed in cells (Fig 3.2c). 
This protein binds methylated CpGs with ~100-fold higher avidity than the 5mC 
antibody. Crucially, unlike with the 5mC antibody, there is no requirement to 
denature cellular DNA with this method. This allows a comparison of the 
distribution of residual DNA methylation with native heterochromatin. Transfection 
and analysis of the poly-MBDx4 protein showed that residual DNA methylation in 
DP cells is localised to non-heterochromatic regions of the genome (Fig 3.2f). In 
contrast, staining in P cells strongly overlapped with DAPI bright spots (Fig 3.2i). 
This suggests that in hypomethylated somatic cells (DP) chromatin remains capable 
of compacting into heterochromatic structures, as has been noted in ES cells, but that 
the low levels of residual methylation no longer localises to heterochromatin (Gilbert 
et al., 2007). It is noteworthy that the apparently high background level of 
methylation in DP cells is a consequence of the high avidity of the fusion protein 
used here combined with diffusely distributed residual methylation and not due to 
intrinsically elevated methylation levels in DP cells. Indeed, mass spectrometry (MS) 
comparison of genome-wide methyl-cytosine levels indicated early passage DP cells 
retained methylation at ~40% of the level of P cells. This is consistent with a 
previous study that reports Dnmt1-null (n-allele) somatic cells (DP) maintain ~35% 
global methylation levels (Lei et al., 1996).  
 
To confirm P cells were comparably methylated to primary cell types I digested 
DNA from brain tissues, P cells and DP cells with methyl-sensitive enzymes. Here, 
ethidium bromide staining of MaeII (methyl-sensitive) digested genomic DNA 
suggested that P cells had similar global methylation levels to primary MEFs 
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(pMEF) whereas DP cells appeared significantly hypomethylated (Appendix 2). I 
further evaluated DNA methylation at minor satellite repeats by Southern blot. Here, 
genomic DNA extracted from the DP line was susceptible to digestion whereas DNA 
from the P line was sensitive to MspI but crucially, was resistant to digestion by 
methyl-sensitive HpaII and CfoI enzymes suggesting minor satellite sequences are 
fully methylated in the P line but hypomethylated in DP cells (Appendix 2). I 
conclude that DP cells are globally hypomethylated whereas P cells retain normal 
genome-wide DNA methylation levels. 
3.3 DP and P cells proliferate and are non-transformed
 
All DP and P cells used in this thesis were male cells between passages p5 to p11. 
Following a short lag after their derivation (p1-p3), both DP and P cells grow at 
normal exponential rates and do not undergo senescence, even after 100 generations 
(Lande-Diner et al., 2006). To investigate both the proliferative capacity and the state 
of transformation of DP and P cells used here, I initially cultured both cell lines on 
Poly-2-hydroxyethyl methacrylate (poly(HEMA)) coated surfaces, which inhibit cell 
adhesion (Fukazawa et al., 1996). Because anchorage-independent growth is a 
property of transformed cells, proliferation in the presence of poly(HEMA) indicates 
cells are transformed (Shin et al., 1975). To measure cellular growth rates I used a 
colourimetric assay whereby yellow MTT is reduced to purple formazon in living 
cells. This can be accurately measured in microplates by a spectrophotometer. This 
analysis demonstrated that neither DP nor P cells (p9) were able to significantly 
proliferate on poly(HEMA) coated plates in comparison with control transformed 
293T cells or with non-coated surfaces (Fig 3.3a & b). This suggests that despite the 
absence of p53 these MEFs (DP & P) have not undergone the transition to a 
transformed phenotype and represent a relatively primary cell-type. Additionally, 
analysis of the control non-coated growth rates suggested that DP cells proliferated at 
~75% the rate of P cells, until contact inhibition slowed cellular division (day5) (Fig 
3.3a). This is consistent with second-order proportionality of rRNA synthesis in 
hypomethylated cells (Maaloe & Kjeldgaard, 1966; Gagnon-Kugler et al., 2009).  To 
confirm the growth properties of DP and P cells I conducted a soft agar assay. Here 
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Fig. 3.3. DP and P cells are non-transformed. Cells were plated at low density on a.) control 
non-coated or b.) poly(HEMA) coated microplates. a.) All cell lines proliferated at similar rates 
until maximum density at ~day 4-5. b.)  Only transformed 293T cells were capable of 
proliferation on poly(HEMA) indicating DP and P cells are non-transformed. c & d.) Cells were 
seeded at low density in an agar/growth medium matrix and cultured for 12 days to determine 
their state of cellular transformation. Anchorage independent colonies were only observed for 
positive control 293T cells shown at c.) low and d.) high magnification. Scale bars c.) 50uM 
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DP, P and positive control 293T cells were seeded in low-density agar/growth media 
matrices and cultured for 12 days (Fig 3.3c & d). Only 293T cells were able to form 
anchorage-independent colonies consistent with the conclusion that both the DP and 
P cells used in this thesis are not transformed.     
3.4 Candidate gene identification principal 
 
The fundamental aim of this chapter is to identify candidate genes regulated 
primarily by DNA methylation. To do this, I resolved that candidate targets must 
pass several experimental criteria. Thus, potential candidate genes will be filtered 
through three successive experiments, which progressively deplete false positives 
and indirect hits. Genes that are positive in all three experiments represent my 
candidate targets and can be analysed further. As such, the experimental criteria for 
candidate genes are thus: 
 
1. They must be de-repressed in hypomethylated DP cells (Section 3.5). 
2. They must be de-repressed in pMEFs and P cells treated with 5-aza 
deoxycytosine (5-aza dC) (Section 3.6). 
3. Following treatment with 5-aza dC, candidate genes must continue to be 
aberrantly expressed after 14 days recovery in the absence of 5-aza dC 
(Section 3.7). 
 
This last criterion is crucial. Genes that turn ‘on’, in response to the demethylation 
inducing nucleoside analogue 5-aza dC, may be affected indirectly (for example as 
part of an apoptotic response) or may be additionally marked by alternative 
epigenetic modifications. Both these classes of target gene would be predicted to re-
impose silencing during a 14 day recovery period either through a return to normal 
cellular physiology or through epigenetic marks re-targeting gene silencing 
(including re-targeting DNA methylation), respectively. However, genes that rely 
exclusively on DNA methylation for epigenetic memory would be predicted to 
remain expressed even after 14 days recovery, as there would be no mechanism of 
reiterative DNA methylation targeting in somatic cells.  Thus, this novel approach 
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Fig. 3.4. Schematic for identification of candidate genes regulated by DNA methylation.
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cross-referenced with experiments 1 and 2 should identify bona fide candidate genes 
potentially regulated by DNA methylation for further analysis (Fig 3.4). 
To evaluate global gene expression levels in each experiment I used Illumina Mouse 
Ref-8 v2 or Mouse Ref-6 v2 Expression BeadChips. The Ref-8 chips contain probes 
for 25,697 transcripts  (18,098 genes) from the mouse NCBI RefSeq database 
whereas the Ref-6 chips include these probes and an additional 19,584 probes that 
correspond to various gene isoforms and repeat elements. A crucial aspect of this 
process is where to set threshold limits that distinguish significant changes in gene 
expression between samples. I initially used a t-test with average normalisation, 
applying multiple testing corrections using Benjamini and Hochberg false discovery 
rate. However, because of the relatively high number of biological and technical 
replicates used, this method would often report expression changes as low as 1.2-fold 
were highly statistically significant (p = <0.01). Biologically, genuine targets 
regulated by DNA methylation would be predicted to change expression 
considerably in the absence of promoter methylation. This is because promoter 
methylation is proposed to promote strong gene silencing. If DNA methylation is the 
primary system for regulating expression, depletion should result in robust gene 
activation (i.e. from nothing to something) and therefore a significant net change in 
expression. To account for the discrepancy between what is statistically significant 
and biologically significant with respect to expression changes according to DNA 
methylation, I resolved to use a highly stringent 6-fold expression change threshold. 
This strict threshold is expected to minimise false-positives and maximise the pool of 
genes crucially reliant on DNA methylation patterns for their expression. In contrast, 
previous studies investigating regulation by DNA methylation have set their 
threshold at 2-fold (Jackson-Grusby et al., 2001; Fouse et al., 2008). While this 
undoubtedly increases the number of potential genuine targets, it makes 
identification of the direct targets within a large dataset very difficult.  
 
3.5 Germline specific genes are de-repressed in DP cells 
 
To identify candidate genes de-repressed in the absence of DNA methylation I 
initially assayed global gene expression levels in DP and control P cells using 
          97
Illumina Mouse Ref-8 BeadChips. To validate the array method I initially plotted 
biological replicates of DP or P hybridisations. Here, DP cRNA replicates showed a 
strong correlation (pairwise r2 = 0.99), as did P cell cRNA biological replicates 
(pairwise r2 = 0.98) (Fig 3.5a & b) and the data was distributed as expected with 
47.5% (DP) and 48.0% (P) of genes considered to be expressed (p = <0.05), 
respectively (Fig 3.5c). The distribution of data and the strong replicate correlations 
indicated that RNA labelling and hybridisation produced accurate and reproducible 
data. Comparison of the DP and P datasets showed a correlation of r2 = 0.94 (Fig 
3.6a). Using a stringent 6-fold relative expression threshold I identified 221 genes 
upregulated in DP cells and 171 genes downregulated. This corresponds to 1.2% and 
0.9% of the array, respectively (Fig 3.6b). As expected, more genes were 
upregulated than downregulated, consistent with the proposed role of DNA 
methylation in gene silencing (Bird, 2002). However, a significant number of genes 
were downregulated in hypomethylated DP cells, potentially due to changes in 
transcription factor availability or epigenetic cascades. Interestingly, many 
expression changes (down & up) must be stochastic or indirect, as comparison of the 
array data generated here with a previously published expression analysis of 
hypomethylated fibroblasts (Lande-Diner et al., 2006) showed only a modest 
correlation. Indeed, I was unable to validate several of the top hits reported in this 
study (data not shown) (Lande-Diner et al., 2006). This may reflect the fact that most 
expression changes in hypomethylated cells occur independently of direct changes in 
DNA methylation and therefore are under multiple, partially stochastic, influences. 
Identifying the potential methylation-dependent targets within this broad DP cell 
dataset is the key aim of this chapter (Fig 3.4).   
 
I validated the microarray expression data through RT-PCR of targets the array 
identified as upregulated >6-fold in DP cells (Dazl, Slpi, IAP elements, Tex13) or as 
showing no significant expression change (Gata6, Krt8, Crip1) (Fig 3.7a).  
Additionally, as a negative control I confirmed that ES-cell specific transcripts were 
not expressed in either cell line, as these genes have been reported to be regulated by 
multiple tiers of epigenetic repression and are not re-activated by demethylation (Fig 
3.7b) (Feldman et al., 2006; Cedar & Bergman, 2009). My RT-PCR analysis was 
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Fig 3.5. Microarray quality control. Log10 expression data points for a.) P and b.) DP 
microarray biological replicates were plotted to asses the reproducibility of the array and 
biological variation inherent within different time points. Both datasets showed strong 
correlation indicating there was little variation between biological replicates of the same 
sample. c.) Box blot showing the distribution of raw data values between P and DP samples 
is comparable. Each box represents the 25th and 75th percentile with the horizontal line the 
median value. Whiskers show the 1st and 99th percetile d.) Raw data from DP cells (green) is 
normally distibuted with a slight shift to the right indicating more genes are upregulated than 
downregulated. Red line shows expected normal distribution.
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Fig 3.6. Microarray expression analysis of DP and P cells. a.) Scatter plot analysis of P vs 
DP Log10 expression values. b.) Number of genes mis-regulated >6-fold in microarray 





































































Fig 3.7. Validation of expression microarray results. a.) Semi quantitative RT-PCR 
validation of genes predicted to be upregulated in DP cells (Slpi, Tex13, Dazl, IAP) or to 
exhibit no change (Krt8, Crip1, Gata6). cDNA dilutions are 1/50, 1/20 and 1x. Hprt and Gapdh 
are loading controls b.) Negative control semi-quantative RT-PCR of ES-cell specific 
transcripts. c.) qRT-PCR confirmation of relative gene expression. Shown is expression 
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highly correlative with the array predictions, with all 12 transcripts tested following 
the expected expression pattern. Furthermore, relative fold-changes in expression 
reported by the array were comparable to quantitative RT-PCR (qRT-PCR) 
validation (Fig 3.7c). However, for large expression changes, the array analysis often 
underestimated the relative fold change. This probably reflects the limited dynamic 
range of Illumina BeadChips but does not significantly effect this analysis, as 
relative discrepancies were only observed with changes >10-fold, beyond the 6-fold 
threshold used here. These validations indicate that this array platform provides high 
quality reproducible data for further analysis. Because this study is focused on genes 
regulated by DNA methylation in cis, only upregulated genes are considered from 
here. A comprehensive list of all targets upregulated >6-fold is shown in Table 3.1. 
 
Gene Chromosome Function Fold change
Tex19 11 Retrotransposon silencing 430.1
Fmr1nb X  317.1 
Rhox5 Homeobox transcription factor 306.2
Casp1 9 Caspase cascade in apoptosis 304.5 
Nckap1l  Regulation of actin cytoskeleton, 280.2 
Slc47a1 11 Ion transport 260.0
Fkbp6 5  208.1 
Magea2 X  198.6 
OTTMUSG0000010673 4  182.8 
Psg23 7 Immunoglobulin 181.0 
Gdf15 8 Growth factor 139.7 
Plac8 5  120.5 
Pet2 X  118.8 
Slpi 2 Leukocyte peptidase inhibitor 111.5 
Krt14 11 Intermediate filament protein 95.6 
MageK1 X Mage protein 93.1
Hamp2 7 Hepcidin antimicrobial peptide 89.3 
EG434729 X Iron storage 87.8 
Taf7l X Basal transcription factor 87.2 
Pkd1l2 8  76.3 
Pira4 7  68.9 
Tex13 X 60.2
Gpr97 8 G-protein coupled receptor 56.3
Gm773 X  51.4 
Rpl39l 16 Ribosomal protein 48.0 
Nlrp4c 7  47.3 
Mrvi1 7  46.4 
2010005H15Rik 16  43.4 
Amhr2 15 Cytokine-cytokine receptor interaction 40.5 
Msln 17 Cell adhesion 39.8 
Mov10l1 Folate biosynthesis 39.1
Apol9b 15 Lipid binding, 36.7 
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Pde6h 6  36.7 
Xdh 17  35.5 
Dpt 1  34.8 
Magea5 X  33.7 
1700034E13Rik 18  33.1 
OTTMUSG00000015743 2  31.9 
Jam4 16 Cell adhesion 31.5 
Tnfrsf26   30.6 
Rps4y2 30.0
Usp18 6 Protease 29.2 
LOC100048346   28.5 
Acpp 9 Riboflavin metabolism 28.4 
A030004J04Rik 3  28.2 
Foxq1 13 Fork head transcription factor 27.9 
Asz1 6 Sam transcription factor 27.8 
Prl 13 Somatotropin hormone 27.7 
Gstp2 19 Glutathione metabolism 27.2
Tex11 X  26.8 
Pvalb 15  26.7 
V1rb3 6  26.4 
D12Ertd647e 12  26.0 
EG433016 16  25.7 
Aim2 1  25.4 
Parp14 16  25.1 
Selp 1 Immune system process 24.9 
Iap Reteroelement 24.4
Rem1 2  23.6 
Serpinb6b 13 Protease inhibitor 22.9 
V1rd21 7 Vomeronasal receptor 21.5
AA467197 2  21.5 
LOC547343 17 Class i histocompatibility antigen, 21.2 
Rhox4d X Homeobox transcription factor 21.1
Tph2 10 Tryptophan metabolism 20.5 
Ugt1a10 1 Androgen and estrogen metabolism 20.5 
Xlr4a X  19.7 
Piwil2 14 Argonaute and dicer protein 19.7
Pira6   19.5 
Ctsk 3 Peptidase 19.5 
Oasl2 5  19.3 
Olfr1463 19 Olfactory receptor 19.2 
Sh3tc2 18  19.0 
Cyp2b13 7 Cytochrome P450 18.9 
Akr1c12 13  18.7 
B3gnt3 8 Glycosphingolipid biosynthesis 18.7 
Trim30 7  18.6 
Dpep1 8 Membrane dipeptidase 17.9 
Hspb2  :Alpha-crystallin-related small heat shock protein 17.8 
Nr1h4 10 Regulation of cholesterol metabolism 17.6 
Gsta1 9 Glutathione metabolism 17.6 
Pla1a   17.4 
AI467606 7  17.2 
LOC100048710   17.1 
Ccdc114 7  16.7 
Xist X X-Chromosome inactivation 16.3 
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LOC100038882 4  16.2 
Efhc2 X  16.0 
Cidec 6 Caspase-activated nuclease 15.4 
Ang2 14  15.3 
Nppb 4 Natriuretic peptide 15.1 
Lpin3 2  15.1 
Kcnab2 4  15.0 
Il15 8 Cytokine-cytokine receptor interaction 14.8 
Krt7 15 Intermediate filament protein 14.6 
Tns4 11  14.1 
Tap2 17 Antigen processing and presentation, 14.0 
Cldn15 5  13.6 
Tex19.2 11 13.5
Mb 15 Myoglobin, metal ion-binding site 13.5 
Fyb 15 Fyn binding protein 13.5 
Defb8 8 Beta defensin, 13.3 
Gsta2 9 Glutathione metabolism 13.1 
Adamts2 11  13.0 
Pstpip1 9  12.7 
Itgb7 15 Cell adhesion 12.6 
Dnase1l3  Deoxyribonuclease 12.4 
Hoxc13 15 Homeobox transcription factor 12.4 
Hspb7  Alpha-crystallin-related small heat shock protein, 12.4 
D6Mm5e 6  12.2 
Arl11 14 Adp-ribosylation 12.2 
Hoxc10 15 Homeobox transcription factor 12.1 
Rasl12 9 Ras gtpase 12.1 
Tnnt1 7 Troponin 12.0 
Slc15a3 19 Amino acid transport and metabolism, 11.9 
Plch2 4 Lipid metabolic process 11.7 
Lamb3 1 Cell communication, Extracellular matrix structural constituent 11.7 
Serpinb9g 13 Protease inhibitor 11.6 
Casp4 9 Induction of apoptosis 11.6 
Was X Regulation of actin cytoskeleton 11.6 
LOC236749 X  11.5 
Hoxd10 2 Homeobox transcription factor  11.3 
AU022751 X  11.3 
Tnfsf13b 8 Cytokine-cytokine receptor interaction 11.1 
Slc12a8 16  11.1 
Dnmt3l 10 Methyltransferase cofactor 11.0 
4930481M05 X Somatotropin hormone 10.9 
Eng 2  10.7 
Mylc2pl   10.6 
Pcdhb3 18 Cell adhesion 10.2 
Uroc1 6 Histidine metabolism 10.1 
Aldh3a1 11 Aldehyde metabolic process 10.0 
Slc12a1 2 Na-k-cl co-transporter, 9.7 
Crip2 12  9.6 
Rsad2 12  9.6 
Cdsn 17  9.5 
LOC100038908 7  9.4 
Prl2c4 13  9.4 
Plscr2 9 Scramblase 9.3 
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Bst2 8 Bone marrow stromal antigen,  Cell communication 9.2 
Acsbg1 9 Amp-dependent synthetase and ligase 9.2 
LOC631002 X  9.2 
Tex14 11  9.1 
Arhgap30 1  9.1 
Acta1 8 Regulation of actin cytoskeleton 8.9 
BB146404 10  8.8 
Prl2c3 13 Somatotropin hormone 8.8 
Prelp 1 Class ii small leucine-rich proteoglycan 8.7 
P2ry14 3 Neuroactive ligand-receptor interaction 8.7 
Mnd1 3  8.7 
Tnnt3 7 Troponin 8.6 
Gpr114 8 G-protein coupled receptor 8.5 
EG667977 17  8.4 
Rapsn 2  8.4 
Chrng 1  8.2 
Cntn3   8.2 
Fkhl18 2 Fork head transcription factor 8.1 
Abi3   8.0 
Ttn   8.0 
EG630499 17  8.0 
Havcr2 11  8.0 
Timm8a2 14  8.0 
Iigp2 11 Interferon-inducible gtpase 8.0 
Gatm  Urea cycle and metabolism of amino groups 8.0 
Ly6c1 15  7.9 
AI747699   7.9 
Fbln7  Calcium ion binding 7.9 
9030224M15Rik 10  7.6 
Slc14a1 18  7.6 
Hao1 2 Glyoxylate and dicarboxylate metabolism 7.6 
Bcar3 3  7.6 
Cgnl1 9 Myosin tail 7.5 
Mgst2 3  7.5 
Uts2r 11 Neuroactive ligand-receptor interaction, 7.4 
Tnnc2 2 Calcium signaling pathway 7.4 
Tcfl5 2 Hlh transcription factor 7.4 
Afp 5 Serum albumin 7.3 
Cyp4a12a 4 Cytochrome P450 7.3 
LOC100044314   7.2 
Mylpf 7 Regulation of actin cytoskeleton 7.2 
Psp 2 Lipid-binding serum glycoprotein 7.2 
Lgals3bp 11  7.1 
LOC100048554   7.1 
Evi2a 11  7.0 
1700012B09Rik 9  7.0 
Myod1 7  6.9 
Aqp1  Aquaporin, 6.9 
Cct6b 11 Molecular chaperone 6.9 
Angpt4 2  6.8 
9130218O11Rik 15  6.8 
Psmb9 17 Multicatalytic endopeptidase 6.8 
Cox8b 7 Oxidative phosphorylation, 6.7 
Arhgap9 10 Gtpase 6.7 
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Tuba3a 6 Cytoskeleton component 6.7 
Isg20 7  6.7 
EG638695 14  6.7 
Samd9l 6  6.7 
Soat2 15 Lipid metabolism 6.6 
Cck 9 Gastrin/cholecystokinin peptide hormone 6.6 
Mfap5 6  6.6 
1500015O10Rik 1  6.6 
S3-12 17  6.5 
1700112C13Rik 9 Protease 6.5 
Tor3a   6.5 
EG633640 13  6.5 
Slc22a4 11 Ion transport 6.5 
Piwil4 9 Argonaute and dicer protein 6.4 
Angptl4 17 Ppar signaling pathway,    angiogenesis 6.4 
D10Bwg1379e 10  6.4 
Hc 2 Complement and coagulation cascades 6.3 
Pip5k1b 19 Inositol phosphate metabolism 6.3 
Opn1mw X Photoreceptor  6.3 
Anxa8 14 Blood coagulation 6.3 
AI451557 8  6.3 
BC010462  Immunoglobulin subtype 6.2 
Actg2 6 Muscle protein 6.2 
Mlkl 8  6.2 
Mmp17 5  6.1 
Ccl17 8 Cytokine-cytokine receptor interaction, 6.1 
H19 7  6.0 
Rpl3l  Ribosomal protein 6.0 
 
Table 3.1. Transcripts significantly de-repressed in DP cells. Shown are all transcripts 
de-repressed >6-fold in DP cells (relative to P cells) and the chromosomal location. Where 
known, the biological role of the encoded protein from each transcript is shown. Shown in 
bold are the final candidate genes (Fig 3.14). 
 
To determine if distinct classes of genes are de-repressed in DP cells I used the 
DAVID v6 programme (http://david.abcc.ncifcrf.gov/) to identify significantly 
enriched gene ontology (GO) categories (Dennis et al., 2003). For this analysis, GO 
categories containing at least 5 genes and with a threshold p-value <0.05 were 
selected using the mouse Ref-8 dataset as background. I used the GO biological 
processes (BP) database, which categorises genes according to broad biological 
goals, such as mitosis or reproduction, that are accomplished by ordered assemblies 
of molecular functions. This can be subdivided into level 1 to 5, with level 1 
providing broad descriptive terms which increase in specificity but decrease in 
coverage (and hence statistical significance) at each successive level. I initially 
interrogated the broadest hierarchical GO level - biological process 1 (BP1). 
Interestingly, only two categories, reproduction (p = 0.0082) and developmental 
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processes (p = 0.032), were significantly enriched. The strong significance level of 
reproduction suggested that germline specific genes may be enriched among genes 
upregulated in DP cells. To investigate this, I interrogated the BP database at the 
more specific hierarchal level 3. At this level the gene-set also showed strong 
enrichment for germline and reproductive processes (gamete generation p = 0.0081) 
but also modest significance for muscle system process (p = 0.046) and response to 
hypoxia (p = 0.03) (Fig 3.8a). In contrast to genes upregulated in DP cells, no 
association with germline processes was found with genes downregulated in DP 
cells. Because germline associated genes were significantly upregulated in DP cells I 
investigated whether any specific tissues were enriched. Analysis of tissue specificity 
identified only testis (p = 0.032) and placenta/embryonic tissue (p = 0.032) as being 
significantly enriched among genes upregulated in DP MEFs (Fig 3.8b). Taken 
together, these data suggest that germline and testis specific genes are preferentially 
de-repressed in the absence of DNA methylation, consistent with previous global 
indications that germline restricted genes may be regulated by promoter methylation 
(Weber et al., 2007; Fouse et al., 2008).  
 
To examine whether genes deregulated in DP cells were enriched in specific 
genomic loci, I mapped the genes to their chromosomal locations. This analysis 
found a significant percentage of upregulated genes were located on the X-
chromosome (11.7%, expected 3.7%) (p = 0.0002, Benjamini correction p = 
0.00044) (Fig 3.8c) as has been previously noted in hypomethylated ES cells (Fouse 
et al., 2008). Because these cells are male, ectopic activation of an inactive X-
chromosome can be excluded as a mechanism causing enrichment of X-linked genes 
in DP cells. Instead, this effect is probably linked to the high proportion of testis-
specific genes located on the X-chromosome (Wang et al., 2001).  
 
To further analyse the dataset I investigated whether any specific promoter 
classification types were enriched among the DP upregulated genes. I used the 
promoter categorization system employed by Mikkelsen et al (2007) and thus 
divided genes into low CpG density promoters (LCP) (500bp Obs/Exp<0.4), 
intermediate CpG density (ICP) (500bp Obs/Exp 0.4-0.6) and high CpG density 
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Fig 3.8. Biological functions of genes upregulated in DP cells. a.) Gene ontology of genes 
upregulated >6-fold in DP MEFs. Shown are all significant enrichment classifications at GO 
biological process level 1 (BP1) & biological process 3 (BP3) (asterik) using the DAVID 
programme. Dashed line indicates p = 0.05 significance.   b.) Tissue specificity of genes 
de-repressed in DP cells. Only testis and placenta/embryonic tissues were significantly 
enriched. c.) Chromosomal location of genes upregulated in DP cells (right panel) and the 
expected distribution (left panel). Only genes located on the X-chromosome are significantly 







0.05 2.5E-2 1.25E-2 6.25E-31E-1
           108
promoters (HCP) (500bp Obs/Exp>0.6, GC>55%). It has been proposed that 
potential targets for regulation by DNA methylation would be associated with ICP 
promoters, so called weak-CpG islands. This is because the density of CpGs at LCP 
promoters is insufficient to promote silencing when methylated. Conversely HCPs 
are very rarely methylated in any tissue and therefore are unlikely be regulated by 
methylation. ICPs therefore represent an intermediate that has a high enough CpG 
density to effect transcription in cis yet also has the potential to acquire 
developmental or tissue specific DNA methylation. It would therefore be predicted 
that genuine direct targets of DNA methylation would be enriched in ICPs. My 
analysis was able to map 162 of the 221 upregulated DP transcripts to promoter 
classifications using the Mikkelsen dataset. These genes showed a strong deviation 
from the expected distribution with a 2-fold enrichment of ICP and LCP promoters. 
There was also a 2-fold reduction in the expected number of HCP promoters (Fig 
3.9a). This suggests that ICP and LCP associated genes are preferentially 
upregulated in DP cells. The enrichment of ICP genes is consistent with the notion 
that this class of genes are likely candidates for regulation by DNA methylation. 
Conversely, the significantly reduced proportion of HCP genes probably reflects 
their already hypomethylated status. In contrast to genes upregulated in DP cells, 
downregulated genes showed no significant deviation from the expected distribution 
of promoter types (Fig 3.9a).  
 
Interestingly, analysis of the HCP genes that were upregulated in DP cells 
demonstrated these genes were greatly enriched (10-fold) in promoters devoid of the 
histone modifications H3K4me3, H3K9me3 and H3K27me3 (as determined by the 
Mikkelsen dataset) (Fig 3.9b). As noted by Fouse et al (2008) HCP genes depleted in 
histone modifications may represent the small fraction of HCP genes that are 
regulated by DNA methylation. It is therefore interesting that such a striking number 
of HCP targets lacking histone modifications should be found among genes 
upregulated in DP cells. Consistent with this notion, at least two upregulated HCP 
genes not marked by histone modifications, Taf7l and Tex13, have been shown to be 
methylated in somatic tissues, in contrast to what would be expected of most HCPs 
(Weber et al., 2007; Meissner et al., 2008). It is noteworthy that 91% of the germline 
























































Fig 3.9. Promoter classification of mis-expressed genes. a.) Genes upregulated >6-fold in 
DP cells are strongly enriched for ICP and LCP promoters and depleted in HCP promoters. In 
contrast, genes downregulated >6-fold in DP cells exhibit no significant deviation from the 
expected distribution.  b.) Analysis of the HCP genes that are upregulated in DP cells 
demonstrates they are highly enriched for loci not marked by bivalent chromatin modifications 
relative to the expected number. HCP genes downregulated >6-fold in DP cells show no 
significant difference from the expected number (p = 0.79). 
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Fig 3.10. Germ-line specific genes are de-repressed in DP MEFs. a.) Semi-quantitative 
RT-PCR of a cohort of germ-line specific genes (Wang et al., 2001).  Analysis was performed 
over increasing cDNA dilutions of 1/50, 1/20 and 1x (black curve). Number of cycles is shown 
on the right-hand side. B-globin and Fshr are negative controls. Fshr is only expressed in the 
somatic cells of the testis. Gapdh is a loading control b.) Quantitative RT-PCR analysis of 
selected germline specific genes normalised to Gapdh. Shown is fold change relative to P 
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specific genes upregulated in DP cells fall into the ICP or HCP category. This is 
consistent with germline genes being direct targets of DNA methylation rather than 
indirect hits as would be predicted of LCP genes.  
Taken together, these analyses suggest that germline specific genes may be targets 
for regulation by DNA methylation. To further investigate the role of DNA 
methylation at germline associated genes I conducted a semi-quantitative RT-PCR 
analysis based on a set of testis-specific genes reported by Wang et al (2001). This 
set of genes was selected based only on their reported testis-specific expression 
pattern and irrespective of the array analysis. Remarkably, RT-PCR showed that 12 
of the 15 testis-specific genes tested were strongly expressed in DP cells but at 
undetectable or significantly reduced levels in P cells (Fig 3.10a). This suggests that 
de-repression of germline associated genes in DP cells is a general phenomenon. I 
over-cycled each reaction (usually 35 cycles) to demonstrate that in most cases 
(80%) a transcript could not be detected in P cells, as would be expected for the 
germline-specific nature of these genes. Quantitative RT-PCR of six genes 
confirmed they were de-repressed between 8-fold and >4000-fold in DP cells (Fig 
3.10b). In contrast, I was unable to detect any transcripts for ES cell specific genes in 
either P cells or DP cells (Fig 3.7b). These data support the conclusion of the gene 
ontology analysis that germline specific genes are highly enriched among genes de-
repressed in DP cells. To refine the 221 genome-wide candidate genes generated 
here to a more specific and testable set, I resolved to profile P cells treated with 5-aza 
dC and cross-reference de-repressed genes with those candidates identified generated 
here. 
3.6 Germline specific & immune response genes are de-
repressed in 5-aza dC treated P cells
 
Candidate target genes regulated by promoter methylation would be expected to 
activate in response to the demethylating agent 5-aza dC. To test this, I treated P 
"\^!-aza dC (P-aza) for 72hrs and profiled global gene expression using 
Illumina mouse Ref-8 BeadChips. At this concentration of 5-aza dC, p53-null cells 
lose ~60% of global methylation but retain viability and continue to proliferate 
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(Nieto et al., 2004). The array analysis identified 308 genes (1.7%) upregulated 
greater than 6-fold in P-aza cells. To identify gene ontology categories significantly 
enriched in this gene set I interrogated the BP1 database using DAVID v6. This 
analysis showed that, similar to hypomethylated DP cells, reproduction (p = 0.00045) 
and developmental processes (p = 0.00022) were significantly enriched in P-aza 
cells. Interestingly, at the more specific hierarchical level BP3, germline processes 
were still significantly enriched (gamete generation p = 0.0008) but several immune 
response categories were also moderately enriched (innate immune response p = 
0.045, response to wounding  p = 0.0044, leukocyte activation  p = 0.0067) (Fig 
3.11a). This analysis is consistent with gene ontologies from DP cells and supports a 
direct role for DNA methylation in regulating germline specific genes. In contrast, 
because immune associated genes are not enriched in DP cells, this class of genes 
may be indirectly activated in P-aza cells, probably as a result of the reported 
cytotoxic effects of 5-aza dC (Oka et al., 2005). Consistent with this, more genes 
were found to be upregulated in P-aza cells (308) than DP cells (221) suggesting 5-
aza dC has at least some methyl-independent effects on gene expression here.  
 
The global analysis carried out on P-aza MEFs showed a strong enrichment of 
germline restricted genes. To examine this further, I investigated the expression 
levels of the set of testis-specific genes shown in Fig 3.10 after 5-aza dC treatment 
by RT-PCR (Wang et al., 2001).  I determined the effect of 1μM 5-aza dC on both P 
cells (P-aza) and pMEFs (pMEF-aza) treated for 48hrs or 96hrs and also, the  
additive effect of 5-aza dC treatment (96hrs) with the histone deacetylase inhibitor 
TSA (Fig 3.11b). All the testis-specific genes identified as being de-repressed in DP 
cells were also expressed in P-aza cells after 48hrs and 96hrs treatment. However, 
some genes activated in P-aza and DP cells were not reciprocally activated in pMEFs 
treated with 5-aza dC. For example, Rnh2 and Stk31 transcripts are clearly detectable 
in DP and P-aza cells but not in pMEF-aza cells (Fig 3.11b). This could indicate that 
p53 plays a direct or ‘priming’ role to sensitise cells to demethylation. Alternatively 
pMEFs may be less sensitive to 5-aza dC than P or DP cells and may require a higher 
dose to induce demethylation, consistent with reports that suggest cell responses to 
5-aza dC vary widely (Qin et al., 2009). It is also possible that genes not activated in 
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Fig 3.11. Analysis of 5-aza dC treated P cells. a.) Gene ontology of genes upregulated 
>6-fold in P-aza cells at BP1 and BP3 (asteriks).  Reproduction (p = 0.00042) and 
developmental process (p = 0.00021 ) were most significantly enriched. b.) RT-PCR of pMEFs 
or P cells treated with 1uM 5-aza dC for 48hrs or 96hrs +/- TSA. All genes de-repressed in DP 
cells (far right columns) were also activated by 5-aza dC in P cells (P-aza) and the majority 
were activated in pMEFs (pMEF-aza). Gapdh is a loading control and B-globin demonstrates 
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pMEF-aza cells are not direct targets for regulation by DNA methylation or may 
require specific transcription factors not present in pMEFs but present in P and DP 
cells. Interestingly, Mvh was not activated in DP or pMEF-aza cells but was in P-aza 
cells (Fig 3.11b). This apparently inconsistent response indicates that at best Mvh is 
indirectly regulated by DNA methylation changes. This is intriguing because Mvh is 
one of three genes reported to be temporally regulated by promoter methylation 
during PGC development (Maatouk et al., 2006). Because this conclusion was 
reached by the authors based on correlative evidence, this example highlights the 
need for comprehensive cause and effect studies on putative methylation-dependent 
genes.  
 
In my analysis, the addition of TSA did not significantly enhance de-repression of 
any of the germline-specific genes examined, suggesting they are primarily 
responsive to demethylation, and histone deacetylation is not additive with this 
effect. To confirm TSA cannot de-repress germline-specific genes independently of 
5-aza dC, I treated P cells and pMEFs with TSA only (Fig. 3.12a). Here, no 
transcripts were detected suggesting these genes fall into the category of genes 
previously described by Schuebel et al (2007) and Lande-Diner et al (2006) that are 
activated by demethylation without the requirement for forced deacetylation and 
alterations to chromatin structure. I conclude that the majority (77%) of germline 
specific genes examined here are de-repressed in all cell-types examined by a 
"\^!-aza dC but not TSA, indicating they could 
be targets for direct regulation by DNA methylation. This, combined with the global 
analysis of P-aza cells and DP cells strongly supports a role of DNA methylation in 
regulating germ cell-specific genes.  
 
To generate a refined list of candidate genes I cross-referenced the genome-wide 
transcripts de-repressed in both P-aza cells and DP cells. Eighty seven genes were 
found to overlap between the global experiments whereas 134 and 221 genes were 
upregulated in only DP cells or P-aza cells, respectively (Fig 3.12b). The relatively 
small degree of crossover (16.5%) suggests that de-repression of many genes may be 
a consequence of stochastic or indirect effects. However, the genes present in both 
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Fig 3.12. Cross-referencing genes upregulated in DP and P-aza cells reveals 
enrichment for germline GO categories. a.) The candidate genes Tex19 and PiwiL2 are not 
activated by TSA  but are de-repressed in response to 5-aza dC in pMEFs and P cells. b.)  
Venn diagram cross-referencing genes upregulated in DP cells and P-aza cells shows 87 
overlapping candidates. Overlapping genes are strongly enriched in germ-line associated 
genes (p = 0.0005) at BP1. The remaining genes de-repressed in DP cells showed no 
significant enrichment (NS) whereas the remaining genes only de-repressed in P-aza cells 
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datasets (overlap) would be predicted to be enriched in targets directly regulated by 
DNA methylation. Strikingly, BP1 GO analysis showed that only the overlapping 
gene set was significantly enriched for only germline associated genes (reproduction 
p = 0.0005). In contrast, the remaining DP and 5-aza dC datasets, lacking the 
overlapping genes, show no significant enrichments (DP) or enrichments for 
developmental and apoptotic GO classifications (P-aza cells). This suggests that the 
genes responsible for the germline gene ontology enrichment in the DP and  P-aza 
datasets are the same genes that overlap between the two gene lists. This strengthens 
the notion that germline genes are strong candidates for regulation by promoter CpG 
methylation. Furthermore, this analysis has identified a refined list of 87 germline-
enriched candidate genes, which are upregulated in both genetically and 
pharmacologically hypomethylated cells. 
3.7 Epigenetic memory of germline specific genes is 
mediated by DNA methylation
To reduce the number of candidate genes to a testable figure and to enrich with 
genuine methylation-dependent targets, I resolved to undertake a third experimental 
approach to identify genes which rely on promoter CpG methylation for epigenetic 
memory. In this approach candidate targets regulated exclusively by DNA 
methylation would be predicted to activate in response to 5-aza dC and crucially, 
remain expressed indefinitely following 5-aza dC removal. Here, the rationale 
predicts that genes that are indirectly activated or regulated by additional epigenetic 
mechanisms would re-impose repression during a recovery period. For example, 
indirect targets activated as a consequence of alterations to transcription factor 
networks would return to their original expression state coincident with cellular 
recovery to normal physiology. Conversely, candidate loci where DNA methylation 
may have a maintenance or secondary role in epigenetic silencing would be predicted 
to re-target repression through alternative epigenetic mechanisms, such as 
H3K27me3, H3K9me2 or antisense RNAs (Vire et al., 2006; Lachner et al., 2001; 
Feladma et al., 2006; Chotalia et al., 2009). In contrast genes that critically rely on 
only DNA methylation for silencing in somatic cells would remain expressed even 
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after removal of 5-aza dC as they would have lost their epigenetic memory (Feng et 
al., 2006).  
 
To test for candidate loci that rely on promoter methylation for epigenetic memory I 
"\^!-aza dC for 72hrs, followed by a 
14 day recovery period under normal culture conditions. Following 5 days of 
recovery P cells exhibited 50-70% cell death, probably as a result of chromosomal 
aberrations and p53-independent apoptosis (Nieto et al., 2003). In contrast NIH/3T3 
cells appeared morphologically normal and proliferated as expected with only 10-
30% cell death. For this reason I chose to use NIH/3T3 cells in this analysis. I 
profiled the global expression levels in NIH/3T3 cells prior to treatment (3T3-
control), immediately following treatment (3T3-aza) and after 14 days recovery 
(3T3-recovery) using Illumina mouse Ref-6 BeadChips. This additionally allowed 
me to compare 5-aza dC induced genes from P cells and NIH/3T3 cells. It is 
noteworthy that the Ref-6 arrays used to profile 3T3 cells here contain 30,775 
transcripts compared to 18,098 transcripts for the Ref-8 arrays used for the previous 
analysis. Therefore in direct comparisons, percentages of the arrayed dataset are also 
given. 
 
This analysis identified 423 genes (1.4%) upregulated >6-fold in 3T3-aza cells. This 
compares similarly to the 1.7% observed in P-aza cells. In contrast, after 14 days 
recovery, only 76 genes (0.25%) were significantly upregulated in the 3T3-recovery 
cells. Of the genes that were upregulated after 14 days recovery, 54 (71.1%) were 
also upregulated >6-fold in the 3T3-aza geneset (overlap) and therefore were turned 
on by 5-aza dC and crucially, remained on (Fig 3.13a). These 54 overlapping genes 
represent those which have putatively lost their epigenetic memory and cannot re-
impose silencing following demethylation. The remaining 22 genes present 
exclusively in the 3T3-recovery geneset were largely (n=18) just below (3-6 fold) the 
>6-fold threshold in the 3T3-aza list, indicating that technical considerations (the 
threshold value) rather than late-onset upregulation per se, excluded them from the 
overlapping geneset. Interestingly, BP1 GO analysis of the overlapping genes, which 
have lost transcriptional memory, showed enrichment for only the germline 






















Fig 3.13. Germline specific genes preferentially rely on DNA methylation for epigenetic 
memory a.) Venn diagram showing the overlap between genes de-repressed by 5-aza dC 
treatment in 3T3 cells (left circle) and following a 14 day recovery period in the absence of 
5-aza dC (right circle). Overlapping genes were significantly enriched in germline specific 
genes (p = 0.03). Dashed line indicates a significance threshold of p = 0.05. b.) Gene ontology 
analysis at BP1 of 3T3-Aza treated cells shows 5-aza dC treatment preferentially activates 
immune response (p = 1.1-9) and multi-organism process (p = 0.042), whereas after 14 days 
recovery only reproduction is significantly enriched (p = 0.03) among genes still upregulated 
>6-fold (overlap). NS = not significant
54348 22
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associated category, reproduction  (p = 0.03). In contrast, the 3T3-aza geneset 
showed significant enrichment for immune system processes (p = 1.1-9) and multi-
organism process (p = 0.0043) but not reproduction (Fig 3.13b). This data strongly 
suggests that germline genes are activated in globally hypomethylated cells and 
crucially, in contrast to other gene categories, are unable to re-impose gene silencing. 
This suggests that in addition to being silenced by CpG methylation, germline 
specific genes critically rely on DNA methylation for epigenetic memory. To 
validate this, I monitored the expression of germline genes during 5-aza dC recovery 
in both P cells and pMEFs by RT-PCR (Fig 3.14a & b). In agreement with the array 
analysis, the germline associated genes remained expressed following 5-aza dC 
treatment whereas control genes rapidly re-imposed gene silencing. I conclude that 
germline genes likely represent a distinct subclass of genes that depend on DNA 
methylation for repression but uniquely, this dependence confers an epigenetic 




To derive a final set of candidate genes for further analysis I cross-referenced data 
from all three experiments (Section 3.5, 3.6 & 3.7) (Fig 3.14c). This analysis 
identified 14 single-copy genes and additionally, IAP elements, as upregulated in 
each of these stringent experiments (Table 3.2). Interestingly, all 14 genes exhibited 
strong tissue-specificity. Of the fourteen genes, nine are primarily expressed in the 
testis with the remaining expressed in liver, kidney, blood and the pituitary gland 
according to the BioGPS and UniGene databases. Furthermore, of the mappable 
genes, 10 out of 13 are associated with ICP or HCP promoters. Interestingly, all eight 
mappable testis-specific genes are on the classification border between ICP and HCP 
promoters i.e. weak CpG island genes, which is precisely what would be expected of 
genes potentially regulated by DNA methylation (all have CpG Obs/Exp 0.57-0.61 
over >400bp) (Fig 4.1). Indeed, the only gene from this gene list, Tex13, which was 
included in the global bisulphite sequencing analysis by Meissner and colleagues 
(2007) was strongly hypermethylated in somatic cells despite being classified as a 
HCP gene (see Table 3.2.). In contrast, 3 out of 5 of the remaining non germline 
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Fig 3.14. Identification of final candidate genes. a & b.) RT-PCR of germ-line genes in a.) 
P cells and b.) pMEFs after 5-aza dC treatment and at days 3, 8 and 14 following recovery 
after 5-aza dC withdrawl. In contrast to germ-line genes, the controls Krt8, Rpp25 and Wnt4 
re-impose silencing during recovery from 5-aza dC. c.) Venn diagram cross-referencing all 
three experiments (Fig 3.4) to identify the final candidate genes. This analysis suggests 15 
transcripts (14 single-copy) are upregulated >6-fold in all three experiments and therefore 
satisfy the stringent criteria to be considered candidate genes here. Notably, additional gene 
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genes are associated with LCP promoters. This suggests that these genes may be 
indirect hits as a result of other epigenetic or transcription factor changes. 
Alternatively, it is possible DNA methylation could be regulating their expression 
through distal CpG rich elements. For example, a CpG island is present 2kb 
upstream of the Gstp2 promoter. However, the prevalent gene ontology conclusion 
reporting enrichment of germline specific genes, considered with the promoter 
classifications, suggest that the nine testis-specific genes identified here represent the 







In summary, my approach to progressively identify potential candidates for 
regulation by DNA methylation has yielded a set of 14 single copy genes. Of these, 9 
are testis-specific and have the promoter characteristics expected of methylation-
dependent targets. Further analysis (Chapter 4) will investigate whether these genes 
are causally regulated primarily by CpG methylation in vivo.
 
 
Gene Genomic location Tissue specificity Promoter type Methylated
Tex19 11 Testis   HCP ND 
PiwiL2 14 Testis ICP ND 
Rps4y2 6 Testis HCP ND 
Rhox5 X Testis Unknown ND 
MageK1 X Testis ICP ND 
Tex13 X Testis HCP Yes 
Mov10l1 15 Testis ICP ND 
Rhox4d X Testis ICP ND 
Tex19.2 11 Testis ICP ND 
Gpr97 8 Blood LCP ND 
Slc47a1 11 Kidney HCP ND 
Akr1c12 13 Liver LCP ND 
Prl 13 Pituitary Gland LCP ND 
Gstp2 19 Liver ICP ND 
IAP element N/A (Testis) ICP Yes 
Table 3.2. Methylation-dependent candidate genes. Candidate genes were derived by 
cross-referencing genes de-repressed in the three experimental approaches used here (Fig 
3.4 & 3.14c). N/A: Not applicable, ND: Not determined. Nb. IAP is expressed preferentially 
but not exclusively in the testis. 
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3.9 Germline specific miRNAs and piRNAs are not de-
regulated in DP cells
This chapter identified a significant enrichment of germline specific genes de-
repressed in the absence of DNA methylation. I decided to examine whether this 
germline specificity could be extended to other varieties of transcript such as testis 
specific microRNAs (miRNA) and piwi-interacting RNAs (piRNAs). piRNAs are 
short RNAs typically 26-32bp in length specifically expressed during 
spermatogenesis where they function to target a silenced chromatin state to 
transposable elements and some genes (Klattenhoff & Theurkauf, 2009). To 
investigate whether piRNAs were globally mis-    " -32P 
labelled total RNA from wt testis, P cells and DP cells (collaboration with Dr A. 
Ruzov, MRC HGU). Separation of RNA through polyacrylamide clearly showed 
strong bands relating to ~30bp in wt testis but not in either P or DP cells (Fig 3.15a). 
This suggests that DNA methylation is not crucially required for regulating global 
piRNA expression in somatic cells. Alternatively, DNA methylation may have a role 
in piRNA regulation but components of the piRNA biogenesis machinery are absent 
in DP cells preventing piRNA production.  
 
To examine the effect of genome-wide hypomethylation on testis specific miRNA 
expression I performed miRNA specific qPCR. Here I was unable to detect 
significant expression of any of the six testis-specific miRNAs tested in pMEFs, P or  
DP cells compared to wild-type testis (Fig 3.15b) (Ro et al., 2007). To extend this 
analysis I collaborated with Dr E. Wade (University of Leicester) to profile genome-
wide miRNA expression in hypomethylated DP and control P cells. This array 
analysis failed to identify any miRNA’s significantly mis-expressed (>2-fold) 
between the cell lines and only limited miRNA with >1.5 fold changes (Appendix 3). 
This work indicates that while DNA methylation has a potentially important role in 
regulating germline specific genes, it does not appear to significantly regulate, testis-
specific miRNAs and piRNAs or indeed the global miRNAs tested here in somatic 
cells. 
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Fig 3.15. piRNAs and testis-specific microRNAs are not de-repressed in DP cells. a.) 
Radiolabelled total RNA from four WT testis, P cells and DP cells was size separated through 
a poly-acrylamide gel. Asterik shows the expected migration of piRNAs at ~31bp. Total 
piRNAs were not detectable in either P cells or DP cells relative to the testis positive control 
b.) qRT-PCR of 4 testis-specific miRNAs in pMEFS, P cells, DP cells and testis positive 
control. Shown is expression relative to P cells, which is set to 1. No signifcant miRNA 
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3.10 Discussion
 
In order to ascertain whether DNA methylation has a primary role in regulating 
developmental or tissue-specific gene expression, it is first necessary to identify 
candidate loci. Previous studies to identify candidate genes have used either a single 
functional assay (i.e. WT vs hypomethylated cell expression array) (Jackson-Grusby 
et al., 2001; Fouse et al., 2008) or differential methylation analysis (Suzuki et al., 
2007; Weber et al., 2007; Rodic et al., 2005). These methods have the drawback of 
generating many indirect hits and false-positives or targets where it is not clear 
whether differential methylation is a consequence or a cause of transcriptional 
activity, respectively. Furthermore, often these analyses are not validated by 
downstream cause and effect experiments. Thus, I set out to identify a set of bona 
fide candidate genes that could be used in further causal analysis of the role of DNA 
methylation. I used a novel functional approach to progressively identify candidate 
loci by selecting genes that fulfil each of three independent experimental predictions 
(Fig 3.4). By cross-referencing the three experimental datasets I minimized false-
positives and indirect hits. Additionally, the highly stringent 6-fold expression 
threshold enriched for genuine targets at each experimental stage. This stringent 
multi-tiered approach has led to the identification of fourteen single-copy candidate 
genes. These genes are activated when DNA methylation is removed either 
genetically or pharmacologically. Crucially, they also appear to rely on methylation 
to retain an epigenetic memory of their lineage specific transcriptional status.  
 
An intriguing and novel aspect of my approach was the final assay to identify genes 
that lose their epigenetic memory when DNA methylation is transiently removed by 
5-aza dC treatment. The majority of de-repressed genes (71.1%) were able to re-
impose gene silencing during a recovery period in the absence of 5-aza dC. However 
54 genes remained highly transcriptionally active throughout this recovery period. 
These genes represent targets that have lost their epigenetic memory and therefore 
cannot re-acquire their original lineage-specific expression state. Unlike genes able 
to re-impose silencing, it would be predicted that these genes critically rely on DNA 
methylation to direct transcriptional memory. Interestingly, targets that lost their 
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epigenetic memory in this assay were highly enriched for germline specific genes. 
Indeed, in each experimental filter germline genes were strongly enriched among de-
repressed targets and nine of the final fourteen candidate genes are testis-specific. 
Taken together, the experimental data generated here strongly suggests that at least a 
subset of germline specific genes could be directly and primarily regulated by DNA 
methylation. In support, the candidate genes identified here did not overlap with 
genes that rely on the H3K9 methyltransferase G9a to target and/or maintain 
promoter DNA methylation (Epsztejn-Litman et al., 2008). This is consistent with 
the epigenetic memory of my candidate genes being mediated by CpG methylation 
per se and not maintained or re-targeted by G9a and/or H3K9me2 as has been 
demonstrated for several other loci (Tachibana et al., 2008; Feldman et al., 2006).  
 
Using my stringent experimental approach, several genes previously reported to be 
putatively regulated by CpG methylation were excluded from the candidate list. For 
example, previous studies have reported that Pgk2 and Mvh directly rely on promoter 
methylation for their in vivo expression pattern (Ariel et al., 1991; Maatouk et al., 
2006). However, in the present analysis these genes were not de-repressed in DP 
cells and showed a cell-type specific response to 5-aza dC treatment. Similarly, 
Pdha2 and Mael were not de-repressed in any assays performed here (Iannello et al., 
2000; Xiao et al., 2009). These data support a potential secondary role for DNA 
methylation at these loci but are not compatible with promoter methylation being the 
primary system for regulating their expression, as has been suggested. Moreover, a 
recent study elegantly demonstrated that Elf5 relied on promoter methylation in 
epiblast cells to maintain embryonic lineage restriction (Ng et al., 2008). However, 
the results generated here indicate that Elf5 was not de-repressed in DP cells of P-aza 
cells. This suggests that while promoter methylation of Elf5 is crucially important 
during early embryonic stages (Ng et al., 2008), other factors contribute to silencing 
of Elf5 in somatic cells and CpG methylation therefore cannot be the primary system 
at this locus in somatic cells. The fact that several genes previously reported to be 
regulated by promoter methylation did not pass the stringent experimental filters 
used here, highlights the requirement for cause and effect studies to validate the 
precise role of DNA methylation at each locus.  
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While several genes previously reported to be regulated by CpG methylation clearly 
failed the parameters set here, some putative methylation-dependent genes were only 
excluded because they failed a single criterion. It is possible these genes represent 
genuine methylation-dependent loci, but were excluded here as a consequence of the 
necessity to impose strict thresholds (>6-fold) to enrich for the most promising 
candidate genes. One example is Dazl, which was significantly upregulated in DP 
cells and P-aza cells but which partially re-imposed silencing below the threshold 
during recovery from 5-aza dC treatment (~10-fold activation by 5aza dC to ~4-fold 
activation after recovery). Thus, the candidate genes generated here are likely not an 
exhaustive list of potential methylation-dependent targets but rather the most 
promising loci. Indeed, it is noteworthy here that the Illumina BeadChiP probe for a 
highly expected methylation-dependent candidate, Ant4, was poorly designed and 
therefore this gene does not feature in my analysis (Rodic et al., 2005).  
 
In summary, my approach was designed to identify candidate targets where DNA 
methylation is the crucial and upstream system for imposing gene silencing and 
maintaining transcriptional memory. This analysis identified 14 single-copy targets, 
which are greatly enriched in germline specific genes. To further investigate and 
confirm that promoter CpG methylation is the causal and primary in vivo regulator 
of these genes, I elected to examine two candidates, Tex19 and PiwiL2 in detail, as 
paradigms for germline-specific genes regulated by DNA methylation.
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Chapter 4 
Promoter CpG methylation developmentally 
regulates Tex19 and Piwil2 
4.1 Introduction 
 
Whether promoter DNA methylation patterns are the cause, a consequence or a 
contributor to gene expression patterns is a question of great debate. The mounting 
body of evidence suggests that the precise function of promoter CpG methylation in 
regulating gene expression is locus specific, depending on the contribution from 
several epigenetic and trans-acting factors. For example at the Oct3/4 promoter, CpG 
methylation is sufficient to maintain repression but is neither necessary nor the 
upstream initiating signal for gene silencing (Feldman et al., 2006). Instead CpG 
methylation at this locus co-operates with other epigenetic systems and trans-acting 
factors to contribute to a complex regulatory system (Gu et al., 2005; Cedar & 
Bergman, 2009). At the Magea2 locus both H3K9me2 and promoter methylation are 
independently sufficient to maintain gene silencing but neither is crucially required 
per se (Tachibana et al., 2008). Here, both epigenetic marks can promote silencing 
and thus each functions as an additional layer of repression to reinforce the 
epigenetic expression state. Several silenced Hox gene promoters also accumulate 
CpG methylation but here, DNA modification acts downstream of polycomb 
mediated repression (Reynolds et al., 2006; Vire et al., 2006; Fouse et al., 2008). At 
these loci, promoter methylation may contribute to maintaining gene repression but 
is generally considered to be a consequence of transcriptional silencing. 
 
In addition to epigenetic regulation, many genes require tissue-specific transcription 
factors to drive expression. This can add an additional layer of regulation such that 
permissive epigenetic marks and appropriate transcription factors must both be 
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present. For example, in somatic cells demethylation of the Elf5 promoter is 
necessary but not sufficient for gene activation due to the absence of trophoblast 
specific transcription factors (Ng et al., 2008). Indeed, the testis specific Rhox6 and 
Rhox9 genes, which have been proposed to be regulated by DNA methylation, are 
not activated in hypomethylated Dnmt1-null ES cells but are aberrantly expressed 
when these mutant ES cells are differentiated (Oda et al., 2006). This indicates that 
either additional mechanisms of epigenetic silencing aside from DNA methylation 
operate at Rhox6 and Rhox9 in ES cells or that there is a change in the availability of 
a limiting transcription factor during differentiation. Thus, the emerging picture is 
that promoter methylation can contribute to maintenance of an expression state but is 
largely a part of complex gene-specific repression systems that include diverse 
histone modifications, histone variants and transcription factor networks (Hemberger 
et al., 2009; Reik, 2007). Indeed, convincing in vivo examples of genes regulated 
exclusively by DNA methylation have not emerged and it remains undetermined 
whether promoter CpG methylation can be the primary and upstream mechanism for 
directing gene expression patterns.  
 
Despite this assertion, there is limited evidence that the restriction of germline 
specific genes is mediated primarily by promoter methylation in somatic tissues 
(Meissner et al., 2008; Rodic et al., 2005; Maatouk et al., 2006). The association 
between germline specific loci and DNA methylation has been noted in expression 
studies on hypomethylated ES cells (Fouse et al., 2008) and also in genome wide 
methylation analyses (Weber et al., 2007). Additionally, Maatouk et al (2006) have 
shown the temporal activation of three germline specific transcripts in PGCs 
correlates with promoter demethylation. However, while it has been hypothesised 
that germline genes could be regulated primarily by DNA methylation, a 
demonstration of a cause and effect relationship has not emerged. Previous reports 
have shown largely correlative relationships between expression and promoter 
methylation status. These studies have not ruled out DNA methylation patterns 
arising as a consequence of transcriptional activity or as a secondary system 
mediated by other epigenetic mechanisms. There is thus a problem in attributing 
causality. Indeed, most studies do not demonstrate that promoter methylation is 
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required for initiating silencing during development only for maintaining it, which 
again is compatible with DNA methylation being a secondary maintenance system. 
A single exception to this is the report by Rodic et al (2005), which convincingly 
demonstrates Ant4 requires de novo methylation to initiate silencing in differentiating 
ES cells. However, this report does not rule out other epigenetic systems, including 
histone modifications, operating upstream of promoter methylation at this locus. 
Additionally, a study from a second group reports Ant4 is already highly methylated 
in undifferentiated ES cells (Suzuki et al., 2007 supp data). Thus, while many 
commentators often propose germline specific genes as examples of genes regulated 
primarily by tissue specific methylation, direct evidence for this assertion, rather than 
correlative evidence, is lacking in the literature. This chapter will aim to 
comprehensively determine whether promoter methylation functions as the primary 
and upstream regulatory system for germline-specific gene expression, 
independently of histone modifications and transcription factor networks. This 
follows from the previous chapter which noted a striking enrichment of germline-
specific genes in a screen for methylation-dependent candidates. Thus here, I will 
employ a novel cause and effect analysis to investigate the precise role of DNA 
methylation at the germline-specific candidate loci Tex19 and PiwiL2, identified by 
my screen (Table 3.2).   
 
4.2 The Tex19 promoter is hypomethylated in expressing cell 
types but hypermethylated when silenced 
Global analyses of the distribution of DNA methylation have shown that CGI 
promoters (HCP and ICPs) remain largely hypomethylated in all tissues (Weber et 
al., 2007; Meissner et al., 2008). The Tex19 promoter is classified as a HCP (516bp 
Obs/Exp=0.6 GC=59.7%) while the PiwiL2 promoter is an ICP (424bp Obs/Exp=0.6 
GC=61.6%) (Fig 4.1a & b). Notably, PiwiL2 only fails to pass the highly stringent 
length parameter for HCP classification (500bp), suggesting it is a bona fide CGI 
promoter. Both of these genes would therefore be predicted to be unmethylated 
throughout development. However, if promoter CpG methylation were the primary 
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Fig 4.1. Promoter structures and bisulphite amplified regions of candidate genes. a.) 
Tex19.  b.) PiwiL2.  c.) Tex19.2 &  d.) Tex13.  Green blocks represent exon structure of each 
gene with CpG content of selected regions magnified below. Each vertical line in the 
magnified region represents a single CpG dinucleotide with the arrow indicating the 
transcriptional start site (TSS). Shown in red are CpG islands (CGI) with obs/exp CpG ratio 
>0.6 and GC content >55%. CGIs should be greater than 500bp to be considered HCPs. CGI 
size is noted next to each CGI. Shown in black are the regions amplified for bisulphite 
sequencing analysis with the genomic location relative to the TSS indicated below.
to Tex19.2
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mechanism regulating Tex19 and PiwiL2 expression, I would expect to observe 
heavily methylated promoters in non-expressing tissue-types.  
 
To investigate whether candidate genes are methylated in non-expressing cells, I 
used the bisulphite sequencing technique to determine the methylation status of 
CpGs at base pair resolution. Bisulphite treatment distinguishes cytosine from 
methyl-cytosine (5mC) because cytosine is deaminated to uracil whereas 5mC 
produces an intermediate that is stable with respect to deamination. Sequencing 
bisulphite treated DNA thus identifies unmethylated cytosines as thymine residues 
and, methyl-cytosines as cytosine residues. I initially assayed two regions of the 
proximal Tex19 promoter (Fig. 4.1a) in pMEFs, P cells and DP cells (performed by 
J. Reddington under my supervision). Here, Tex19 was found to be heavily 
methylated (>94%) in non-expressing pMEFs and P cells but as expected, 
hypomethylated in DP cells (Fig. 4.2a). Importantly, this analysis demonstrates that 
despite being a HCP promoter, which would be predicted to be constitutively 
hypomethylated, Tex19 is highly methylated in non-expressing cell-types. This is 
consistent with promoter CpG methylation potentially being the primary mechanism 
of silencing Tex19 expression. Additionally, Tex19 exhibits markedly reduced 
promoter methylation in expressing DP cells, supporting the conclusion that these 
cells are globally demethylated (Section 3.3) and consistent with the notion that 
promoter methylation is critically required to maintain silencing at this loci.  
 
To evaluate whether hypermethylation of the Tex19 CGI promoter was 
representative of all the germline specific candidate genes, I examined three more 
candidate promoters. Similarly to Tex19, I found that the PiwiL2, Tex19.2 and Tex13 
promoters were all heavily methylated in non-expressing pMEFs (Fig 4.2b), despite 
the fact these genes were HCPs or strong ICPs (Fig 4.1b, c, d & Table 3.2). I 
conclude that the candidate germline genes tested here represent a novel sub-class of 
CGI genes that acquire developmental promoter DNA methylation.  It is noteworthy 
that with the exception of Tex13 these genes were excluded from published genome-
wide methylation analyses and consequently, this is the first data demonstrating that 
Tex19, PiwiL2 and  Tex19.2 are novel methylated CGI genes in somatic cells.    
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Fig 4.2. Methylation of candidate gene promoters. Closed circles represent methylated 
CpGs, open circles represent unmethylated CpGs. Each horizontal clone represents a unique 
genomic allele. a.) Bisulphite analysis showing Tex19 is hypermethylated at both promoter 
regions (BS1 & BS2) in pMEFs and P cells but hypomethylated in DP cells. b.) Candidate 
gene CGI promoters are hypermethylated in non-expressing pMEFs, despite being CpG 
islands. c.) Tex19 (BS1) is hypermethylated in non-expressing tissues in vivo but 
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One possibility is that Tex19 is methylated in all tissues regardless of expression 
status or that the cell lines used here are not representative of methylation patterns in 
vivo. To investigate this, I examined the in vivo methylation of Tex19 in non-
expressing brain, spleen and FACS sorted somatic cells from testis. Additionally, I 
profiled promoter methylation in expressing purified embryonic day (E)13.5 
primordial germ cells (PGC) and mature sperm. Consistent with bisulphite analysis 
from pMEFs, Tex19 was highly methylated in non-expressing tissues in vivo (>93%), 
including in somatic cells from the testis. Importantly, Tex19 was found to be 
specifically hypomethylated in expressing PGCs and sperm, consistent with in vivo 
demethylation being required for gene activation (Fig. 4.2c). These data indicate that 
promoter CpG methylation strongly correlates with in vivo expression patterns and 
supports the notion that the Tex19 promoter represents a novel CGI that acquires 
tissue-specific methylation.  
    
4.3 Tex19 protein is de-repressed in DP cells
RT-PCR analysis of DP cells detected significant de-repression of Tex19 transcript. 
To investigate whether Tex19 transcript in DP cells was full-length and translated I 
{@-Tex19 antibody  I was able to 
detect strong staining in DP cells that was blocked by pre-incubation with a Tex19 
derived epitope protein, suggesting Tex19 was a unique target (Fig. 4.3b). In 
contrast, P cells exhibited strongly reduced staining (Fig. 4.3a). Western blot 
analysis (performed by E. Hall under my supervision) indicated that a band 
migrating at ~42kDa, the expected size of Tex19, was present specifically in DP cells 
and testis but not in P cells (Fig. 4.3c). I conclude that Tex19 protein is present in DP 
cells and testis but not in P cells suggesting that demethylation of the Tex19 promoter 
is sufficient to promote expression and translation of full length Tex19 transcript.   
4.4 Tex19 and PiwiL2 promoters drive expression of reporter 
genes in somatic cells
The data presented here suggests that Tex19 and PiwiL2 are methylated in cultured 
non-expressing cells (Section 4.2), that experimental demethylation induces 
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Fig 4.3. Tex19 protein is expressed in DP cells but not P cells. a.) Tex19 staining cannot 
be significantly detected in P cells by immunofluoresence. DAPI shown in blue, stains nuclei. 
b.) Strong Tex19 staining (red) is evident in DP cells (bottom panel) which is abrogated by 
pre-incubation with a Tex19-specific peptide. c.) Western blot demonstrating that Tex19 can 
be specifically detected in DP cells and testis but not in P cells. Asterik denotes non-specific 
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expression (Section 3.5 & 3.6) and that the in vivo promoter methylation status 
correlates with protein expression (Section 4.3). As part of a strategy to attribute 
functional significance to DNA methylation at candidate loci, I cloned the proximal 
promoters of Tex19, PiwiL2 and Tex13 into luciferase reporter constructs (pGL3-
basic). Additionally I cloned the promoters of three control germline-specific genes 
(Rnh2, Pramel1 and Tex11), that each failed at least one criterion required to be 
considered as methylation-dependent candidates (Section 3.4). For all constructs I 
cloned the promoter region from approximately 1kb upstream to up to 250bp 
downstream of the transcriptional start site (TSS) of the primary isoform (RefSeq). 
Transient transfection of these constructs into mouse Neuro2a cells or human 293T 
cells demonstrated that all three bona fide candidate gene promoters (Tex19, PiwiL2, 
Tex13) could drive strong expression (up to 130-fold) of the luciferase reporter 
compared to vector only (Figure 4.4). Indeed Tex19 was observed to drive 
comparable reporter expression to the highly active CMV promoter (~25% of 
maximal CMV) (data not shown). This indicates that unmethylated Tex19 is an 
inherently strong promoter. In contrast, two of the three control germline promoters 
(Rnh2 and Tex11) and the negative control, Oct3/4, were unable to promote 
significant reporter expression above background (Fig 4.4). 
 
This analysis reveals two important points. Firstly, all three candidate genes tested 
here, Tex19, PiwiL2 and Tex13, were able to drive strong reporter expression in 
terminally differentiated mouse and human somatic cells. This demonstrates that 
these genes do not have a critical reliance on germline-specific transcription factors 
(TF) for expression. Instead, it is likely that ubiquitous and general TFs are driving 
the observed expression from these promoters. Secondly, despite the fact that the 
Tex19, PiwiL2 and Tex13 promoters are able to drive strong transcription in Neuro2a 
and 293T cells, the endogenous loci are silenced in both cell-types. This indicates 
that the endogenous loci critically rely on an epigenetic mechanism to maintain their 
silenced state. Both of these conclusions are consistent with promoter CpG 
methylation being the primary and exclusive mechanism regulating expression of 
these candidate genes. 
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In contrast, the germline control genes that were predicted not to be regulated 
primarily by DNA methylation exhibited only weak or background expression in 
these experiments (Fig 4.4). It would be predicted these genes partly rely on lineage 
specific TFs for their expression, as has been demonstrated for Oct3/4 (Yoem et al., 
1996; Gu et al., 2005). At these loci, DNA methylation may contribute to the 
regulatory mechanism and/or demethylation may be required to ‘poise’ these genes 
for activation in the presence of appropriate TFs but CpG methylation cannot be the 
only or primary mechanism of regulating their transcription. The exception to this is 
Pramel1, which is expressed strongly in these reporter assays. Interestingly, Pramel1 
was considered a germline-specific control gene here because it was marginally 
below the threshold in 3T3-recovery cells, although it was activated in DP cells and 
P-aza cells. In contrast, the other control genes such as Oct3/4 and Rnh2 were not 
activated by 5-aza dC treatment. Pramel1 may therefore represent a gene that was 
excluded from the candidate list due to the highly stringent thresholds employed here 
and may indeed critically rely on epigenetic mechanisms for regulation. In summary, 
this reporter analysis demonstrates that Tex19 and PiwiL2 do not require germline 
specific TFs and suggests that an epigenetic mechanism exclusively mediates the 
expression pattern of the endogenous loci irrespective of cellular lineage.  
  
To investigate the role of distinct cis elements in the Tex19 and PiwiL2 promoters I 
generated a set of deletion constructs from each promoter. Following transient 
transfection into 293T cells, I observed no significant differences between the two 
PiwiL2 promoter regions (Fig 4.5). However, transfection of the Tex19 constructs 
identified discrete functional regions within the promoter. Interestingly, the proximal 
downstream +58 - +198 region strongly repressed transcription by ~7-fold compared 
to the empty vector background level. In contrast, the proximal upstream –224 - +58 
construct was able to drive strong expression ~245-fold above background and ~2.5-
fold higher than the entire promoter construct. Removal of the region upstream of     
-304bp had no significant effect on transcription (compare -1034 - +224 and –304 - 
+198) indicating that all the functional Tex19 cis motifs reside proximal to the TSS 
or outside of the regions assayed here. These data indicate that Tex19 contains at 
least two functional elements, which strongly activate (–224 - +58)  or weakly 

















































































































































































































































































































   
   















































































































































































































































































































   
   
   
 1
39
repress (+58 - +198)  transcription, respectively (Fig 4.5). When both elements are 
present (–304 - +198) strong expression is still observed but reduced by 
approximately 2.5-fold suggesting that the cis-activating motif is dominant but 
influenced by the cis-repressor domain. Analysis of each promoter region with the 
Transcription Elements Search System (TESS) programme failed to identify any 
significant (Poisson model p = <0.05) differences in transcription factor sites 
between the Tex19 activating (–224 - +58) and repressing (+58 - +198) regions. 
Electrophoretic mobility shift assays (EMSA) will be required here in future to 
identify protein factors that bind each distinct Tex19 cis element and direct their 
distinct properties. I conclude that the strong Tex19 expression in somatic cells is 
predominantly driven by the –224 - +58 region of the promoter but partially 
constrained by an adjacent repressor +58 - +198 motif. 
4.5 Promoter CpG methylation silences the Tex19 and PiwiL2
reporters 
Reporter analysis of unmethylated Tex19 and PiwiL2 promoters suggested that 
transcription factors are not limiting for expression of the endogenous loci and that 
an epigenetic mechanism must therefore exclusively silence their transcription. To 
investigate whether DNA methylation is capable of repressing Tex19 and PiwiL2 
activity, I in vitro methylated the reporter constructs using Sss.I methylase, which 
methylates all CpG sites and transiently transfected methylated or mock methylated 
constructs into 293T cells. Here, expression of Tex19 was repressed ~105-fold and 
PiwiL2 was repressed ~145-fold compared to mock methylated controls. In contrast, 
methylation of the empty reporter construct only repressed transcription by 17-fold 
(Fig 4.6a). This translates into a net repression of 6-fold (Tex19) and 8.5-fold 
(PiwiL2), which suggests CpG methylation can repress expression from these 
promoters significantly below background effects.  
 
A drawback of the above experimental method is that the entire construct becomes 
CpG methylated including the reporter coding region. This could potentially have 
indirect effects independent of promoter methylation. To address this, I used the 
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experimental scheme shown in Fig 4.6b to generate reporter constructs with only the 
promoter region methylated. Using this approach I investigated the effect of 
promoter-specific methylation on each Tex19 deletion construct. Here I found that 
methylation of the +58 - +198 repressor region had no significant effect on 
transcription compared to the mock methylated construct (Fig 4.6c). This is 
consistent with this domain already functioning as a transcriptional repressor element 
independent of methylation. In contrast, methylation of the –224 - +58 activator 
region strongly repressed transcription by 12-fold compared to mock methylated 
controls (Fig 4.6c). This assay clearly demonstrates that promoter CpG methylation 
is sufficient to promote strong repression of Tex19 and is consistent with DNA 
methylation mediating silencing of endogenous Tex19. It is noteworthy that these 
assays are conducted with reporters that are outwith a chromatin environment. 
Therefore the degree of silencing attainable by promoter DNA methylation will be 
limited by context. These assays merely provide proof of principle that CpG 
methylation can have a significant effect on Tex19 repression and do not provide a 
quantitative measure of the effect of endogenous promoter methylation, which may 
be considerably more effective. Thus, these data suggest that in a chromatin context, 
methylation of the CpG dense Tex19 promoter would induce significant 
transcriptional silencing.
4.6 Tex19 and PiwiL2 are not de-repressed in Lsh-/- MEFs
 
To further investigate the direct link between Tex19 expression and promoter 
hypomethylation I used globally hypomethylated Lsh-null MEFs. Lsh is a putative 
SWI/SNF chromatin remodelling protein that is essential for maintaining DNA 
methylation at specific transposable elements, Hox genes and imprinted loci, 
probably via its interaction with the de novo methyltransferases (Zhu et al., 2006; Xi 
et al., 2007; Fan et al., 2005). I predicted that the absence of Lsh would lead to 
hypomethylation and activation of Tex19. Importantly, this would exclude the 
possibility that de-repression of Tex19 in DP and P-aza cells occurred due to loss of 
Dnmt1 protein per se, which has been reported to repress transcription independently 
of its methyltransferase activity (Fuks et al., 2000; Robertson et al., 2000; Dunican et 
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Fig 4.6. Promoter methylation of the Tex19 and PiwiL2 reporters represses 
transcription. a.) PiwiL2 and Tex19 reporters were in vitro methylated or mock methylated 
and transiently transfected into 293T cells. Shown is relative repression as determined by the 
ratio of methylated reporter expression (M) to unmethylated reporter expression (U). b.) 
Schematic of method used to generate reporter constructs with promoter specific methylation. 
Briefly, the promoter region was digested out with restriction endonucleases, in vitro 
methylated and re-ligated to the unmethylated reporter backbone. This was linearised, size 
seperated to extract the limited number of single promoter region insertions and purified. c.) 
Relative repression of Tex19 deletion constructs specifically methylated only in the promoter 
region relative to mock methylated controls 
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al., 2008). In the present study, digestion of genomic DNA from Lsh-deficient cells 
with the methyl-sensitive HpaII restriction enzyme confirmed these cells were 
globally hypomethylated (data not shown). Surprisingly, bisulphite analysis of Tex19 
and Tex19.2 demonstrated that these loci retain fully methylated promoters in Lsh-
null MEFs (Fig 4.7a). In contrast, Oct3/4 was highly demethylated, confirming that 
Lsh-null cells were hypomethylated and that promoter regions were susceptible to 
demethylation (Fig 4.7b). RT-PCR analysis of several candidate germline genes 
revealed no de-repression of transcripts in Lsh-null cells, consistent with promoter 
specific demethylation being required for activation of these genes (Fig 4.7c). In 
contrast despite promoter hypomethylation, Oct3/4 was not activated in Lsh-deficient 
cells, probably because this locus is regulated by multiple levels of epigenetic and 
trans-acting systems in addition to DNA methylation (Fig 4.7d) (Feldman et al., 
2006).  Notably, the critical reliance on Lsh to maintain promoter methylation at 
Oct3/4 was a novel observation at the time of these experiments (2008) but has 
recently been reported elsewhere (Xi et al., 2009).  
 
While Tex19 unexpectedly retained methylation in globally hypomethylated Lsh-null 
cells, this analysis revealed several interesting observations. Firstly, despite global 
demethylation in Lsh deficient cells, including at Oct3/4 and three other non-
candidate promoters tested (data not shown), Tex19 maintains normal promoter 
methylation. This suggests that, unlike most loci examined here and elsewhere (Zhu 
et al., 2006; Fan et al., 2005), Tex19 does not rely on Lsh to retain CpG methylation 
and instead utilises a distinct and/or combination of mechanisms to target and 
maintain promoter methylation. This property could potentially reflect the critical 
reliance on promoter CpG methylation to maintain Tex19 silencing. Secondly, 
methylated Tex19  is not activated in a globally demethylated environment. This 
indicates that Tex19 is not activated by the secondary or indirect effects of cellular 
demethylation and supports the argument that this locus is directly regulated by 
promoter CpG methylation in cis. However, these experiments cannot rule out loss of 
Dnmt1 protein per se activating Tex19 in DP and P-aza cells.     
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Fig 4.7. Germ-line candidate genes are not demethylated and activated in 
hypomethylated Lsh-deficient MEFs. a.) Bisulphite methylation analysis of candidate 
genes Tex19 and Tex19.2 in primary MEFs (pMEF) and Lsh-null MEFs. b.) Methylation of 
control Oct3/4 in pMEFs and Lsh-null MEFs. c.) RT-PCR analysis of candidate gene 




































          144
4.7 Tex19 & PiwiL2 acquire promoter methylation and 
silencing during ES cell differentiation
 
To investigate the role of promoter CpG methylation at Tex19 and PiwiL2 during 
cellular differentiation, I induced ES cells to differentiate into embryoid bodies (EB). 
The central concept of EB culture is to mimic the embryonic process of germ layer 
formation from the ICM. Here, aggregated ES cells develop into a cavity  structure 
that includes multiple lineages derived from the primitive ectoderm and visceral 
endoderm. This structure, while less organised than an embryo, has been shown to 
contain antero-posterior polarity and form a primitive streak-like region (ten Berge et 
al., 2008). EB differentiation thus closely parallels in vivo development (Nishikawa 
et al., 2007). In the present study, RT-PCR analysis demonstrated that Tex19 and 
PiwiL2 were strongly expressed in undifferentiated mouse E14 ES cells, consistent 
with the GNF microarray database, which indicates these genes are expressed in 
zygotes and blastocysts (GNF Symatlas - http://biogps.gnf.org) and previous reports 
(Kuntz et al., 2008; Silva et al., 2009). However, both genes underwent progressive 
temporal repression upon induction of EB differentiation, with silencing observed by 
day 4 (Fig 4.8a).  
 
If promoter methylation were the primary mechanism directing silencing of these 
loci, it would be predicted that DNA methylation would accumulate prior to or 
coincident with gene silencing. To test this, I evaluated Tex19 and PiwiL2 promoter 
methylation dynamics during EB differentiation. Here, Tex19 was hypomethylated in 
undifferentiated ES cells (day 0) but acquired significant methylation by day2 (57%) 
and was fully methylated (87%) by day 4 of EB formation (Fig 4.8b). PiwiL2 
followed similar developmental CpG methylation dynamics (Fig 4.8c). The small 
number of methylated clones at day 0 probably represents a sub-population of 
partially differentiated ES cells. These data strongly support the conclusion that 
promoter methylation is targeted to Tex19 and PiwiL2 coincident (at least) with gene 
silencing (compare Fig 4.8a with Fig 4.8b & c). In contrast, studies on the 
developmental silencing of Oct3/4 have shown that DNA methylation accumulates at 
the promoter after transcriptional silencing has been imposed and is therefore a 
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Fig 4.8. Promoter methylation dynamics during EB differentiation. a.) RT-PCR analysis 
of Tex19 and PiwiL2 expression during ES cell EB differentiation. Oct3/4 demonstrates EBs 
are differentiating. Right panel shows cycle number. b.) Tex19  and c.) PiwiL2 promoter 
methylation dynamics during EB formation. Percentage methylation shown on bottom right. 
Methylation accrues at gene promoters before or coincident with transcriptional silencing. d.) 
& e.) Comparison of qRT-PCR expression and promoter methylation during EB differentiation 
shows an inverse correllation at d.) Tex19 & e.) PiwiL2. Expression is relative to day 10, which 
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Fig 4.9. 5-aza dC re-activates silenced candidate genes after EB differentiation. a.) 
RT-PCR expression analysis of candidate (asterik) and germline genes demonstrates they 
are silenced during EB formation and subsequently re-activated by 5-aza dC (Aza) treatment 
for the final 72hrs of EB differentiation. Control pluripotentcy  genes Oct3/4 and Nanog are not 
re-activated. b.) qRT-PCR of Tex19 expression in EBs +/- 5-aza dC. Expression is relative to 
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secondary repressive system at this locus (Feldman et al., 2006). Here, the data is 
consistent with promoter methylation being the primary mechanism of Tex19 and 
PiwiL2 silencing as methylation occurs in parallel with repression. To quantitatively 
confirm the dynamic relationship between gene expression and CpG methylation I 
used qRT-PCR. This analysis clearly demonstrates a direct inverse relationship 
between acquisition of promoter methylation and silencing of Tex19 and PiwiL2 (Fig 
4.8d & e)  
To further analyse promoter methylation dynamics, I used 5-aza dC to study the 
effects of demethylation on candidates genes silenced during EB differentiation. 
Here, I treated EBs with high (10uM) or low (1uM) 5-aza dC for the final 3 days of 
EB culture. Notably, all the candidate genes tested, including Tex19 and PiwiL2, 
were silenced during differentiation but de-repressed by addition of 5-aza dC. In 
contrast, mock treated EBs (0uM) maintained repression of candidate genes (Fig 
4.9a & b). This analysis suggests that candidates are not being silenced through 
changes in transcription factor availability during differentiation, as they can be 
readily reactivated by demethylation. Additionally 5-aza dC treatment was 
insufficient to de-repress the pluripotency factors Nanog and Oct3/4, consistent with 
these loci acquiring several tiers of repressive modifications, in contrast to Tex19 and 
PiwiL2, which critically rely on CpG methylation for silencing (Fig 4.9a). In 
summary, this analysis has demonstrated that Tex19 and PiwiL2 are methylated 
before or in parallel with transcriptional silencing during EB differentiation and that 
this silencing can be relieved by promoter demethylation. 
4.8 Tex19 and PiwiL2 rely on de novo methylation mediated 
by Dnmt3b for silencing during ES cell differentiation
To conclusively demonstrate that DNA methylation is both causal and necessary to 
direct gene silencing at Tex19 and PiwiL2 I used ES cells deficient for Dnmt3a and 
Dnmt3b. These enzymes have been proposed to be the primary mediators of de novo 
methylation during murine embryonic development (Okano et al., 1999). 
Consequently, ES cells lacking both Dnmt3a and Dnmt3b have undetectable de novo 
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methylation activity. Despite this, early passage Dnmt[3a 3b]-null ES cells retain 
global methylation, due to Dnmt1 activity, and can differentiate in vitro (Jackson et 
al., 2004; Gilbert et al., 2007). Here, I differentiated early passage Dnmt[3a 3b]-null 
ES cells into embryoid bodies in parallel with parental (wild-type) J1 ES cells. As 
observed with E14 ES cells, Tex19 and PiwiL2 were strongly silenced during EB 
differentiation of wild-type J1 ES cells (Fig 4.10a). However intriguingly, Tex19 and 
PiwiL2 were unable to impose transcriptional silencing during differentiation in the 
absence of Dnmt3a and Dnmt3b (Fig 4.10b). In contrast, Oct3/4 was silenced 
comparatively to wild-type cells, indicating Dnmt[3a 3b]-null ES cells proceed with 
normal differentiation, as has been previously reported (Fig 4.10b) (Gilbert et al., 
2007; Li et al., 2007). To confirm that Tex19 and PiwiL2 were intrinsically unable to 
silence expression and not just delayed in Dnmt[3a 3b]-null ES cells, I cultured EBs 
for an extended period. Here strong expression of Tex19 and weak expression of 
PiwiL2 could still be detected, even after 15 days differentiation, indicating that both 
genes are unable to impose full gene silencing without de novo methylation (data not 
shown). The failure of Tex19 and PiwiL2 to silence expression strongly supports the 
notion that de novo promoter methylation is the critical and primary mark mediating 
repression at these loci. Additionally, this evidence supports the conclusion that 
Dnmt1 protein per se is not the causal factor repressing Tex19 and PiwiL2 in DP and 
P-aza cells, as Dnmt1 is present in expressing day 10 Dnmt[3a 3b]-null EBs. 
 
Notably, qRT-PCR analysis suggested PiwiL2 transcript levels were repressed ~7-
fold by day 10 in Dnmt[3a 3b]-null EBs. While this is considerably less than wild-
type embryoid bodies (51-fold), it still represents significant gene repression. This 
may reflect a change in the availability of transcription factors or may indicate that 
other epigenetic systems have a secondary influence on PiwiL2 regulation. 
Interestingly Ant4, which is the only other gene to my knowledge reported to rely on 
de novo methylation for silencing (see Section 4.1 & Rodic et al., 2006), exhibited 
similar moderate repression to PiwiL2 in Dnmt[3a 3b]-null EBs. Thus while 
promoter methylation is critically required for silencing of PiwiL2 and Ant4, my data 
suggests that the precise level of expression of these genes may also be influenced by 
other factors. In contrast, Tex19 expression remained completely unaffected during 
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Fig 4.10. Tex19 and PiwiL2 are not silenced in differentiating Dnmt3-null ES cells. 
RT-PCR analysis of Tex19 and PiwiL2 expression during EB differentiation in  a.) WT (J1) and  
b.) early passage Dnmt [3a 3b]-null ES cells. Tex19 and PiwiL2 are silenced during WT ES 
cell differentiation but Dnmt [3a 3b]-null ES cells are unable to impose silencing on Tex19 and 
PiwiL2 is severaly delayed. Note Oct3/4 silencing is unaffected by the absence of Dnmt [3a 
3b]. c.) & d.) RT-PCR analysis of Tex19 and PiwiL2 expression in single Dnmt3a-null or 
Dnmt3b-null EBs. e.) RT-PCR genotyping of Dnmt3a and Dnmt3b single null ES cells. f.) 
qRT-PCR analysis of Tex19 expression during EB differentiation in wild-type, Dnmt3a-null and 
Dnmt3b-null ES cells relative to parental undifferentiated ES cells (day 0), which are set to 1. 
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differentiation of Dnmt[3a 3b]-null EBs, strongly suggesting that promoter 
methylation is the crucial and exclusive mechanism of regulating this gene.  
 
To test whether either of the Dnmt3 family members played a predominant role in 
targeting methylation to Tex19 or PiwiL2 I used ES cells singly lacking Dnmt3a or 
Dnmt3b (Fig 4.10e). RT-PCR analysis of EB differentiated Dnmt3a-null ES cells, 
showed that Tex19 and PiwiL2 imposed silencing comparably to wild-type parental 
J1 ES cells (Fig 4.10c). However, differentiation of Dnmt3b-null ES cells clearly 
demonstrated that Tex19 was unable to silence transcription and that PiwiL2 
repression was strongly delayed (Fig 4.10d). Importantly, both cell lines were 
capable of differentiation, as Oct3/4 was repressed similarly to wild-type ES cells. 
qRT-PCR confirmed that wild-type and Dnmt3a-null ES cells imposed strong 
repression of Tex19 but Dnmt3b-null ES cells were unable to impose such silencing 
(Fig 4.10f). This data suggests that Dnmt3b is the critical enzyme responsible for 
directing promoter methylation to Tex19 and thus mediating silencing at this locus. 
Furthermore, the incomplete silencing of PiwiL2 in Dnmt3b-null cells suggests 
Dnmt3b is a crucial component required for repression of PiwiL2. In summary these 
data provide strong cause and effect evidence that promoter methylation, targeted by 
Dnmt3b, is the primary and exclusive mechanism of regulating Tex19 expression. In 
contrast, this data is consistent with de novo DNA methylation functioning as a 
crucial component of the regulatory system of PiwiL2.  
4.9 Silenced Tex19 is not marked by histone modifications
While the data presented here strongly supports a primary and causal role for DNA 
methylation in regulating Tex19, one possibility is that histone modifications 
contribute to a secondary or targeting regulatory system at the locus. To evaluate the 
role of histone modifications at Tex19, I initially interrogated the genome-wide 
histone  modification database generated by Mikkelsen et al (2007). This indicated 
that the promoter region of Tex19 (~1.5kb around TSS) was not enriched for any of 
the histone modifications examined (Appendix 4). Indeed, the Tex19 promoter was 
highly depleted of histone modifications. Importantly, there was no difference in the 
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modification profile between expressing ES cells and non-expressing pMEFs, 
strongly suggesting that histone modifications do not play an important role in 
promoting the differential expression observed between these cell types.  
 
To experimentally validate the relative depletion of histone modifications at Tex19, I 
performed native chromatin-immunoprecipitation (n-ChIP) from P and DP cells at 
the two regions of Tex19 shown in Fig 4.11a. Of particular interest are the 
modifications present in non-expressing P cells which could potentially contribute to 
silencing of Tex19. The absence of histone marks in P cells would render promoter 
CpG methylation as the likely exclusive mechanism directing gene silencing. ChIP 
analysis of the repressive polycomb mark H3K27me3 demonstrated that this 
modification is absent from, or only weakly deposited, at Tex19 in P cells as 
determined by the B-actin negative control and Oct3/4 positive control (Fig 4.12a). 
Furthermore, ChIP of the activating mark H3K4me2, which has been reported to 
structurally inhibit de novo methylation (Ooi et al., 2007), indicated that this 
modification is also depleted from Tex19 in P cells compared to the negative Oct3/4 
control but increased moderately in DP cells (Fig 4.12b). Importantly, these analyses 
suggest that neither H3K27me3 nor H3K4me2 is significantly present at Tex19 in 
non-expressing P cells and therefore cannot be involved in regulating Tex19 
silencing. Further ChIP analysis of the H3K9ac mark and the histone variant H2A.Z 
suggested that neither of these epigenetic states were significantly enriched in P cells 
either (Fig 4.12a & b). This is consistent with the Mikkelsen global modification 
database (Appendix 4), which indicated Tex19 was generally depleted of histone 
modifications and supports the hypothesis that DNA methylation is the primary and 
exclusive epigenetic mark mediating silencing of Tex19 in non-expressing cells.  
 
Notably, the relative enrichment of both H3K4me2 and H3K27me3 is altered in DP 
cells. This is consistent with DNA methylation and histone modifications 
functionally interacting (Vire et al., 2006; Cedar & Bergman, 2009). However, the 
observed chromatin modification changes in DP cells must occur downstream of 
promoter demethylation and therefore would be predicted to be a consequence of 
transcriptional activity. Of interest, the enrichment of H2A.Z increased in DP cells, 
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Fig 4.11. Schematic of genomic regions assayed by ChIP.  Green boxes represent the 
exon structure at each locus and arrows the transcriptional start site (TSS). Sites assayed by 
chromatin immunoprecipitation (ChIP)  are shown as black boxes under the appropriate 
genomic region and the location given relative to the TSS. a.) Two regions of Tex19 were 
assayed by ChIP. The promoter proximal region (Pr) and an upstream region (Up). b.) An 
upstream region of Oct3/4 predicted to be enriched in H3K27me3 (Mikkelsen et al., 2008) was 
assayed as a positive control for this mark. c.) A promoter proximal region of B-actin predicted 
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Fig 4.12. ChIP analysis and nucleosome occupancy of Tex19. a.) ChIP of H3K27me3 
shows Tex19 is depleted of this modification in P and DP cells. Importantly this mark is 
significantly depleted in non-expressing P cells indicating this modifciation is not a significant 
part of the repression mechanism at this locus. Oct3/4 acts as positive control and B-actin 
represents background levels b.) Tex19 is depleted of H3K4me2 in silenced DP cells but is 
enriched in hypomethylated DP cells. Here B-actin is the positive control and Oct3/4 
represents background levels  c.) ChIP of H3K9ac and d.) histone variant H2A.Z in P cells and 
DP cells. e.) Computational prediction of nucleosome occupancy at Tex19 using the Segal et 
al algorithm (2006). Each block represents the likely nucleosome positioning within the 
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consistent with reports from Arabidopsis that DNA methylation and H2A.Z 
deposition are mutually exclusive epigenetic states (Zilberman et al., 2008). In 
summary, this ChIP analysis strongly suggests that histone modifications are not 
significantly present at the Tex19 promoter in repressed cell-types, consistent with 
promoter CpG methylation exclusively directing gene silencing. 
 
Because neither activating nor repressive marks could be localised to the proximal 
Tex19 promoter in nonexpressing cells I considered the possibility that this region 
was nucleosome-free. Extensive ChIP optimisation with the available H3 antibodies 
failed to enrich any loci above IgG controls, indicating that the antibody was 
ineffectual for this purpose. As an alternative, I used the computational algorithm 
devised by Segal et al (2006) (http://genie.weizmann.ac.il/software/nucleo_ 
prediction.html) to determine nucleosome occupancy at Tex19. This analysis 
suggested that the promoter region (+500bp to -400bp) was strongly predicted to be 
devoid of stable nucleosomes (Fig 4.12e). Indeed the Tex19 promoter sequence is 
significantly depleted of the periodic AA/TT dinucleotides that favour DNA bending 
and stable nucleosome assembly. Considered with the global histone modification 
profile (Mikkelsen et al., 2007) and the absence of chromatin modifications in the 
ChIP analysis performed here, this strongly suggests that the Tex19 promoter could 
be refractory to nucleosome assembly and hence histone modifications. Therefore, 
this locus may critically rely on DNA methylation rather than histone modifications 
for epigenetic regulation. Ongoing collaborative experiments are being carried out 
here to confirm Tex19 is nucleosome-free in vitro and in vivo. Interestingly, 
activation of nucleosome-free CGI promoters has been reported to be SWI/SNF 
independent, potentially suggesting why Tex19 was unexpectedly resistant to 
demethylation in the absence of the putative SWI/SNF remodeller Lsh (Ramirez-
Carrozzi et al., 2009).       
4.10 Tex19 remains silenced in differentiating ES cells 
lacking histone-modifying proteins
To functionally confirm that histone modifications do not have a crucial role in the 
regulation of Tex19 I used ES cells with homozygous deletions for Eed or Hdac1 
          155
(Niswander et al., 1988; Zupkovitz et al., 2006).  Eed is a critical component of the 
PRC2 complex and ES cells lacking this protein are unable to impose polycomb 
mediated silencing via the H3K27me3 modification (Montgomery et al., 2005; Boyer 
et al., 2006). Hdac1 is a histone deacetylase that contributes to several repressive 
complexes (Li j et al., 2002b; Zhang y et al., 1999). The absence of each of these 
proteins will enable the analysis of the role of the central polycomb and 
deacetylation repressive pathways at Tex19. I initially differentiated Eed-null, 
Hdac1-null or parental (wild-type) ES cells through embryoid body (EB) formation 
as previously. However, in the absence of Eed or Hdac1, ES cells failed to 
differentiate, as determined by Oct3/4 expression and morphological criteria (data 
not shown). This suggests that Eed and Hdac1 are both critically necessary for 
cellular differentiation through EB formation. Therefore in this context, analysis of 
Tex19 expression is uninformative. 
 
To address this, I used an alternative experimental approach to induce ES cell 
differentiation. Here, I cultured Eed-null, Hdac1-null or parental (wild-type) ES cells 
with retinoic acid (RA) for three days. To validate the approach I also treated 
Dnmt3a-null, Dnmt3b-null and Dnmt[3a 3b]–null ES cells with RA for 3 days. Here 
qRT-PCR analysis demonstrated Oct3/4 was strongly downregulated compared to 
mock-treated ES cells, indicating Dnmt3 family-null ES cells undergo differentiation 
in response to RA (Fig 4.13a & b). Consistent with the EB studies, Tex19 was 
silenced in RA treated WT and Dnmt3a-null ES cells but remained strongly 
expressed in Dnmt3b-null and Dnmt[3a 3b]–null ES cells (Fig 4.13a & b). This 
confirms the previous conclusion that Dnmt3b mediated de novo methylation is 
critically required for silencing Tex19.   
 
To evaluate the role of Eed and Hdac1, I determined Tex19 expression in mutant 
cells by qRT-PCR. After RA treatment both Eed-null and Hdac1-null ES cells 
repressed Oct3/4 expression, indicating they have initiated differentiation in this 
approach (Fig 4.12c & d). Analysis of Eed-deficient ES cells showed Tex19 was 
strongly silenced after 3 days RA treatment. This is consistent with Tex19 repression 
occurring independently of H3K27 methylation and polycomb complexes. However 
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intriguingly, Tex19 was not repressed in RA treated Hdac1-deficient ES cells (Fig 
4.13a & c). This observation supports a critical role for Hdac1 and histone 
deacetylation in the initiation of Tex19 silencing. However, treatment of somatic 
cells with the histone deacetylase inhibitor TSA, did not de-repress Tex19 (Fig 
3.12a). This suggests that deacetylation is insufficient to reactivate stably silenced 
Tex19 but that it may have a role in initiating silencing. One possibility is that 
deacetylation is required to create a permissive environment or ‘prime’ Tex19 
chromatin for de novo methylation (Bird, 2002). However, this is not compatible 
with the putative conclusion that the Tex19 promoter may be nucleosome-free.  
 
It is therefore prudent to consider the alternative possibility that Hdac1-null cells 
have initiated atypical lineage-specific differentiation or have not differentiated at all 
here, as has been reported previously, and are thus are uninformative for this analysis 
(Lee et al., 2004). In this scenario Oct3/4 could impose RA responsive silencing 
independent of Hdac1, but other differentiation programmes would not initiate and 
therefore de novo methylation activity (at Tex19) may not be induced. This notion is 
supported by the relatively moderate level of Oct3/4 repression (compare Hdac1-/- 
with Eed-/-) and the fact that Hdac1-null cells were unable to differentiate into EBs.  
Indeed preliminary optimisation experiments with wild-type OS25 ES cells, which 
carry a Oct3/4 selectable marker, suggested endogenous Oct3/4 silencing in the 
absence of other differentiation events was a conceptual possibility. Here, 10 days 
EB differentiation of OS25 ES cells resulted in silencing of Oct3/4 but not of Tex19. 
Crucially, bisulphite sequencing demonstrated that Tex19 had not acquired any 
promoter methylation during this period suggesting the normal programme of 
differentiation had not occurred (Tex19 is methylated in differentiated cells in vivo). 
This probably reflects the unique properties of OS25 cells as a result of extended 
Oct3/4 selection (for example they appear morphologically fibroblast-like). Likewise 
Hdac1 deficient cells may have acquired unique plasticity properties as a result of 
global deacetylation. Thus, further studies are needed to determine the precise 
contribution of Hdac1 to Tex19 silencing as it is not clear whether Hdac1-null ES 
cells differentiate here or simply repress Oct3/4 in response to RA.  
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Fig 4.13. Tex19 requires Dnmt3b and Hdac1 for silencing in RA differentiated ES cells. 
a.) RT-PCR and b.) qRT-PCR analysis of Tex19 expression in retinoic acid (RA) differentiated 
mutant ES cells. Consistent with EB studies Dnmt3b is required for silencing Tex19 during RA 
differentiation. c.) RT-PCR and qRT-PCR analysis of Eed-null and Hdac1-null ES cells 
differentiated with RA. Oct3/4 is repressed in all mutant ES cells indicating they are 
differentiating after RA addition. Tex19 is silenced in differentiated Eed-null ES cells but not 
Hdac1-null ES cells.
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In any case, these experiments have confirmed that de novo methylation is critically 
required for Tex19 silencing and that polycomb histone modifications are entirely 
dispensable. Another possibility is that G9a, which catalyses H3K9 methylation, may 
play a role in repressing Tex19. Indeed G9a has been shown to target DNA 
methylation to several gene promoters (Tachibana et al., 20008; Dong et al., 2008). 
However, recent reports have indicated that G9a knockdown, leading to a global 
H3K9me2 reduction, has no effect on Tex19 expression compared to controls 
(Chaturvedi et al., 2009: Yokochi et al., 2009 GEO accession database). Moreover in 
the absence of G9a, Tex19 still acquires de novo methylation in differentiating ES 
cells (Epsztejn-Litman et al., 2008 supp data). In the present study, specific 
inhibition of G9a (and hence H3K9me2) with Bix-01294 (Kubicek et al., 2007) did 
not de-repress Tex19 in pMEFs and the combination of Bix-01294 and TSA was also 
insufficient to de-repress Tex19 (data not shown). In contrast 5-aza dC strongly 
activated expression (Fig 3.11b). Taken together these data strongly suggest that 
neither polycomb mediated H3K27me3 nor G9a mediated H3K9me2 have a 
significant role in regulating Tex19. Considered with the general depletion of histone 
modifications at Tex19, this provides compelling evidence that DNA methylation is 
the primary and exclusive mechanism regulating lineage specific Tex19 expression.  
 
4.11 DNA methylation regulates the lineage specific 
expression of Tex19 in PGCs
In the present study I have presented strong evidence that promoter methylation 
directs tissue-specific expression of Tex19. Because previous reports have suggested 
that methylation may regulate the activation of some germline specific genes during 
PGC development, I considered the possibility that promoter methylation also directs 
the temporal activation of Tex19 (Maatouk et al., 2006).  PGCs are specified in the 
extra-embryonic mesoderm at E7.25 and then commence actively migrating through 
the hindgut endoderm by E8.5 (Ginsberg et al., 1990). They colonise the gonads 
between E10.5-E11.5 and enter a phase of epigenetic reprogramming which includes 
global erasure of DNA methylation and histone modifications (Hajkova et al., 2002; 
Hajkova et al., 2008). During this time, the Dazl promoter is demethylated and this 
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correlates with the temporal activation of Dazl expression. To investigate whether 
Tex19 undergoes a similar demethylation and activation phase in epigenetically 
reprogrammed PGCs, I FACS sorted migratory E10.5 PGCs and post-migratory 
E13.5 PGCs from embryonic gonads according to expression of a transgenic Oct3/4  
driven GFP marker (Fig 4.14a) (Boiani et al., 2002). This process resulted in 
populations of PGCs that were typically >95% (E10.5) or >98% (E13.5) pure, as 
judged by staining for endogenous Oct3/4 (Fig 4.14b) and Nanog (Appendix 5). In 
addition, I was unable to detect expression of the somatic cell marker Sf1 in purified 
PGCs by qRT-PCR but could readily detect expression in the remaining somatic 
cells of the sorted gonad (Fig 4.14c). I was also able to confirm that visual 
discrimination between male and female gonads at E13.5 was accurate, as male 
E13.5 PGCs exclusively expressed Dnmt3l, as expected (Fig 4.14c) (Small et al., 
2005 supp data).  
 
To validate the approach I examined the methylation status of Dazl in E10.5 and 
E13.5 male and female PGCs. Consistent with previous reports, Dazl was found to 
be methylated in E10.5 PGCs but hypomethylated by E13.5 (Maatouk et al., 2006). 
In contrast, the somatic cells of the gonad remained methylated throughout this 
period. Interestingly, while previous reports have noted the correlation between Dazl 
demethylation and upregulation of protein levels in PGCs, this has not been 
confirmed to be a transcriptional effect. To assess this, I performed qRT-PCR on 
sorted PGC populations. An important aspect of qRT-PCR analysis of developing 
PGCs is selection of an appropriate reference (normalising) gene, particularly with 
limited cell numbers. This is because the global transcriptional profile of PGCs alters 
dramatically between E10.5 and E13.5, including expression of commonly used  
reference genes. To identify a suitable reference gene, I tested five candidates, 
Oct3/4, Atp5b, Gapdh, Hprt and 18S rRNA and used the geNorm algorithm to 
evaluate the most stably expressed gene (Vandesompele et al., 2002). This analysis 
identified 18S rRNA as maintaining constant expression between samples and also at 
a similar level to the algorithm derived average of all 5 candidates. 18S rRNA has 
also been used as a reference gene in several previous PGC studies (Svingen et al., 
2007; Beverdam & Koopman, 2006; Silva et al., 2008). Using 18S rRNA to 
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Fig 4.14. Quality control analysis of GFP sorted primordial germ cells and somatic 
cells. a.) Male (right) and female (left) gonads with PGCs expressing transgenic Oct3/4 GFP 
were dissected from E10.5 or E13.5 (shown) embryos. b.) Staining for endogenous Oct3/4 
from FACS sorted cells. Shown is E13.5 males cells which were typically >98% pure. c.) 
qRT-PCR analysis demonstrating male sorted PGCs express the male specific marker 
Dnmt3l (left panel) and that only somatic cells express the somatic gonad marker Sf1 (right 
panel). d.) Methylation analysis of Dazl showing the promoter is methylated in E10.5 
migratory PGCs but demthylated by E13.5. This correllates with increased expression of Dazl 
in E13.5 PGCs by qRT-PCR (right panal). Expression is relative to E10.5 germ cells, which 




























































































































          161
normalise expression, qRT-PCR showed that demethylation of Dazl does correlate 
with strongly increased transcription after epigenetic reprogramming (Fig 4.14d). 
These results suggest I have generated purified populations of PGCs that are 
consistent with expression and methylation analyses from previous studies.    
 
To test whether Tex19 showed similar promoter dynamics to Dazl during PGC 
maturation I investigated Tex19 methylation in E10.5 and E13.5 PGCs. Surprisingly, 
I found Tex19 to be hypomethylated prior to epigenetic reprogramming at E10.5 in 
addition to hypomethylation of male and female PGCs at E13.5 (Fig 4.15a). As 
expected, Tex19 was heavily methylated in the somatic cells of the gonad.  Notably, 
qRT-PCR indicated there was no significant change in Tex19 expression between 
E10.5 and E13.5 PGCs (Fig 4.15a). This data suggests that, unlike Dazl, Tex19 is 
unmethylated and expressed in PGCs prior to entry into the gonad and epigenetic 
reprogramming. To ensure that Tex19 had not entered early epigenetic 
reprogramming in E10.5 PGCs, I examined the methylation of sorted E9.5 PGCs. 
Here, Tex19 was also found to be severely hypomethylated (Appendix 5), strongly 
supporting the hypothesis that Tex19 is demethylated prior to entry into the gonads. 
Analysis of PiwiL2 promoter dynamics and expression indicated that this gene 
followed a similar pattern to Tex19 and was demethylated and expressed prior to 
epigenetic reprogramming (Fig 4.15b). In contrast Tex19.2 was methylated in E10.5 
PGCs and demethylation in E13.5 male and female PGCs correlated with 
transcriptional activation (Fig 4.15c). These data  indicate that promoter methylation 
does not regulate the temporal activation of Tex19 at ~E11.5 during the PGC-specific 
epigenetic reprogramming event.  
 
Interestingly, expression analysis of several other germline specific genes 
demonstrated that there is a bimodal distribution of expression at this stage, such that 
genes are either strongly activated between E10.5 and E13.5 or exhibit no significant 
expression change (Fig 4.16a & appendix for qRT-PCR). Based on methylation 
analysis of Tex19, PiwiL2 and Tex19.2 and previous studies, I would predict that the 
genes expressed prior to entry into the gonad would be previously hypomethylated 
whereas the genes activated at E13.5 undergo promoter demethylation coincident 
          162
Germ
Soma















































E10.5 E13.5 Female E13.5 Male
Germ
Soma
























































































Fig 4.15. Analysis of methylation status and expression in GFP sorted E10.5 and E13.5 
primordial germ cells. a.) Promoter methylation of Tex19 (BS1) in E10.5 PGCs, E13.5 male 
or female PGCs and matched somatic cells of the gonad. Right panel, qRT-PCR analysis of 
Tex19 expression. b.) Methylation and expression of PiwiL2 from somatic cells and PGCs of 
E10.5 embryos and male and female E13.5 embryos. c.) Tex19.2 methylation and expression 
analysis. Note missing panel for somatic E13.5 females. Successive attempts to PCR this 
sample failed, however, it would be strongly predicted that Tex19.2 would be methylated in 
E13.5 female somatic gonad tissue. Expression is relative to E10.5 PGCs, which is set to 1. 
and normalised to 18S RNA. Error bars represent the propergated S.E.M.   
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Fig  4.16. Tex19 is methylated in somatic cells by E7.5. a.) Germline genes tested fall into 
one of two distinct categories depending on expression change between E10.5 and E13.5. 
The first set (left peak) are expressed prior to entry into the gonad at ~E11.5 and therefore 
exhibit limited or no change in expression. These loci, like Tex19, would be predicted to be 
hypomethylated at E10.5. The second set (right peak) are strongly upregulated by E13.5 and 
like Dazl, would be predicted to be hypermethylated at E10.5 and demethylated coincident 
with expression by E13.5. (see Appendix 5) b.) Tex19 is fully methylated by E7.5 in whole 
embryonic tissues coincident with gene silencing throughout the embryo. This suggests early 
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with epigenetic erasure. Notably, several of the genes that fall into this latter 
category (Tex13, Tex19.2, Mov10l1) were included in the candidate gene list 
generated in Chapter 3. These genes may represent novel targets crucially reliant on 
DNA methylation for lineage-specific expression and temporal activation in ~E13.5 
post-migratory PGCs similarly to Dazl (Appendix 5).  
 
Because Tex19 is hypomethylated in migratory E10.5 PGCs but methylated in 
somatic tissues, I investigated the developmental time-point at which lineage-specific 
methylation occurs. Tex19 is demethylated and expressed in the zygote and ES cells, 
therefore there were two broad possibilities. Firstly, Tex19 becomes methylated in 
only somatic cells after PGC specification (after ~E7.5), which themselves avoid de 
novo methylation or secondly, Tex19 is methylated in all lineages during zygotic 
remethylation (between E4.5-E6.5) and is then specifically demethylated in early 
PGCs. To distinguish between these possibilities I examined the methylation of 
Tex19 in the embryonic tissues of E6.5 to E8.5 embryos. Here the Tex19 promoter 
was found  to be methylated at E7.5 and E8.5 but interestingly, in an intermediate 
state in E6.5 embryos. (Fig 4.16b) This suggests that Tex19 is undergoing a process 
of de novo methylation until E6.5 that is complete by E7.5. Notably, Tex19 protein is 
expressed throughout all lineages from the zygote stage until late E7.5 embryos 
(personal communication - J. Reichmann). This data supports the second hypothesis 
that Tex19 is methylated in all lineages and is specifically demethylated in early 
PGCs. Moreover, the promoter methylation data is consistent with expression of 
Tex19 during embryonic development being regulated by CpG methylation, probably 
mediated by Dnmt3b, which is strongly expressed at this time. Importantly, similarly 
to EB formation (Section 4.6), Tex19 acquires DNA methylation prior to repression 
suggesting promoter methylation is the upstream and primary mechanism of 
silencing.  
 
PGCs have been reported to enter a preliminary phase of epigenetic reprogramming 
at ~E8.5 including partial erasure of DNA methylation (Seki et al., 2007; Hajkova et 
al., 2008). A likely possibility is that Tex19 is specifically demethylated in PGCs 
during this event leading to germline specific expression of this transcript. Consistent 
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with this, Tex19 protein has been detected in PGCs at E9.5 (Kuntz et al., 2008). 
Based on the experimental evidence presented here, Tex19 represents a novel gene 
regulated by lineage-specific demethylation in PGCs before E9.5. Furthermore, 
Tex19 is the first reported gene to unequivocally and exclusively rely on promoter 
methylation for directing its in vivo expression pattern and epigenetic memory 
independently of other epigenetic and trans-acting factors.    
 
4.12 Discussion  
The precise role of DNA methylation in regulating in vivo patterns of gene 
expression is currently unclear. Genetic studies have demonstrated that loss of 
methylation leads to global gene de-repression (Jackson-Grusby et al., 2001; Lande-
Dinder et al., 2006; Fouse et al., 2008) and that developmental or tissue specific 
expression of some genes correlates with promoter methylation suggesting 
methylation may regulate some loci (Maatouk et al., 2006; de Smet et al., 1999; 
Rodic et al., 2005). However crucially, these reports do not demonstrate a cause and 
effect relationship. Therefore there are currently no examples of genes that crucially 
and exclusively rely on promoter CpG methylation for regulation in all lineage 
contexts. This chapter has progressively demonstrated that transcription factor 
availability and histone modifications do not have a significant role in regulating 
expression of the germline restricted gene Tex19. Instead, promoter CpG methylation 
is the primary and exclusive mechanism of directing developmental lineage-specific 
Tex19 expression.  
 
The CpG-dense Tex19 promoter is heavily methylated in silenced tissues but 
hypomethylated in expressing cells in vivo. Furthermore, de novo promoter 
methylation is targeted to Tex19 upstream of gene silencing during ES cell 
differentiation. Genetic inhibition of de novo methylation by Dnmt[3a 3b] deletion 
prevents Tex19 silencing in ES cells but not Oct3/4 silencing, strongly supporting 
methylation as the key event directing regulation of Tex19. This key observation 
demonstrates the cause and effect relationship between promoter CpG methylation
and Tex19 silencing. Consistent with this, promoter methylation strongly repressed 
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expression of a Tex19 reporter. Moreover, experimentally induced demethylation by 
5-aza dC treatment or Dnmt1 deletion strongly activates Tex19 expression in somatic 
cells. In contrast treatment with TSA or Bix-01294 had no effect. Following 
demethylation and gene activation, transcriptional silencing is unable to be re-
imposed upon Tex19 suggesting DNA methylation is the critical component directing 
epigenetic memory of the gene. In vivo, Tex19 is likely de novo methylated by 
Dnmt3b between implantation and E6.5-E7.5, after which expression is silenced in 
somatic cells. PGCs avoid methylation or are specifically demethylated, leading to 
lineage-specific expression of Tex19 in germ cells from at least E9.5. According to 
this study and others, the core Tex19 promoter is depleted of histone modifications, 
which may reflect the inherent instability of nucleosome-assembly at Tex19. 
Furthermore, the proximal promoter of Tex19 can drive precocious expression in all 
cell-lineages investigated, suggesting an epigenetic mechanism silences endogenous 
Tex19 in somatic cells. Taken together, these observations strongly support promoter 
CpG methylation as the primary and upstream mechanism of regulating in vivo 
expression of Tex19. To my knowledge, this is the first cause and effect report of a 
gene directly and exclusively regulated by developmental and tissue-specific DNA 
methylation.   
This study also revealed that promoter CpG methylation is an important component 
of the regulatory system of PiwiL2. Here, in the absence of de novo methylation 
complete silencing cannot be imposed on PiwiL2 during ES cell differentiation. 
Moreover PiwiL2 is specifically hypomethylated in expressing tissues and 
demethylation by 5-aza dC or Dnmt1 deletion strongly activates gene expression in 
somatic cells. The PiwiL2 promoter can also drive moderate expression (although 
significantly lower than Tex19) in somatic cell types indicating general transcription 
factors can activate the gene, which therefore does not rely on germline specific 
factors. However crucially, in this study PiwiL2 was significantly repressed, but not 
silenced, in differentiating Dnmt[3a 3b]-null ES cells. This indicates that while DNA 
methylation may be an important and crucial contributor to PiwiL2 regulation, other 
epigenetic or trans-acting systems must also target the locus. Notably, the other CGI 
candidate loci tested here were also specifically hypomethylated in expressing 
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germline tissues. It is possible that these genes could exclusively rely on promoter 
methylation for repression in vivo, similarly to Tex19. Intriguingly, many of these 
genes (Mov10l1, Tex13, Tex19.2) are strongly activated during PGC epigenetic 
reprogramming at ~E11.5. It is therefore possible that these genes represent novel 
targets that utilize the PGC-specific wave of demethylation at ~E11.5 to mediate 
their temporal and germline specific activation.        
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Chapter 5
Kaiso mediates methylation-dependent 
silencing of Tex19
5.1 Introduction
DNA methylation was recognized as a mechanism that stably silences transcription 
over 30 years ago (Holliday & Pugh, 1975; Razin & Riggs 1980; Felsenfeld & 
McGhee, 1982;). However, the precise mechanism through which CpG methylation 
interferes with transcriptional activation still remains undetermined. Two models 
have been proposed, both of which could be biologically relevant. Firstly, 
methylated-CpGs may directly exclude regulatory proteins from binding to their 
target DNA sites (Kovesdi, et al. 1987). Secondly, methyl-CpG binding proteins 
(MBPs) may be recruited to methylated target sites where they direct transcriptional 
repression (Meehan., et al 1989; Boyes & Bird, 1991; Bird, 2002). The former model 
is supported by studies of the chromatin insulator protein CTCF, which binds the 
unmethylated maternal Igf2 enhancer, but is inhibited from binding the paternal copy 
due to dense CpG methylation (Hark et al., 2000; Szabo et al., 2000). Additionally, 
methylated target sequences interfere with the binding of CREB and E2F 
transcription factors (Iguchi-Ariga & Schaffner, 1989; Campanero et al., 2000). 
However, while these examples provide strong evidence for the biological relevance 
of the direct exclusion model, further reports of DNA methylation inhibiting protein 
binding in vivo have not emerged and indeed, some factors have been demonstrated 
to be impervious to CpG methylation within their binding site (Zhu et al., 2003). 
Furthermore many important DNA-binding proteins lack a CpG dinucleotide in their 
consensus recognition motif, rendering them insensitive to DNA methylation. These 
observations suggest that the direct exclusion model is not applicable as a general 
methylation-dependent silencing mechanism. Thus, the alternative mechanism 
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whereby MBPs are selectively targeted to methylated CpGs, has emerged as the 
favoured paradigm for methyl-dependent gene repression. In this model, complexes 
containing MBD or Kaiso family proteins bind methyl-CpGs via their MBD or zinc-
finger domains, respectively, and target co-repressor activity to bound loci (Section 
1.4.6.1) (Sasai & Defossez, 2009).  
 
The recruitment of methyl-binding repressor proteins to methylated target sites 
provides an attractive mechanism through which transcriptional silencing can be 
targeted to methylated domains. However, similarly to the direct exclusion model, 
the recruitment of MBPs fails to explain all the experimental evidence and 
predictions expected of a global methylation-dependent silencing mechanism. Here, 
the early in vitro evidence demonstrating that MBPs repress methylated reporters has 
not been supported by recent genetic and in vivo studies (Boyes & Bird, 1991; 
Martin Caballero et al., 2009). One substantial area of contention are the genetic 
knockouts for each MBD or Kaiso gene. These mutant mice are viable and exhibit no 
overt phenotype, suggesting methyl-binding proteins do not have a general role in 
regulating developmental expression patterns (Hendrich et al., 2001; Zhao et al., 
2003; Prokhortchouk et al., 2006; Chen et al., 2001; Guy et al., 2001). Indeed the 
recently generated MeCP2, MBD2 and Kaiso triple-null mice are also viable 
demonstrating that these three proteins do not functionally compensate for each other 
in this respect (Martin Caballero et al., 2009). Furthermore, analysis of mutant 
MeCP2 or MBD2 cells revealed that only modest changes in gene expression occur 
(Tudor et al., 2002; Hutchins et al., 2002; Kriaucionis et al., 2006 Berger et al., 2007) 
although a significant role for MBD2 has been noted in contributing to Xist 
repression (Barr et al., 2007). Additionally, while there is some evidence that Kaiso 
may target the MTA2 gene in aberrantly methylated HeLa cells, currently there are 
also no examples of methyl-dependent genes regulated by Kaiso in normal cells 
(Yoon et al., 2003; Sasai & Defossez, 2009).  
 
One possibility for the mild phenotype and the lack of gene expression changes in 
MBP deficient cells, is that remaining MBPs (those not knocked-out in mice as of 
yet) are functionally degenerate and compensate for loss of other MBPs, a notion that 
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is supported by some genetic evidence (Martin Caballero et al., 2009). Alternatively, 
DNA methylation may inherently repress transcription through one or a combination 
of other mechanisms (such as transcription factor exclusion, Dnmt co-repressor 
recruitment or chromatin condensation) and thus methyl-binding proteins may have 
subtle roles in fine-tuning gene silencing. In any case, despite the current favoured 
model predicting that MBPs are the primary mediators of methylation-dependent 
repression, the current body of evidence offers little support for this model and 
convincing examples of genes clearly regulated by a methyl-binding protein in vivo 
are rare in the literature. Thus, the precise mechanism through which DNA 
methylation silences transcription on a global scale remains unresolved. 
 
In the present study I have identified a gene, Tex19, which relies exclusively on 
promoter CpG methylation for its tissue-specific and developmental expression 
pattern. In this chapter, I consider whether methyl-binding proteins could be the 
mechanism of coupling Tex19 methylation to gene silencing. I reasoned that for a 
gene to critically rely on MBPs for repression it must also critically depend on CpG 
methylation. Therefore, Tex19 represents an excellent candidate for MBP-mediated 
repression. Moreover, defining the mechanism of methyl-dependent silencing would 
provide compelling support for the argument that Tex19 is primarily and exclusively 
regulated by DNA methylation. The analysis presented here strongly suggests that 
Kaiso is a primary mediator of silencing at Tex19, and that Tex19 therefore 
represents a novel example of a methylation-dependent gene regulated by an MBP in 
normal cells. In this chapter, I also investigate the potential mechanisms that could 
specifically target the Tex19 CGI promoter for de novo methylation during 
development. 
5.2 Tex19 is de-repressed in Kaiso-null fibroblasts
As part of a strategy to determine the role of MBPs at Tex19, I initially examined 
Tex19 expression in single mutant MBD2-/- or Kaiso-/- mouse fibroblasts and MeCP2, 
MBD2 and Kaiso triple-null (MKO) fibroblasts. These simian virus-40 transformed 
(SV40) cell lines were derived from the tails of mutant or wild-type mice (Barr et al., 
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2006). RT-PCR genotyping of each cell line revealed that the MBD2-/- and Kaiso-/- 
fibroblasts were genotyped as predicted (Fig 5.1a). However, while MKO fibroblasts 
did not express MBD2 and MeCP2, a weak band of Kaiso expression could be 
detected (Fig 5.1a). qRT-PCR showed that this Kaiso expression was in the order of  
~30-fold lower than parental wild-type fibroblasts (data not shown). It is unclear 
whether there is a contaminating sub-population of double-null cells (MeCP2 & 
MBD2) among the MKO population or residual Kaiso is expressed at low levels in 
all MKO cells. Because Kaiso transcripts were not detected at any level in the single 
Kaiso-null cells, the former possibility is most likely here. Importantly, in any case, 
the low levels of Kaiso present (~3%) would be predicted not to maintain significant 
biological activity or significantly affect population expression analysis, indicating 
these cells can be considered as de facto MKO fibroblasts.  
 
Unexpectedly, RT-PCR analysis of mutant MBP cells showed that Tex19 was 
strongly de-repressed in Kaiso-null fibroblasts and reciprocally, in MKO fibroblasts. 
Limited Tex19 transcript was also detected in MBD2-null cells (Fig 5.1b). This data 
suggests that Kaiso is a critical mediator of Tex19 repression in somatic fibroblasts 
and that MBD2 may have a minor or complimentary role. To determine the precise 
degree of de-repression in MBP mutant fibroblasts I performed qRT-PCR. Tex19 
was found to be de-repressed ~45-fold in Kaiso-/- cells and ~39-fold in MKO cells 
relative to wild-type parental fibroblasts. The moderately lower expression levels in 
MKO fibroblasts relative to Kaiso-null cells was not significant (students t-test p = 
0.23) and may reflect residual Kaiso present within the MKO population. The fact 
that MKO fibroblasts exhibited statistically equivalent expression of Tex19 to Kaiso-
null fibroblasts suggests that the weak activation observed in the MBD2-null 
fibroblasts is not additive with Kaiso-deficiency. This analysis thus indicates that 
Kaiso may be a primary mediator of methylation-dependent Tex19 silencing 
 
Because Tex19 relies on promoter methylation to maintain epigenetic silencing I 
investigated the possibility that de-repression in MBP mutant fibroblasts was due to 
partial or complete demethylation of the promoter. Bisulphite analysis revealed that 
all MBP mutant cell lines examined retained fully hypermethylated Tex19 relative to 
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Fig 5.1. Tex19 is expressed in Kaiso-/- fibroblasts but remains hypermethylated. a.) 
RT-PCR genotyping of methyl-binding protein (MBP) deficient tail-tip fibroblasts. Cell 
genotypes are shown across the top panel. MKO are triple-null for MBD2, Kaiso and MeCP2. 
b.) RT-PCR and c.) qRT-PCR expression analysis of Tex19 in MBP mutant cells. Gapdh was 
used to normalise loading. d.) Tex19 BS1 promoter methylation in mutant MBP fibroblasts. 
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wild-type fibroblasts and in vivo tissues (Fig 5.1d & Fig 4.2c). This data indicates 
that despite maintaining methylation of a CpG dense (HCP) promoter, strong 
transcription initiates from the Tex19 locus in Kaiso-deficient cells. To my 
knowledge, Tex19 represents a novel example in the literature of a heavily 
methylated CpG-dense gene being strongly transcribed above background (29-cycles 
here). This suggests that Kaiso represents a primary mechanism through which DNA 
methylation mediates transcriptional repression at Tex19. Interestingly, while strong 
expression was observed in Kaiso-null and MKO cells, it was significantly less than 
transcription levels in DP cells or wild-type testis (Fig 5.1c). This indicates that 
while Kaiso is a critical component of silencing at Tex19, it is not the only pathway 
through which methylation-dependent repression is imposed at the locus. One 
possibility is that Tex19 promoter methylation per se directly inhibits transcription or 
that it excludes binding factors. Therefore, abrogation of Kaiso may only cause 
partial de-repression relative to hypomethylation. In summary, deletion of Kaiso and 
to an extent MBD2, leads to partial but significant de-repression of the methyl-
dependent gene Tex19 without changes in promoter methylation. This data is 
consistent with these MBPs being crucially required to impose full gene silencing at 
Tex19 but also indicate that DNA methylation at this locus imposes partial repression 
through alternative mechanisms to the MBPs tested here.  
5.3 Global analysis identifies a limited number of de-
repressed genes in Kaiso-null fibroblasts
Because Tex19 was unexpectedly de-repressed in MBP mutant fibroblasts, I 
considered whether any other candidate or germline-specific genes were activated in 
MBP-null cells. I investigated expression of germline transcripts by RT-PCR 
analysis. In contrast to Tex19, I could not detect de-repression of any genes tested in 
Kaiso-null fibroblasts (Fig 5.2a). This indicates that in the context of germline-
specific genes, Tex19 is a specific target of Kaiso, and that recruiting Kaiso is not a 
general mechanism of repressing methylated germline-specific genes. However 
intriguingly, PiwiL2 was specifically de-repressed in MBD2-null and MKO 
fibroblasts. No other transcripts were found to be activated in MBD2-/- or MKO cells 
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(Fig 5.2a). qRT-PCR analysis suggested that PiwiL2 was de-repressed 4.2-fold in the 
absence of MBD2 but no change was detected in Kaiso-null cells (data not shown).  
This indicates that MBD2 could be mediating at least part of the methyl-dependent 
silencing of PiwiL2 in somatic cells.
RT-PCR analysis suggested that MBP-mediated repression was not a broad 
mechanism for silencing methylated germline-specific genes but instead was 
restricted to specific but novel loci (Tex19 and PiwiL2). To examine whether Kaiso 
had a role in global gene silencing, I investigated the genome-wide expression 
profile of Kaiso-null and MKO fibroblasts relative to wild-type using Illumina Ref-6 
BeadChips. Consistent with the mild phenotype of Kaiso-knockout mice 
(Prokhortchouk et al., 2006), I found only 31 transcripts upregulated in Kaiso-null 
fibroblasts using a stringent 6-fold change threshold (Fig 5.2b) (Table 5.1). Notably, 
I was unable to detect expression changes in putative Kaiso target genes (S100A4, 
MTA, Wnt11 & Rapsyn), in agreement with recent studies that indicated these genes 
are not regulated by Kaiso (Prokhortchouk et al., 2006; Ruzov et al., 2009a) 
However, I did detect strong de-repression of Tex19 (>34-fold) in Kaiso-null cells. 
This supports the RT-PCR analysis suggesting Tex19 silencing is dependent on 
Kaiso (Fig 5.1b). In contrast to Kaiso-deficient cells, 234 transcripts were 
upregulated in MKO cells. This is surprising given the mild-phenotype of triple-null 
mice (Martin Caballero et al., 2009). However, consistent with my array analysis, a 
study using siRNAs to specifically knockdown MBD2, MeCP2 and MBD1 in HeLa 
cells, reported that 15% of transcripts were significantly upregulated (Lopez-Serra et 
al., 2008). This suggests that abrogation of multiple MBPs can lead to de-repression 
of a significant number of genes but that the phenotypic consequences of this altered 
gene expression are relatively mild (Martin-Caballero et al., 2009). An alternative 
possibility is that the ex vivo culture and/or SV40 transformation of the mutant and 
wild-type fibroblasts used here (and HeLa cells elsewhere) has influenced expression 
patterns. However, the relatively modest number of expression changes in co-
cultured Kaiso-null fibroblasts argues against this.   
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Fig 5.2. No global gene de-repression of in Kaiso-null fibroblasts. a.) RT-PCR expression 
analysis of candidate and germline-specific genes in MBP mutant fibroblasts reveals only 
PiwiL2 is de-repressed. b.) Scatter plot of log10 expression values from microarray analysis of 
global gene expression in wild-type and Kaiso-null fibroblasts. Few significant changes in 
expression were detected. For comparison see Fig 3.6a. c.) Gene ontology analysis of 
transcripts de-repressed >6-fold in Kaiso-null cells at hierarchial level BP1. d.) Scaled venn 
diagram cross-referencing genes de-repressed in Kaiso and MKO fibroblasts. To account for 
variations in de-repression, MKO genes are considered to overlap the >6-fold Kaiso dataset 
if they were de-repressed >2-fold. e.) Venn diagrams cross-referencing genes upregulated 
the indicated degree in DP MEFs and  Kaiso-null fibroblasts. Genes de-repressed in both data 
sets would be predicted to be putitative methylation-dependent Kaiso targets. Note only 
Tex19 is common between both dataset at the most stringent >6-fold threshold. Additional 
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Transcript Chromosome Fold-change Kaiso-/- Fold-change MKO 
Zic1 9 65.2 (1) 
Tex19 11 34.5 21.2 
Bcl11b 12 24.6 (1) 
Mid1 X 19.6 3.5 
Ebf3 7 18.7 (1) 
Tssc8 7 11.6 2.8 
Pcsk9 4 10.7 (1) 
Erdr1 ND 10.2 10.3 
LOC674912 ND 9.6 12.2 
C330015L04Rik ND 8.9 5.3 
Igfbp2 1 8.7 52.4 
Uhmk1 1 8.3 5.9 
Frmpd4 X 7.7 4.7 
Hic1 11 7.5 3.9 
A630064P09Rik ND 7.5 5.0 
LOC100044257 ND 7.4 (1) 
Lhx9 1 7.3 21.5 
Igfbp5 1 7.2 -4.8 
Megf6 4 7.2 (1) 
1500009L16Rik 10 7.0 9.0 
LOC100039175 14 6.9 0.9 
Mgp 6 6.9 3.0 
Klhl10 11 6.8 1.5 
Gdf1 8 6.7 (1) 
BC048679 7 6.7 2.8 
Mgll 6 6.6 4.7 
Dlk1 12 6.3 9.3 
Itga11 9 6.3 47.7 
9930105H17Rik ND 6.3 3.3 
B230397F11Rik ND 6.2 (1) 





To investigate whether any biological ontologies were significantly enriched among 
genes upregulated in Kaiso-/- and MKO fibroblasts, I used the DAVID v6 
programme, employing the same parameters as previous analyses (Section 3.5).         
I found that genes upregulated in the absence of Kaiso were enriched for the 
categories biological process (p = 0.0012) and developmental process (p = 0.02) at 
the hierarchical level biological process 1 (BP1) (Fig 5.2c). Moreover, these genes 
Table 5.1. Transcripts significantly de-repressed in Kaiso-null fibroblasts. Shown is 
the chromosomal location of each transcript and the fold expression change in Kaiso-null 
and MKO fibroblasts relative to wild-type. A bracketed number one (1) indicates expression 
was not detected in either wild-type or MKO cells and therefore there was no expression 
change. 
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were also enriched for brain specific expression (p = 0.046), consistent with strong 
Kaiso expression in brain tissues (Della Ragione et al., 2006). In contrast, genes 
upregulated in MKO fibroblasts were strongly enriched for immune system 
processes (p = 8-10) and also developmental process (p = 0.000052). Consistent with 
this strong enrichment of genes associated with the immune system, MKO 
upregulated genes were preferentially expressed in activated spleen (p = 0.00083), 
bone marrow (p = 0.0022), spleen (p = 0.0026) and also interestingly, mammary 
tumours (p = 0.015). The strong enrichments for immune associated ontology’s and 
tissues suggests that MKO cells may be inherently stressed and/or responding 
immunologically. However, MKO cells appear morphologically normal and 
proliferate comparably to wild-type parental fibroblasts. Thus, it is also possible that 
MeCP2, MBD2 and Kaiso have specific or degenerate roles in regulating immune 
and stress-response genes, although this would not necessarily be a methylation-
dependent function. 
 
Notably, gene ontology analysis suggested neither Kaiso-null nor MKO fibroblasts 
were enriched in expression of germline-specific transcripts (Fig 5.2c), supporting 
the earlier conclusion that MBPs are not the preferential mechanism that mediates 
repression of methylated germline genes (Fig 5.2a). However intriguingly, the genes 
upregulated in Kaiso-deficient cells exhibited a striking level of tissue-specificity, 
but not for any particular tissue. For example upregulated Bcl11b is normally 
specifically expressed in the thymus, Zic1 only in the cerebellum, Megf6 exclusively 
in osteoblasts, Lhx9 in the hippocampus and Klhl10 specifically in testis (Table 5.1). 
This general tissue-specificity of upregulated genes may hint at a role for Kaiso in 
fine tuning tissue-specific expression of putative target genes, particularly in the 
brain, which is significantly enriched (p = 0.046). This function could potentially be 
methylation-dependent or regulated by alternative mechanisms such as tissue-
specific canonical Wnt signalling, or both (Ruzov et al., 2009b). 
 
Because DNA methylation is a crucial component of the regulation of genomic 
imprinting, it has been proposed that MBP deficiency might lead to dysregulation of 
imprinted gene expression (Bird, 2002). To explore the possibility that Kaiso 
          178
mediates methylation-dependent regulation of imprinted loci, I determined whether 
imprinted genes were upregulated greater than 1.5-fold in the absence of Kaiso. I 
imposed this 1.5-fold threshold as it would be predicted that one imprinted allele 
would already be expressed (depending on cell-type) and therefore the theoretical 
maximum upregulation would be 2-fold i.e. de-repression of the second allele. This 
analysis found 6 imprinted genes were de-repressed >1.5-fold in Kaiso-null 
fibroblasts (Table 5.2). However, using the premise that there are 131 imprinted loci 
(MRC Harwell Mousebook), it would be expected that 9 imprinted genes would be 
found in this dataset by chance, indicating Kaiso is not a general regulator of 
imprinted gene expression. Nonetheless, this does not preclude the possibility that 
Kaiso has locus-specific functions at the imprinted genes identified here. It would be 
interesting to investigate this possibility in future studies.  
 
Imprinted gene Chromosome Expression allele Fold-change in Kaiso-/- 
Dlk1 12 P 9.3 
Snurf 7 P 3.2 
Magel2 7 P 2.2 
Mest 6 P 2 
Mkrn3 7 P 1.8 





It has been reported that Kaiso is a bimodal transcriptional repressor that can bind 
both methylated target genes and CTGCNA motifs (Prokhortchouk et al., 2001; 
Daniel et al., 2002; Kim et al., 2004b). To identify the potential methylation-
dependent targets of Kaiso, I cross-referenced genes de-repressed in Kaiso-null cells 
and genes de-repressed in hypomethylated DP cells. It would be predicted that genes 
critically reliant on the methyl-CpG binding function of Kaiso for repression would 
be de-repressed in both datasets. However, genes de-repressed exclusively in Kaiso-
null cells and not DP cells would be predicted to be regulated via methylation-
independent Kaiso functions or as a consequence of indirect effects. Because the 
Ref-6 BeadChip used for analysis of Kaiso-null fibroblasts contained an additional 
Table 5.2. Imprinted genes dysregulated in Kaiso-null fibroblasts. Shown is the 
chromosomal location of each imprinted locus and the actively transcribed allele where P: 
paternal allele and M: maternal allele. Fold changes represent expression values in Kaiso-
null cells relative to wild-type. 
          179
12,668 transcripts to the Ref-8 BeadChip used for DP cell analysis, I excluded these 
additional transcripts from this analysis. This exclusion left 21 genes (of 31) 
common between both datasets and upregulated >6-fold in Kaiso-null cells. Of these, 
I found that only one gene, Tex19, was also de-repressed >6-fold in DP cells. This 
suggests that Kaiso may only have one physiological methylation-dependent target 
gene. However, this conclusion may reflect the stringent thresholds used here and not 
a unique biological Kaiso target. For example, when the threshold value is altered to 
include genes expressed >4-fold in Kaiso-null and DP cells, 6 genes are present in 
both datasets. Indeed, when transcripts upregulated >2 fold in Kaiso-null cells are 
cross-referenced with transcripts upregulated >6-fold in DP cells there are 14 
common genes and when both datasets are set to a >2-fold threshold, 50 genes are 
de-repressed in both (Fig 5.2e). This suggests that there could potentially be multiple 
methylation-dependent Kaiso target genes. Indeed, the relatively strong activation of 
Tex19 in both Kaiso-deficient and DP cells compared to other de-repressed genes
(and hence the only gene activated >6-fold in both datasets) could be accounted for 
by its inherently strong promoter (Section 4.4) and not because it is the preferential 
Kaiso target. However, this study indicates that Tex19 probably does represent a 
relatively rare and specific methylation-dependent Kaiso target – the proverbial 
‘needle in a haystack’.  
In summary, this global expression analysis has demonstrated that only a modest 
number of genes are significantly de-repressed in Kaiso-deficient fibroblasts. The 
lack of general gene activation is consistent with genetic studies that suggest MBPs 
do not act as global regulators of gene expression. However, the data is also 
consistent with Kaiso potentially contributing to gene silencing at a number of loci 
and importantly, at a few limited genes (Table 5.1) being a primary mechanism 
through which methylation dependent silencing is mediated. Tex19 falls into this 
latter category as my expression array suggests it is strongly de-repressed in Kaiso-
null, MKO and DP cells. It is likely that the genes de-repressed in Kaiso-null and 
Dnmt1-null cells, such as Tex19, represent a small minority of loci that rely 
exclusively on DNA methylation and Kaiso for silencing. This data thus supports the 
          180
argument that Tex19 is a specific and rare target for methylation-dependent silencing 
by Kaiso.
5.4 Exogenous Kaiso can rescue Tex19 de-repression and is 
essential for silencing during ES cell differentiation
The present study has indicated Tex19 is de-repressed but still methylated in the 
absence of Kaiso indicating Kaiso couples methylation to transcriptional silencing at 
this locus. Moreover, global expression data suggests Tex19 is a specific Kaiso-target 
on a genome-wide scale. To confirm that loss of Kaiso is the causal factor for Tex19 
de-repression, I examined whether expression of exogenous Kaiso could rescue 
Tex19 silencing. I transiently transfected GFP-tagged Xenopus Kaiso (xKaiso) into 
Kaiso-/- fibroblasts for 24hrs and flow sorted cells according to GFP expression. 
qRT-PCR analysis of GFP positive (xKaiso rescued) and GFP negative (control) 
cells demonstrated that transient expression of xKaiso can re-impose Tex19 
repression by ~5-fold (Fig 5.3a). Thus, Xenopus Kaiso, which retains methyl-binding 
activity, can partially rescue the de-repression of Tex19 as a result of mouse Kaiso 
deficiency. This strongly supports the argument that loss of Kaiso per se is the cause 
of Tex19 activation in Kaiso-null fibroblasts 
 
To determine the precise importance of Kaiso for initiating developmental silencing 
of Tex19, I collaborated with the Prokhortchouk laboratory. Here, I was able to 
analyse Tex19 expression in Kaiso-/- ES cells during differentiation into embryoid 
bodies (EB). qRT-PCR demonstrated that wild-type parental ES cells fully silenced 
Tex19 expression during EB formation comparably to wild type E14 and J1 ES cells 
used previously (Section 4.7 & 4.8). Strikingly, Kaiso-deficient ES cells were unable 
to impose Tex19 silencing during EB formation. Following 9 days EB 
differentiation, Tex19 was still expressed at ~25% of the levels at day 0 in Kaiso-null 
EBs compared to 0.002% in wild-type EBs (Fig 5.3b). Both ES cell lines were able 
to silence Oct3/4 expression comparably during EB formation indicating they both 
underwent equivalent programmes of differentiation (Fig 5.3c) and consistent with 
previous reports that Kaiso-null ES cells differentiate efficiently (Prokhortchouk et 
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Fig 5.3. Kaiso is required to silence Tex19 in differentiating ES cells and partially 
rescues repression in Kaiso-null fibroblasts. a.) qRT-PCR expression analysis of Tex19 in 
wild-type and Kaiso-mutant fibroblasts transiently transfected and FACS sorted for GFP 
expressing xKaiso (GFP+) or untransfected (GFP-). qRT-PCR of b.) Tex19 and c.) Oct3/4 
expression in wild-type and Kaiso-null ES cells during embryoid body formation. b.) Tex19 is 
strongly silenced in wt EBs but fails to impose silencing in the absence of Kaiso. c.) Oct3/4 is 
silenced comparably between differentiated wt and Kaiso-null ES cells. Shown is relative 
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al., 2006). These data strongly support a critical role for Kaiso in mediating initiation 
and maintenance of gene silencing at Tex19. Considered with the data presented in 
previous chapters (Fig 4.8 & 4.9), this work suggests that Kaiso is the critical factor 
that couples promoter methylation at Tex19 to downstream silencing.   
5.5 Kaiso is localised to the methylated Tex19 promoter
Analysis of the Tex19 promoter showed that it is enriched with the symmetrically 
methylated CGCG tetranucleotides that Kaiso preferentially binds to in a 
methylation-dependent manner, and that these are located adjacent to the TSS (Fig 
4.1a & 4.2) (Prokhortchouk et al., 2001). In contrast, Kaisio binding sequences 
(KBS) were not detected within 20kb of the Tex19 TSS (see  Section  1.4.6.1) 
(Daniel et al., 2002). This suggests that Kaiso could strongly bind Tex19 at 
methylated CGCG motifs indicating a potential mechanism for targeting Kaiso 
specifically to this locus. To confirm that Kaiso is localised to the Tex19 promoter in 
methylated somatic cells, I performed ChIP of endogenous Kaiso protein with a 
mon -Kaiso antibody (Abcam ab12723) in wild-type tailtip fibroblasts. 
Optimisation protocols demonstrated that, in my hands, this antibody had highly 
limited avidity for mouse Kaiso and/or was not ChIP grade, as judged by 
enrichments for putative positive control genes. Despite this, successive experiments 
demonstrated that Kaiso was consistently, but modestly, enriched at the methylated 
Tex19 promoter in wild-type fibroblasts (Fig 5.4a). No enrichment of Kaiso at Tex19 
was detected in Kaiso-/- fibroblasts suggesting enrichment in wild type cells was a 
specific effect. 
 
To confirm that Kaiso specifically targeted only methylated Tex19, I explored other 
approaches. I created a fusion protein between the zinc-finger domain of Xenopus 
Kaiso, which is responsible for methyl-binding, and the viral VP16 activation 
domain, which strongly activates transcription of promoters to which it is localised 
(xZF-VP16). I reasoned that the xZF-VP16 fusion protein would specifically activate 
a methylated Tex19 reporter relative to VP16, as only xZF-VP16 would putatively 
bind methylated Tex19. In contrast, the ratio of activation between VP16 and xZF-
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Fig. 5.4. Kaiso is recruited to methylated Tex19 promoter. a.) ChIP of endogenous Kaiso 
from control Kaiso-null and wild-type fibroblasts. Enrichments were determined by qRT-PCR 
of the Tex19 promoter region. Error bars are S.E.M b.) Kaiso zinc-finger domain only binds 
methylated Tex19 reporter. Unmethylated or methylated Tex19 luciferase reporter was 
transiently transfected into 293T cells with either xZF-VP16 or VP16. xZF-VP16 specifically 
activates methylated (Sss.I) Tex19, shown as a ratio to VP16 alone. xZF-VP16 does not 
significantly activate mock methylated or partially methylated  (Hha.I) Tex19 relative to VP16. 
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VP16 at unmethylated Tex19 reporter would be predicted to be ~1 as neither would 
preferentially bind. Transient transfection of these constructs into 293T cells 
demonstrated that xZF-VP16 strongly activated fully methylated (Sss.I) reporter at a 
ratio of 5.15-fold relative to VP16 (Fig 5.4b). However as predicted, the ratio of 
activation at unmethylated Tex19 was 1.06, suggesting neither VP16 nor xZF-VP16 
preferentially localised to the unmethylated reporter. Consistent with Kaiso having 
weak binding activity for methylated CpGs in a non-CGCG context, partially 
methylated reporters (Hha.I) only exhibited a modest ratio shift towards xZF-VP16 
preference (ratio = 1.32) (Fig 5.4b). This data strongly suggests that Kaiso binding 
activity can strongly localise to Tex19, but only when methylated. This supports the 
argument that Kaiso is responsible for mediating the methylation-dependent 
silencing of Tex19 expression.
5.6 Tex19 is transcribed from the canonical promoter in 
Kaiso-null cells
Potentially, Tex19 expression in Kaiso-null and MKO fibroblasts could initiate from 
an alternative promoter through a Kaiso-independent mechanism, which would thus 
account for de-repression in MBP mutant cells. To evaluate this possibility, I used a 
5’ rapid amplification of cDNA ends (5’-RACE) assay to map the transcriptional 
start sites (TSS) of Tex19 in multiple cell types. The primers which I designed were 
predicted to generate a 314bp product if Tex19 transcription originated from the 
canonical annotated TSS (RefSeq - http://www.ncbi.nlm.nih.gov/refseq/ & 
DataBaseTSS - http://dbtss. hgc.jp/). I found that MBD2-/-, Kaiso-/-, and DP cells all 
generated a band of ~314bp that, as expected, showed proportional intensity to the 
levels of expression in the cells i.e. highest in DP and lowest in MBD2-/-cells (Fig 
5.5a). This suggests that DP, MBD2-null and Kaiso-null cells all transcribe Tex19 
from the canonical TSS and therefore have lost silencing of Tex19 rather than 
utilised alternative transcription start sites. Interestingly, overcycling the 5’RACE 
reactions generated a weak product from both P cells and wild-type fibroblasts, that 
appeared larger than expected (Fig 5.5a). This may reflect weak basal expression 
that initiates from an alternative promoter in non-expressing cell types. 






























Fig 5.5. Tex19 is transcribed from the annotated promoter in mutant cells. a.) 
Products generated from 5’ rapid amplification of cDNA ends assay (5’RACE). A band of 
~314 bp indicates Tex19 transcription initiates from the annotated canonical promoter. b.) 
Sequencing of the products generated in 5.5a. Three independent sequenced clones are 
shown with the expected ‘canonical’ AGT start site shown below. Sequencing confirmed 
that Tex19 is transcribed from the expected ‘AGT’ start site in DP, Kaiso-null, and MBD2-
null cells. In contrast, weak transcription initiates ~51bp upstream of this in non-expressing 
wild-type cells. The poly-G residues (left) are a consequence of the cloning strategy.   
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To confirm that expression in mutant cells occurs from the canonical TSS and 
investigate the weak transcript in P and wild-type cells I sequenced the 5’-RACE 
products. This analysis confirmed that in the absence of DNA methylation (DP) or 
MBPs (Kaiso and MBD2), Tex19 is de-repressed and that transcription initiates from 
the annotated ‘AGT’ TSS (Fig 5.5b). This supports a conclusion whereby loss of 
promoter methylation or Kaiso deficiency is sufficient to allow active transcription 
from the canonical Tex19 promoter and thus suggests that these components 
critically promote gene silencing and regulate expression patterns. This data rules out 
the possibility that de-repression of Tex19 in Kaiso-null fibroblasts occurs due to 
alternative promoter usage. Intriguingly, the weak transcript detectable (with 
overcycling) in non-expressing P cells and wild-type fibroblasts initiated from ~51bp 
upstream of the canonical Tex19 ‘AGT’ TSS (Fig 5.5b). This suggests that any 
background basal expression from this locus is unable to initiate from the native 
TSS, presumably due to inhibition by promoter methylation and Kaiso, but is capable 
of weak transcriptional initiation from an upstream cryptic TSS. Notably this cryptic 
transcript is present at >4000-fold lower levels than transcripts generated from the 
canonical unmethylated TSS and is therefore likely not biologically relevant (Fig 
3.10b). Importantly, this analysis confirms the key role of Kaiso in interpreting 
Tex19 methylation and coupling transcriptional silencing to the canonical promoter 
in a methyl-dependent manner.     
 
5.7 An antisense transcript is transcribed through the Tex19
coding region and promoter
An intriguing aspect of this work is that Tex19 (and several other germline candidate 
genes) are targeted for promoter methylation in somatic cells in vivo, despite being 
CGI promoters (HCPs) that would normally avoid de novo methylation. The 
mechanism that identifies Tex19 as a target for DNA methylation yet excludes the 
majority of other CGIs is of great interest for understanding the regulation of this 
locus and indeed for determining how CGIs are excluded from de novo CpG 
methylation in general.  Previous studies have noted that antisense transcripts can 
affect transcription in cis both negatively (Yu et al., 2008) and positively (Scheele et 
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al., 2007) and can target DNA methylation to promoters in cis (Chotalia et a., 2009). 
To investigate whether antisense transcripts could have a role in regulating Tex19 
through guiding DNA methylation to the promoter, I initially interrogated the NCBI 
EST database. This analysis found that an antisense transcript complimentary to the 
upstream proximal promoter of Tex19 was expressed specifically in testis. To 
validate expression of this putative antisense transcript in testis and define its size 
and origin I designed antisense qRT-PCR primers both upstream and downstream of 
the Tex19 coding region (Fig 5.6a). I also designed antisense primers to a CpG island 
8kb downstream of Tex19. qRT-PCR analysis of testis detected strong expression of 
an antisense transcript 200bp downstream of the 3’ end of Tex19 (3’) and also at the 
5’ Tex19 promoter (Prox). This expression declined ~4-fold 600bp upstream of the 
promoter (Dis) indicating the antisense transcript, at least partially, terminates 
transcription after reading through the Tex19 promoter. No expression was detected 
at the distal region 8kb downstream of Tex19 (CpG), adjacent to the CpG island (Fig 
5.6b). This data suggests that expression of an antisense transcript (asTex19) initiates 
between the 3’end of Tex19 and 8kb downstream of this and that it is constitutively 
transcribed through the entire Tex19 coding and promoter region in testis. 
 
It has been postulated that antisense transcripts could function to guide DNA 
methylation to specific sites (Bernstein & Allis, 2005). Moreover, work at maternally 
imprinted loci has demonstrated antisense transcription establishes an open 
chromatin domains that allow DNA methylation machinery access to de novo 
methylate the region (Chotalia et al., 2009). However, in the present study expression 
of asTex19 seems to occur in testis, precisely where Tex19  is protected from DNA 
methylation. Thus, if asTex19 were to have a functional epigenetic role, it would not 
be in targeting Tex19 promoter methylation but a novel role in protecting it from 
methylation. To investigate this possibility I examined asTex19 expression in wild-
type, Kaiso-null, and DP cells. Because these cell-types each have a unique 
combination of Tex19 methylation and expression status, I would be able to correlate 
the expression of asTex19 to downstream effects i.e. Tex19 methylation and 
expression. This analysis demonstrated that expression of asTex19 could not be 
detected in wild-type fibroblasts but was readily detected at all loci (Dis, Prox, CpG) 
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Fig. 5.6. Identification of antisense Tex19 transcripts in testis. a.) Schematic of regions 
amplified to identify the antisense transcript. The upstream and downstream antisense 
regions tested for expression are shown as black bars. The Tex19 exon structure is shown 
and the TSS marked by arrow. A downstream CpG island (CGI) is marked in red. b.) qRT-PCR 
expression analysis of the four antisense regions in testis. Expression is relative to CpG, 
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in Kaiso-null and DP cells, although not to the same extent as testis (Fig 5.7). 
Importantly, as both Kaiso-null and DP cells express Tex19 but only DP cells are 
hypomethylated this suggests that asTex19 transcription is correlated with Tex19 
expression and not Tex19 methylation status. This conclusion is supported by the 
observation that MBD2-null cells express asTex19 but P cells do not (Fig 5.7). Taken 
together, this data suggests that antisense transcription through Tex19 is a 
consequence of expression of Tex19 itself and not a regulatory mechanism per se.  
 
One conceptual possibility is that Tex19 transcription generates a permissive or open 
downstream chromatin domain that allows activation of a cryptic antisense promoter 
and thus transcription of asTex19. This is supported by the observation that asTex19 
is expressed at comparable levels in MBD2-null, Kaiso-null and DP cells despite the 
disparate range of expression of Tex19 between these cells. Here the argument 
suggests that transcription of Tex19, at any level, would cause full activation of 
asTex19. Indeed, in turn asTex19 could potentially have a role in targeting gene body 
methylation to the Tex19 coding region, which has been associated with gene activity 
and is thought to prevent cryptic transcriptional initiation (Eckhardt et al., 2006; 
Suzuki & Bird, 2008). Interestingly, a cryptic transcriptional start site was observed 
in wild-type and P cells, both of which do not express asTex19, but this cryptic 
transcript was not present in cell types that did express asTex19. However, no 
evidence for any regulatory function for asTex19 has been generated here and future 
work will be required delineate the role of this antisense transcript, if any. In 
summary, the data generated here is consistent with asTex19 expression being a 
downstream consequence of Tex19 activation and therefore not a primary regulator 
of Tex19 methylation patterns.  
 
5.8 The Tex19 promoter is characterised by retroelements.
 
My studies suggested that an antisense mediated mechanism was not responsible for 
the observed Tex19 methylation patterns. To explore alternative mechanisms that 
potentially target methylation to the Tex19 CGI promoter, I investigated the promoter 
sequence structure using RepeatMasker (http://www.repeatmasker.org/). 
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Retroelement derived sequences are present at ~13% of mouse proximal promoters 
and have been shown to have dramatic epigenetic effects on adjacent genes (Tomilin, 
2008). For example, LINE1 elements can induce extensive DNA methylation and 
silencing of local genes whereas in some contexts SINEs have been shown to block 
this effect by functioning as insulators against the spreading of DNA methylation and 
chromatin compaction (Noma et al., 2006). Analysis of Tex19 demonstrated that a 
significant proportion (~49%) of the extended promoter (-2500bp – TSS) was 
composed of retroelement derived sequences (Fig 5.8).  Across this region 26.3% 
were short interspersed nucleotide elements (SINEs), 9.1% long interspersed 
nucleotide elements (LINES) and 13.4% were long terminal repeat derived elements 
(LTRs). No DNA elements were detected.  
 
Following their insertion into DNA, LINE and LTR elements are targeted for 
heritable methylation to ensure their transcriptional silencing. The ‘genome defence’ 
hypothesis argues that DNA methylation evolved primarily for this purpose (Yoder 
et al., 1997). However, it is also argued that insertion of retroelements can drive 
evolution of the expression pattern of adjacent genes. One possibility is that the 
Tex19 promoter is targeted for DNA methylation, despite being a CGI, because of a 
spreading effect from local retroelement methylation. LINEs and LTRs are highly 
depleted at mouse promoters (4.34% at promoters’ vs 27.92% in the genome) and 
thus their strong enrichment at Tex19 may reflect a distinctive role, such as targeting 
methylation to the CGI promoter in somatic cells (Tomilin, 2008).  
 
Further analysis of Tex19 demonstrated a SINE element was also present ~2000bp 
downstream of the TSS and thus the Tex19 promoter is flanked by SINE elements 
(Fig 5.8). While SINES are also often de novo methylated, this opens up the 
intriguing possibility that the flanking SINEs may act as epigenetic insulators against 
chromatin spreading analogous to the mechanism reported in S. pombe and at the 
mouse growth hormone locus (Noma et al., 2006; Lunyak et al., 2007). Here, CpG-
rich sequences that are flanked by SINE elements have been shown to be protected 
from repressive histone modifications. Taken together these observations hint at a 
potential but highly speculative mechanism for guiding CpG methylation to Tex19  
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(targeting by LINEs and LTRs) and also suggest why histone modifications are 
depleted at the locus (insulation by flanking SINEs). However, further work to 




Despite considerable research, the in vivo mechanism of methylation-dependent gene 
silencing remains unclear. A likely scenario is that at many loci, both epigenetic 
modifications and DNA methylation contribute to transcriptional silencing. At these 
loci the CpG methylation portion of repression may be mediated, at least in part, 
through methyl-binding proteins. However, importantly other epigenetic marks 
and/or trans-acting factors would also be predicted to maintain silencing 
independently of CpG methylation. That is to say, DNA methylation is generally a 
secondary epigenetic system that reinforces epigenetic states but does not direct 
them. Therefore, abrogation of a methyl-binding protein would not be predicted to 
significantly affect transcription as loss of DNA methylation per se would not 
directly affect transcription levels at most loci (although there may be indirect 
effects). Unless DNA methylation were the primary mechanism of silencing at a 
gene locus, it would be predicted that methyl-binding proteins would be dispensable 
for gene repression. Indeed, genetic studies have demonstrated that at the phenotypic 
and molecular expression level, MBPs are dispensable. Conceptually this is not 
surprising given that currently, there are very few, if any, examples of genes that are 
regulated primarily and exclusively by promoter CpG methylation. As noted earlier, 
most genes are thought to be regulated by multiple layers of epigenetic and trans-
acting systems. Therefore, to identify genes regulated by MBPs it is also necessary to 
identify genes regulated exclusively, or at least primarily, by DNA methylation.  
 
In this thesis I identified a set of germline-specific genes that were candidates for 
direct regulation by promoter CpG methylation. Further characterisation of two 
candidates demonstrated Tex19 was exclusively reliant on DNA methylation for 
silencing. Because of this crucial requirement for promoter methylation to maintain 
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repression, I investigated whether MBPs were responsible for imposing methyl-
dependent silencing at Tex19. This analysis demonstrated that in the absence of 
Kaiso, Tex19 was highly de-repressed, yet retained full promoter methylation. This 
strongly suggests that Kaiso is critically responsible for coupling promoter CpG 
methylation at Tex19 to transcriptional silencing. However, whilst Tex19 lost 
silencing in Kaiso-null cells, it remained partially repressed compared to 
hypomethylated DP cells. This is consistent with Kaiso being required to fully 
silence Tex19 expression but also with CpG methylation per se significantly 
repressing transcription, either directly or through an alternative mechanism such as 
protein exclusion or recruitment of other MBPs. An interesting possibility here is 
that the other two Kaiso-like proteins, ZBTB4 and ZBTB38 may partially 
compensate for loss of Kaiso (Filion et al., 2006). siRNA knockdown studies of these 
proteins in Kaiso-null fibroblasts will be important to determine if Tex19 can be de-
repressed further. Importantly, analysis of Kaiso-null ES cells demonstrated 
silencing could not be imposed upon Tex19 during differentiation, indicating that 
Kaiso is crucially required for initiation, in addition to maintenance, of Tex19 
repression. Moreover exogenous expression of xKaiso could partially re-impose 
Tex19 repression in Kaiso-deficient fibroblasts. Further studies confirmed that 
endogenous Kaiso is recruited to the Tex19 promoter, which contains several Kaiso 
methyl binding sites. Indeed, Kaiso association with Tex19 depended on the 
promoter being methylated. Taken together these data provide compelling evidence 
that Tex19 is a methylation-dependent Kaiso target.  This thesis represents a novel 
report of gene that relies on both promoter methylation for gene silencing and Kaiso 
to mediate the downstream silencing effects of CpG methylation. 
 
Interestingly, global expression analysis suggested that Tex19 was one of a highly 
limited number of methylation-dependent genes de-repressed in Kaiso-null cells and 
therefore a highly specific target. This is consistent with the relatively small number 
of genes that rely primarily on DNA methylation and also previous Kaiso studies 
(Section 3.9) (Prokhortchouk et al., 2006). Ongoing analyses will confirm whether 
the remaining putative Kaiso targets identified here, are direct or indirect/false-
positive hits. 




6.1 Promoter CpG methylation regulates germline-specific 
gene expression 
It has been demonstrated by multiple studies that lineage-specific genes are co-
ordinately regulated by epigenetic systems and trans-acting factors which impose 
heritable transcriptional memories (Chen et al., 1998; Feldman et al., 2006; 
McCarrey et al., 2006; Ng et al., 2008; Hemburger et al., 2009; Jaenisch and Bird, 
2003). In contrast, it has been proposed that a subset of germline-specific genes are 
regulated primarily by DNA methylation per se (Oda et al., 2006; Maatouk et al., 
2006; Weber et al., 2007). A fundamental drawback of this proposal is that it is only 
supported by correlative or indirect evidence and thus remains to be proven. In the 
present study, I provide novel cause and effect data comprehensively demonstrating 
that at least one germline-specific gene, Tex19, is regulated primarily and exclusively 
by DNA methylation. Additionally I have identified a novel set of germline-specific 
candidate genes that putatively rely on promoter DNA methylation analogously to 
Tex19. This work provides the first causal evidence that CpG methylation directly 
regulates gene expression exclusive of tissue-specific trans-acting factors and 
alternative epigenetic systems. This affords novel proof of principle that promoter 
DNA methylation could be a general mechanism for regulating a subset of germline-
specific genes.  
 
I investigated the role of DNA methylation by examining the transcriptional effect of 
cellular demethylation through three different experimental approaches – (i) Dnmt1 
inactivation, (ii) 5-aza dC treatment and (iii) recovery following 5-aza dC treatment 
(Section 3.5, 3.6 & 3.7). I found germ cell-associated genes were highly enriched 
among upregulated transcripts in each approach, and by cross-referencing the 
experiments, I identified 14 genes (9 testis-specific) as candidates for regulation by 
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DNA methylation (Section 3.8). Although most CpG islands (CGI) are unmethylated 
regardless of tissue or expression status (Rollins et al., 2006; Weber et al., 2007), I 
found each CGI candidate gene tested was highly methylated in somatic cells but 
demethylated in expressing germ cells (Section 4.2). Moreover, candidate promoters 
could drive strong expression in somatic cells, suggesting non-expressing cells carry 
activating transcription factors and therefore that an epigenetic system (putatively 
promoter methylation) must mediate silencing of endogenous candidate loci (Section 
4.4). Indeed, in vitro methylation of candidate promoters caused strong repression of 
reporter transcription. To test whether DNA methylation was the upstream epigenetic 
system repressing the candidate gene Tex19, I investigated promoter methylation 
dynamics during ES cell differentiation. Importantly, I found that DNA methylation 
accumulated at the Tex19 promoter coincident with or prior to gene silencing i.e. was 
functionally upstream of silencing (Section 4.7). To confirm CpG methylation was 
the cause of repression (rather than just correlated with it) I demonstrated that 
inactivation of the de novo methyl-transferase Dnmt3b suppressed Tex19 silencing in 
differentiated ES cells. These data suggest that de novo DNA methylation is 
sufficient and necessary for Tex19 silencing (Section 4.8). Considered with the 
absence of histone modifications at Tex19 (Section 4.9 & 4.10), the data supports a 
model whereby promoter DNA methylation is the primary and exclusive mechanism 
of directing Tex19 expression. This model fits the in vivo developmental expression 
pattern of Tex19, whereby expression is observed throughout the embryo until ~E7.5, 
when Tex19 is de novo methylated and silenced, probably by Dnmt3b. In PGCs, 
Tex19 either avoids this de novo methylation event or more likely, is specifically 
demethylated during an epigenetic reprogramming phase at ~E8.5 and is therefore 
expressed specifically in the germline (Section 4.11).  
  
The data presented here strongly supports the conclusion that Tex19 is regulated 
primarily by promoter DNA methylation. However when making such a defined 
conclusion, it is important to also consider alternative possibilities in the context of 
previously published data. For example, it has been reported that the polycomb 
(PcG) component EZH2 can serve as a recruitment platform for DNA 
methyltransferases (Vire et al., 2006). Thus, one possibility is that DNA methylation 
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at Tex19 is a consequence of PcG activity. However in this case, my data suggests 
that the polycomb mark H3K27me3 is only weakly deposited at Tex19 in silenced 
cell-types (Section 4.10). This suggests that H3K27me3 has, at best, a secondary 
epigenetic role at Tex19, a premise supported by the lack of Tex19 activation in T-
cells deficient for EZH2 and also Eed-null embryoid bodies (Su et al., 2005 & 
Section 4.10). Alternatively, an intriguing recent study noted Tex19 exhibited a weak 
but significant enrichment of H3K9me3, an epigenetic mark not examined here 
(Yuan et al., 2009). It is therefore important to consider the possibility that this 
epigenetic modification might have a role in regulating Tex19. However, 
examination of the data suggests that H3K9me3 was localised significantly 
downstream of the Tex19 promoter and was only weakly enriched. Moreover, despite 
being typically associated with a repressed chromatin structure, the H3K9me3 
enrichment was present in ES cells, where Tex19 is strongly expressed. These 
observations indicate that like H3K27 methylation, H3K9me3 is not a significant 
part of the Tex19 regulatory mechanism. In addition to epigenetic factors, it is 
important to consider that transcription factors could functionally operate upstream 
of CpG methylation at Tex19. For example, it has been demonstrated that E2F6-
deficient mice exhibit dysregulated expression of Tex12 coupled with demethylation, 
indicating that promoter methylation is a consequence of E2F6 activity at this locus 
(Pohlers et al., 2005). However, Pohlers and colleagues noted that two genes 
identified as methylation-dependent candidates here (Tex13 & Mov10l1), were not 
de-repressed by E2F6-deficiency. This is consistent with the premise that CpG 
methylation, and not E2F6, is the primary upstream mechanism regulating the 
candidate genes identified here, including Tex19.
 
However, to consider the broadest possible scope of alternative epigenetic or trans-
acting factors that could contribute to Tex19 regulation, I performed a comprehensive 
analysis of Tex19 expression across the entire body of published microarray data 
deposited in the GeoProfiles database. I found Tex19 was not dysregulated in any 
loss or gain of function studies of epigenetic mediators, including HDAC1, HDAC2, 
Sirt1 (HDAC), EZH2 and linker Histone H1 (Zupkovitz et al., 2006; Alcendor et al., 
2007, Su et al., 2005, Fan et al., 2005b) or transcription factors, including; Rb, Myc, 
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c-Jun, Oct3/4, the MAPK pathway, Wilms-Tumour protein, Lim1 and Nanog 
(McCabe et al., 2005; Lawlor et al., 2006; Drosatos et al., 2007; Maekawa et al., 
2005; Klattig et al., 2007; Potter et al., 2007; Loh et al., 2006). In contrast, the top 
hits for Tex19 de-repression were from forced DNA demethylation studies 
(Vallender & Lahn, 2006, Perez-Iratxeta et al., 2005 (GDS2905), Lande-Diner et al., 
2007). This analysis, and that presented in this thesis, has thus considered the widest 
possible range of alternative interpretations for the mechanism of Tex19 regulation. 
Taken together they provide compelling evidence that Tex19 is causally regulated 
exclusively by promoter DNA methylation upstream of any epigenetic or trans-
acting factors. Moreover, this is consistent with a recent study which reported that 
promoter CpG methylation may be the exclusive epigenetic mark at ~30% of genes 
in ES cells (Fouse et al., 2008). 
 
The identification of Tex19 as a locus that is causally regulated by DNA methylation 
represents a novel example of a single-copy gene unambiguously controlled 
exclusively by the presence or absence of promoter CpG methylation. However, my 
data and others indicate that Tex19 is unlikely to be the only target critically reliant 
on CpG methylation. Instead it is possible that Tex19 belongs to a small but 
significant group of germline restricted methylation-dependent genes. For example, 
the stringent candidate screen performed here (Chapter 3) identified eight other 
germline-specific genes that could be regulated by DNA methylation. Indeed, 
analysis of three of these candidates demonstrated they all exhibited highly 
methylated promoters in somatic cells despite being CGIs (Section 4.2). It will be 
important to determine whether these genes are causally regulated exclusively by 
promoter CpG methylation analogously to Tex19 or whether promoter methylation 
only contributes to their regulation similarly to PiwiL2. Here, cause and effect 
analysis suggested that DNA methylation was an important component of PiwiL2 
silencing but not the exclusive mechanism (Section 4.8). Thus, while each of the 
remaining candidates identified here are potentially part of a methylation-dependent 
subset of germline-specific genes, further causal studies are needed to determine this.  
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Additional putative methylation-dependent germline genes have been reported 
elsewhere. The foremost drawback to these studies was the lack of cause and effect 
evidence. This left open the possibility that promoter methylation at these loci was 
occurring as a consequence of transcriptional activity (Weber et al., 2007; Maatouk 
et al., 2006; Shen et al., 2007) or that de-repression following global demethylation 
was a consequence of indirect effects such as changes in transcription factor 
availability and/or epigenetic modifications (Tachibana et al., 2009; Oda et al., 2006; 
McCarrey et al., 2005; Fouse et al., 2008). However, the comprehensive cause and 
effect analysis of Tex19 presented here, provides proof of principle that some or 
many of the reported targets could be genuine methylation-dependent genes. One 
strong example is Dazl, which was one of three genes reported to rely on promoter 
methylation for temporal activation in post-migratory PGCs (Maatouk et al., 2006). 
Dazl only failed to be considered as a candidate here because it was de-repressed 
only 4.3-fold (6-fold threshold) after 14 days recovery from 5-aza dC treatment 
(10.2-fold immediately after). Thus, considering Dazl is de-repressed in both DP and 
P-aza cells, effectively loses epigenetic memory after demethylation and that its 
methylation status in vivo correlates with expression (Maatouk et al., 2006), Dazl 
represents an excellent future candidate. However, that the other two genes reported 
by Maatouk and colleagues (2006) (Mvh and Scp3) were not de-repressed in DP or 
P-aza cells highlights the requirement for downstream cause and effect analyses, as 
performed here (Chapter 4), to confirm causal regulation by promoter methylation. 
Indeed, the example of PiwiL2 supports the necessity for comprehensive analysis to 
determine the precise regulatory contribution of DNA methylation at each locus 
 
Until comprehensive cause and effect studies are carried out on germline genes 
putatively regulated by DNA methylation, the number of genes that primarily utilise 
promoter methylation to regulate developmental and tissue specific expression will 
remain unknown. However, the data presented here suggest that it is possible that 
there are a significant number of germline-specific genes that rely exclusively on this 
mechanism. Indeed, Tex19 may only represent the first bona fide example of 
multiple methylation-dependent germline genes.   
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6.2 Developmental targeting of de novo methylation to Tex19
and germline-specific genes 
The identification of Tex19 and several other putative germline genes regulated by 
promoter CpG methylation raises several salient questions. For example, which 
enzyme targets methylation to CGIs during development? How are germline-specific 
CGI promoters, such as Tex19, specifically targeted for de novo methylation in 
somatic cells while other CGI promoters remain protected? And how do PGCs 
uniquely protect these promoters from methylation and/or direct their demethylation? 
To address the former question, it is notable that my data indicates that Dnmt3b is 
responsible for de novo methylation of Tex19 in ES cells during embryoid body (EB) 
formation. Because embryoid body development closely parallels in vivo 
development, it is likely, though not certain, that Dnmt3b plays the prominent role in 
methylating Tex19 during embryogenesis. Indeed, Dnmt3b is expressed at its peak in 
E6.5 mouse embryos whereas Dnmt3a is absent or at best, present at very low levels 
at this stage (Watanabe et al., 2002 & UniGene EST database). Analysis of 
developmental Tex19 methylation suggests the de novo process starts at ~E6.5 and is 
complete by E7.5 at the latest – timings that fit well with the developmental 
expression of Tex19 and importantly, with the expression of Dnmt3b, but not 
Dnmt3a. This observation strongly supports the conclusion that Dnmt3b is 
responsible for de novo methylation of Tex19 in vivo. 
 
However whether Dnmt3b is responsible for general germline-specific CGI 
methylation is an intriguing question. Dnmt3a and Dnmt3b have been shown to have 
both distinct and overlapping functions. For example, both Dnmt3a and Dnmt3b 
target Xist, the noncoding RNA essential for female X-inactivation (Sado et al., 
2004) whereas Dnmt3a is solely responsible for the establishment of the majority of 
mono-allelic imprinted marks in germ cells (Kaneda et al., 2004). This suggests that 
de novo methylation of germline specific CGI promoters could conceptually be a 
distinct biological role of a single de novo methyltransferase, potentially Dnmt3b. 
Moreover the strong expression of Dnmt3b compared to Dnmt3a during early 
development is consistent with Dnmt3b being the primary methyltransferase 
          201
responsible for general germline CGI de novo methylation (e.g. at Tex13, PiwiL2, 
Dazl etc). Dnmt3b inactivation also leads to a significantly earlier developmental 
phenotype than Dnmt3a inactivation (Okano et al., 1999). Arguing against Dnmt3b 
being responsible for developmental methylation of CGIs, it has been reported that 
the de novo methylation of Rhox6 and Rhox9 is dependent on both Dnmt3a and 
Dnmt3b (Oda et al., 2006).  However, examination of this data can reconcile this 
apparently contradictory conclusion to the Dnmt3b-dependent model proposed here. 
The authors found that methylation of Rhox6 and Rhox9 in Dnmt [3a 3b]-double null 
ES cells could be rescued by overexpressing Dnmt3a. This suggests that Dnmt3a 
expressed at nonphysiological levels has the capacity to target de novo methylation 
to these loci. However, analysis of embryonic tissue indicated that Dnmt3a-null cells 
retained full methylation at Rhox6 and Rhox9 but crucially, that Dnmt3b-null 
embryonic cells were demethylated. This suggests that in vivo Dnmt3b alone 
methylates these loci but that when present, Dnmt3a has the capacity to target these 
genes. Because Dnmt3a is expressed very weakly during early development it is 
likely that there is a crucial reliance on Dnmt3b to methylate Rhox6 and Rhox9 in 
vivo. This data is thus ultimately consistent with Dnmt3b being the primary enzyme 
that targets CGI promoters in somatic cells during development. It would be 
interesting to confirm germline-specific CGI methylation as a specific role for 
Dnmt3b analogous to the specific role of Dnmt3a in methylating imprinted loci 
during PGC maturation.     
 
A curious aspect of the developmental timing of Tex19 methylation is the relatively 
late onset of de novo methylation at the locus. During development de novo re-
methylation of the bulk genome commences from the early blastocyst stage (~E3.5) 
and is largely completed by the onset of gastrulation (~E6.5) (Fig 1.7) (Santos et al., 
2002). However, my data suggests that Tex19 is only partially methylated by E6.5 
and not fully methylated until E7.5, albeit at the latest (Section 4.11). While this 
methylation profile is consistent with the developmental expression of Tex19, it is 
intriguing to consider why de novo methylation at this locus is relatively delayed 
compared with the bulk genome (Fig 6.1 upper panel). One possibility is that late-
onset  timing of Tex19  methylation  and silencing  was evolutionarily  selected for to  
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Fig 6.1. Developmental dynamics of Tex19 methylation and expression. Shown is 
genome-wide methylation levels (black) and Tex19 expression (green). Upper panel: During 
early embryonic development (zygote to E7.5) Tex19 remains hypomethylated and 
expressed throughout all embryonic and extra-embryonic tissues. A delayed wave of de 
novo methylation is targeted to Tex19 between E6.5 and E7.5 leading to stable silencing of 
Tex19 expression in all somatic tissues by late E7.5. Lower panel: Germ cells are specified 
at ~E7.5 and undergo an initial wave of epigenetic reprogramming at ~E8.5 leading to partial 
DNA demethylation (Fig 1.7) and activation of Tex19 and other methylation-dependent 
germline genes specifically in PGCs (Fig 4.16 & Appendix 5). A second wave of 
reprogramming at ~ E11.5 leads to complete erasure of DNA methylation in PGCs and 
activation of a second set of methylation-dependent germline-specific genes including Dazl.  
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promote the potential biological function of Tex19 (Section 6.4). Mechanistically, 
Tex19 may be bound by specific cis-regulatory proteins which protect the promoter 
from de novo activity until ~E6.5. Alternatively, Tex19 may be inherently resistant to 
de novo methylation (it is a CGI) and therefore may require a high local 
concentration of Dnmt3b. Indeed Dnmt3b reaches its peak expression at ~E6.5, 
precisely the timepoint de novo methylation is predicted to occur at Tex19 (UniGene 
EST database; Watanabe et al., 2002). It will be interesting to investigate the 
developmental timing of de novo methylation at other germline-specific candidate 
genes such as Tex13 and Dazl to determine if this relative delay is a general 
characteristic of developmentally methylated CGIs. Indeed supporting this premise, 
de novo methylation of the Oct3/4 CGI promoter is also delayed, occurring after 
E6.5, thereby hinting that there may be conserved or parallel mechanisms of delayed 
de novo activity at specific CGI promoters in vivo (Gidekel & Bergman, 2002). 
 
While the evidence suggests Dnmt3b is responsible for catalysing de novo 
methylation of Tex19 at ~E6.5 in vivo, the mechanism that targets this activity to 
Tex19 and indeed other germline-specific CGI promoters but excludes the vast 
majority of genomic CGIs is unknown. One possibility is that antisense mechanisms 
alter chromatin structure or recruit methyltransferases to germline CGIs thereby 
promoting de novo activity at these loci (Chotalia et al., 2009; Sleutaels et al., 2002). 
However, my analysis suggested that the antisense RNA I identified at Tex19, was 
transcribed as a consequence of Tex19 expression and was therefore downstream of 
promoter methylation status at this locus (Section 5.7). This supports the notion that 
antisense mechanisms may potentially have a locus-specific role in targeting 
methylation to non-imprinted germline CGI genes but this is not the mechanism at 
Tex19. I therefore considered the possibility that cis-regulatory elements had a role in 
directing de novo methylation to Tex19 in somatic cells. Retroelement derived 
sequences and tandem repeat arrays are rapidly targeted for CpG methylation in 
mammals (Walsh et al., 1999; Reinhart et al., 2006; Yoder et al., 1997) and also 
partially avoid demethylation during epigenetic reprogramming (Hajkova et al., 
2002). My analysis demonstrated that the proximal Tex19 promoter is composed of 
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~49% retroelement derived sequences (Section 5.8). Therefore it is possible that 
these insertions contribute to or direct de novo methylation to this locus. However, 
further analysis of both this locus and other methylated CGIs is necessary to validate 
this proposal.  
 
An alternative possibility is that the inherent CpG density at Tex19 and methylated 
germline CGI promoters promotes de novo methylation. Indeed, it is striking that all 
9 of the germline-specific candidate genes identified here have promoters that are of 
very similar CpG density (obs/exp 0.53-0.6) (Section 3.8). This corresponds to 
promoter classifications that are on the border between ICP and HCPs. Thus, while 
considered as CGIs, my candidate genes and other reported genes such as Dazl are 
all at the lower limit of CGI classification (weak-CpG islands). As several genome-
wide studies have reported that precisely this class of CGI promoter is preferentially 
de novo methylated during development (Weber et al., 2007; Meissner et al., 2008), 
it is possible that germline candidate genes including Tex19 are targeted due to their 
inherent  promoter characteristics or ‘CpG-ness’.  However, an argument against this 
proposal is that many genes that have equivalent CpG densities to Tex19 and 
candidate loci do not become methylated during development. Therefore in this 
model, at least one other system in addition to CpG density must co-ordinately direct 
CGI methylation. Structural studies have revealed that the Dnmt3a-Dnmt3L complex 
methylates DNA templates with an optimal CpG spacing of 8–10bp, hinting that 
Dnmt3b could have a similar preference (Jia et al. 2007). Moreover, it has been 
reported that Dnmt3L is structurally inhibited by methylated Histone 3 lysine 4 
(H3K4) (Ooi et al., 2007). Thus, the presence of unmethylated H3K4 at weak CpG 
islands and/or with a specific CpG periodicity could potentially account for targeting 
methylation to germline promoters. Interestingly, my data indicated that the core 
promoter of Tex19 was depleted of histone modifications and could potentially 
remain nucleosome-free in some contexts. This may reflect an important aspect of 
targeting de novo methylation to this locus.  
 
However, a recent report argues against this proposal and suggests that CGIs 
generally remain methylation-free due to sequence specific motifs irrespective of 
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CpG density or histone modifications (Straussman et al., 2009). In this model CGIs 
avoid de novo methylation during early development because they contain specific 
sequence motifs that confer protection. The authors argue that conceptually, 
methylation of CGIs is the default state unless they are protected by specific DNA 
sequences. Another study has additionally reported complementary sequence motifs 
associated with methylated CGIs (Shen et al., 2007). In spite of this, cross-
referencing these motifs with Tex19 demonstrated that sequences associated with 
methylated CGIs were not present at Tex19 and conversely that the motif most 
highly enriched at unmethylated CGIs (CGCGC) was present adjacent to the Tex19 
TSS. Thus, this argues against sequence specificity targeting Tex19 for 
developmental methylation.     
 
The body of evidence presented here strongly supports the notion that Dnmt3b is 
responsible for de novo methylation of Tex19 at ~E6.5 and indirectly suggests this is 
a general role for Dnmt3b. However, the precise mechanism that targets Tex19 and 
indeed germline-restricted CGI promoters in general is not determined in this thesis. 
Thus, it remains speculation as to how CGI promoters are located and selected by the 
de novo methylation machinery in vivo.  
   
6.3 Evolution of DNA methylation as a regulatory mechanism 
While it is beyond the scope of this thesis to determine how germline-specific CGI 
promoters are targeted for de novo methylation, a key observation is that several are 
targeted for methylation (Section 4.1) (Meissner et al., 2009; Lister et al., 2009) . The 
question therefore follows, why are these germline-specific CGI promoters afforded 
this privileged state? In other words, why does DNA methylation preferentially 
regulate germline-specific genes. One answer to this question lies in the inherent 
mutability of methylated cytosines to thymine by deamination. In this model germ 
cell expressed genes would be hypomethylated in the germline and therefore avoid 
losing CpGs from their promoters over evolutionary time, as only germ cell DNA is 
transmitted to progeny (Siegfred & Cedar, 1997). In contrast, a somatic cell-specific 
gene regulated by CpG methylation would, by definition, be hypermethylated in the 
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germline. This would lead to the unstable situation whereby the promoter would 
have a tendency to progressively lose CpGs by deamination over successive 
generations (MacLean II & Wilkinson, 2005). Thus, through being impervious to 
evolutionary loss of CpGs, germline-specific genes have the unique advantage of 
being capable of preserving their ability to be regulated by promoter DNA 
methylation. Therefore conceptually, not only are germline-specific genes 
preferential targets for regulation by CpG methylation, over long evolutionary 
stretches they are the only class of genes able to maintain methylation-dependent 
regulation (with the exception of imprinted loci).   
 
Even though germ cell-specific expression is effectively a requirement for stable 
methylation-dependent regulation, only a limited subset of germline-restricted genes 
are regulated by this mechanism for several putative reasons. Firstly, many germ 
cell-specific genes are associated with low CpG density promoters. As suggested by 
Weber et al (2007), below a certain threshold of CpG density, DNA methylation has 
little or no effects on transcription. Thus, a prerequisite for being regulated by DNA 
methylation is a promoter containing a sufficient density of CpGs to interfere with 
transcription. Secondly and perhaps more importantly, many genes are regulated by 
the co-ordinated effects of epigenetic and trans-acting factors. Therefore, if a gene 
required a germ cell-specific transcription factor for activation (e.g. FIGalpha or 
Sohlh2), promoter demethylation may be necessary, but would not be sufficient for 
gene expression in somatic cells (Soyal et al., 2000; Ballow et al., 2006). At such 
loci, DNA methylation may contribute to gene regulation but would not be the 
exclusive mechanism. PiwiL2 and previously reported genes such as Tex12, Rhox6 
and Pgk2 may fall into this class of genes whereby DNA methylation is a crucial 
contributor to regulation but transcription factor availability and/or additional 
epigenetic modifications also modulate the precise cell-type expression pattern 
(Pohlers et al., 2005; Oda et al., 2006; McCarrey et al., 2006). In contrast, germline-
specific genes that are activated by ubiquitous transcription factors would critically 
rely on DNA methylation (or an alternative epigenetic mechanism) to maintain 
silencing in somatic cells. Only at these germline-specific loci could DNA 
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methylation potentially be the primary and exclusive mechanism for regulating tissue 
specific expression. 
 
Thus, for a gene to be regulated by DNA methylation, it must satisfy several 
prerequisites. It should be (i) germline specific, (ii) activated by ubiquitous 
transcription factors, (iii) have a CpG-dense promoter and, (iv) not have acquired 
additional upstream epigenetic regulation. Additionally it must acquire tissue-
specific de novo methylation during development. I propose the necessity for these 
several requirements imposes a severe limit on the number of genes that can 
theoretically be regulated primarily by promoter CpG methylation. This accounts for 
the lack of bona fide methylation-dependent targets currently characterised and is 
consistent with Tex19 relying exclusively on DNA methylation, as it satisfies these 
requisites. It is noteworthy that the requirements outlined here are not strictly 
necessary (but are likely) for methylation-dependent regulation. For example a 
somatic cell-specific gene could conceptually be regulated by DNA methylation if 
methylation mediated control was established so quickly over evolutionary time that 
few CpGs were lost by deamination and were then maintained by strong selection. 
Additionally, genes targeted specifically by germline transcription factors can be 
temporally regulated by DNA methylation per se in germ cells although crucially, 
loss of methylation in somatic cells would not induce activation. Thus, while the 
requisites proposed here generally apply, there may  be exceptions.     
 
The discussion thus far has considered the technical reasoning for why germline-
specific genes are regulated by DNA methylation i.e. CpG density, retroelement 
derived promoters, germline deamination etc. However, it is also interesting to 
consider why these genes are regulated by promoter methylation from an 
evolutionary-developmental (evo-devo) perspective. My data indicates that Tex19 is 
fully methylated in embryonic cells before E7.5, which is about the same time as 
germ cells are specified in the primitive hindgut (Saitou et al., 2002; Ohinata et al., 
2005). This suggests that nascent PGCs are methylated at Tex19. However by E9.5 
Tex19 is demethylated and expressed in PGCs but remains fully methylated and 
silenced in somatic cells at the same stage (Section 4.11). Therefore it is likely Tex19 
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is demethylated as a consequence of the global epigenetic reprogramming phase that 
occurs in PGCs at ~E8.5 (Fig 6.1 lower panel) (Seki et al., 2005; Seki et al., 2007; 
Hajkova et al., 2008). Likewise, other germline specific genes such as Dazl are 
demethylated and expressed during the second wave of PGC reprogramming at 
~E11.5 (Fig 6.1) (Section 4.11) (Maatouk et al., 2006; Hajkova et al., 2008). It is 
interesting to consider the possibility that genes such as Tex19 and Dazl are 
potentially expressed specifically in the germline simply as an indirect consequence 
of the requirement for genomic reprogramming. Here, Tex19 and others may be 
expressed solely in germ cells by virtue of being (i) de novo methylated during early 
development and (ii) having a sufficient CpG density to silence transcription. That is, 
germline genes regulated by promoter methylation may be the consequence of their 
promoters exhibiting the novel combination of attracting developmental de novo 
methylation and containing a relatively high CpG density. Expression in the germline 
is then an inevitable outcome of passage through reprogramming germ cells (as long 
as appropriate transcription factors are available). In contrast the majority of 
remaining genes are either not de novo methylated (CGI genes) or do not contain a 
sufficient density of CpGs to interfere with transcription when they are methylated.  
 
Once a germ cell-restricted expression pattern is established, it is likely that genes 
will acquire germline-specific functions. Indeed genetic deletion of Tex19, Dazl or 
PiwiL2 each causes severe reproductive phenotypes (Ollinger et al., 2008; Ruggiu et 
al., 1997; Kuramochi-Miyagawa et al., 2004). It is possible these roles evolved after  
the acquisition germline-specific expression and thus as an indirect consequence of 
DNA demethylation during PGC reprogramming. To paraphrase, these genes may 
not be expressed in the germline because they have germ cell specific functions but 
rather have germ cell specific functions because they are expressed in the germline. 
Indeed, it is unclear whether expression of Tex19 in somatic cells would have any 
negative effects, particularly given that its reported physiological role is in repressing 
an endogenous retrovirus, a seemingly advantageous function (Ollinger et al., 2008). 
Thus, the biological reasoning for silencing Tex19 by promoter methylation in 
somatic cells is uncertain, supporting the concept that Tex19 attracts methylation (or 
is unable to repel it) by default and is expressed in the germline as an indirect 
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consequence of genomic reprogramming. However, an alternative possibility is that 
DNA methylation evolved to regulate the timing and tissue-specific activation of key 
genes required for germ cell differentiation such a Tex19 and Dazl. This model 
predicts that these genes co-opted DNA methylation as a regulatory mechanism to 
ensure stable and heritable expression in the germline.  
 
It would be interesting to distinguish between these possibilities by examining the 
role of promoter methylation in germline-specific gene regulation in distantly related  
organisms. For example, if DNA methylation was found to regulate Dazl in 
salamanders (Axolotl), which specify their germ cells through an ‘inductive’ 
mechanism similar to mammals but not in Xenopus, which specify their germline 
through a ‘preformation’ germplasm mechanism, this would support the former 
model (Johnson et al., 2003; Lawson et al., 1999; Seydoux and Braun, 2006). That is, 
that DNA methylation regulates germline specific genes as an indirect consequence 
of the requirement for epigenetic reprogramming of germ cells. However, if both 
organisms were found to regulate xDazl and axDazl via DNA methylation, this 
would support the latter model, which predicts that DNA methylation evolved at key 
germline genes to direct expression in germ cells regardless of how they are 
specified. Interestingly, identification of multiple methylation-dependent germ cell-
specific genes in either organism would suggest that the evolutionarily role of DNA 
methylation in regulating germline gene expression predated its role in genomic 
imprinting (which is mammalian specific). Thus, this would indicate DNA 
methylation initially arose as a gene regulatory mechanism to promote germ cell 
development.      
6.4 Methyl-binding proteins couple DNA methylation to gene 
silencing 
While the role of promoter CpG methylation at Tex19 in mice seems clear, the 
precise mechanism through which transcriptional silencing per se is achieved is 
unclear. Indeed, several mechanisms have been proposed to underpin the relationship 
between DNA methylation and transcriptional silencing (Klose & Bird, 2006). 
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However, it is still uncertain what contribution each putative mechanism has to gene 
silencing at both a global and locus-specific level. In this thesis, I have demonstrated 
that the methyl-binding protein (MBP) Kaiso, critically couples DNA methylation to 
transcriptional silencing of Tex19. In the absence of Kaiso, Tex19 is strongly de-
repressed despite retaining promoter methylation, establishing that Kaiso interprets 
CpG methylation at this locus and directs downstream silencing (Section 5.2). 
Consistent with this, Tex19 silencing can be partially re-imposed by expression of 
exogenous xKaiso (Section 5.4). The fact the Xenopus Kaiso can rescue repression 
suggest Tex19 inherently attracts conserved Kaiso methyl-binding activity, probably 
through the multiple CGCG motifs present in the Tex19 promoter. Indeed, Kaiso is 
recruited to Tex19 in a methylation-dependent manner (Section 5.5). Moreover Kaiso 
is crucially required to repress Tex19 transcription during ES cell differentiation, as 
Kaiso-null embryoid bodies fail to impose silencing of Tex19. Taken together, my 
results reveal that the methylation-dependent silencing of Tex19 is critically 
mediated by recruitment of Kaiso. The observation that Tex19 is regulated by Kaiso 
reinforces the conclusion that Tex19 represents a novel and bona fide gene regulated 
exclusively by promoter CpG methylation (Chapter 4).        
 
Interestingly, a key point is that because Kaiso is ubiquitously expressed throughout 
development and in all tissues at comparable levels (Unigene EST and BioGPS 
databases), silencing at Tex19 is entirely dependent on the presence of DNA 
methylation. That is to say, differential promoter CpG methylation is the key variable 
that directs Tex19 silencing as Kaiso is continually available. This is distinct from a 
previous study of MBP regulation, which reported that gene silencing in the colon is 
mediated by elevated MBD2 levels specifically in the colon and not changes in CpG 
methylation per se (Berger et al.,2007). While it is possible that  p120ctn-mediated 
depletion of the nuclear pool of Kaiso could affect silencing, this effect has not been 
observed in normal cells (Daniel & Reynolds, 1999; Daniel, 2006). Thus, the 
relatively stable expression and nuclear localisation of Kaiso allows a binary system 
of methylation-dependent regulation at Tex19. Kaiso therefore fulfils the role of a 
novel methylation-dependent repressor of this locus rather than effectively being a 
tissue-specific repressor, as for the discussed MBD2 example (Berger et al., 2007)  
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An intriguing question that arises from this study is precisely how does Kaiso bring 
about methylation-dependent repression of Tex19? One previous study has indicated 
that Kaiso is part of a multiprotein histone deacetylase complex in HeLa cells, where 
it interacts with N-CoR (Yoon et al., 2003). Here, it was reported that Kaiso targeted 
deacetylase activity to the methylated MTA2 gene and that this was essential for gene 
silencing. While MTA2 probably does not represent a physiological target of Kaiso, 
as it is unmethylated in normal cells (as opposed to HeLa cells), this report may hint 
at a potential mechanism of repression at bona fide Kaiso targets. Indeed, in the 
present study, HDAC1-null ES cells failed to silence Tex19 after treatment with 
retinoic acid as compared to wild-type ES cells, suggesting HDAC activity is 
required to initiate Tex19 silencing. Thus, one possibility is that Kaiso targets histone 
deacetylation to Tex19 following de novo methylation. However, consistent with 
previous global expression analyses (Lande-Diner et al., 2006), I observed no de-
repression of Tex19 in somatic cells treated with the histone deacetylase inhibitor 
TSA. This therefore suggests a model whereby HDAC activity is targeted by Kaiso 
to initiate repression of Tex19 but that once silenced this HDAC activity is 
dispensable to maintain stable silencing.  
 
A key aspect of this model is the distinction between initiation and maintenance of 
Tex19  silencing. Microinjection of unmethylated and methylated DNA in Xenopus 
oocytes and mammalian cells has demonstrated a crucial role for chromatin 
compaction in initiating silencing of methylated templates. Here, methylated DNA is 
initially highly transcribed but becomes progressively silenced coincident with 
assembly into condensed chromatin (Kass et al., 1997).  As HDAC activity has an 
important role in initiating chromatin condensation, a potential mechanism for Kaiso 
mediated silencing of Tex19 could be as follows: (i) Tex19 acquires de novo 
methylation and recruits Kaiso (ii) Kaiso associated HDAC activity initiates 
chromatin compaction and (iii) once assembled into a condensed chromatin 
structure, CpG methylation and Kaiso co-operatively maintain transcriptional 
silencing (Fig 6.2a & b). Here, initiation of Tex19 silencing would be critically 
dependent on DNA methylation, Kaiso and HDACs whereas maintenance would 
































































































































































































































































































































































































































































































































only rely on DNA methylation and Kaiso. Mechanistically, once Tex19 acquires a 
compacted chromatin structure (methylated and deacetylated) it may directly 
preclude histone acetyltransferases (HATs) from gaining access, thereby negating the 
role of HDACs at the locus. This model provides an attractive mechanism for 
methylation-dependent silencing that accounts for all the experimental data 
generated here. However, the model predicts that HDAC1-null ES cells would still 
methylate Tex19 during differentiation but would be unable to initiate silencing 
through chromatin compaction. It is therefore crucial to test this prediction to 
confirm the model. The observation that HDAC1 deficient ES cells fail to methylate 
Tex19 after retinoic acid treatment, potentially through inhibited differentiation, 
would explain the failure of Tex19 to silence in HDAC1-null cells (Lee et al., 2004). 
Moreover, when considered with the TSA data, this eventuality would suggest Kaiso 
directed repression at this locus was independent of HDACs. Indeed, the interaction 
between Kaiso and N-CoR is yet to be independently confirmed in normal mouse 
cells despite several attempts. It is therefore crucial for future studies to clarify the 
Kaiso interaction with N-CoR and the role of HDACs at Tex19. 
 
There are several non-mutually exclusive alternative possibilities for the mechanism 
of Kaiso mediated silencing at Tex19. Firstly, Kaiso could act as a binding platform 
that may recruit multiple enzymatic activities important for maintaining chromatin 
structure and/or transcriptional silencing to methylated Tex19. In this respect, Kaiso 
has recently been shown to interact with the PRC1 component Ring1b and the 
chromatin insulator CTCF, which may contribute to co-repressor activity (Sánchez et 
al., 2007; Defossez et al., 2005) (Fig 6.2c). Alternatively Kaiso may directly inhibit 
transcriptional initiation and/or elongation by steric hindrance. Depending on Kaiso’s 
affinity for Tex19 and its dynamic dissociation constant, Kaiso could dominantly 
prevent transcription factors gaining access to methylated but not unmethylated 
Tex19 (Fig 6.2d). Importantly, like the Kaiso-HDAC model, these predictions are 
testable through yeast-two-hybrid and co-IPs or FRAP and EMSA assays, 
respectively. Thus, while the precise mechanism of Kaiso mediated silencing has not 
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been determined here, I have provided a framework for future investigations into the 
mechanistic basis of Kaiso activity 
It is notable that, whatever the mechanism of Kaiso-mediated silencing, Kaiso is not 
responsible for the full programme of repression at Tex19, as in the absence of Kaiso 
Tex19 is only partially de-repressed. Thus, although Kaiso is the critical component 
that ensures full silencing (i.e. turns Tex19 completely ‘off’), alternative 
mechanism(s) must contribute to methylation-dependent repression at this locus. 
Intriguingly this could be an inherent effect of the underlying DNA methylation. In 
this model, a deficiency of Kaiso would lead to loss of Tex19 silencing, but 
maintenance of the underlying DNA methylation would sustain partial repression 
leading to an intermediate state of activation. DNA methylation per se could 
potentially maintain partial repression through maintaining chromatin condensation, 
excluding DNA binding factors, recruiting alternative MBPs or even through the 
direct repressive function of methyltransferases (Fig 6.3) (Gilbert et al., 2007; 
Campanero et al., 2000; Bird & Boyes, 1991; Bachman et al., 2001, Rountree et al., 
2000). This model could account for the relatively weak activation of genes genome-
wide in the absence of Kaiso and is consistent with Tex19, whereby expression in 
Kaiso-null cells is intermediate between hypomethylated DP cells and methylated 
wild-type cells (Section 5.2 & 5.3). It will be intriguing to determine whether Tex19 
can maintain a repressive chromatin structure in the absence of Kaiso and/or whether 
alternative MBPs, particularly ZBTB38 and ZTBT4, can be recruited to this locus as 
a redundant mechanism. In this respect, it is notable that in the present study I 
observed weak de-repression of Tex19 in the absence of MBD2. Establishing the 
chromatin structure at Tex19 and whether alternative MBPs are recruited could point 
toward the mechanistic basis of Kaiso-mediated silencing.  
 
The observation that most genes are, at best, only partially de-repressed in the 
absence of Kaiso suggests a tantalising rationale for the mild phenotypes of MBP 
deficient mice. That is, while MBP mediated transcriptional repression may 
contribute to silencing at a number of loci, MBP inactivation can be compensated for 
by either the underlying methylation or, unlike at Tex19, alternative epigenetic 
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systems (e.g. histone lysine methylation). As discussed above, DNA methylation per 
se could sustain partial silencing through maintaining repressive chromatin structure, 
direct exclusion or redundant MBP binding (Fig 6.3). Indeed this could be in 
addition to alterative epigenetic mechanisms at any particular locus. Thus, a 
consequence of self-reinforcing epigenetic regulation is that repressive networks are 
able to compensate for the loss of one, or even several, methyl-binding proteins. This 
model predicts that very few genes would be critically dependent on MBPs to 
maintain silencing and is thus consistent with the molecular and phenotypic data. To 
this extent Tex19 may represent a rare example of a gene that is dependent on a 
single epigenetic regulatory pathway, namely DNA methylation. Therefore, loss of 
DNA methylation or one of the downstream effectors (Kaiso) leads to significant de-
repression of Tex19 compared to most loci. Interestingly, inactivation of MBPs on an 
already epigenetically disrupted background, such as a PcG group component or a 
H3K9 methyltransferase, could identify MBP targets that, on a wild-type 
background, would be able to compensate for MBP loss. The concept of self-
reinforcing epigenetic interactions has been experimentally demonstrated between 
multiple epigenetic systems and it is therefore not a giant conceptual leap to include 
MBPs within a robust epigenetic network. Importantly, this is distinct from the 
reported physical interactions between for example MeCP2 and HDACs (Nan et al., 
1998, Rietveld et al., 2002). Whilst this physical interaction can co-target repressive 
activity, the model proposed here predicts that these activities can be targeted 
independently and thus compensate for each other. Thus, in the absence of MeCP2, 
HDAC activity could still be targeted to a locus through an alternative mechanism, 
thus creating a robust compensatory repression system. As it stands, Tex19 is very 
much the exception to this rule and thus represents the first bona fide MBP target 
gene that relies exclusively on promoter CpG methylation.      
6.5 Relationship between the role and regulation of Tex19 
Tex19 encodes a 42kDa protein that was originally identified in a subtractive 
hybridisation screen to identify genes transcribed in spermatogonia but not somatic 
cells (Wang et al., 2001). Subsequent work demonstrated that Tex19 is expressed in 
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germ cells from at least E9.5 and pluripotent mES cells (Kuntz et al., 2008). The 
primate genome contains a single Tex19 gene, however, a rodent-specific duplication 
event has produced two related genes in mice (Tex19 & Tex19.2) that are separated 
by ~30kb and are inversely transcribed. Tex19 seems to play an important role 
during male germ cell maturation as deletion of Tex19 in mice causes disrupted 
chromosome synapses during meiosis, and impaired spermatogenesis (Ollinger et al., 
2008). Interestingly, global analysis of gene expression in Tex19-mutant mice 
identified only one transcript, the class II LTR-retrotransposon MMERVK10C, as 
significantly upregulated. Further analysis indicated that the elevated expression of 
this transcript was the likely cause of meiotic chromosome asynapses and the 
spermatogenesis defect in Tex19-null mice. It was unclear whether this is a direct or 
indirect consequence. However, the resemblance to other mutant phenotypes that 
exhibit defects in meiotic chromosome synapses as a consequence of increased 
retrotransposon activity in the germline is striking (Aravin et al., 2006; Bourc'his et 
al., 2004). This suggests that Tex19 may be a crucial component of a repressive 
system that regulates a specific class of LTR retrotransposon in the germline thereby 
promoting germ cell development. Interestingly, Tex19 is primarily localised in the 
cytoplasm and therefore likely regulates MMERVK10C retrotransposon levels post-
transcriptionally, possibly through reducing RNA stability (Ollinger et al., 2008).  
 
Because increased retrotransposon expression in the germline can lead to mutational 
transposition events that transmit to future generations, germ cells have evolved 
multiple mechanisms to maintain retrotransposon suppression. One key mechanism 
is to target retroelements for dense CpG-methylation and hence transcriptional 
silencing. The crucial role of this mechanism in germ cells can be seen in mice 
lacking genes involved in methylation-dependent transcriptional silencing. For 
example, deletion of Dnmt3L, Lsh or PiwiL2 causes strong de-repression of LTR and 
LINE retrotransposons in germ cells, leading to defects in meiotic chromosomes 
synapses (Bourc'his t al., 2004; Da La Fuente et al., 2006; Aravin et al., 2007). 
Indeed, many have argued that the primary role of DNA methylation per se is the 
maintenance of transposon inactivation in germ cells - the ‘genome defence’ 
hypothesis (Yoder et al., 1997; Bestor & Tykco, 1996). However, one drawback of 
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methylation-dependent retrotransposon silencing is that PGCs must undergo phases 
of epigenetic reprogramming which can result in partial demethylation of 
retroelements (Hajkova et al., 2002). This demethylation could conceptually lead to 
transient expression and mutagenic genomic insertion (Walsh et al., 1998; Malik et 
al., 1999). To counter this, alternative mechanisms of retrotransposon suppression 
must be in place in germ cells.  
 
Thus, Tex19 could represent one alternative mechanism for suppressing certain 
classes of retrotransposons and thereby compensating for the transcriptional effects 
of DNA demethylation in the germline. Strikingly, this hypothesis could account for 
the distinct methylation-dependent regulation of Tex19 expression. In this intriguing 
model, Tex19 expression is inherently linked to global demethylation and therefore, 
activation of methylation-dependent retroelements is coupled by concomitant 
activation of Tex19. Because Tex19 functions through a putative post-transcriptional 
mechanism of retroelement suppression, it thus acts as a compensatory mechanism 
for the requirement of genomic reprogramming. In effect, whenever retroelements 
are demethylated and expressed so is Tex19, ensuring that retrotransposons are 
constantly suppressed throughout germ cell development (Fig 6.1). It would be 
interesting to test this by examining whether MMERVK10C elements are 
significantly upregulated by 5-aza dC treatment of Tex19-null fibroblasts. 
Interestingly, PiwiL2 also plays an important role in suppressing retroelements by 
directing CpG methylation to them via piRNAs (Aravin et al., 2006). It is striking 
that PiwiL2 is also highly responsive to promoter demethylation in this study and 
could therefore utilise global demethylation as an expression cue to re-target de novo 
methylation to retroelements. Thus, both Tex19 and PiwiL2 may couple their 
expression pattern to that of their functional target, retroelements, by utilizing the 
same regulatory mechanism - promoter CpG methylation. 
6.6 Epigenetic memory of germline-specific genes
As part of my initial screen to identify methylation-dependent targets, I examined the 
transcriptional effect of 5-aza dC treatment, followed by 14 days of recovery. It was 
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predicted that genes that rely exclusively on CpG methylation would be unable to 
recover gene silencing. This analysis found an enrichment of germline specific genes 
including, Tex19 and PiwiL2, that were still strongly expressed 14 days after 5-aza 
dC withdrawal. The loss of epigenetic memory at these loci is likely an inevitable 
consequence of being regulated primarily by a single, or at least a primary, 
epigenetic mechanism. It is likely bona fide methylation-dependent genes are unable 
to re-target CpG methylation, through mechanisms such as polycomb (Vire et al 
2006), or maintain silencing through an alternative mechanism to DNA methylation 
(Feldman et al., 2006). Thus, the loss of epigenetic memory at these loci may have 
wide-reaching transcriptional implications. For example, many cancers exhibit 
progressive global hypomethylation during tumour development (Esteller, 2007). 
The germline-specific genes identified here, which are predicted to lose their 
epigenetic memory when demethylated, would therefore be likely candidates for de-
repression in hypomethylated tumours. Indeed, an association between germline-
specific genes and genes ectopically activated in tumours has been noted. These are 
termed cancer/testis antigens (CTA) and over 100 have been identified (Caballero & 
Chen, 2009; Scanlan et al., 2004; De Smet et al., 1996). It is possible that CTA 
expression only represents a consequence of global hypomethylation in cancer cells. 
However as expression of many germ cell specific genes is associated with 
pluripotent cell-types, one possibility is that aberrant loss of epigenetic memory of 
CTAs contributes to tumour plasticity and progression. The identification of several 
germline restricted methylation-dependent genes here may lead to further 
identification of CTAs. Moreover, this would strengthen the proposal that CTAs are 
de-repressed in cancers primarily due to promoter hypomethylation (De Smet et al., 
1999). Indeed, genes such as Tex19 could potentially act as biomarkers to flag 
epigenetically disrupted cells for clinical diagnosis or immunotherapy.  
6.7 Future directions
This thesis has attempted to answer the question of whether any physiological target 
genes are causally regulated by promoter CpG methylation, and if so, by what 
mechanism is transcriptional silencing achieved. Here, while I have identified a 
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novel bona fide MBP- and methylation-dependent target, Tex19, many questions 
remain. One question of particular import is whether Tex19 is a representative 
paradigm of multiple genes in the context of methylation-dependent and MBP-
dependent regulation, or whether it is a highly specific example of this regulatory 
mechanism? Thus, future studies could investigate the causal role for promoter 
methylation at the remaining candidate genes identified here and those genes de-
repressed in MBP mutant cells. Moreover as a conclusive experiment to validate the 
essential and causal role of CpG methylation at these loci and Tex19, the generation 
of rescued DP cell lines expressing ectopic Dnmt1 and Dnmt3b could demonstrate de 
novo promoter re-methylation imposes gene silencing. It would also be interesting to 
delineate the precise factors involved in Tex19 regulation. Here EMSA assays could 
identify factors that bind either methylated or non-methylated Tex19 template. This 
could indicate potential mechanisms for targeting de novo methylation to Tex19 and 
hint at the key factors which activate expression of the unmethylated promoter. 
Indeed, we are currently generating transgenic mice expressing GFP driven by 
minimal or extended Tex19 promoters to dissect the key cis elements required for 
germline specific expression and somatic cell-specific CpG methylation of Tex19. 
Finally, it would be interesting to consider the possibility that the newly discovered 
DNA modification 5-hydroxymethylcytosine (hmC) could have a role at Tex19 
(Tahaliani et al., 2009; Kriaucionis & Heintz, 2009). As this modification is 
experimentally indistinguishable from DNA methylation by bisulphite sequencing 
(and restriction digestion), it is possible that the observed CpG methylation profiles 
at Tex19 could be entirely or in part 5’hydroxymethylcytosine. However, given the 
predicted low levels of this modification in somatic cells this seems an intriguing but 
unlikely possibility.           
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Appendix 1 – Primer Sequences
Transcript Primer Sequence Ta Product Size (bp)
18S rRNA GATCCATTGGAGGGCAAGTCT 56ºC 103
CCAAGATCCAACTACGAGCTTTTT
Ant4 ATGTCGAACGAATCCTCCAAGA 56ºC 140
AGCTTCACACGCTCGATGG
Apobec4 ACTGCTGCATCAGCAAAATG 52ºC 183
GGCCACCACATATTGGACTC
Atp5b GGTTCATCCTGCCAGAGACTA 56ºC 120
AATCCCTCATCGAACTGGACG 
Beta Actin GAAATCGTGCGTGACATCAAAG 56ºC 216
TGTAGTTTCATGGATGCCACAG 
B-Globin GCACCTGACTGATGCTGAGAA 54ºC 164
TTCATCGGCGTTCACCTTTCC 
Crip1 AAGTGCGACAAGGAGGTGTAT 56ºC 105
AGAGGTCAGTGTCTTTCCACATT 
Dazl TCTTTGCCAGATATGGCTCAGT 56ºC 110
CTTCTGCACATCCACGTCATTA 
Dnmt1 GCTACGAGGAGAACCACCAG 54ºC 209
GTTCCCGCTGTTACCTCTTC 
Dnmt1-3’ AAGAATGGTGTTGTCTACCGAC 56ºC 178
CATCCAGGTTGCTCCCCTTG 
Dnmt3a TACATCAGCAAACGGAAACG 56ºC 245
GCTGCTTTGGTAGCATTCTTG 
Dnmt3b CAGCTTGGAGAGGCAAAGAG 56ºC 216
TGGCTCAAGTCAACTGATGG
Dnmt3L GCTCTAAGACCCTTGAAACCTTG 56ºC 213
GTCGGTTCACTTTGACTTCGTA 
Dppa2 TCAACGAGAACCAATCTGAGGA 56ºC 102
GCGTAGCGTAGTCTGTGTTTG
Dppa4 AGTCAACCTAGCACGGCTC 56ºC 120
TCCTGGCGTCTCAGTGTCT
Eed TCTTGGGCGATTTGATTACAG 58ºC 175
GCCACATTTATGATGGGTCAG 
Epiregulin TCCGAGGATAACTGTACCGC 55ºC 136
CTCTCATGTCCACCAGGTAGAT 
Fshr GAATCCGTGGAGGTTTTCG 56ºC 171
CACCTTGCTATCTTGGCAG 
Fthl17 TACTTTGACCGTGATGACGTG 56ºC 292
AGTTTTGCTCCAGGAAATGGC 
Gata 6 CTCAGGGGTAGGGGCATCA 56ºC 114
GAGGACAGACTGACACCTATGTA
GCNA CGCAACGGTTTCTGTCAGGAT 56ºC 225
GTTCAGCTCGATCATCTGGGA 
Gro1 CCCGCTCGCTTCTCTGTG 56ºC 232
AAGGGAGCTTCAGGGTCAAG 
Gapdh ACCCAGAAGACTGTGGATGG 56ºC 289
GGTCCTCAGTGTAGCCCAAG 
Hdac 1 CCATGCAAAGAAGTCTGAAGC 56ºC 271
GTCTCGCAGTGGGTAGTTCAC
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Iap TTGTGGCCAGAATGACAGAG 56ºC 229
GAGCGGTTCTGAGATTGGAG
Iap – LTR TTGATAGTTGTGTTTTAAGTGGTAAATAAA 58ºC -
AAAACACCACAAACCAAAATCTTCTAC
Kaiso TGGTCCCTCAGGCTGATAAC 56ºC 242
TGCATAAACCTTGCAACCAG 
Krt8 GACCAAGTGGAGCCTGTTG 56ºC 199
ACGCTGTTGGATCTCATCCTC 
Mael CGAGGATTTCGATTCCATTGCC 56ºC 171
GGCTCTATCATCAGACTTGCAGT 
Mbd1 GACTTCTGCTGCGACAAGC 56ºC 182
GAAGCAGGCCTCTTTTGATG
Mbd2 CTCAGTGCTGGCAAGATGTC 56ºC 186
TCTGATTGAGGGGGTCATTC
Mbd3 GCTGGGAAAGGGAAGAAGTG 56ºC 151
AAGTCGAAGGTGCTGAGGTC 
Mbd4 TGTGGATGGGAAAGAGTTGTG 56ºC 197
GGATTGATGCTCCCTTTCG 
MeCP2 CCGGGGACCTATGTATGATG 56ºC 187
AGGGTCCAAGGAGGTGTCTC 
Mov10L1 TTCCCTCTATGCAGGTGACAA 56ºC 208
AAGTGCATAGTGACACCGTCT
Mvh TTGGTTGATCAGTTCTCGAG 56ºC 224
CCAAAAGTGACATATATACCC 
Oct3/4 CAAATCGGAGACCCTGGTG 56ºC 238
AGCCTCATACTCTTCTCGTTGG 
p57Kip2 CAAGAGAACTGCGCAGGAG 56ºC 92
CCCAGAGTTCTTCCATCGTC 
Nanog AGGGTCTGCTACTGAGATGCTCTG 56ºC 364
CAACCACTGGTTTTTCTGCCACCG 
Nxf2 CTGAACTGTTGTCCTTGAACT 56ºC 657
AAGGAACTGACAAGGAGAAGC 
Pea3 CGGAGGATGAAAGGCGGATAC 56ºC 179
TCTTGGAAGTGACTGAGGTCC
PiwiL2 CATTATGGTCAAGTATCTGTT 56ºC 241
AGAGGTTGGCGAGGAATAAGG 
PiwiL4 ACTCCCAAACTCCGAGTCACA 56ºC 116
GGCCCGTCCACTCATGTTC 
Pramel1 ACTCCCATGACTTCTGTCAAT 56ºC 448
GGGAACTATATCTCCATGCCT
Rbmy AACCGAAGTAACATATACTCA 56ºC 209
ATCTGCTTTCTCCACGACCTC 
Rex1 CACCGACAACATGAATGAACAAAAA 56ºC 893
CAATCTGTCTCCACCTTCAGCATTT 
Rnh2 CCTTAAAGCACTTGTGGTAAA 56ºC 218
CCTTGCAGTCATCTGGTGAAA
Sall1 CACCATGTCACGGAGGAAGCAAGCGAAGC 60ºC 856
TTACAAGGGGTTGGCAGATGTTCGTAAA
Scyup CCAGCTCTCTCTTCCTCCAC 56ºC 214
CAGCTTCTTTGGGACACCTG 
Slpi GGCCTTTTACCTTTCACGGTG 56ºC 148
TACGGCATTGTGGCTTCTCAA
Sox2 TAGAGCTAGACTCCGGGCGATGA 56ºC 296
TTGCCTTAAACAAGACCACGAAA 
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Stella CACCATGGAGGAACCATCAGAGAAAGTC 58ºC 457
CTAATTCTTCCCGATTTTCGCATTCT 
Sycp1 TGAGGGGAAGCTCACGGTT 56ºC 125
CGAACAGTGTGAAGGGCTTTTG 
Stk31 GGAAATGACCTTTCAGATGCTATGCA 56ºC 408
CTGCAGAGATGCCTCTGTT
Taf7l TCCGCTGGGAAGTCGTTGATG 56ºC 620
GTGGTTCCACCCAGTCTTCAT 
Tex11 TATCAGATTCCCTGGAACTGG 56ºC 208
GCACCCTCAAAACAAGCTATG
Tex12 AAGAGAATTGGAGCCTCAGGT 56ºC 489
TATAATGTGCCAAATATTTGACCCTC 
Tex13 TTTTGGCCCACACTAAACTCG 56ºC 108
TGTAGTCTCGCACAACTCTCA 
Tex14 CTCATGCTCTATACTGGAAGCTG 56ºC 185
CGGATTCTACTCCGATTCCTCTT 
Tex15 TTCAAACCTAACAGCAGGAAA 54ºC 411
GACTGTGGAGGTATATTCCTG 
Tex18 GATCATTGCTTCAGGCTACCA 56ºC 453
CTTCACTTAAAAGGAGGCAAA
Tex19 AAAATGGGCCACCCACATCTC 56ºC 184
CCACTGGCCCTTGGACCAGAC 
Tex19  3’ CGTGTCAGTGTTCAGTGTTTG 56ºC 140
ATGACAGTAAGGTCAACTAGTGC 
Tex19.2 TGGCTCATCCCTCCTTTGTC 56ºC 198
CAGCATGTAGCAAATGGCGTC
Tex19.2  3’ CGGAAGGTTAGACTCAGCTTC 55ºC 200
AACTCTGAATCCAGGACTCAC 
Trap1a CGGTGATGGGAATAGGTGCAA 56ºC 111
TGGAGCGCCAGAAAACTTGT 
Table A1.1. RT-PCR primer sequences and cycling conditions. Shown is information for 
all RT-PCR and qRT-PCR primers used within this thesis. Primer sequences are shown 5’ to 
3’ with the forward primer above the reverse primer. Ta refers to the annealling temperature 
used during thermal cycling and product size is the expected size in base pairs (bp) of the 
amplified PCR product.  
miRNA Primer Sequence Ta Product size (bp)
miR 469 CCTCTTTCATTGATCTTGG 54ºC ND
miR 17 TGATTAGTTCAGAATCTGGT 54ºC ND
miR 25 GAGAGAAGTAGCAGTTACT 54ºC ND
miR T4 GTAGCTCACACCTGTAAT 54ºC ND
miR t3 TATGATTTTGAGCTCATGTAA 54ºC ND
snRNA U6 TTCGGCAGCACATATAC 55ºC ND
Table A1.2. RT-PCR primer sequences and cycling conditions for miRNA 
amplification. The forward primer sequence for each miRNA is shown 5’ to 3’. A universal 
reverse primer was used in each reaction (Section 2.4.4). Ta refers to the annealling 
temperature used during thermal cycling and product size is the expected size in base pairs 
(bp) of the amplified PCR product.  
          226
Gene Locus Primer Sequence CpG’s Ta Product Size
Dazl GAGGTAATGATTTGAATAAA 33 50ºC 405
ATAAAAAAAAAACCCACRACCAC 
Dazl Nested AGGTAATGATTTGAATAAAT 15 50ºC 240
AAAAAAACCAAAAAACCCAC 
Dnmt3L GGTTATGAATAGGAAGGATTATT 11 54ºC 627
CAAAAAAATTAAAAAAAAAATATACCC 
Dnmt3L Nested TATTTTTTAAGAGGTTGGTAGGT 52ºC 527
AACTAATTAAAAAAAACCTT 
Piwil2 GTTTGAGAGTAATTTTTATATAG 24 50ºC 547
AAATCTAATACCACTAAACC
Piwil2 Nested AGGTTTATTTTAAGAGGT 16 52ºC 346
TCCTTTCCCTCCTATTCCAA 
Tex13 GATAAATTATTATATTTGGGGGT 15 52ºC 443
AACCTCACCTCTCTAAAAACTA
Tex13 Nested TGGGTTTTAATAAATAGTTG 13 51ºC 293
AAAATAAACAATCCTAAAACC 
Tex19-Prox GGAAGTATATAGGGTATTTA 26 50ºC 526
AAAATATTAAAACTCTAACCCCC 
Tex19-Prox Nested GTTTTTTGTTGTTTTGGGAT 17 52ºC 373
CTATTCACTCTAAACAAACT 
Tex19-Distal GGTTTTGTTTTTTGTTGTTG 20 52ºC 617
CATTTACATATCTCCCATAAAATC 
Tex19-Distal Nested TTATTAAAGAGATAGGGAAGAAG 15 52ºC 273
ATCCCAAAACAACAAAAAAC
Tex19.2 AAATTTTTGTGTGGTTAAGGTTG 14 50ºC 535
CAACAAAACCTTATAAAAAATCAAC 
Tex19.2 Nested TTAAAGAGTTTGAGAATAAAAAG 13 52ºC 356
AACCCCAAAACAACAAAAAAC
Table A1.3. Bisulphite primer sequences and cycling conditions.. Primer sequences are 
shown 5’ to 3’ with the forward primer above the reverse primer.  Where necessary a second 
round of PCR with nested primer sets was used to improve specificity and yield. CpG’s 
refers to the number of CpG dinucleotides present within the PCR product of each primer 
pair. Ta refers to the annealling temperature used during thermal cycling and product size is 
the expected size in base pairs (bp) of the amplified PCR product.  
Target Primer Sequence Ta Product Size (bp)
Tex19-GSP1 TGACTCTGACAAGTATTCC 48ºC N/A
Tex19-GSP2 CTCTTGCCAGTCTCCCATCTC 56ºC 411
Tex19-GSP3 TGGTACAGCCATGCCTCATAG 57ºC 314
Table A1.4. RACE primer sequences and cycling conditions. Primer sequences for the 
foward are shown 5’ to 3’. A specific tagged reverse primer was used to pair each forward 
primer (Section 2.6.7). Ta refers to the annealling temperature used during thermal cycling 
and product size is the expected size in base pairs (bp) of the final PCR product.  




































































Figure A2. Genomic methylation levels in cell lines and in vivo. Upper panel: Genmoic 
DNA from mouse brain, P-MEFs or DP MEFS was digested with MspI (methyl-sensitive) or its 
methyl-sensitive isoschizomer HpaII and also MaeII. Digestion by HpaII or MaeII indicates 
hypomethylation. Lower panel: Southern blotfor mouse minor satellite following genmic DNA 
digestion with the indicated enzyme 
Appendix 2 – Genomic Methylation levels
in P & DP cells 
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Appendix 3 – miRNA Microarray Analysis 




















Upregulated Downregulated No Change
Fig A3. miRNA expression array analysis. The expression of diverse miRNA species
in hypomethylated DP cells as compared to P cells was ascertained by through array
analysis. Expression of >99% of miRNA was unchanged between the samples. Only 4
miRNAs were upregulated (>2-fold) and 4 downregulated (>2-fold). This data indicates
that a globally demethylated environment is not sufficient for robust miRNA de-
regulation.  
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Fig A4. Histone modification profile of Tex19 in ES cells and pMEFs derived from
the Mikkelsen dataset. Data was acquired from the Braod Chip-Seq database
(http://www.broadinstitute.org/science/projects/epigenomics/chip-seq-data) using the
UCSC browser. The Tex19 TSS is shown by the arrow with the modification profile of
H3K4me3 (green), H3K27me3 (red), H3K36me3 (blue) and H3K9me3 (purple) shown
below. No significant enrichment for any histone modification was shown 1.5kb either
side of TSS in non-expressing (pMEF) or expressing (ES) cell types indicating tha
histone modifications are downstream of expression changes at this locus.  
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Fig A5.1. PGC population purity. FACS sorted PGCs and somatic flow-through were fixed 
and stained for endogenous Nanog expression using a monoclonal antibody (red). Nanog 





Fig A5.2. Tex19 methylation in PGCs and somatic cells at E9.5 . Tex19 is hypomethylated 
at E9.5 in PGCs. This confirms that the hypomethylated state of Tex19 at E10.5 (Fig 4.2) is 
not due to prmature genomic reprogramming but due to an early PGC-specific demethylation 
event.
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Publications arising
 
Throughout my PhD I have worked on several projects aside from that presented 
here, particularly on the roles and functions of Dnmt1 and Kaiso during Xenopus 
development. Shown overleaf are the publications that have resulted from these 
studies.  
 
An additional chapter to this thesis entitled “The non-catalytic roles of Dnmt1 in 
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The BTB/POZ transcriptional factor xKaiso is a bimodal DNA-
binding protein that is reported to specifically bind methyl-CpGs, or
a CTGCNA consensus DNA sequence (Ruzov et al., 2004; Park et
al., 2005). Our previous work has established the essential and
global role of xKaiso in regulating the timing of zygotic gene
activation at the mid-blastula transition (MBT) (Ruzov et al., 2004).
Other work proposes a model in which xKaiso specifically binds
CTGCNA sequences present in the promoter region of Siamois (and
also xWnt11) and interacts with the Wnt effector molecule xTcf3 to
promote its stable repression (Kim et al., 2004; Park et al., 2005).
In recent work that is not in keeping with the latter model, we
demonstrated that the CTGCNA motifs derived from the
promoters of Siamois and xWnt11 are not sequence specific
xKaiso-binding sites and these genes are not mis-expressed in
xKaiso morphants (Ruzov et al., 2009). Although our loss-of-
function experiments did not identify a role for xKaiso in
regulating Wnt target genes, two observations suggest a potential
role for it in canonical Wnt signalling: the xKaiso protein can be
co-immunoprecipitated with xTcf3, and over-expression of
xKaiso can suppress axis-duplication that is induced by over-
expression of β-catenin in the ventral regions of a four-cell
embryo (Park et al., 2005). We wished to determine the molecular
basis of the Kaiso/Tcf3 interaction as it has profound implications
for the intersection of two important regulatory pathways in
amphibian development: regulation of transcriptional silencing in
pre-MBT Xenopus embryos and in Wnt signalling pathways
(Heasman, 2006). We find that the interaction surfaces for both
proteins correspond to their previously identified DNA-binding
domains. Our data squarely rules out a model for xKaiso
repression through stabilisation of xTcf3 binding to DNA.
Instead, our analysis suggests that the xKaiso and xTcf3/4
interaction results in their mutual delocalisation from chromatin,
a prediction that we demonstrate at the cellular and the DNA
levels.
MATERIALS AND METHODS
Reporter assays and expression constructs
The xKaiso expression constructs (XKaiso/pCS2+MT and HA-tagged)
(Kim et al., 2004) were provided by Pierre McCrea. The dKaiso expression
construct was from (Ruzov et al., 2004). The Myc-xTcf3, xTcf3dn and β-
catenin expression vectors were provided by Randall Moon. The VP16
fusions with the ZF1-3 region of xKaiso (amino acids 447-635) and the
HMG domain of xTcf3 were from Ruzov et al. (Ruzov et al., 2009). All
reporter assays using SuperTOP/FOP, Tex19 and Siamois luciferase
reporters were performed as described previously (Houston et al., 2002;
Ruzov et al., 2009).
Embryos and microinjections
Embryos were manipulated as described previously (Houston et al., 2002;
Ruzov et al., 2009). At the two-cell stage, the embryos were injected into the
animal half with 200-750 pg of sense capped RNA (c-myc-xKaiso mRNA)
synthesized in vitro (T3/T7 Cap-Scribe kit, Boehringer).
GST pull-down assays, immunoprecipitation and EMSA
The Kaiso GST fusions were from Ruzov et al. (Ruzov et al., 2009). The
TCF4 constructs were provided by Vladimir Korinek. A coupled
transcription/translation kit (Promega) was used for in vitro translation/
labelling with 35S-Met. GST pull-down assays and immunoprecipitations
were performed according to standard protocols in the presence of a 10- to
100-fold excess of recombinant full-length xKaiso or GST where indicated.
Samples were visualized by phosphoimaging. EMSA was performed as
described previously (Ruzov et al., 2009).
Chromatin immunoprecipitation (ChIP) assay
The ChIP assay was performed as described previously (Ruzov et al., 2009)
using myc tagged xTcf3.
Immunostaining
Immunostaining was performed according to standard techniques using
P53–/– (Trp53–/–) mouse embryonic fibroblasts. Cells were analysed 24 hours
after transfection. Mouse monoclonal anti-T7 tag (Novagen), anti-HA-tag
(Sigma), rabbit polyclonal anti-myc (Upstate) and Alexa secondary
antibodies were used.
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Real-time RT-PCR
Quantitative real-time RT-PCR of Siamois was evaluated as described
previously (Houston et al., 2002).
RESULTS AND DISCUSSION
Kaiso directly interacts with the HMG domain of
TCF factors via ZF1-3
The TCF family proteins have a multi-domain organisation with
a central HMG box DNA-binding region recognizing the
sequence A/TA/TCAAA; an N terminus containing the β-catenin-
interacting domain adjacent to a Groucho-binding region; and a
C-terminal CtBP1 interaction domain (Roose et al., 1998). We
demonstrate using recombinant proteins that the DNA-binding,
zinc-finger domain of xKaiso (xZF1-3) is sufficient for direct
interaction with full-length xTcf3 and dominant-negative xTcf3
(xTcf3dn), which lacks the β-catenin-interacting region (Fig.
1A,B). The ability of Kaiso to bind xTcf3 is conserved, as
comparable zinc-finger regions from zebrafish Kaiso (dZF1-3)
and chicken Kaiso (gZF1-3) can also interact with xTcf3 (Fig.
1B). The same pattern of interaction is seen between mouse TCF4
and xZF1-3. Deletion analysis suggests that the interaction occurs
through the HMG domain of TCF4 (Fig. 1C,D). The experiment
was performed in the presence of high concentrations of ethidium
bromide to exclude the possibility that the interaction was
mediated by non-specific binding to DNA. This suggests that the
interaction between Kaiso and TCF3/4 is mutually exclusive of
their binding to DNA, and that inhibition of β-catenin activation
by Kaiso is not through competitive binding of a shared
interaction domain on xTcf3 and TCF4. We tested the first
possibility by performing an EMSA with xTcf3 and its target
DNA binding site (ATCAAA) in the presence of GST-Kaiso
fusions. Binding of xTcf3 to its target sequence was abolished in
the presence of the full-length xKaiso, GST-xZF1-3 and GST-
dZF1-3. GST alone or GST-xZF1-2 had no effect (Fig. 1E).
Increasing the amount of xTcf3 overcomes the inhibitory effect of
GST-xZF1-3. Moreover, the interaction between xTcf3 and β-
catenin in vitro is not compromised by xZF1-3 (Fig. 2A). We also
examined the cellular location of myc-tagged xTcf3 in the absence
and presence of Kaiso. xTcf3 localisation in mouse cells is
nuclear, with about 40% of cells with a homogenous, as opposed
to a speckled, pattern (60%) (Fig. 2B); the latter is reminiscent of
the discrete foci observed for endogenous mouse TCF4 (Valenta
et al., 2006). xKaiso in mouse fibroblasts exhibits homogenous
nuclear staining (Fig. 2C). In the presence of either xKaiso or
dKaiso, the pattern of xTcf3 staining was uniformly homogenous,
suggesting they alter its nuclear sublocalisation (Fig. 2D).
RESEARCH REPORT Development 136 (5)
Fig. 1. Kaiso ZF1-3 interacts directly with the
HMG domain of TCF factors. (A) Kaiso deletion
constructs used in pull-down experiments. (B) GST
pull-down using in vitro transcribed xTcf3 or xTcf3dn
with Kaiso recombinant proteins indicated in A. GST
was used as a control. (C) TCF4 constructs used for in
vitro transcription in D. β-cat, β-catenin interaction
domain; TLE, TLE/Groucho binding domain; CtBP,
CtBP-binding sites; HMG, DNA-binding domain.
(D) GST pull-down using TCF4 constructs and xKaiso
GST-ZF domain (KaisoZFs). GST was used as a control;
1/10 of inputs (xTcf3 and xTcf3dn) are shown.
(E) EMSA assay using in vitro translated xTcf3 and its
DNA-binding site (TCF bs-oligo) in the absence and
presence of GST fusions with ZF1-3 of xKaiso, full-
length xKaiso or ZF1-3 of dKaiso. xZF2-3 and
BTB/POZ fusions, which do not interact with xTCF3
were used as controls. Note absence of the
xTcf3/DNA complex (arrow) in the presence of the
Kaiso fusions. Increasing the xTcf3 concentration in
the presence of xZF1-3 restores the binding of xTcf3
to DNA, supporting the hypothesis that sequestration
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xKaiso displaces xTcf3 from its target promoters
The interaction data suggests that overexpression of xKaiso can
displace xTcf3 from its genomic binding sites. Using the chromatin
immunoprecipitation (ChIP) technique we could localise myc-xTcf3
to the Siamois promoter in A6 cells (Fig. 3A). However, myc-xTcf3
was delocalised in the presence of either Ha-xKaiso or T7tag-dKaiso
(Fig. 3A). In contrast to the model of Park et al. (Park et al., 2005),
this suggests that Kaiso can disengage xTcf3 from its target genes
and alter their expression state. Under the same conditions, we could
not localize dKaiso or xKaiso alone to the Siamois promoter; this is
not surprising in view of the absence of high-affinity CTGCNA or
methyl-CpG binding sites in it (Ruzov et al., 2009).
The SuperTopflash Wnt reporter plasmid contains the luciferase
gene under the control of multiple TCF3/4-binding sites, which is
activated by the addition of exogenous β-catenin and endogenous
TCF3/4 in HeLa cells (Veeman et al., 2003) (Fig. 3B). This
725RESEARCH REPORTKaiso interaction with TCF3
Fig. 2. Kaiso does not affect β-catenin interaction with xTcf3 but
can alter the nuclear localisation of TCF3 in mouse fibroblasts.
(A) In vitro translated 35S-methione labelled β-catenin and HA-tagged
xTcf3 were incubated in the presence of an excess of xKaiso full-length
(xKaisoFL) protein or GST. xTcf3 was immunoprecipitated with an anti-
HA antibody. β-Catenin and xTcf3 proteins are indicated by arrows.
1/10 of inputs are shown. The interaction between β-catenin and xTcf3
is not impaired in the presence of GST-xKaiso or GST. (B,C) Localisation
of myc-xTcf3 upon transient transfection into mouse MEFs in the
absence and presence of Ha-xKaiso and T7tagged-dKaiso. (B) By itself,
myc-xTcf3 either exhibits staining at nuclear foci (60% of cells) or
homogenous nuclear staining (40%). (C) xKaiso by itself exhibits
homogenous nuclear staining in 100% of cells. (D) In the presence of
xKaiso or dKaiso the myc-xTcf3 protein exhibits only homogenous
nuclear staining (100% of cells with double staining).
Fig. 3. Kaiso prevents xTcf3 localising to its target promoter and
its subsequent activation or repression functions. (A) ChIP assay
showing that, after transient transfection into A6 cells, myc-xTcf3 can
be located at the Siamois promoter. Co-expression of xKaiso or dKaiso
prevents xTcf3 binding at the promoter. Inputs are shown on the right
and the myc-Tcf3 ChIP on the left with a non-specific antibody (Ig)
control. (B) Overexpression of both dKaiso and xKaiso represses β-
catenin-dependent transcription activity in transient transfection assays
in HeLa cells. SuperTopflash (SuperTop) was used as a Wnt reporter and
SuperFopflash (SuperFop) with mutated TCF3 sites as a control.
(C) Expression from a methylated luciferase reporter can be enhanced
by co-transfection with an xKaisoZFVP16 (KaisoZFVP16) expression
plasmid. Targeting to the methylated reporter is provided by the Kaiso-
ZFs and transcription activation function by VP16. Increasing amounts
of xTcf3HMGVP16 (Tcf3VP16) reduce the activation potential of
xKaisoZFVP16. In a reciprocal experiment, activation a Siamois luciferase
reporter by xTcf3HMGVP16 is inhibited by the presence of
xKaisoZFVP16. (D,E) Overexpression of myc-xKaiso in Xenopus embryos
results in the formation of exogastrulae compared with controls at
stage 12. Graph shows that by stage 12, over 80% of the embryos
(n=55) exhibit exogastrulae. (F) Real-time RT-PCR analysis of Siamois
expression in stage 10 control and embryos injected with myc-xKaiso
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activation was inhibited between four- to sevenfold by co-
expression of either xKaiso or dKaiso (Fig. 3B). The
transcriptional activity of a control reporter with mutated TCF3-
binding sites is unresponsive to β-catenin induction and unaffected
by the presence of either Kaiso (Fig. 3B). An obvious explanation
of these results is that the Kaiso interaction with the HMG domain
of endogenous TCF3/4 blocks its ability to bind DNA and inhibits
β-catenin-dependent activation of transcription (Fig. 3B).
Conversely, overexpression of xTcf3 interferes with transcriptional
activation of a methylated reporter template by an xKaisoZFVP16
fusion (Fig. 3C) in a dose-dependent manner suggesting the
Kaiso/TCF3 interaction results in a mutual disengagement of these
factors from chromatin-binding sites. This model can account for
the inhibition of dorsal axis formation when Kaiso mRNA is co-
injected with β-catenin mRNA (Park et al., 2005) as excess xKaiso
will displace the xTcf3/β-catenin complex and inhibit axis
duplication. Similarly, xKaisoZFVP16 directly inhibits
xTcf3HMGVP16 activation of a Siamois reporter in a dose-
dependent manner (Fig. 3C).
Loss-of-function studies in Xenopus suggest the primary role of
xTcf3 is as a repressor of organiser genes, such as Siamois,
throughout the early embryo (Houston et al., 2002). This repression
is inactivated on the dorsal side by a maternally encoded Wnt
signalling pathway. Based on the above results, we predicted that
overexpression of xKaiso in developing Xenopus embryos would
mimic certain aspects of xTcf3 depletion such as ectopic Siamois
expression (Houston et al., 2002). To test this, we injected xKaiso
mRNA into two-cell embryos and allowed them to develop until
gastrulation (stage 10.5-11) (Fig. 3D). In comparison with controls,
this results in an exogastrulae phenotype that is distinct from the
developmental delay phenotype observed in xKMO morphants, but
is similar to the phenotype of embryos that are maternally depleted
of xTcf3 (Fig. 3D,E) (Houston et al., 2002; Ruzov et al., 2009). The
normalised (relative to histone H4 or GAPDH levels) expression
levels of Siamois are increased in the xKaiso mRNA-injected
embryos (Fig. 3F). This observation suggests that high levels of
xKaiso can interfere with xTcf3 function, resulting in a relative relief
of xTcf3/Groucho-mediated repression of Siamois in gastrulating
embryos.
These new results call for a revision of the model connecting the
xKaiso repressor function and the xTCF3 repression/activation of
Wnt-target genes (Kim et al., 2004; Park et al., 2005). The mode of
interaction between xKaiso and xTCF3 mutually prevents binding
to their cognate DNA sites, which can potentially inhibit the two
pathways in which these transcription factors are major participants
(Heasman, 2006). However, the recent observation that neither
xWnt11 or Siamois expression is altered in xKMO morphants
suggests that there is no intersection between these pathways during
gastrulation (Ruzov et al., 2009).
Is this model operative in other biological
contexts?
The role of Kaiso expressed in adult somatic tissues is not clear
as there is no obvious mis-expression of normally silent genes in
Kaiso-null mice (Prokhortchouk et al., 2006). In cancer cells,
gene expression patterns are highly disturbed and this is mirrored
by alterations in the level and genomic distribution of DNA
methylation, as well as histone modifications (Ohm et al., 2007).
Interestingly, Kaiso levels are increased in colon cancer cells and
enhance polyp formation in Min mice (ApcMin/+) (Prokhortchouk
et al., 2006). This is juxtaposed by positional differences in TCF
variant expression in colon cancer (Clevers, 2006). In this case,
there is a possible intersection of Kaiso with Wnt signalling
pathways, where overexpression of Kaiso could attenuate
constitutive Wnt signalling, while at the same time promote
cancer progression through silencing of de novo methylated
tumour suppressor genes. By the same token, there is a potential
for TCF3/4 to displace Kaiso from its cancer target genes and
promote their re-expression, which may be coincident with
alterations in the tumour environment, such as the transition to
metastases phenotype (Fig. 4E). There are two related Kaiso-like
proteins, Zbtb4 and Zbtb38, that may also mediate an intersection
between epigenetic and cellular signalling pathways in cancer via
protein-protein interactions (Filion et al., 2006; Weber et al.,
2008). Zbt4 has been shown to inhibit MIZ1 regulation of
p21CIP1 expression possibly by displacing this transcription
factor from the p21CIP1 promoter (Weber et al., 2008). This
suggests that the distributions of these Kaiso-like proteins and
their relative abundance within nuclear sub-compartments has the
potential to determine their transcriptional output of many
signalling pathways.
RESEARCH REPORT Development 136 (5)
Fig. 4. Models for mutual interference of DNA-binding functions
by Kaiso and TCF3. (A) A schematic representation of β-catenin-
dependent activation of TCF3 target genes. β-Catenin displaces the
Groucho/CtBP complex from TCF3 leading to gene activation. (B) A
model for Kaiso-mediated repression of Wnt target genes that was
suggested by Park et al. (Park et al., 2005). Here, it was proposed that
repression of the Siamois gene occurs by xKaiso binding to CTGCNA
sequences in its promoter and the possible interaction pf Kaiso with
xTcf3. Our results suggest this model is not operative (Ruzov et al.,
2009). (C,D) Our model of non-DNA-dependent xKaiso displacement of
xTcf3 from target genes proposes that Kaiso overexpression may result
in either a block of repression by xTcf3/Groucho or a block of β-
catenin/xTcf3-dependent activation. (E,F) TCF3 can potentially displace
Kaiso from its methylated (filed circles) DNA-binding sites and interfere
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Reduction in xKaiso protein levels by morpholino (xKMO)
injection into Xenopus laevis embryos results in developmental
delay during gastrulation relative to control morpholino (CMO)-
injected embryos (Kim et al., 2004; Ruzov et al., 2004). xKMO
morphants subsequently die during neurulation with all the
hallmarks of apoptosis (Ruzov et al., 2004). Differing interpretations
exist as to the molecular basis of the mutant phenotype. Our work
suggests that xKaiso regulates general gene silencing before the
mid-blastula transition (MBT) through its ability to bind methylated
DNA via its zinc-finger domains (ZF1-3) (Ruzov et al., 2004). In this
respect, it is notable that the ectopic gene expression profile in pre-
MBT xKMO embryos corresponds to a subset of genes that are
prematurely activated when levels of the maintenance
methyltransferase, xDnmt1, are decreased (Ruzov et al., 2004). A
different study (using the same xKaiso morpholino) was restricted
to the analysis of potential gastrulation defects (stages 10-12), in
which the same gastrula phenotype, corresponding to developmental
delay and an open blastopore, was observed (Kim et al., 2004). Here
it was suggested that xKaiso could also directly repress canonical
and non-canonical Wnt gene targets (Siamois, Fos, Cyclin-D1, Myc
and xWnt11) based on its ability to bind non-methylated CTGCNA
sites that are present in target promoters (Kim et al., 2004; Park et
al., 2005). These distinct reports suggested that xKaiso has bimodal
gene regulatory roles during animal development; as a participant in
an embryonic general transcription repression pathway and as a
regulator of canonical and non-canonical Wnt-signalling pathways
during gastrulation. These data also raise questions as to the
underlying molecular pathology of the observed phenotypes. Do
they result from Kaiso’s role as a component of the xDnmt1/DNA
methylation repression pathway in pre-MBT embryos and
subsequent activation of apoptosis, or are the phenotypes due to its
ability to specifically regulate the expression of genes such as
Siamois and xWnt11 via defined non-methylated DNA binding
sequences? One way to discriminate between these potentially
differing roles in X. laevis development is to try to rescue the mutant
phenotype with a Kaiso variant that can only bind methylated DNA
and not CTGCNA-binding sites.
The original DNA-binding site selection experiments with mouse
Kaiso under low stringency conditions identified a non-methylated
DNA-binding motif, Hmat, with a conserved 6 bp core sequence
CTGCNA that was first identified in the promoter of the human
matrilysin gene (Daniel et al., 2002). Previously we had noted that
xKaiso was not as robust as its mammalian counterparts in binding
Hmat (Ruzov et al., 2004). We therefore undertook a
characterisation of the DNA-binding properties of Kaiso in three
species (zebrafish, frog and chicken) to determine if their methylated
and non-methylated DNA-binding functions are conserved. In this
study we demonstrate that the ZF1-ZF2 region of all three Kaiso
homologues is sufficient for binding methylated DNA but that the
ability to bind Hmat is not conserved. Zebrafish Kaiso is unable to
bind Hmat or CTGCNA sequences present in the Siamois and
xWnt11 promoters. Despite its reduced DNA-binding repertoire
(compared with frog and human Kaiso), co-injection of dKaiso
mRNA rescues developmental defects associated with xKMO
morphants. This observation suggests that the reported CTGCNA-
binding function of xKaiso does not have a key role during early
Xenopus laevis development. In agreement with this observation,
we did not observe ectopic activation of Siamois or xWnt11
expression in xKMO morphants. A global analysis of Kaiso
occupancy in chromatin derived from human 293 cells also did not
find any evidence for enrichment of CTGCNA-containing
sequences. We propose that the main role of Kaiso in early X. laevis
development is more restricted than previously suggested and
intimately linked with the maintenance of transcriptional silencing
before the onset of zygotic transcription at the MBT (Park et al.,
2005; Ruzov et al., 2004).
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MATERIALS AND METHODS
Plasmids, recombinant proteins and reporter assays
The coding regions of Danio rerio and Gallus gallus Kaiso were
amplified from genomic DNAs and cloned into pGEM-T-easy vector
(Promega). A Kozak sequence and stop codon were introduced to the
dKaiso plasmid used for in vitro transcription in rescue experiments.
xKaiso ZF123 (GST-xZF, aa 470-609) was described previously (Ruzov
et al., 2004). The same region was cloned into a modified pet25A-6xHis-
tag expression vector (Allen et al., 2006). The xBTB/POZ region (aa 2-
120) of xKaiso was cloned into pGEX-4T1. dKaisoZF123 (aa 371-550)
and gKaisoZF123 (aa 419-611) were cloned into both pGEX-6P-1 and
pet25A-6xHis-tag. Full-length xKaiso was cloned into pGEX-6P-2.
xKaisoZF12 (aa 470-558) and xKaisoZF23 (aa 523-608) were cloned into
pGEX-6P-1 and pGEX-6P-3, respectively. gKaisoZF12 (aa 419-558) and
gKaisoZF23 (aa 524-611) were cloned into the pGEX-6P1 vector. GST-
fusion proteins were expressed in Rosetta-gami cells (Novagen) and
purified on GST Sepharose. 6xHis-tag fusions were expressed in BL21-
Codon Plus (DE3)-RIPL (Stratagene) and affinity purified on Ni-NTA
Superflow (Qiagen) according to the manufacturer’s instructions. The
mKaiso construct was made by cloning the full-length mKaiso cDNA into
the EcoRI site of the LZRS vector. The HA-tagged dKaiso construct was
made by cloning into the C-terminal polylinker of CMV2-FLAG together
with an HA epitope. The T7-tagged dKaiso and xKaiso expression
constructs were made in pCGT7 by cloning into XbaI-BamHI sites
(Cazalla et al., 2005). These were expressed in 293T cells and T7-tagged
proteins affinity purified (Cazalla et al., 2005). To obtain VP16 fusions
zinc-finger domains of xKaiso (aa 447-635) and the HMG domain of
xTcf3 were cloned into the EcoRI and XbaI sites downstream of the VP16
activation domain in pVP16 (Clontech). The –304 to +198 bp region of
the mouse Tex19 promoter was cloned into the MluI and BglII sites of
pGL3-basic (Promega) using primers with restriction site overhangs.
S01234 and S constructs were previously described (Brannon et al.,
1997). The constructs were in vitro methylated according to standard
techniques. Luciferase reporters were transfected (Lipofectamine 2000)
into 293T cells and analysed according to Dunican et al. (Dunican et al.,
2008).
Electrophoretic mobility shift assay (EMSA) experiments
Binding reactions were as described, using 5% PAGE in 0.5  TBE to
resolve DNA-protein complexes with S (non-methylated), Sm (methylated-
Sm) probes (Prokhortchouk et al., 2001), the human matrilysin (Hmat) oligo
(Daniel and Reynolds, 1999), wild-type KCS-Siamois oligo (Park et al.,
2005), wild-type Xenopus Wnt11 oligo (Kim et al., 2004) and TCFbs oligo
derived from Xenopus Siamois promoter: F catcagaatcATCAAAGgacctccc,
R gggaggtccTTTGATgattctgatg. Purified GST proteins, 6xHis-tag proteins,
T7-tagged proteins, Escherichia coli extracts containing GST-fusion
proteins or in vitro translated myc-xTcf3 were used in EMSAs. After gel
scanning on an FLA2000, signal quantification was performed using AIDA
software.
Embryos and microinjections
Xenopus embryos were obtained from in vitro fertilised eggs. They were
grown, staged and microinjected according to standard procedures
(Stancheva and Meehan, 2000). At the two-cell stage, the embryos were
injected into the animal half with 10-40 ng/cell of the xKMO or control
morpholino (Gene-Tools), and/or 200-750 pg of sense capped RNA (dKaiso
or myc-xKaiso mRNA) synthesized in vitro (T3/T7 Cap-Scribe kit,
Boehringer) (Ruzov et al., 2004). Zebrafish Wik embryos, obtained from in
house breeding, were maintained at 28°C as described previously (Detrich
et al., 1999). Between 5 and 15 ng/embryo of dKaiso morpholino
(ATATCAGCTTCAGTTTCGACATGCC) was injected according to
Nasevicius and Ekker (Nasevicius and Ekker, 2000). A second MO,
TGCAGAGCGACCCGTACAAATCCAC, was also used and gave similar
phenotypes. For the rescue experiment equal volumes of dKMO and dKMO
plus xKaiso mRNA (1 ng/nl) were injected. The phenotypes of surviving
embryos (48) were scored after 24 hours. In experiments on apoptosis
inhibition embryos were placed in 0.1XMMR containing 20 μM caspase-3
inhibitor Z-DEVD-FMK (R&D Systems) immediately after microinjection.
xp53 morpholino was described in Cordenonsi et al. (Cordenonsi et al.,
2003). All in situ hybridisations were performed according to published
procedures (Hauptmann and Gerster, 1994). xWnt11 full-length cDNA was
cloned into pGEMT-easy and used as a probe. xID2 probe was provided by
Richard Harland (Liu and Harland, 2003).
Semi-quantitative and real-time RT-PCR
Semi-quantitative RT-PCR was performed as reported before (Ruzov et al.,
2004) using published primers for xWnt11 (Kim et al., 2004), Siamois (Park
et al., 2005) and H4 (Ruzov et al., 2004). Quantitative real-time RT-PCR of
xWnt11, Siamois, Caspase7 and Caspase9 was evaluated as follows
(Houston et al., 2002). Primer sequences for Caspase7 and Caspase9 are
available upon request. Total RNA was extracted with TriReagent (Sigma).
Samples were reverse transcribed using random primers (Promega) and
Superscript II RT (Invitrogen). Products were detected using SYBR Green
PCR Mastermix (Applied Biosystems) and a PTC-200 cycler with a
Chromo-4 detection system (MJ Research). Data were normalised relative
to both GAPDH and H4 RNA, with comparable results. Error is expressed
as s.e.m.
Chromatin immunoprecipitation (ChIP) assay and bisulfite
sequencing
The chromatin immunoprecipitation (ChIP) assay was performed in an A6
Xenopus cell line according to (Dunican et al., 2008) using HA-tagged
xKaiso or T7 tagged dKaiso with published ChIP primers for the Siamois
promoter region (Park et al., 2005) or the Oct91 distal promoter region
(Dunican et al., 2008). Bisulfite sequencing was performed according to
standard procedures (Dunican et al., 2008).
HEK cells were used for genome-wide ChIP. Anti-HA tag polyclonal
antibody (Bethyl Laboratories), ZFH6 rabbit polyclonal mKaiso antibody
(Prokhortchouk et al., 2001), IgG or anti-T7 tag antibody (Novagene) were
used. The transfection levels were checked by western blot hybridisation.
ChIP DNA was amplified using anWGA4 kit (Sigma) and sequenced using
the Genome Sequencer FLX System (Roche).
Genome-wide ChIP/sequencing data analysis
The ChIP DNA sequences were analysed using Perl, Blast and GS FLX
Mapper software.
Initially PCR primer sequences were excluded from the analysis.
Sequences obtained in the same experiment that were 97% or more
homologous to each other and had the same 5 end (with not more than 5 bp
difference) were regarded as the same sequence that had become amplified
during whole-genome amplification (WGA) PCR. All the remaining
sequences were mapped on to the human genome (version 36.1) with a
homology threshold of at least 95% throughout the whole length of the
sequence. Only the unique genomic sequences were selected for further
analysis. For all selected sequences the central positions were used as
reference points for mapping onto the genome. If less than three such central
positions were mapped onto a 1 kb segment of the genome the
corresponding sequences were excluded from further analysis. In the case
where central sequences positions from four different experiments (using
different antibodies) were scored onto the same 1 kb region of the genome,
the corresponding sequences were also excluded from the analysis. After
this filtration protocol, the numbers of sequences for mKaiso ChIP with
ZFH6 antibody, mKaiso ChIP with preimmune serum, dKaiso-HA ChIP
with HA antibody and mock transfection with HA antibody experiments
were 27,000, 72,000, 55,000 and 28,000, respectively. The 1 kb genomic
regions anchored by the central sequences after filtration were analysed for
the presence of CpG-rich regions or CTGCNA sites. Raw genome-wide
ChIP/sequencing data are available upon request to Egor Prokhortchouk
(Prokhortchouk@biengi.ac.ru).
CpG island array design
To design the CpG island array, CpG islands were selected from the human
genome sequence (version 36.1) according to the following parameters:
CpG island length >250 bp, expected/observed ratio >0.6, percentage of
CpGs >50. There were 46,957 CpG islands chosen in total. These CpG
islands were used by NimbleGene for the synthesis of 36,7802 isotermic
oligonucleotides (38-70 bp each).











          282
Genome-wide methylation status analysis
The MBD domain of human MBD2 was cloned into EcoRI, SalI sites of
pGEX 4T-1 vector to make MBD2 GST fusion construct. To prepare
MBD2B-GST sepharose the MBD2B-GST fusion was purified on
glutathione sepharose 4b (Amersham Biosciences, Piscataway, NJ)
without elution. Fifty microlitres of sepharose saturated with GST-tagged
MBD2B were incubated with 200 μl binding buffer (25 mM Hepes KOH,
pH 7.5, 300 mM KCl, 12.5 mM MgCl2, 10% glycerol, 1 mM DTT). ChIP
HEK293 genomic DNA, 500 ng fragmented with an average size of 200-
300 bp and ligated with adaptors (5-GCGGTGACCCGGGAGATC -
TGAATTC-3 and 5-GAATTCAGATC-3), was used for binding with
MBD2-GST-sepharose using a procedure adapted from Rauch and Pfeifer
(Rauch and Pfeifer, 2005). Fifty nanograms of DNA was used as an input
control. Briefly, DNA was incubated with MBD2 resin for 2 hours,
washed three times with washing buffer (25 mM Hepes KOH, pH 7.5,
600 mM KCl, 12.5 mM MgCl2, 10% glycerol, 1 mM DTT), eluted with
elution buffer (25 mM Hepes KOH, pH 7.5, 1.5 M KCl, 12.5 mM MgCl2,
10% glycerol, 1 mM DTT), purified using Qiaquick PCR purification kits
(Qiagen, Valencia, CA), amplified and Cy3(Cy5) labelled. Equal amounts
of MBD2B-GST bound and input labelled DNA were hybridised with our
NimbleGene CpG island array for 40 hours according to the
manufacturer’s instructions. After hybridization, the array was processed
with NimbleGene buffers and washes. The arrays were scanned on a
GenePix scanner to measure Cy3 and Cy5 intensity. To identify signal
peaks SignalMap software (NimbleGene) was used with a threshold 2.
The CpG rich sequences obtained in the genome-wide ChIP/sequencing
experiment were analysed for their correspondence (overlap) with the
methylated CpG islands using a ChIP sequence/CpG island distance
thresholds from 500 to 2000 bp.
RESULTS
The methyl-CpG-binding function of Kaiso is
conserved
We identified full-length zebrafish (Danio rerio), Fugu rubripes and
chicken (Gallus gallus) Kaiso homologues by database screening
with human and Xenopus Kaiso sequences. In each case, the
structural organisation was similar, with an N-terminal BTB/POZ
domain and a C-terminal region containing three zinc fingers
(ZF1-3). Alignment of these Kaiso protein sequences with their
mammalian counterparts showed that BTB/POZ domains are very
similar (53% identity, 82% similarity), as are ZF1 (85% identity,
90% similarity) and ZF2 (72% identity, 90% similarity). The ZF3
regions are much more variable, exhibiting 38% identity and 61%
similarity overall (Fig. 1A). By contrast, the intervening region
between the BTB and ZF domains exhibits low levels of overall
similarity. Phylogenetic analysis reflected the evolutionary
relationship between vertebrate species and suggested that fish
Kaiso proteins form a group that is most distantly related from their
tetrapod counterparts (see Fig. S1A,B in the supplementary
material).
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Fig. 1. The methyl-CpG binding activity of Kaiso is
confined to ZF1 and 2. (A) Alignment of the zinc-
finger domains of Gallus, Xenopus, mouse and Danio
Kaiso proteins. The regions required for Hmat-
dependent binding (solid line) and methyl-CpG-
specific binding (dotted line) according to our results
are compared with the previously published DNA-
binding motif (dashed line) (Daniel et al., 2002).
(B) SDS-PAGE showing the indicated purified 6xHis-tag
ZF1-3 fusion proteins (arrow) used in the EMSAs. Size
markers are on the left. (C) EMSA experiment with the
indicated purified ZF1-3 proteins of xKaiso, dKaiso and
gKaiso with methylated Sm, non-methylated S or
human matrilysin (Hmat) probes in the presence of
2μg pdIC competitor. Arrow indicates the Kaiso ZF-
specific band shift. (D) EMSA using GST-ZF12 (xKZF12,
gKZF12) and GST-ZF23 (xKZF23, gKZF23) deletion
constructs from xKaiso and gKaiso, respectively, with
Sm and Hmat oligos. xKaiso and gKaiso ZF domains
(KZF123) were used with Sm probe as positive
controls. (E) EMSA using eukaryotically expressed and
affinity-purified full-length Xenopus (xKaisoFL) and
Danio (dKaisoFL) Kaiso proteins with Sm (1), S (2),
Hmat (3) and CTGCNA-containing probes from the
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The sequence variability in ZF3 is intriguing, as the ZF2-3
modules were reported to be necessary and sufficient for DNA
binding (Daniel et al., 2002). We therefore determined the DNA-
binding specificity of recombinant Kaiso-ZF1-3 modules in band
shift assays. All the Kaiso proteins tested (Xenopus, zebrafish and
chicken) were able to specifically bind the Sm oligo (3 MeCpGs)
but not the S oligo, its non-methylated counterpart (Fig. 1C). By
contrast, gKaiso had a similar affinity for the non-methylated Hmat
sequence as for Sm, whereas xKaiso had a lower affinity for the
Hmat oligo. Remarkably, dKaiso had no detectable binding to Hmat.
This is probably due to sequence differences in ZF3. The same
results were obtained using GST-ZF1-3 fusions (see Fig. S2A in the
supplementary material). For a summary of the binding results see
Fig. S2B in the supplementary material. It is notable that ZF3 in
Kaiso proteins that can bind Hmat contains a core SHIR/KS
sequence. This is replaced by THCKQ or THCKS in zebrafish and
fugu, respectively (Fig. 1A), which may account for the lack of
Hmat binding by dKaiso.
ZF1-2 is sufficient for binding to methylated DNA
Our comparative analysis demonstrates that the methyl-CpG-
binding function is highly conserved in the three species tested,
despite obvious sequence differences in ZF3. We investigated the
ZF requirement for DNA binding using recombinant GST fusion
proteins. We found that ZF1-2 from Xenopus and chicken is
sufficient for binding to the Sm oligo (Fig. 1D). By contrast, an
intact Xenopus and chicken ZF1-3 module is required to bind Hmat
(Fig. 1C,D). This suggests that there is a correlation between the
evolutionary conservation of ZF1-2 and the ability to bind methyl-
CpGs. Full-length Xenopus and Danio Kaiso expressed and purified
from 293 cells had the same DNA-binding specificity as their ZF1-
3 counterparts (Fig. 1E); xKaiso could bind Sm (lane 1) but had a
reduced affinity for Hmat (lane 3), whereas dKaiso could bind only
Sm (lane 6). Our observations contrast with published work
suggesting that ZF2-3 in mKaiso is sufficient for Hmat and Me-Sm
binding (Daniel et al., 2002). The mKaiso analysis was based on
EMSAs done under reduced stringency conditions with low
amounts of competitor DNA and high amounts of fusion protein
(Daniel et al., 2002). This may account for our differing conclusions;
in our experiments, such EMSA conditions led to non-specific DNA
binding (see Fig. 3E).
dKaiso is a methylation-specific repressor and is
essential for zebrafish development
Apart from expression in X. laevis being limited to the animal pole,
Kaiso mRNAs do not exhibit any regionally restricted expression
pattern that would suggest Kaiso has a specific role in dorsoanterior
specification (see Fig. S3A-C in the supplementary material). Given
the unique DNA-binding properties of dKaiso, we tested whether it
can repress transcription in a methyl-CpG dependent manner. We
used a murine Kaiso/Mecp2/Mbd2–/– recipient cell line, which is
defective in its ability to inhibit expression from methylated reporter
plasmids (Filion et al., 2006). In these cells the methylated reporter
plasmid was de-repressed to approximately 23% of a control non-
methylated plasmid. Co-transfection of Xenopus, zebrafish or
human Kaiso (hKaiso) expression plasmids resulted in enhanced
repression of the methylated reporter, but not from the non-
methylated control (Fig. 2A). Thus, dKaiso is a methyl-CpG
repressor protein like its amphibian and mammalian counterparts.
Since dKaiso cannot bind the non-methylated Hmat sequence, we
determined whether it was essential for early zebrafish development
using used a fluorescein-labelled morpholino (dKMO), which has
the same specificity of action as its unlabelled counterpart. Embryos
microinjected with dKMO at the 1- to 4-cell stage (Nasevicius and
Ekker, 2000) were scored for survival and morphology after 24 and
48 hours of development (Fig. 2B,C). The dKMO morphants had
significantly higher rates of embryo mortality at 48 hours: 89%
compared with 17% for a non-inhibitory control morpholino,
including any associated microinjection damage. Surviving dKMO
morphants exhibited gross phenotypic defects, including
microcephaly, that were coincident with the presence and dose of the
morpholino. All the surviving control embryos (83%) went on to
develop normally compared with only 2.5% of the dKMO
morphants. Most of the remaining dKMO survivors at 48 hours
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Fig. 2. Danio rerio Kaiso is a methyl-CpG-dependent repressor
that is necessary for zebrafish development. (A) Methyl-CpG-
dependent repression by dKaiso in a transient transfection assay. Kaiso
expression constructs were co-transfected with a methylated SV40-
luciferase reporter into mouse cells that are compromised in methyl-
CpG-dependent transcriptional repression (Kaiso/Mecp2/Mbd2–/–). The
methylated SV40-luciferase reporter is repressed in the presence of
dKaiso. The relative percentage (methylated reporter
expression/nonmethylated reporter expression) is the average of at least
three experiments. Human Kaiso (hKaiso) and xKaiso expression
constructs were used as positive controls for methyl-CpG-dependent
transcriptional repression. (B) The phenoptypes of KMO-injected
zebrafish embryos compared to control embryos 24 hours after
fertilisation. Lower panel is an FITC image of the upper panel and
shows that the severity of phenotypical defects correlates with the
amount of injected fluorescein-labelled morpholino. (C) The
percentages of normal embryos, embryos dead at 24 hours of
development and embryos with strong (non-viable) and medium
developmental abnormalities at 48 hours after fertilisation are shown
for non-injected (n=259), standard control MO (Std Ctrl MO, n=62) and
dKMO (n=182) embryos. (D) The microcephaly phenotype of dKMO
morphants at 24 hours post-fertilisation (left panel) can be rescued by
xKaiso mRNA (middle panel). A control (CMO-injected) embryo (right
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(8.5%) exhibited developmental delay, axial defects and incomplete
head formation. Although 2.5% were normal in appearance, these
embryos displayed abnormal neural responses compared with
controls (not shown) and represented a low-dose phenotype. These
features are similar to the phenotypes associated with xKaiso or
xDnmt1 depletion in Xenopus embryos and dDnmt1 depletion in
zebrafish (Rai et al., 2006; Ruzov et al., 2004; Stancheva and
Meehan, 2000). The range of dose-dependent phenotypes could be
ameliorated by co-injection of xKaiso mRNA (Fig. 2D; see Fig.
S4A,B in the supplementary material) and we observed similar
phenotypes with a second non-overlapping dKaiso morpholino (not
shown). We conclude that dKaiso is essential for zebrafish
development.
Neither dKaiso or xKaiso can bind to CTGCNA
sequences in the Siamois or xWnt11 promoters
Although it was unable to bind Hmat, it was possible that dKaiso
could bind the CTGCNA-containing sequences associated with the
Siamois and xWnt11 promoters (Park et al., 2005), and this feature
underlies its essential function in zebrafish development. However,
we could only detect binding by ZF1-3 (Xenopus, zebrafish and
chicken) recombinant proteins to the Sm sequence and not the
Siamois- and xWnt11-derived sequences (Fig. 3A,B; see Fig. S2C,D
in the supplementary material), irrespective of using poly dI-dC or
E. coli DNA as a non-specific competitor (data not shown). No
binding to the promoter CTGCNA sequences was observed even
with either a full-length GST-xKaiso fusion (see Fig. S2D in the
supplementary material) or T7-tagged xKaiso or dKaiso (Fig. 1E).
In competition experiments, unlabelled Sm oligo could efficiently
compete with binding to itself, whereas Hmat was less efficient as a
competitor of Sm binding to xZF1-3 (Fig. 3C,D). The competition
experiments suggest that Hmat is 10-fold less efficient in binding
xKaiso compared with Sm, whereas a 200-fold excess of either the
Siamois- or xWnt11-derived sequences did not interfere with Sm
binding (Fig. 3D). The specificity of the Kaiso/DNA complex is
demonstrated by a supershift with an anti-His tag antibody (Fig. 3C).
As a further test of stringency, we used a fixed amount of purified
xZF1-3 protein in the presence of decreasing amounts of competitor
DNA (2-10 ng) with labelled Hmat, Siamois, xWnt11 probes or a
control duplex oligo with xTcf3- (non-CTGCNA) binding site. As
expected, lowering the amount of competitor DNA led to increased
formation of the xZF1-3/Hmat complex (Fig. 3E). However, we did
not observe an interaction between Siamois- or xWnt11-derived
sequences and xZF1-3 until the competitor was reduced to 10 ng;
under these same conditions the unrelated xTcf3 target oligo also
bound (Fig. 3E). On this basis we conclude that the Siamois- or
xWnt11-derived sequences do not represent specific xKaiso-binding
sites in vitro.
Kaiso preferentially associates with methylated
CpGs rich sequences but not with CTGCNA
sequences in vivo
To validate our in vitro EMSA results we performed a global
analysis of Kaiso-binding sites in human HEK293 cells that were
transiently transfected with either murine or Danio Kaiso expression
plasmids. We sequenced and mapped chromatin-derived DNA
fragments that were bound by these proteins and found a significant
enrichment of CpG-rich sequences in both cases (Fig. 4A,C). A
genome-wide analysis of DNA methylation in HEK293 cells
showed that these CpG sequences bound by Danio and murine
Kaiso are also enriched in methylated CpGs (see Fig. S5A in the
supplementary material; data not shown). By contrast, our analysis
did not detect an enrichment of CTGCNA sites in the chromatin
fraction associated with mKaiso and dKaiso (Fig. 4B,D). These data
do not exclude the possibility that mKaiso binds to a small number
of CTGCNA-containing sequences in vivo but it does suggest that
CTGCNA does not represent a general consensus sequence for
mKaiso binding in vivo. The results are in remarkable agreement
with our EMSA analysis and a ChIP experiment in which we could
not detect any binding of transiently transfected dKaiso or xKaiso at
the Siamois promoter in Xenopus A6 cells (Fig. 4F). By contrast, we
could detect promoter occupancy by both dKaiso and xKaiso at the
methylated distal promoter region of the Oct91 gene in the A6 cell
line (Fig. 4E,F). An additional proof of the inability of xKaiso to
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Fig. 3. xKaiso has no specific affinity for CTGCNA-binding sites in
the Siamois and xWnt 11 promoters. (A) EMSA experiment with the
indicated purified 6xHis-ZF1-3 proteins dKaiso and gKaiso with
methylated Sm probe and CTGCNA-containing probes derived from the
promoter regions of Siamois (Siam) and xWnt11 (Wnt) in the presence
of 2μg pdIC competitor (B) Same experiment as in A but with xKaiso.
(C) Competition experiment with 6xHis-ZF1-3 xKaiso protein under
standard EMSA conditions with the Sm probe but with 200-fold excess
of the following cold competitors: S, Sm, Siamois, xWnt11 and Hmat.
Notice only the Sm and Hmat probes compete effectively. The last lane
is a super-shift experiment in which an anti-His-tag antibody is included
that shifts the 6xHis-Kaiso-specific complex. (D) Competition
experiment as in C, with increasing amounts of cold competitors (2,
20 and 200). The signal quantification using AIDA software is
shown below. Note that the Hmat oligo competes at least 10 times less
efficiently than Sm. (E) EMSA with purified GST fusions of ZF1-3
domains of xKaiso with labelled Hmat, Siamois, xWnt11 and (non-
CTGCNA) TCF3-binding site (TCFbs) probes. A fixed amount of protein
and the indicated decreasing amount of pdIC competitor was used.
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bind the Siamois promoter in vivo comes from luciferase reporter
assays in which the xKaiso zinc fingers are fused to the VP16
activator domain (xKaisoZFVP16). xKaisoZFVP16 cannot activate
transcription from a Siamois reporter (Fig. 4G, upper) but can
activate transcription from a methylated Tex19 reporter 2.7 times
(Fig. 4G, lower). It is important to note that a VP16 fusion with the
xTcf3 DNA-binding HMG domain activated the Siamois-driven
luciferase reporter 5-fold in the same set of experiments (Fig. 4G).
These experiments support the view that xKaiso has a preference
towards methylated DNA and not for the CTGCNA sequence
present in the Siamois promoter.
dKaiso can rescue Kaiso-depleted Xenopus laevis
embryos
The unique DNA-binding and transcriptional repressor specificity
of dKaiso provides us with a perfect tool to test if the ability to bind
methylated DNA is sufficient to rescue xKMO morphants. Although
we previously found that 10 ng morpholino is sufficient to elicit a
phenotype, we injected a high dose (40 ng), as used by Kim and
colleagues, into Xenopus two-cell-stage embryos (Kim et al., 2004;
Ruzov et al., 2004). In xKMO morphants the dorsal lip was less
prominent at stage 10 and by stage 12 there was an extended open
blastopore (see also Fig. 7A). This resulted in gastrulation delay
followed by the characteristic appearance of white apoptopic cells
near the edge of the open blastopore by stage 15 (Fig. 5A, xKMO
and Fig. 7A). This gastrulation phenotype is identical to that
reported by Kim and colleagues (however, they did not report on
later stage phenotypes) with the same morpholino sequence and
dose (Kim et al., 2004) and can be rescued by co-injection of either
xKaiso, dKaiso or hKaiso mRNAs (Fig. 5B) (A.R. and R.R.M.,
unpublished). We found at stage 14 (neurulation) that a high rate of
mortality (80%) occurred in the xKMO morphants compared with
controls (Fig. 5B), and the embryos were developmentally arrested
with, as noted before, a phenotype resembling that of xDnmt1-
depleted embryos (Ruzov et al., 2004; Stancheva and Meehan,
2000). Embryos injected at the two-cell stage with dKaiso RNA and
xKMO increased the proportion of normally gastrulating embryos
(stage 12), from just over 10% to more than 45%. By stage 14
(neurulation) the mortality rate was reduced to 18% compared with
more than 80% for xKMO-only injected embryos (Fig. 5A,B,
xKMO+dKaiso). The presence of dKaiso mRNA enabled nearly
half of the morphants (46%) to successfully complete
gastrulation/neurulation compared with none for the xKMO alone
(Fig. 5B). By tadpole stage, the rate of survival for dKaiso/xKMO-
injected embryos was reduced, but it is notable that a few
phenotypically normal embryos could develop even though the
morpholino was still present (Fig. 5A,B). These rescued embryos
differed in appearance from the few arrested xKMO morphants that
survived to late stages (Fig. 5A). Importantly, the rescuing capacity
of dKaiso mRNA was similar to that observed with wild-type (but
not a DNA-binding mutant) hKaiso mRNA, which binds the Sm and
Hmat sequences (Fig. 5B) (Ruzov et al., 2004). These experiments
strongly suggest that the capacity to bind CTGCNA-containing
sequences is not obligatory for rescuing xKMO-injected embryos;
instead, the ability to bind methylated DNA correlates with the
capacity to rescue early developmental deficits. This observation is
in line with the proposed role of Kaiso as a transcriptional silencer
in pre-MBT embryos (Ruzov et al., 2004). The ability of dKaiso to
rescue the xKMO morphants is incompatible with a model in which
a CTGCNA-binding activity is necessary to target the repression
function of Kaiso to Wnt-signalling target genes (Kim et al., 2004;
Park et al., 2005).
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Fig. 4. Kaiso preferentially interacts with methylated CpGs but
not with CTGCNA sequences in vivo. (A-D) The results of genome-
wide ChIP/sequencing experiments in HEK293 transiently transfected
with mouse Kaiso (mKaiso) and HA-tagged Danio Kaiso (dKaiso-HA).
The ChIPs were performed using anti-mKaisoZF or anti-HA-tag
antibodies with additional controls using preimmune serum (control for
mKaiso ChIP) or anti-HA-tag antibody on non-transfected cells (control
for dKaiso-HA experiment). The DNA obtained in the ChIP was
amplified and 454 sequenced. After initial data filtering all the
remaining sequences were mapped on to the human genome,
susbsequently 1 kb regions in the vicinity of the ChIP sequences were
analysed for the presence of either CpG-rich regions or CTGCNA sites.
The ChIP sequences for both the mKaiso and dKaiso-HA experiments
were enriched in CpG-rich regions in comparison to either to
preimmune serum or anti-HA-tag antibody on non-transfected cells,
respectively (A,C), but not in CTGCNA sites (B,D). The data were
normalised with respect to the genome-wide distribution of CpG rich
regions and CTGCNA sites as shown. (E) Diagram indicating the DNA
methylation status of the Oct 91 distal promoter fragment used for
ChIP in (F) in A6 cells. Filled circles represent methylated, and empty
circles non-methylated, CpGs. (F) ChIP experiment using transiently
transfected Xenopus HA-tagged Kaiso (xKaiso) and T7 tagged Danio
Kaiso (dKaiso) on A6 cells. Both xKaiso and dKaiso bind to the heavily
methylated distal region of the Oct91 gene, but do not show any
detectable binding to the Siamois promoter under the same
experimental conditions. IgG was used as an antibody control. 1/10 and
1/50 of inputs are loaded for the Siamois and Oct91 experiments,
respectively. (G) The xKaiso ZF domain VP16 fusion (xKZF) does not
activate transcription of a Siamois-driven luciferase reporter (S01234)
but does activate transcription from a methylated Tex19 promoter
(Tex19Me). The xTcf3 HMG domain fusion (xTcf3) activates transcription
from the Siamois reporter 5.5 times. A Siamois luciferase reporter
containing mutated xTcf3-binding sites (S0) and an unmethylated Tex19
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Inhibition of apoptosis in KMO embryos results in
their successful gastrulation
xKMO morphants exhibit a developmental delay in closing the
blastopore relative to control morpholino injected or wild-type
embryos and subsequently die during neurulation with all the
hallmarks of apoptosis (Fig. 7A) (Ruzov et al., 2004). We
reasoned that inhibitors of the apoptotic pathway would reduce
the high rates of lethality associated with the high-dose xKMO
morphants. This would allow us to determine whether the
resulting embryos exhibit a phenotype that would be indicative of
ectopic Wnt signalling function. Incubation of wild-type embryos
with the caspase-3 inhibitor, Z-DEVD-FMK, did not interfere
with normal development (Fig. 6A). In high-dose xKMO
morphants, the presence of Z-DEVD-FMK inhibited apoptosis
and allowed up to one-third of embryos to progress through to the
equivalent of tadpole stage (St. 38) (Fig. 6A; see Fig. S6 in the
supplementary material). However, even though these embryos
still underwent developmental delay, they gastrulated successfully
but exhibited a short axis phenotype at later stages with obvious
eye defects (Fig. 6A). We also suppressed the apoptotic effect of
xKaiso depletion by directly inhibiting xp53 function by co-
injecting a well-characterised xp53 morpholino (xp53MO)
(Cordenonsi et al., 2003). The double xKMO/xp53MO morphants
also underwent developmental delay but eventually underwent
blastopore closure (Fig. 6B,C). The survival rate of these double
morphants was high (90%) but none developed normally (Fig. 6C;
see Fig. S6 in the supplementary material). These morphants did
not exhibit an axis duplication phenotype that might be indicative
of hyperactivation of downstream Wnt-signalling target genes
(Tao et al., 2005). More importantly, these experiments imply that
much of the phenotypic defects associated with xKaiso depletion
are associated with a general failure to complete proper
gastrulation/neurulation along with a concomitant activation of a
p53-mediated cell-death pathway.
735RESEARCH ARTICLEKaiso and the Wnt signalling pathway
Fig. 5. dKaiso can rescue Kaiso-depleted Xenopus laevis embryos
to the same extent as its human counterpart. (A) The phenotypes
of uninjected control (n=150), KMO (n=53) and xKMO co-injected with
dKaiso RNA (n=84) embryos (KMO+dKaiso). Development stages are
indicated. FITC image of two pictures are presented as well as an
injection control; arrow indicates neural fold. Notice that even at the
later stage (St. 39), when there are reduced numbers of survivors, the
xKMO morphants are arrested whereas the rescued embryos can form
complete tadpoles or attenuated tadpoles that differ in appearance
from the xKMO morphant. (B) Bar graphs showing the percentages of
normal embryos and embryos with developmental defects in the rescue
experiments using xKMO co-injected with dKaiso or human Kaiso
(hKaiso) RNA. Dead embryos are not included. The stages of
development are indicated.
Fig. 6. Inhibition of apoptosis in KMO embryos results in their
successful gastrulation. (A) The presence of a caspase inhibitor, Z-
DEVD-FMK, prevents apoptosis in xKMO morphants and allows
development to proceed. The rescued embryos can complete
gastrulation but neurulation is impaired and they exhibit development
delay compared to control embryos. Arrows indicate a poorly
developed neural fold in the rescued xKMO morphant at stage 19. The
rescued xKMO morphants do not show evidence of axis duplication
(indicating no hyper β-catenin activation during gastrulation) at stage
38. In addition they exhibit developmental delay and axis defects that
result from poor neurulation. Control embryos incubated with Z-DEVD-
FMK are phenotypically normal. (B,C) Phenotypes of embryos co-
injected with xKMO together with an xp53 morpholino (p53MO) are
presented at stages 15 and 26. Uninjected control embryos are also
shown (C in figures). Note the completion of delayed gastrulation in
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xWnt11 and Siamois are not mis-expressed in
xKMO morphants
As result of our phenotypic analysis and the inability of xZF1-3 to
bind the Siamois and xWnt11 probes, we decided to verify if these
genes were aberrantly expressed in xKMO morphants, as reported
previously (Kim et al., 2004; Park et al., 2005). Although xKMO
embryos are delayed in gastrulation compared to wild-type embryos
(Fig. 7A), we did not observe upregulation of Siamois and xWnt11
levels in xKMO morphants by semi-quantitative RT-PCR (Fig. 7B).
Real-time quantitative RT-PCR suggests that Siamois levels are
actually reduced by 30% in xKMO stage 10 morphants, which may
reflect the developmental lag (Fig. 7A,C). By contrast, there were
no significant differences in xWnt11 levels at the equivalent of stage
12 (Fig. 7C). In the same sets of embryos Caspase-7 and Caspase-9
RNA levels were increased 2.5-3.5 times in stage 10 and 12 xKMO
embryos, respectively, compared with controls, which is in line with
activation of a programmed cell-death pathway (Fig. 7C). We also
used whole-mount RNA in situ analysis to compare the expression
of xWnt11 in wild-type and xKMO pre-MBT embryos. Unlike
previous reports (Kim et al., 2004), we could not find differences in
expression: the maternal xWnt11 transcript was present at similar
levels in both types of embryo (Fig. 7D; see Fig. S7A in the
supplementary material). A control in situ with xID2, identified in a
screen for genes that are mis-expressed in KMO embryos (Ruzov et
al., 2004), confirms that it is upregulated in xKMO morphants
(Fig. 7D; see Fig. S7B in the supplementary material). XWnt11
expression can be induced by the mesoderm-specific transcriptional
activator Xbra (Tada and Smith, 2000), but we have not observed
ectopic induction of Xbra in xKMO embryos, suggesting that
xKaiso depletion does not result in the direct or indirect activation
of xWnt11 (D.S.D., unpublished). We conclude that it is unlikely
that xKaiso strongly influences the expression of xWnt11 and
Siamois either before the MBT or during subsequent gastrulation.
DISCUSSION
We find that the methyl-CpG-binding function of the Kaiso
transcription repressor is highly conserved in three species; by
contrast, the non-methylated Hmat-binding affinity varied from zero
activity and weak binding for dKaiso and xKaiso, respectively, to
levels comparable with methyl-CpG binding for gKaiso. In addition,
our localisation of the Kaiso methyl-CpG-binding domain to ZF1-2
conflicts with previously published work that defined ZF2-3 as
sufficient for both methyl-CpG-dependent and CTGCNA-based
binding (Daniel et al., 2002). This previous observation may be
attributable to differences in the stringency of the DNA-binding
assays employed. However, the evolutionary conservation of the
first two Kaiso ZF domains is in step with the experimental outcome
of our DNA-binding analysis, which indicated that the methyl-CpG
binding function resides in ZF1-2. Two other Kaiso-like proteins
(ZBTB4 and ZBTB38) in mice also have a strong methyl-CpG-
binding function, but only ZBTB4 has a weak affinity for the Hmat
sequence, whereas ZBTB38 does not (Filion et al., 2006). Based on
this, we come to a broad conclusion that the primary DNA-binding
activity of all members of the Kaiso-like family (Kaiso, ZBTB4 and
ZBTB38) is for methyl-CpGs, which can act as ligands in chromatin
for the transcription repression function associated with these
proteins (Filion et al., 2006; Prokhortchouk et al., 2001; Ruzov et
al., 2004). Our global analysis of Kaiso-binding sites in HEK293
cells also supports the view that they are associated with methylated
CpGs and not CTGCNA sites. In addition it has recently been shown
that Kaiso represses methylated tumour suppressor genes and can
bind in a methylation-dependent manner to the CDKN2A gene in
human colon cancer cell lines (Lopes et al., 2008).
The DNA-binding ability of Kaiso is primarily dependent on its
three zinc fingers (ZF1-3), which belong to the C2H2 class. It has
been proposed that each ZF can be regarded as an independent
DNA-binding module, and an additional ZF in an array specifies
three base pairs of adjacent, but discrete, subsites (Choo and Klug,
1997). This would predict a 9 bp binding site for Kaiso if each ZF
bound equally to its respective subsite. An inference of the
requirement for all three ZFs to bind Hmat is that its true recognition
sequence may correspond to a 9 bp sequence and not 6 bp as
previously reported (Daniel et al., 2002). The requirement for ZF1-
2 for binding to the Sm oligo is consistent with a minimum
recognition sequence of 6 bp that contains two methyl-CpGs
(Prokhortchouk et al., 2001). Comparison of the three CTGCNA
substrates used (Hmat, Siamois and xWnt11) shows that they are
RESEARCH ARTICLE Development 136 (5)
Fig. 7. The Wnt signalling pathway is not activated in xKMO
morphants. (A) The xKMO morphants exhibit a delay in closing the
blastopore (short arrows) compared with wild-type embryos. This
phenotype appears in 85-90% of the embryos and is identical to that
presented by McCrea and colleagues (Kim et al., 2004; Park et al.,
2005). By stage 15 (neurulation), the xKMO morphants (downward
arrow) cannot form a neural fold; they are apoptotic and are shedding
cells through the open blastopore. Control embryos are shown with a
proper neural fold (long arrows). (B,C) Neither Siamois nor xWnt11 are
ectopically activated in xKMO morphants when assayed by semi-
quantitative RT-PCR according to Park et al. (Park et al., 2005) or real-
time PCR relative to a histone H4 control at stage 10 (Siamois) or 12
(xWnt11). Caspase7 and Caspase9 expression is activated in 2.5-3.5
times compared to control in the same sets of KMO embryos at stages
10 and 12, respectively. (D) Whole-mount RNA in situ analysis
demonstrates that xWnt11 is not prematurely activated in pre-MBT
xKMO morphants in comparison to a control transcript, xID2, that is
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flanked by distinct sequences that probably account for their
differential binding to gKaiso and xKaiso. Notably, like xKaiso,
gKaiso cannot bind the CTGCNA-containing sequences in the
xWnt11 and Siamois promoter regions (Fig. 3) despite its high
affinity for Hmat. This suggests that the non-methylated binding
ability of gKaiso is restricted to one or a few unique sequences that
have yet to be identified. Our analysis suggests that CTGCNA
sequences in the promoters of Siamois and xWnt11 are not high-
affinity Kaiso-binding sites, which would be incompatible with the
proposed role of xKaiso as a direct repressor of these genes (Park et
al., 2005).
We also show, that like its amphibian counterpart, dKaiso is
essential for early zebrafish development. The phenotypes of
dKMO-injected embryos, the percentages of abnormal embryos and
the developmental stages in which these embryonic defects are
detected resemble those of xKMO-injected Xenopus embryos
(Ruzov et al., 2004). In our previous study we showed that xKaiso
is required for genome-wide transcription silencing in embryos
before the MBT. In zebrafish the MBT begins at cycle 10 and, as in
amphibians, is characterised by cell-cycle lengthening, loss of cell
synchrony, appearance of cell motility and activation of transcription
(Kane and Kimmel, 1993). Noting the similarity of the Danio rerio
and Xenopus Kaiso loss-of-function phenotypes, we can hypothesise
that in both cases mis-regulation of similar mechanisms leads to
close phenotypic abnormalities. Another conclusion from the
comparison of zebrafish and Xenopus KMO embryos and from the
dKaiso ability to rescue the xKMO phenotype, is that the main
phenotypical features of xKMO-injected embryos are not dependent
on CTGCNA-binding ability, which is not conserved between
zebrafish and Xenopus. The observation that mice do not have an
extended period of transcriptional silencing during early
development may partly explain the absence of an embryonic lethal
phenotype in Kaiso null mice (Prokhortchouk et al., 2006). These
mutant mice also do not exhibit mis-regulation of candidate target
genes such as Wnt11.
In parallel with the mouse study, we did not observe the reported
mis-regulation of the Wnt signalling pathway in xKMO stage 8 or
stage 10 morphants. Indeed, inhibition of the cell death pathway in
xKMO morphants by incubation with apoptotic inhibitors does not
uncover any gross axis duplication phenotypes, which is also
indicative that β-catenin signalling is not ectopically activated under
these conditions. A potential role for xKaiso in Wnt signalling was
initially suggested by non-physiological experiments in which
xKaiso and Wnt-signalling components are overexpressed. This is
probably mediated by Kaiso/TCF3 interactions and not via
CTGCNA-binding sites (Kim et al., 2004; Park et al., 2005; Ruzov
et al., 2009). In a companion paper, we demonstrate that xKaiso
interacts directly with TCF3/4 and thereby masks their HMG DNA-
binding domains (Ruzov et al., 2009). As a result, overexpression of
xKaiso inhibits the ability of β-catenin to mediate transcription
activation through xTcf3 by displacing it from a target promoter.
This mode of action can account for the inhibition of dorsal axis
formation when Kaiso mRNA is co-injected with β-catenin mRNA
into the ventral marginal region of four-cell-stage embryos (Park et
al., 2005).
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INTRODUCTION
DNMT1 is a multi-domain protein with an N-terminal regulatory
domain and a C-terminal catalytic domain (Goll and Bestor, 2005).
The enzymatic function of DNMT1 is necessary to maintain and
perpetuate DNA methylation patterns at CpGs laid down by de novo
methyltransferases in response to developmental cues. DNA
methylation in mammals is essential for transcriptional silencing of
transposons, regulation of many imprinted genes and the maintenance
of X-inactivation in female somatic cells (Goll and Bestor, 2005).
Methylated CpG pairs can repress transcription of adjacent genes
either by directly interfering with nuclear factor site recognition or,
indirectly by binding methyl-CpG specific binding proteins (Klose
and Bird, 2006). Altered patterns of gene expression (including
single copy genes, imprinted genes and transposons) occurs in
hypomethylated (dnmt1) mutant mouse embryonic fibroblasts
(Jackson-Grusby et al., 2001). Nonetheless, many tissue-specific gene
promoters are hypo-methylated and are not expressed in early mouse
or Xenopus embryos (Walsh and Bestor, 1999; Stancheva et al., 2002),
implying that additional silencing mechanisms may be operative. A
screen of dnmt1n/n fibroblast cells also noted that a high proportion of
mis-expressed genes are transcribed from CpG-island promoters that
are constitutively unmethylated (Lande-Diner et al., 2007).
A decrease in DNMT1 levels results in early embryonic lethality
in mouse, frog and zebrafish, probably owing to multiple defects,
including activation of a cell death pathway (Li et al., 1992;
Stancheva and Meehan, 2000; Jackson-Grusby et al., 2001;
Stancheva et al., 2001; Rai et al., 2006). Recently a mutant mouse
with a catalytically inactive form of Dnmt1 has been generated that
exhibits a developmental arrest phenotype that is very similar to
those observed for targeted deletion mutants (Takebayashi et al.,
2007). This suggests that the catalytic function of DNMT1 is very
important in early mouse embryogenesis, although undifferentiated
embryonic stem cells are relatively unaffected by loss of DNMT1
activity (Jackson-Grusby et al., 2001; Tsumura et al., 2006). By
contrast, complete inactivation of DNMT1 in human cancer cells
leads to activation of a G2/M checkpoint and mitotic catastrophe
with minimal changes in DNA methylation levels (Chen et al.,
2007). Taken together these studies suggest the reported phenotypes
of DNMT1 depletion in early development and cell lines may reflect
the loss of both its enzymatic and non-enzymatic functions.
Although there is no evidence of global demethylation,
imprinting, or inactivation of sex-specific chromosomes in Xenopus
laevis, we have shown previously that xDnmt1 has an essential
function in maintaining gene silencing prior to zygotic gene
activation at the mid-blastula transition (MBT) in early amphibian
development (Stancheva and Meehan, 2000). However, it was not
clear from this study whether maintenance of gene silencing prior to
the MBT in Xenopus depended on the enzymatic or non-enzymatic
functions of xDnmt1. Here, we show that the silencing function of
xDnmt1 in early amphibian development is independent of its
methyltransferase activity. We report that a partial reduction in
xDnmt1p levels by morpholino (xDMO) injection into Xenopus
laevis embryos results in premature zygotic gene activation without
a concomitant decrease in DNA methylation levels, either globally
or at specific loci. Rescue experiments with an mRNA encoding a
catalytically inactive form of human Dnmt1 (DNMT1) strongly
suggest that DNA methylation is not used as a general silencer of
gene expression in Xenopus embryos. Our data support a model in
which xDnmt1 can regulate embryonic gene silencing directly and
independently of its catalytic function.
MATERIALS AND METHODS
Oligonucleotides and morpholinos
The sequences of the primers and morpholinos used in this study are shown
in Table 1.
Embryo manipulations
Xenopus embryos were handled as described (Ruzov et al., 2004).
Morpholino oligonucleotides against xDnmt1 (xDMO) were
designed and synthesised by GeneTools. Human rescue mRNAs
xDnmt1 regulates transcriptional silencing in pre-MBT
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were synthesised from wild-type or mutant (C1226Y) DNMT1
plasmids (gift from Michael Rountree) using the T3/T7 Capscribe kit
(Boehringer).
TNT
cDNA encoding full-length xDnmt1 was used as a template in coupled in
vitro transcription-translation (TNT, Promega) reactions performed in the
absence or presence of xDMO followed by PAGE.
RT-PCR
RT-PCR was performed as published (Ruzov et al., 2004).
In situ analysis
In situ protocols were performed using standard methods.
Southern blotting
Southern blotting was performed as described (Stancheva and Meehan,
2000). xSatellite I (xSatI) probe was generated by PCR.
Bisulfite sequencing
The bisulfite sequencing protocol has been described previously (Stancheva
et al., 2002).
Promoter cloning
xOct91 and xOct25 promoter regions were cloned from Xenopus laevis
genomic DNA using the DNA Walking Kit (SeeGene, Korea). xOct60
promoter was cloned by synteny PCR and the xOct91 promoter region (–463
to –12) was cloned into SacI/BglII sites of pGL3-Luc basic.
Western blotting
Embryonic extracts were isolated using RIPA buffer and xDnmt1 levels were
detected by immunoblotting with -xDnmt1 antibody 3C6 (Shi et al., 2001).
Mouse cell extracts were prepared and the following antibodies were used:
-T7 (T7-xSp1) (Novagen); -human DNMT1 (NEB); and PCNA
(Abcam). Embryonic histone extracts were prepared by acid extraction and
blotted with the following antisera: panAcH4 (Cell Signalling, 9441S),
H3K9Ac (Abcam, AB4441), H4K5Ac (Upstate, 06-759), PanMethKH3
(Abcam, AB7315), H3K4me3 (Abcam, AB8580), H4K20me3 (Abcam,
AB9053), H3K9me3 (Abcam, AB8898 and H3 (Abcam, AB1791).
GST pull down
Binding reactions for DNA GST pull downs were prepared as for EMSA
(Ruzov et al., 2004). CpGpos oligonucleotide probes were used (Voo et al.,
2000). Reactions were incubated for 10 minutes on a shaker at 30°C, washed
four times with PBS, treated with Proteinase K, extracted and analysed using
PAGE.
Transient transfections and reporter assays
Human 293T cells and mouse N2A cells were cultured using standard
methods. Constructs for reporter assays were transfected into Neuro2A cells
using established methods (Invitrogen). Assays were carried out
independently in quadruplicate.
ChIP analysis
Xenopus A6 cells were transfected with xDnmt1-GFP, pCMVxDnmt1 or
without plasmid DNA. CHIP was performed with a GFP antibody (Abcam).
RESULTS
xDnmt1p reduction causes premature gene
activation
In previous work we used an antisense RNA (AS) strategy to
knockdown xDnmt1p transiently in early embryos; it resulted in
DNA hypomethylation and premature gene activation (Stancheva
and Meehan, 2000). Here, we use highly stable (xDMO)
morpholinos, which inhibit xDnmt1 mRNA translation in vitro and
in vivo (Fig. 1A), and result in a phenotype that is indistinguishable
from antisense RNA depletion. The xDMO morphants develop
normally up to MBT but at gastrulation exhibit an extended open
blastopore, which by neurulation results in the appearance of dead
shedding white cells on the surface of a high proportion (80%) of
embryos (arrows in Fig. 1B and insert) and a failure to form a neural
tube. By tadpole stage, only 2% of the xDMO morphants are
phenotypically normal compared with 91% for controls (see Fig. 3).
This is intriguing as antisense injection results in almost complete
depletion of xDnmt1 in stage 8 pre-MBT embryos (Stancheva and
Meehan, 2000), whereas xDMO injection results in a 40-50%
reduction of xDnmt1 protein (Fig. 1A). Despite this difference, the
phenotypes of the AS and xDMO embryos are virtually
indistinguishable.
Array screens in our laboratory (D.S.D. and R.R.M., unpublished)
indicate that up to 25% of genes in these experiments are mis-
expressed in stage 8 xDMO morphants. We used RT-PCR to verify
the expression of these putative methyl-CpG dependent target genes
in pre-MBT (stage 7-8) embryos (wild type and xDMO morphants).
All tested genes were mis-expressed in xDMO morphants (xCycD1,
xSox17, xMix1, xp68, xDep, xOct91 and xID2) relative to histone
H4 and xOct60 expression (Fig. 1C; see Fig. S1 in the
supplementary material). Whole-mount RNA in situ hybridisation
revealed that ectopic transcripts are present throughout the animal
pole of xDMO stage 8 morphants (Fig. 1D). A control shows equal
expression of the maternal oocyte-specific gene xOct60 between the
two embryo sets. We conclude that the xDnmt1p reduction in
xDMO morphants is sufficient for premature gene activation before
MBT, the induction of apoptosis and phenotypic defects that result
in reduced survival rates. More importantly, premature gene
activation is a general feature of xDMO embryos, implying an
essential global role for xDnmt1p in embryonic gene repression.
xDMO morphants retain normal DNA methylation
at repeat and unique sequences
To determine whether global methylation levels were altered in
xDMO morphants, we tested the dispersed satellite I repeat (xSatI)
by Southern blotting, which is methylated at its two HpaII (CCGG)
sites through development (Stancheva et al., 2002). Genomic DNA
from both wild-type and xDMO siblings showed a comparable
resistance to HpaII digestion either by itself or in double digestion
with HindIII (Fig. 2A). We used bisulphite sequencing analysis to
precisely map CpG methylation at xSatI sequences in wild-type and
xDMO genomic DNA. No hypomethylated CpGs were observed in
xDMO DNA relative to the wild type (Fig. 2B; boxed numbers
indicate % methylation at each CpG). As xSatI is distributed through
the Xenopus genome, this suggests there are no genome-wide
changes in DNA methylation in xDMO morphants.
Subsequent to finding normal methylation patterns in xDMO
repeat DNA, the next issue was to evaluate the methylation profile
of xDMO target genes (xOct91 and xCycD1, Fig. 2C). This analysis
showed that the pattern of methylation at xOct91 and xCycD1
promoters and upstream regions in stage 8 xDMO morphants was
identical to stage 8 wild type (Fig. 2D). xOct91 and xCycD1 are
zygotically activated during normal development after MBT (see
Fig. S2A in the supplementary material) so we compared bisulfite
maps when they are either transcriptionally silent (stage 8) or active
(stage 10). There was no significant difference in CpG methylation
at the xOct91 and xCycD1 loci between the inactive and active
stages (data not shown), indicating that DNA methylation does not
play a direct role in regulating their expression during normal
development. We made similar observations for the xOct25 and
xSox17 promoter regions (data not shown). Together with the
xSatI methylation analysis, this led us to conclude that DNA
methylation is not directly regulating the expression of the xOct91
and xCycD1 loci in xDMO morphants and by extension other genes
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that are misexpressed in stage 8 xDMO embryos. Our data imply
that premature gene activation during Xenopus embryogenesis is
governed by a mechanism independent of DNA modification.
Several studies have identified crosstalk between the DNMT1
proteins and histone modifying enzymes (Fuks, 2005). One
possibility is that premature transcription in xDMO morphants may
be due to global alterations in histone modification states as a
consequence of xDnmt1p depletion. We tested this possibility by
direct comparisons of histone mark abundance levels by
immunoblotting. These experiments revealed no significant
differences for various histone acetylation and histone methylation
marks globally in early (stage 8) or later (stage 15) xDMO
morphants (Fig. 2E). In stage 8 embryos, most histone marks are low
to undetectable and only accrue as development proceeds,
particularly in the case of H3K4me3 (see Fig. S2 in the
supplementary material) and H4K20me3. However, these
experiments cannot completely rule out subtle histone mark changes
at specific gene promoters. Our data imply that neither global
1297RESEARCH ARTICLEDnmt1-mediated repression
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changes in DNA methylation or specific histone modifications are
associated with activation of xDMO target genes in stage 8 embryos,
but rather that high levels of xDnmt1p that are present in early
Xenopus embryos are essential for their repression (Shi et al., 2001).
Dnmt1p catalytic activity is not essential for
repression
To explore the possibility that xDnmt1 may have a non-enzymatic role
in gene silencing, we carried out a series of rescue experiments with
wild-type and mutant forms of human DNMT1 (Fig. 3A). Two-cell
embryos were injected with xDMO alone or in combination with
either wild type or mutant human DNMT1 (hDNMT1C1226Y) mRNA
(which xDMO does not bind), and fixed for whole-mount RNA in situ
analysis. xBF2 and xOct25 were ectopically activated (in agreement
with our array and RT-PCR screens) in xDMO morphants, but the
presence of either wild-type DNMT1 or hDNMT1C1226Y mRNA (1
ng) significantly reduced the extent of activation by up to 50%
as measured by densitometry (Fig. 3B; see Fig. S3B in the
supplementary material). In two further series of experiments, both
types of hDNMT1 mRNAs increased the frequency of phenotypically
normal embryos at stage 15 (neurulation) two-fold (from 20% to more
than 40%), indicating the specificity of the morpholino, but more
importantly that the catalytic function of human DNMT1 is not
required to rescue the xDMO morphant phenotype and re-impose
gene silencing (Fig. 3C,D). A high proportion of rescued embryos do
not show evidence of developmental delay and form neural folds (Fig.
3D, black arrows) equivalent to those seen in wild-type neurula
embryos. Unlike xDMO morphants, the rescued embryos continue to
develop and can form tadpoles at a high frequency (Fig. 3E). The
major conclusion from these developmental studies is that a
catalytically inactive human mRNA can partially restore the normal
transcriptional program and phenotype in Xenopus embryos, thereby
underlining a physiologically relevant non-enzymatic role for
xDnmt1p in gene repression.
xDnmt1p is a transcriptional repressor and can be
localised to target gene promoters
In light of the above data, we sought to explore potential
mechanisms for DNMT1-mediated repression. The N-terminal non-
catalytic region of mammalian DNMT1 is an effective transcription
repressor when artificially recruited to a promoter (Fuks, 2005), and
knockdown of DNMT1 in transformed cells specifically activates
expression of two genes, independently of DNA methylation
(Milutinovic et al., 2004). We hypothesised that if xDnmt1, like its
mammalian counterparts, contained regions that can directly bind
non-methylated DNA, this would enable it to act as a general
repressor of transcription during early Xenopus development
(Chuang et al., 1996; Suetake et al., 2006). We tested three candidate
regions (Fig. 4A, black bars G1-G3) of xDnmt1 as GST fusion
proteins for DNA binding activity in vitro using a pull down assay.
Under the stringent conditions employed, all three GST fusion
proteins bound the CpGpos oligonucleotide (Voo et al., 2000) as
shown in Fig. 4A. Additional experiments suggest that xDnmt1
binding has relaxed sequence specificity (data not shown).
We tested whether xDnmt1 can repress the activation of a
minimum promoter that has four copies of the xSp1-binding site
driving luciferase expression (p4xSp1-Lucif) (Kockar et al., 2001).
Relative induction by xSp1 is reduced by 55% in the presence of
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Fig. 1. xDMO embryos have reduced
xDnmt1 levels, are abnormal and mis-
express genes. (A) Top panel: in vitro inhibition
of xDnmt1 translation (black arrowhead) using
xDMO (compare lanes 2 and 3). Bottom panel:
in vivo inhibition of xDnmt1 translation in pre-
MBT (stage 7-8) embryos (compare wild-type
and xDMO extracts). Tubulin is used as a loading
control. (B) Left panel: phenotypes of stage 15
embryos. Morphant xDMO embryos exhibit
apoptotic lesions (arrowheads and enlargement)
and lack neural folds (black arrow) compared
with control stage 15 embryos. xDMO embryos
contain fluorescein, unlike the control embryo
(compare arrowed embryos). Right panel:
comparison of percentage (n=100) of
successfully neurulating embryos for wild type
and xDMO. (C) xDMO embryos mis-express a
range of transcripts. Wild-type and xDMO RNA
was assayed by RT-PCR over a 10-fold dilution
range (0.1, 0.3 and 1 l cDNA for each sample
indicated by the black triangles). H4 is a loading
control. (D) In situ analysis reveals ectopic
expression of the indicated xDMO targets
throughout the animal pole (compare wild-type
and xDMO panels). The maternally expressed
gene xOct60 is not mis-expressed. Scale bars: 1
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xDnmt1 and both the catalytically active and inactive forms of
human DNMT1 (Fig. 4B), which are expressed equally in transient
transfection assays (Fig. 4C, left panel). Analysis of the raw
luciferase data suggests that as the Dnmt1 dose is increased, p4xSp1
activation is repressed up to 10-fold without affecting cell numbers
(data not shown). However, the expression of the co-transfected
luciferase (Renilla) reporter is concomitantly repressed by fivefold
and results in a normalised value of a twofold (50%) reduction.
Western blot analysis shows that there is no observable difference in
xSp1 levels between cells transfected with a 10-fold difference of
the xDnmt1 expression plasmid (Fig. 4C, right panel). Our data
suggest that untethered DNMT1 can act as a general repressor of
promoters when it is abundant, and that its catalytic activity is
dispensable for this function.
To reflect the xOct91 repression scenario in early development, we
measured the effect of Dnmt1 overexpression on xOct91 promoter
activity. Each form of DNMT1 repressed the activity of the xOct91
reporter construct by ~50% or more relative to the empty vector
control (Fig. 4D). The repressive capacity of hDNMT1C1226Y strongly
indicates that the mechanism of inhibition of these transgenes is
independent of DNA methylation. In addition, repression by DNMT1s
is not relieved by an HDAC inhibitor (TSA) and requires full-length
1299RESEARCH ARTICLEDnmt1-mediated repression
Fig. 2. No changes in DNA methylation at repeat or single copy sequences in xDMO morphants. (A) xDMO DNA is heavily methylated at
xSatI HpaII sites (compare lanes 2 and 4). HpaII is a methyl-sensitive restriction enzyme and MspI is the methylation insensitive (CCGG) counterpart
(lane 5). Right panel: HindIII was used to generate the 750 bp xSatI monomer (black arrow); double digestion with HindIII and HpaII showed no
difference in monomer methylation in the wild-type and xDMO samples (lanes 2-3). (B) Bisulphite sequencing (clones n=40) shows no significant
difference in CpG methylation between wild-type and xDMO genomes at xSatI sequences. Boxed numbers are percentage CpG methylation; black
circles indicate CpG distribution in xSatI. (C) CpG distribution in cloned promoters of xOct91 and xCycD1. Blue bars, CpG; black arrows,
transcription start sites; red bars, regions sequenced. (D) Bisulfite analysis (sequences n=40, ten representative clones are shown) was used to
determine the methylation status of xOct91 (left) and xCycD1 (right) promoters and upstream regions. Numbers above each CpG indicate genomic
position relative to transcription start. Filled circles, methylated CpGs; empty circles, non-methylated CpGs. (E) Immunoblot analysis of wild-type
and xDMO histones shows no significant change in various histone modification marks between histone WT and xDMO extracts at stages 8 and 15.
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forms of the protein for efficient silencing and xDMO rescue (J.A.H.,
A.R. and R.R.M., unpublished). We conclude that DNMT1 can act as
a general repressor of non-methylated promoters and that its catalytic
activity is not required for this function.
As a putative repressor of gene expression and possessing DNA
affinity, we hypothesised that xDnmt1 should bind the loci it
regulates. We were unable to perform ChIP assays against
endogenous xDnmt1 using monoclonal antibodies as they were
sensitive to formaldehyde crosslinking (D.S.D., unpublished). We
performed ChIP with Xenopus laevis A6 cells that were transfected
with a GFP-xDnmt1 expression construct and an anti-GFP
polyclonal antibody. This analysis localised GFP-xDnmt1 to the
xOct25 and xCycD1 non-methylated promoters in A6 cells (Fig.
4E,F) but not to an intronic region of the constitutively active
Xenopus -Tubulin gene. Enrichment of GFP-xDnmt1 at non-
methylated, non-expressed loci (xDMO target genes) is consistent
with a model in which xDnmt1p can bind and repress gene
expression independently of DNA methylation during development.
DISCUSSION
Our experiments and recent reports both suggest that DNMT1 has
an essential role in early amphibian and mouse development
(Takebayashi et al., 2007). Mutant mice expressing a DNMT1 point-
mutant protein lacking catalytic activity (DNMT1-C1229S) fail to
develop, arrest after gastrulation (E9.5) with a near-complete loss of
DNA methylation and mis-express normally methylated genes with
phenotypes very similar to those of the dnmt1c/c mutant (Lei et al.,
1996; Takebayashi et al., 2007). This indicates that the catalytic
function of Dnmt1 is required to support early mouse
embryogenesis, probably owing to the many developmental
processes, including X-chromosome inactivation, suppression of
retrotransposon activity, imprinting and regulation of germ-cell
specific gene expression, that are dependent on DNA methylation
(Goll and Bestor, 2005; Maatouk et al., 2006). By contrast, Xenopus
laevis lacks imprinting and processes equivalent to X-inactivation,
which may underlie its non-dependence on DNA methylation in
early development. Additionally primordial germ cell development
is specified by different mechanisms in amphibians and mammals
(Crother et al., 2007). Our work suggests that the intrinsic repression
function of xDnmt1p has been used to maintain gene silencing in
pre-MBT embryos until co-ordinated and precise zygotic activation
occurs at multiple gene loci. This period of gene silencing over 11
cell divisions is not observed during mouse embryogenesis (Meehan
et al., 2005) and implies distinct regulatory mechanisms for zygotic
gene activation are used between mice and frogs.
Zygotic activation of gene expression during early Xenopus
development is mainly dictated by maternal inheritance of repressor
and activator components (Veenstra, 2002). A two-cell Xenopus
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Fig. 3. A catalytically inactive form of human
DNMT1 can restore repression and rescue xDMO
morphants. (A) Functional domains present in human
DNMT1 and an inactivating point mutation of
hDNMT1 (hDNMT1C1226Y) (Jair et al., 2006).
(B) Catalytic function of human DNMT1 is not
required to rescue xOct25 and xBF2 gene repression.
Compare rescue in situ intensities (iii and iv) with
signals in control (i) and xDMO morphants (ii). Animal
pole views are shown. (C) hDNMT1WT and
hDNMT1C1226Y restore normal Xenopus neurulation
with comparable efficiency. Experiment 1 (n=100) is in
red and experiment 2 (n=60) is in blue. Compare
number of normally neurulating embryos in xDMO
only (~20%) with rescued injected embryos (>40%).
(D) Rescued embryos are similar in phenotype to wild-
type siblings. Neurulating embryos are shown. There
are apoptotic cells and open blastopores (white
arrowheads) in xDMO embryos (bottom left). Such
lesions are absent in rescued embryos (right panels),
which are similar to control injected embryos (top left)
(black arrows indicate neural folds). (E) Phenotypes of
late stage (stage 27) embryos. Only 2% (i.e. 98% of
embryos fail) of xDMO morphants develop to late
tadpole stage (stage 27) compared with 35% and
30% for wild-type (hDNMT1WT) and mutant
(hDNMT1C1226Y) rescued embryos, which develop
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embryo contains up to 100 ng of histones and 10 ng of xDnmt1 (Shi
et al., 2001; Veenstra, 2002), which together impose dominant
repression of transcription. At MBT, virtually all of the free histone
pool has been depleted and we hypothesize that transcription
repression is now sensitive to xDnmt1 protein levels. Radioactive
labelling experiments and successful depletion by antisense RNA and
morpholinos suggest that continuous translation is required to
maintain high xDnmt1p levels in oocytes and embryos (Kimura et al.,
1999). The rate of transcription per cell increases ~200-fold when
xDnmt1p levels are reduced to approximately 2 pg/cell in normal
embryos (Newport and Kirschner, 1982a; Hashimoto et al., 2003). In
xDMO morphants, a 40-50% reduction in xDnmt1p before the MBT
is sufficient to allow the low level of general transcription machinery
components that are present, such as RNA Pol I, Pol II and TBP, to
dramatically activate a generalised pattern of gene expression
approximately two cell cycles earlier than normal. However, this
pattern of gene activation does not equate with a normal
transcriptional activation profile as the spectrum of genes that are mis-
expressed in xDMO morphants (and antisense-depleted embryos) is
much greater, as measured by cDNA library screens and array analysis
(D.S.D. and R.R.M., unpublished). This suggests that the
transcriptional competence of normal late blastula/early gastrula
embryos is crucially dependent on the non-catalytic and catalytic
silencing function of xDnmt1. In general, transcription at MBT occurs
before histone modifications, such as H3K4M3 (Fig. 2E) or H4
acetylation, accumulate (Almouzni et al., 1994). This may explain
why we do not observe an accumulation of histone modifications in
pre-MBT xDMO morphants. It is possible that changes in histone
modifications during Xenopus development are linked with a dynamic
alteration in the organization of different chromatin domains that
occurs after the MBT when gene-specific subdomains are set up
(Vassetzky et al., 2000).
By depleting xDnmt1p in stage 8 embryos, we propose that this
interferes with its non-catalytic repression function, which is
crucially dependent on its high abundance in early Xenopus
embryos. Some developmentally decisive genes, such as xBra,
remain silenced unless DNA hypomethylation also occurs (see Fig.
S4 in the supplementary material). In this instance, we suggest that
xBra must represent a minor class of genes that are regulated directly
by DNA methylation, as the extent of transcription activation in
antisense and xDMO stage 8 embryos is essentially equivalent (data
not shown). A generalised interpretation of the data is that repression
by xDnmt1 in vivo is bimodal. In early development, xDnmt1
functions as a maintenance methyltransferase to perpetuate patterns
of DNA methylation globally and at distinct loci (xBra). At these
loci, silencing is dependent on the catalytic function of Dnmt1 and
potential interpretation of the methyl-CpG mark. However, our data
suggest that xDnmt1p may also act as a direct titratable repressor
component at multiple loci that has been previously hypothesised to
be present in Xenopus embryos (Newport and Kirschner, 1982b).
1301RESEARCH ARTICLEDnmt1-mediated repression
Fig. 4. Dnmt1 represses activation of non-
methylated transgenes in vivo and xDnmt1
localises to non-methylated target genes. (A) N-
terminal xDnmt1 fusions bind dsDNA oligos. The
domain structure of xDnmt1 (top). xDnmt1-Gst
fusions domains G1-G3 (black bars). CpGpos
oligonucleotides were used in pull-down assays with
the three Gst fusions and Gst only. All three
constructs bound CpGpos compared with the Gst
protein (G) lane. (B) In vivo assays to test the
repression activities of xDnmt1, hDNMT1WT and
hDNMT1C1226Y. Exogenous xSp1 was used to activate
the Sp1-Luc reporter in the presence of increasing
amounts of Dnmt1 [black triangles; 0.125-2 g
plasmid DNA per transfection]. xSp1 activation of the
reporter alone was assigned 100%. Data were
obtained from nine independent assays and
normalised to TK-Renilla. (C) Left panel: both forms
of human DNMT1 (hDNMT1WT  and hDNMT1C1226Y)
are expressed equally after transfection into 293T
cells relative to PCNA and endogenous hDNMT1
(–plasmid). Right panel: N2A cells were transfected
with T7xSp1 against low or high xDnmt1 levels (black
bar), cell extracts were blotted with -T7. Tubulin
was used as a loading control. (D) An xOct91
promoter (–111 to +343) reporter construct is
repressed by co-transfection with 500 ng of xDnmt1,
hDNMT1WT and hDNMT1C1226Y but not by the
empty vector control. (E) Chromatin IP (ChIP) analysis
shows recruitment of GFP-xDnmt1 to the non-
methylated xOct25 and xCycD1 promoters, but not
an -tubulin intron in A6 cells. Note the enrichment
of GFP-xDnmt1 at both promoters using -GFP (lane
2) but not the control xDnmt1 lacking GFP (panel
xDnmt1). Lane 1, input (1/20 used in IP); –ve, no
antibody control. (F) Bar chart shows fold enrichment
of GFP-xDnmt1 at the xOct25 (eightfold) and xCycD1
(4.5-fold) promoters compared with a non-tagged
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It is possible that mammalian DNMT1 also has multiple silencing
functions because screens of mis-expressed genes in Dnmt1–/–, Trp53–/–
MEFs indicate that a high proportion (up to 80%) of mis-expressed
genes have CpG island promoters, which would be predicted to be
methylation free at all times (Jackson-Grusby et al., 2001; Lande-Diner
et al., 2007). Similar to our xDMO targets, it is highly possible that
these genes are inhibited through direct action of the Dnmt1 protein at
promoters, hinting at conservation of non-methyl dependent functions.
Recent work demonstrates that complete inactivation of DNMT1
function in human cancer cells results in cell death (Chen et al., 2007),
but this decrease in viability occurs with minimal changes in global
DNA methylation. This observation supports the hypothesis that
DNMT1 possesses essential functions independent of its role as a
maintenance methyltransferase, and links its absence with activation
of a cellular checkpoint response. Unlike the situation in tumour cells
(Spada et al., 2007), limited reduction in xDnmt1p levels appears to be
sufficient to activate a cell death program in Xenopus embryos. The
pathway that mediates activation of apoptosis in DNMT1-deficient
cells is dependent on TRP53 function, but the activating signal has yet
to be identified (Jackson-Grusby et al., 2001; Stancheva et al., 2001).
It has also been observed that undifferentiated Dnmt1c/c ES cells have
a growth advantage compared with wild-type controls, but this
advantage was lost in the presence of a normal or mutant (C1229S)
DNMT1 mini-genes (Damelin and Bestor, 2007). These observations
support multifunctional non-enzymatic roles for DNMT1 in
development, cellular differentiation and cancer.
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